data_1ba9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ba9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.45 -1.041 0 N-CA-C 109.102 -1.153 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 N-CA-C 111.209 -0.343 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.493 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.493 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.455 -0.772 0 CA-C-O 120.953 0.314 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 43' ' ' HIS . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 110.736 -0.524 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.448 0.642 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.42 HD23 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.42 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.373 0.489 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.476 HD22 ' CB ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.476 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' HZ3' ' C ' ' A' ' 153' ' ' GLN . 1.3 ptpt . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.449 -1.109 0 N-CA-C 109.64 -0.946 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.551 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 110.051 -0.788 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.45 -1.087 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.454 -0.85 0 CA-C-O 121.397 0.499 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.423 HD21 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 N-CA-C 109.647 -0.944 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 CA-C-O 121.449 0.521 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.442 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.442 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.442 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.442 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 N-CA-C 110.85 -0.481 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HG ' ' CE1' ' A' ' 43' ' ' HIS . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.424 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.449 -1.091 0 CA-C-O 121.552 0.563 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 . . . . . 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.449 -1.105 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.023 -1.184 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 112' ' ' ILE . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 N--CA 1.448 -1.173 0 N-CA-C 109.413 -1.034 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 131' ' ' ASN . 0.1 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 N--CA 1.442 -1.526 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.462 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.462 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.451 -0.974 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 122.229 0.845 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.447 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' CD ' ' HZ2' ' A' ' 122' ' ' LYS . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HZ2' ' CD ' ' A' ' 121' ' ' GLU . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 133' ' ' GLN . 1.3 t30 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.485 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.434 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 N--CA 1.45 -1.078 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 121.432 0.513 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.432 ' HE ' ' CD1' ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.432 ' CD1' ' HE ' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 6.9 ptpt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 27.8 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 111.023 -0.414 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.412 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.1 m-70 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.641 -0.561 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.41 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.5 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.408 ' C ' HE21 ' A' ' 133' ' ' GLN . 0.0 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.41 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 121.292 0.455 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.45 -1.067 0 N-CA-C 109.699 -0.923 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' HZ2' ' A' ' 136' ' ' LYS . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HZ2' ' CD ' ' A' ' 132' ' ' GLU . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 N--CA 1.454 -0.828 0 N-CA-C 109.09 -1.158 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.428 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.428 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.473 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 N-CA-C 110.786 -0.505 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 CA-C-O 121.496 0.54 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 110.783 -0.506 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 CA-C-O 122.667 1.028 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 120.454 0.169 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 110.875 -0.471 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 N-CA-C 110.783 -0.507 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.401 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.024 0.44 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 N-CA-C 111.377 -0.278 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.444 -1.438 0 N-CA-C 109.81 -0.881 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.449 HD22 ' CB ' ' A' ' 133' ' ' GLN . 1.8 t30 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.449 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.419 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 N-CA-C 109.569 -0.973 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.448 -1.152 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.492 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.445 -1.359 0 CA-C-O 120.8 0.25 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.425 HD22 ' CB ' ' A' ' 133' ' ' GLN . 0.1 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.425 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 31' ' ' VAL . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.45 -1.059 0 N-CA-C 109.657 -0.94 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 109.987 -0.813 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 109.712 -0.919 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.705 0.627 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 109.018 -1.185 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 122.112 3.851 . . . . 0.0 122.112 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.51 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.51 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.48 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 111.396 -0.271 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 CA-C-O 121.251 0.438 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 118.545 -0.741 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 131' ' ' ASN . 0.1 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.407 . . . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -99.76 13.56 33.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.979 0.809 . . . . 0.0 111.792 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.39 88.98 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.538 1.135 . . . . 0.0 109.585 -173.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -123.73 124.69 43.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -112.32 -65.86 1.14 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.432 1.093 . . . . 0.0 108.801 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 tttp 66.66 -60.99 0.33 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.12 1.368 . . . . 0.0 112.081 -166.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -77.66 137.15 38.37 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.239 1.016 . . . . 0.0 110.654 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -53.67 -42.6 68.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.445 -0.784 . . . . 0.0 112.065 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -133.34 34.4 3.52 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.348 0.659 . . . . 0.0 110.682 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.05 174.69 27.84 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 118.77 5.81 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.391 2.727 . . . . 0.0 109.102 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -34.05 -82.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -148.93 -178.37 6.32 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.41 68.64 2.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.554 1.142 . . . . 0.0 108.571 -170.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.75 84.48 1.94 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.799 1.639 . . . . 0.0 110.546 -165.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -51.91 -43.36 63.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.59 1.156 . . . . 0.0 112.262 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -53.65 -23.41 11.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.91 -13.45 62.44 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.51 -86.62 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 118.889 0.768 . . . . 0.0 112.884 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.7 p -70.96 179.27 2.79 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -35.03 -38.75 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.982 1.713 . . . . 0.0 113.499 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -168.2 125.71 1.11 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.675 1.19 . . . . 0.0 110.532 163.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.67 74.22 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.26 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.28 -178.68 0.58 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.434 1.492 . . . . 0.0 111.161 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.82 167.75 20.48 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 CA-C-N 120.279 2.04 . . . . 0.0 111.209 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.493 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 66.92 -4.33 0.81 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.69 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 107.224 -168.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.5 -165.48 30.01 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 105.95 -2.86 . . . . 0.0 105.95 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.96 -53.45 12.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.247 1.419 . . . . 0.0 109.993 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -94.52 45.57 1.13 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.493 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.345 . . . . . . . 0 C--O 1.242 0.677 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.1 p -54.66 136.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 160.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 132.34 54.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 165.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.74 126.67 55.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -91.26 -54.64 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.108 0.963 . . . . 0.0 108.408 174.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 tttt 74.25 -58.64 0.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 110.615 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -113.69 113.41 24.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.823 1.649 . . . . 0.0 109.554 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -46.61 -34.3 4.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.804 1.642 . . . . 0.0 112.762 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.932 0.893 . . . . 0.0 111.365 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.79 179.76 16.7 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.83 131.67 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.369 2.713 . . . . 0.0 111.61 -169.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 43' ' ' HIS . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.41 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CZ ' HD23 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -153.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 69.11 -62.82 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.379 1.872 . . . . 0.0 110.296 -168.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 69.0 154.18 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.573 1.949 . . . . 0.0 110.168 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.9 t0 8.5 73.2 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.496 2.318 . . . . 0.0 115.782 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.33 -41.31 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.259 0.623 . . . . 0.0 111.794 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.0 t -75.52 50.2 0.52 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.042 0.937 . . . . 0.0 112.282 -174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.73 10.59 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 126.027 1.731 . . . . 0.0 112.505 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.1 52.83 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.85 18.31 7.28 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.731 0.813 . . . . 0.0 112.197 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -71.59 -75.45 0.13 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.31 1.844 . . . . 0.0 113.207 -163.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -36.3 70.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.457 1.103 . . . . 0.0 111.503 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.68 52.07 5.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.999 0.92 . . . . 0.0 111.076 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.79 142.54 12.21 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.02 174.28 9.97 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 119.056 1.428 . . . . 0.0 110.736 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 107' ' ' SER . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -23.83 0.2 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 105' ' ' SER . 1.4 p -169.0 89.11 0.2 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 106.184 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 165.64 -142.38 7.65 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -67.67 -59.47 3.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -84.26 48.57 1.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.403 -0.811 . . . . 0.0 111.237 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.42 HD23 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.42 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.358 . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 117.224 -1.369 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -77.67 57.72 1.68 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.383 1.447 . . . . 0.0 111.203 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -159.3 78.0 0.72 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.714 2.006 . . . . 0.0 106.093 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.37 145.91 46.69 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -166.96 -67.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.357 1.463 . . . . 0.0 111.711 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 67.45 -52.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.766 2.026 . . . . 0.0 112.731 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -70.32 142.83 52.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.341 1.056 . . . . 0.0 110.028 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -56.86 -42.65 80.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.532 0.333 . . . . 0.0 110.772 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -136.8 21.55 3.08 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.152 1.381 . . . . 0.0 110.354 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.5 172.32 44.65 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.92 134.8 51.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.895 2.396 . . . . 0.0 110.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.33 172.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 80.65 168.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.079 2.151 . . . . 0.0 111.161 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.37 -103.08 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.696 2.398 . . . . 0.0 106.129 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -80.16 78.9 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.427 -0.796 . . . . 0.0 110.581 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -162.18 -40.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.167 0.587 . . . . 0.0 112.212 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -75.2 46.43 0.32 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.725 1.61 . . . . 0.0 113.041 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.73 -41.61 3.23 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.785 2.034 . . . . 0.0 113.153 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.0 51.43 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 32.61 17.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 m -66.09 -66.26 0.57 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.441 1.096 . . . . 0.0 112.059 -168.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 p -78.2 -59.14 2.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.633 1.173 . . . . 0.0 107.901 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.99 66.1 1.3 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.821 1.248 . . . . 0.0 109.991 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.34 160.82 5.84 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.28 -171.05 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.72 1.613 . . . . 0.0 111.456 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.515 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.15 43.52 1.06 Allowed 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 p -175.29 169.49 3.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.707 1.603 . . . . 0.0 107.104 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.1 -152.99 46.06 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -85.04 -10.11 57.29 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.333 0.587 . . . . 0.0 111.689 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -13.62 31.19 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.476 HD22 ' CB ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.476 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -53.11 112.37 0.85 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.687 0.676 . . . . 0.0 109.71 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' HZ3' ' C ' ' A' ' 153' ' ' GLN . 1.3 ptpt -129.8 143.56 50.87 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.707 1.603 . . . . 0.0 110.436 -174.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.18 148.67 43.36 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -117.72 -63.58 1.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.906 1.283 . . . . 0.0 109.035 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 71.29 -50.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.958 1.703 . . . . 0.0 112.235 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.15 -11.31 19.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.372 1.469 . . . . 0.0 112.817 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.21 -58.61 0.54 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.671 1.588 . . . . 0.0 110.749 -168.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -125.89 37.93 4.25 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.469 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.35 -159.91 13.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.759 0.695 . . . . 0.0 111.508 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.2 119.19 5.49 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.218 2.612 . . . . 0.0 109.64 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.58 113.31 17.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 164.5 -47.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.603 2.761 . . . . 0.0 108.872 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 68.69 -68.01 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.266 1.426 . . . . 0.0 110.823 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -61.99 101.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.832 0.853 . . . . 0.0 111.732 -168.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -80.77 42.88 0.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.936 -1.102 . . . . 0.0 112.625 -169.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 49.6 p -56.11 -42.07 76.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.578 1.551 . . . . 0.0 112.419 -169.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -15.0 8.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.461 1.104 . . . . 0.0 113.072 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.04 51.88 1.05 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.75 32.93 22.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.558 0.743 . . . . 0.0 111.303 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 m -135.86 157.07 47.75 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.646 2.379 . . . . 0.0 105.903 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m 60.46 -79.56 0.02 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.894 0.878 . . . . 0.0 110.777 -169.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 45.8 -137.33 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -155.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.64 177.73 17.28 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 167.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.25 -174.07 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.708 2.939 . . . . 0.0 110.998 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.17 29.71 4.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 m -76.76 -135.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.352 1.061 . . . . 0.0 112.702 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.93 -73.94 0.9 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.89 -58.86 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.341 1.067 . . . . 0.0 109.936 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -73.19 -13.83 61.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.551 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.46 ' N ' ' OE2' ' A' ' 21' ' ' GLU . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.5 m 57.16 51.16 10.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.698 0.761 . . . . 0.0 110.631 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -75.61 156.98 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 1' ' ' ALA . 41.8 tt0 -103.21 138.42 40.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -126.02 -47.83 1.63 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.566 0.541 . . . . 0.0 111.04 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 67.91 -60.89 0.39 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.988 1.715 . . . . 0.0 110.859 -168.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.63 -22.97 60.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.375 1.07 . . . . 0.0 111.653 -165.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 74.31 -36.52 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.331 1.452 . . . . 0.0 111.681 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.05 -8.43 19.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.376 1.87 . . . . 0.0 112.205 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.33 -174.01 34.14 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.202 0.906 . . . . 0.0 112.144 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.17 118.64 5.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.251 1.967 . . . . 0.0 110.051 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -162.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 63.7 -175.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.179 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.41 -53.73 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.504 1.522 . . . . 0.0 109.151 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.52 89.17 1.54 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.127 0.971 . . . . 0.0 108.645 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -161.88 -47.66 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.028 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -69.43 65.82 0.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.407 1.083 . . . . 0.0 110.893 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.63 -29.5 17.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 0.0 112.398 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.54 -108.17 0.2 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.0 t -178.07 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.67 1.188 . . . . 0.0 110.717 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.5 m -51.64 136.81 26.22 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.925 -0.484 . . . . 0.0 110.118 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 68.2 -72.92 0.09 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.825 1.25 . . . . 0.0 109.448 -170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.47 18.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.558 1.143 . . . . 0.0 110.818 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.11 142.44 0.53 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.46 175.45 5.99 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-N 119.789 1.795 . . . . 0.0 109.193 166.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.32 -13.52 58.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.4 m -70.16 141.72 52.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.827 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.59 146.19 0.16 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.779 1.181 . . . . 0.0 112.692 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.0 t70 78.76 -61.75 0.34 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.348 1.859 . . . . 0.0 110.495 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -77.06 -23.36 52.01 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.448 . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -139.99 39.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.946 0.779 . . . . 0.0 109.806 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -77.13 101.42 6.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -144.03 145.23 32.06 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -109.77 -42.25 4.31 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.641 1.176 . . . . 0.0 110.323 172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 74.49 -49.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.064 1.346 . . . . 0.0 111.51 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.89 176.73 8.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.264 0.938 . . . . 0.0 110.447 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 m -99.94 -6.77 26.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.166 1.387 . . . . 0.0 111.901 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.01 34.04 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.713 -0.617 . . . . 0.0 111.02 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.63 177.81 22.94 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 142.84 48.46 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.809 2.339 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -76.77 68.25 2.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -148.3 177.39 9.46 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 109.719 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -139.97 -66.67 0.45 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.002 1.721 . . . . 0.0 110.245 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.76 90.24 3.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.029 0.931 . . . . 0.0 110.556 -173.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.39 46.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.6 0.76 . . . . 0.0 112.353 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p -59.41 -30.56 68.54 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.293 1.437 . . . . 0.0 112.039 -168.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.26 -17.82 5.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.923 1.289 . . . . 0.0 113.97 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 62.97 1.78 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m 45.05 28.23 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.342 2.257 . . . . 0.0 114.297 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -98.6 -66.6 0.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.472 1.109 . . . . 0.0 108.878 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -85.25 0.04 OUTLIER 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 52.06 -143.31 0.69 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -168.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.46 168.92 30.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.4 -177.99 3.93 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.31 2.673 . . . . 0.0 111.068 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.26 19.59 12.85 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -173.71 178.24 2.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.323 1.849 . . . . 0.0 106.3 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.13 56.02 9.6 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.36 -60.49 0.32 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 127.006 2.123 . . . . 0.0 112.338 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -73.74 42.49 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.468 1.507 . . . . 0.0 112.298 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.423 HD21 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.354 . . . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 68.02 -147.89 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.616 1.098 . . . . 0.0 112.224 150.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.46 127.34 18.27 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.547 1.939 . . . . 0.0 108.982 -173.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.52 143.57 45.94 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -128.76 -55.04 1.22 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.851 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttm 70.25 -53.14 0.64 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.632 1.173 . . . . 0.0 112.729 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -78.49 144.41 35.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.661 1.184 . . . . 0.0 108.834 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -59.24 -51.87 68.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.481 0.712 . . . . 0.0 109.554 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -126.25 38.31 4.16 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.153 0.981 . . . . 0.0 109.901 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.36 171.98 18.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 128.74 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.523 2.149 . . . . 0.0 109.647 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.61 -24.07 66.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -48.4 -45.88 36.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.764 0.826 . . . . 0.0 113.012 -178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 51.22 -133.48 1.76 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.989 1.315 . . . . 0.0 108.062 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.3 86.0 6.73 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.083 0.953 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.27 -51.59 0.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.7 t -76.43 63.9 2.07 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.616 -0.678 . . . . 0.0 109.554 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.18 -45.48 22.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.18 0.992 . . . . 0.0 111.23 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.49 118.51 4.74 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 161.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.6 m -63.73 106.35 0.97 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.5 m -149.21 -68.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 m -58.46 -49.37 77.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.06 66.12 1.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.24 1.016 . . . . 0.0 109.853 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -40.12 149.12 0.16 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 128.509 2.957 . . . . 0.0 112.105 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.06 176.69 4.3 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 CA-C-N 118.232 1.016 . . . . 0.0 111.562 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.98 25.19 10.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 p -110.94 154.78 23.62 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.546 1.938 . . . . 0.0 108.842 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -27.09 -56.73 0.09 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.237 1.875 . . . . 0.0 112.092 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.71 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.085 2.954 . . . . 0.0 114.976 169.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -117.45 12.0 14.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.442 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.442 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.398 . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 117.071 -1.442 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -158.66 -172.01 3.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.512 1.525 . . . . 0.0 108.119 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -129.08 148.22 51.01 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.75 0.82 . . . . 0.0 112.321 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.34 126.42 33.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -90.44 -66.77 0.9 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 170.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.8 -49.03 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.593 1.557 . . . . 0.0 112.702 -170.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -73.03 -7.97 53.64 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.995 1.318 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.05 -50.43 0.66 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.431 1.492 . . . . 0.0 111.896 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.93 41.93 1.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.298 0.639 . . . . 0.0 109.331 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.92 -170.33 11.85 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.46 130.01 35.34 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.148 2.565 . . . . 0.0 110.85 -166.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HG ' ' CE1' ' A' ' 43' ' ' HIS . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.424 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.464 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -150.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.318 2.8 pp20? 37.07 -143.71 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 164.85 -82.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.879 3.672 . . . . 0.0 106.74 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -77.55 77.1 4.07 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.411 -0.805 . . . . 0.0 110.796 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -158.1 -42.53 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.545 1.138 . . . . 0.0 111.219 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -73.68 51.05 0.35 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.35 -38.14 40.6 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.362 1.065 . . . . 0.0 111.922 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.9 0.95 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.132 0.872 . . . . 0.0 111.115 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -55.23 0.68 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.817 1.647 . . . . 0.0 112.439 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -53.3 154.5 3.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.977 1.311 . . . . 0.0 110.078 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m 83.76 4.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.698 1.999 . . . . 0.0 112.168 -173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 117.69 7.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 176.87 24.29 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.53 -179.3 3.15 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.955 1.77 . . . . 0.0 112.541 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.71 31.65 5.3 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 p -151.92 155.53 38.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.376 1.07 . . . . 0.0 108.905 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.97 -167.84 3.24 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -171.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.8 -16.78 30.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 122.066 -0.667 . . . . 0.0 112.332 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.12 -7.66 53.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.464 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 t -63.76 156.42 27.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.33 0.968 . . . . 0.0 109.147 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -157.42 117.8 3.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -138.72 147.15 42.36 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -99.26 -56.58 2.37 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.301 1.041 . . . . 0.0 109.622 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? 73.13 -52.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.16 114.38 28.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.44 1.096 . . . . 0.0 110.594 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -47.5 -31.44 4.27 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -124.7 32.61 5.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.339 0.518 . . . . 0.0 111.166 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.49 -179.66 21.05 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.84 0.733 . . . . 0.0 112.755 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.11 143.46 20.25 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.435 2.757 . . . . 0.0 109.228 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -74.52 70.67 1.79 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -150.66 -179.95 7.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.733 0.813 . . . . 0.0 109.635 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.41 -73.86 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 125.941 2.026 . . . . 0.0 109.077 171.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.75 13.83 27.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 112.732 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.83 52.96 12.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.629 1.572 . . . . 0.0 110.151 -176.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.6 p -45.3 -35.71 3.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -165.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.1 -14.89 41.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 48.43 1.59 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.084 1.326 . . . . 0.0 111.624 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.05 12.91 8.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.436 1.094 . . . . 0.0 112.971 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -96.76 -59.9 1.71 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 126.879 2.071 . . . . 0.0 111.09 -168.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.39 88.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.503 2.321 . . . . 0.0 108.075 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.0 -88.4 0.24 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 160.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.32 125.29 31.41 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.63 -174.16 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.343 1.571 . . . . 0.0 109.023 165.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 112' ' ' ILE . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -97.29 10.21 40.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.46 6.73 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 123.878 0.871 . . . . 0.0 110.098 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.91 -84.18 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.578 1.085 . . . . 0.0 114.371 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.84 -26.64 60.7 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.292 0.568 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -58.05 -48.78 79.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.4 ' CG2' ' HB ' ' A' ' 104' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.482 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.405 . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -152.64 69.66 0.87 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 149.01 41.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 167.75 9.92 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -152.87 -43.81 0.1 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.098 0.559 . . . . 0.0 110.233 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.17 -50.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.87 1.668 . . . . 0.0 110.89 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -77.47 -17.7 57.8 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.802 1.241 . . . . 0.0 112.814 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 74.94 -39.87 0.42 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.027 0.831 . . . . 0.0 111.734 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -127.46 33.46 4.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.918 -1.114 . . . . 0.0 111.049 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.23 -164.64 13.93 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.63 1.11 . . . . 0.0 111.339 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.49 134.02 34.29 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.47 2.113 . . . . 0.0 109.435 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.447 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.66 63.03 1.09 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -131.24 173.48 11.01 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.968 1.307 . . . . 0.0 108.957 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.74 101.95 1.03 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.141 2.576 . . . . 0.0 104.776 168.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 t0 29.85 66.78 0.11 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.71 2.004 . . . . 0.0 114.515 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 -54.61 0.67 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.04 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -69.64 67.06 0.23 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.103 0.865 . . . . 0.0 112.015 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.1 66.56 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.544 -1.347 . . . . 0.0 111.595 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.89 -8.41 73.11 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.998 -0.335 . . . . 0.0 113.057 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.5 t 41.09 45.71 2.39 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.854 2.462 . . . . 0.0 114.141 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -80.48 -60.34 2.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.049 0.54 . . . . 0.0 111.04 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.6 p 176.45 51.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.8 -1.188 . . . . 0.0 110.118 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.2 -115.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.82 121.23 26.0 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.839 1.2 . . . . 0.0 112.121 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.97 -165.14 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.99 1.794 . . . . 0.0 109.413 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.25 7.98 38.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 p -146.4 174.62 11.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.488 1.515 . . . . 0.0 108.545 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.05 -162.18 27.75 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -67.36 -20.54 65.58 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 122.583 1.183 . . . . 0.0 111.724 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.6 -15.48 54.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.408 HD21 ' C ' ' A' ' 131' ' ' ASN . 0.1 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 p -79.07 -162.7 0.41 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -165.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -77.99 114.96 17.37 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 9.4 tm-20 -122.23 154.53 37.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -149.45 -56.08 0.19 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.094 0.95 . . . . 0.0 111.576 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER 69.58 -50.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.34 2.656 . . . . 0.0 111.966 -173.195 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -45.86 -22.71 0.21 Allowed 'General case' 0 C--N 1.342 0.26 0 C-N-CA 128.365 2.666 . . . . 0.0 114.638 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t 81.31 -44.03 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.537 1.135 . . . . 0.0 110.727 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -128.31 10.5 6.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.13 1.372 . . . . 0.0 112.44 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.75 -167.68 42.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.8 131.4 18.37 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.438 2.092 . . . . 0.0 110.465 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 166.65 8.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 80.25 174.92 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.049 2.54 . . . . 0.0 110.797 -174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -178.22 162.03 1.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.904 2.882 . . . . 0.0 107.138 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t0 27.51 65.59 0.08 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.753 3.221 . . . . 0.0 114.682 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -161.86 -47.58 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.22 1.008 . . . . 0.0 109.363 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.9 p -82.07 51.58 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.858 0.863 . . . . 0.0 111.673 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.14 -41.96 1.91 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 112.491 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.98 58.3 0.67 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 56.1 57.96 4.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.241 0.616 . . . . 0.0 112.115 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.9 p -89.68 -87.28 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.677 -0.639 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.9 m -84.22 18.33 2.2 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.896 0.879 . . . . 0.0 112.7 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.43 111.48 0.23 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.908 1.283 . . . . 0.0 111.109 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.8 171.24 22.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.11 173.99 9.59 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 120.903 1.069 . . . . 0.0 109.988 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.462 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.425 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.22 15.81 4.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 p -165.86 174.34 9.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.425 1.09 . . . . 0.0 108.109 -167.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.0 59.15 8.93 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 69.88 -35.63 0.32 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.418 2.287 . . . . 0.0 113.562 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -86.95 5.62 36.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.462 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.357 . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 116.683 -1.627 . . . . 0.0 108.122 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.4 p -159.31 -160.5 0.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.733 2.013 . . . . 0.0 105.814 163.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -47.37 122.08 4.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.325 0.511 . . . . 0.0 110.181 155.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -99.26 149.33 23.22 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -163.63 -66.31 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 67.37 -50.87 0.5 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.748 1.619 . . . . 0.0 112.244 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.51 158.95 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.897 1.279 . . . . 0.0 113.01 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.9 t -73.23 -40.88 64.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.674 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -140.58 38.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.85 1.26 . . . . 0.0 109.576 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.94 49.94 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.65 116.98 4.61 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.689 2.26 . . . . 0.0 109.113 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -62.14 179.32 0.3 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 76.12 -175.96 0.12 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.942 2.097 . . . . 0.0 109.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -152.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.62 92.0 3.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.936 1.695 . . . . 0.0 107.852 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -168.58 -54.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.07 0.948 . . . . 0.0 109.365 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 t -70.02 60.93 0.18 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.61 1.164 . . . . 0.0 111.133 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.19 -36.29 51.47 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.45 -1.406 . . . . 0.0 112.031 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 -9.97 67.28 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.965 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 48.29 50.38 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.98 1.712 . . . . 0.0 111.979 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.2 -60.64 1.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.141 0.976 . . . . 0.0 108.907 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.4 -38.22 58.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.525 2.33 . . . . 0.0 112.967 -171.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.07 118.14 1.4 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.965 0.791 . . . . 0.0 108.961 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.33 -131.58 2.55 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.36 -160.91 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.992 1.795 . . . . 0.0 113.092 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.447 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 mp -98.84 21.04 12.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.5 p -172.74 -169.23 0.56 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.017 1.327 . . . . 0.0 108.843 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.01 -71.77 2.7 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.73 -53.06 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 107.181 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -69.57 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.29 1.436 . . . . 0.0 113.214 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' CD ' ' HZ2' ' A' ' 122' ' ' LYS . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.495 ' HZ2' ' CD ' ' A' ' 121' ' ' GLU . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.485 HD22 ' CB ' ' A' ' 133' ' ' GLN . 1.3 t30 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.485 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.434 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.397 . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.3 p -78.93 83.93 5.0 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.065 0.848 . . . . 0.0 109.126 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 97.4 5.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 167.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -123.2 155.77 36.44 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -135.88 -56.58 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.177 1.791 . . . . 0.0 108.779 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 72.8 -52.61 0.71 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.685 1.994 . . . . 0.0 110.035 -169.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.75 166.67 19.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.479 1.512 . . . . 0.0 111.874 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 m -86.04 -34.44 20.73 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -133.28 44.71 2.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.559 1.144 . . . . 0.0 109.461 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.33 -174.24 32.75 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.77 132.43 15.74 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.417 2.078 . . . . 0.0 109.123 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.437 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -173.74 2.44 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 69.98 -47.38 0.61 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.192 2.597 . . . . 0.0 114.324 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 73.15 -63.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.31 1.444 . . . . 0.0 111.041 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.25 67.79 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.41 1.484 . . . . 0.0 112.724 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.8 57.16 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 120.798 -1.189 . . . . 0.0 110.083 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.5 p -55.27 -34.48 64.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.196 1.398 . . . . 0.0 112.225 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.07 -18.75 26.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.773 1.229 . . . . 0.0 113.772 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.04 -92.36 0.26 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.0 t -142.42 15.21 2.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.297 0.57 . . . . 0.0 111.899 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -137.44 103.12 4.98 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m 178.19 -51.16 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 127.455 2.302 . . . . 0.0 108.485 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.54 -78.1 0.02 OUTLIER 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.533 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.25 30.31 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.18 -161.6 0.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.817 3.012 . . . . 0.0 110.774 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.4 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.4 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.37 36.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -176.63 178.14 1.3 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.636 1.174 . . . . 0.0 108.443 -168.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.67 -72.02 2.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.02 -53.87 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.512 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -70.83 28.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.695 1.198 . . . . 0.0 113.591 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.432 ' HE ' ' CD1' ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.432 ' CD1' ' HE ' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.7 m -51.27 128.37 22.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.141 0.901 . . . . 0.0 109.347 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 6.9 ptpt -142.33 151.84 42.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.964 0.906 . . . . 0.0 109.014 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 27.8 mt-10 -107.84 134.99 50.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -153.89 77.25 1.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 108.713 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -57.4 -40.62 78.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.764 -0.585 . . . . 0.0 109.921 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -87.51 111.35 21.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.0 108.262 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -42.22 -47.61 4.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.086 1.354 . . . . 0.0 112.974 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.55 45.94 1.93 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.65 0.78 . . . . 0.0 109.725 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.27 176.58 16.18 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 171.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.43 127.17 16.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.761 2.974 . . . . 0.0 111.023 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.25 -55.68 2.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -146.4 178.21 8.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.494 1.518 . . . . 0.0 107.774 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.9 -46.8 89.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.015 0.37 . . . . 0.0 110.153 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -42.41 106.84 0.07 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.193 1.397 . . . . 0.0 112.325 -165.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.65 76.77 1.56 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.8 p -50.79 -37.54 43.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 112.82 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.03 -16.78 47.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.183 0.993 . . . . 0.0 113.655 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 67.71 1.07 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.699 1.142 . . . . 0.0 112.275 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 9.6 m 42.36 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.549 1.94 . . . . 0.0 112.107 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.1 m -152.03 -51.46 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.121 -0.987 . . . . 0.0 111.024 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -148.72 -77.88 0.15 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.716 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 30.81 -105.74 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.419 1.488 . . . . 0.0 112.052 -173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.54 112.97 5.4 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.5 -169.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.531 1.487 . . . . 0.0 109.144 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.34 6.08 44.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.8 p -160.54 -158.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.613 -0.68 . . . . 0.0 109.232 -169.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.45 -71.77 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -165.56 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.452 1.596 . . . . 0.0 107.247 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -70.47 10.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.412 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.1 m-70 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.37 . . . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 t -79.33 174.85 11.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 130.9 12.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -100.17 120.69 40.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -106.11 66.51 0.72 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 63.72 3.75 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.01 -1.056 . . . . 0.0 109.539 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 178.39 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.336 2.254 . . . . 0.0 111.554 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t 81.82 -51.87 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.696 1.598 . . . . 0.0 109.843 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -112.56 6.6 18.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.647 0.779 . . . . 0.0 111.877 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.17 -164.91 26.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -174.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.36 118.61 5.76 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.106 1.871 . . . . 0.0 110.88 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -136.64 177.03 8.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.754 1.615 . . . . 0.0 110.269 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.2 65.34 5.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 64.43 8.38 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.612 1.196 . . . . 0.0 112.07 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -23.26 63.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.774 -1.204 . . . . 0.0 110.932 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.95 -38.78 17.52 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 128.563 2.745 . . . . 0.0 112.329 172.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.78 -10.23 59.07 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.08 41.6 2.07 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.777 1.656 . . . . 0.0 111.78 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.51 -64.12 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.522 1.929 . . . . 0.0 113.137 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.7 p -79.46 54.85 1.81 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.419 1.487 . . . . 0.0 110.342 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 m -167.98 -67.57 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.927 1.691 . . . . 0.0 108.105 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.82 -128.05 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.812 1.245 . . . . 0.0 110.852 -171.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.51 159.29 24.9 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.04 -166.24 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.18 2.587 . . . . 0.0 110.641 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.41 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.5 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' NZ ' ' OD1' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.53 19.97 15.86 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.0 p -172.4 -165.24 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 109.364 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 -73.28 2.7 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.03 -60.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -74.35 53.81 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.972 0.909 . . . . 0.0 109.985 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.408 ' C ' HE21 ' A' ' 133' ' ' GLN . 0.0 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.41 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.43 . . . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.8 t -117.83 54.32 0.91 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.239 1.019 . . . . 0.0 108.535 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.53 121.98 26.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -114.67 151.45 33.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -155.36 54.69 0.63 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.662 1.185 . . . . 0.0 108.453 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 32.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.093 -1.005 . . . . 0.0 113.302 -177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -119.63 -14.03 9.11 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.498 1.919 . . . . 0.0 111.069 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m 73.24 -52.14 0.7 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.639 1.576 . . . . 0.0 112.601 176.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -135.42 45.58 2.45 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 124.088 0.955 . . . . 0.0 108.6 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.15 -179.46 16.14 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.27 151.58 80.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.632 2.221 . . . . 0.0 111.402 -171.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.78 84.09 3.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -177.22 -159.7 0.05 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.611 1.964 . . . . 0.0 107.384 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 -165.54 2.09 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.966 1.706 . . . . 0.0 109.219 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.06 83.26 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.507 1.123 . . . . 0.0 110.868 172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -144.38 -54.14 0.33 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 124.534 1.134 . . . . 0.0 110.36 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p -74.57 62.96 1.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.5 -36.86 16.07 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.759 -1.213 . . . . 0.0 113.407 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -27.17 62.22 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.482 0.563 . . . . 0.0 113.321 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.5 t 59.72 45.34 13.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.927 1.691 . . . . 0.0 111.288 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.3 m -98.93 -81.56 0.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.963 1.305 . . . . 0.0 110.05 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -66.47 -51.52 55.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 65.62 -102.61 0.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.98 35.19 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.15 168.57 23.73 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.502 1.651 . . . . 0.0 109.699 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -99.45 24.55 7.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -155.16 166.85 32.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.733 1.213 . . . . 0.0 110.151 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 -149.6 51.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.83 -34.64 71.89 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.986 -0.714 . . . . 0.0 110.469 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.61 -22.8 67.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.468 ' CD ' ' HZ2' ' A' ' 136' ' ' LYS . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.468 ' HZ2' ' CD ' ' A' ' 132' ' ' GLU . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.1 m -166.55 135.88 3.03 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -176.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.98 84.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.288 1.435 . . . . 0.0 107.924 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -126.09 138.05 53.67 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -161.71 80.85 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.921 2.088 . . . . 0.0 106.244 171.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -28.67 67.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.912 -1.117 . . . . 0.0 108.946 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -59.4 124.47 20.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.088 2.555 . . . . 0.0 110.064 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 m -50.32 -42.01 52.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.349 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -139.83 42.0 1.98 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.406 0.683 . . . . 0.0 109.363 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.22 52.27 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.42 139.93 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.528 2.819 . . . . 0.0 109.09 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -74.03 70.76 1.56 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -149.01 177.93 9.14 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.32 -111.9 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.829 1.252 . . . . 0.0 108.901 168.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -104.71 103.5 13.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.185 0.994 . . . . 0.0 108.7 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.9 -41.56 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.345 1.058 . . . . 0.0 109.75 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 t -77.17 59.06 1.68 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.642 0.734 . . . . 0.0 110.34 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -40.17 66.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.006 1.323 . . . . 0.0 112.608 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.98 -101.11 0.33 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.054 -2.019 . . . . 0.0 108.054 170.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.13 34.51 0.1 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.904 0.859 . . . . 0.0 110.36 165.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -119.94 139.66 52.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.215 1.806 . . . . 0.0 106.687 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 m 108.6 -45.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.519 3.128 . . . . 0.0 111.307 -169.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -24.46 102.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.225 1.81 . . . . 0.0 113.098 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.84 -176.34 12.19 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.57 -174.83 1.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.398 1.399 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.408 ' C ' ' H ' ' A' ' 107' ' ' SER . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.7 mt -76.28 38.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 105' ' ' SER . 12.7 p -156.11 146.35 21.54 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.936 1.294 . . . . 0.0 108.608 -174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.25 -177.93 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -161.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.61 -14.81 55.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.155 0.982 . . . . 0.0 112.818 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -72.03 -17.77 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.341 1.056 . . . . 0.0 112.726 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.442 . . . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 t -120.63 97.52 5.6 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.926 0.89 . . . . 0.0 109.638 -169.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 90.19 1.72 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.95 157.61 30.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.78 -65.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.103 0.561 . . . . 0.0 110.811 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? 72.84 -44.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 113.857 168.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.72 -10.93 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.849 0.86 . . . . 0.0 112.676 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 t 74.86 -55.46 0.65 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.817 2.047 . . . . 0.0 109.161 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -129.49 48.22 2.4 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.06 -167.86 12.24 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.72 129.14 18.16 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.597 2.198 . . . . 0.0 111.306 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -63.85 -179.43 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.64 -163.92 0.22 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.101 1.76 . . . . 0.0 112.106 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -152.42 -110.17 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.35 137.72 57.69 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 120.428 1.467 . . . . 0.0 110.595 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 164.86 -38.31 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 127.969 2.508 . . . . 0.0 109.714 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -79.43 44.14 0.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.055 0.942 . . . . 0.0 112.681 -166.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.47 -40.16 1.71 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.757 2.023 . . . . 0.0 113.313 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.51 51.59 0.74 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.19 40.34 28.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.826 0.822 . . . . 0.0 110.795 173.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 p -73.06 -84.96 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -170.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -104.8 -50.37 3.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.527 1.131 . . . . 0.0 109.773 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 68.17 -65.65 0.25 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 125.161 1.384 . . . . 0.0 111.574 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.42 171.49 20.03 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.2 179.71 6.25 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.49 . . . . 0.0 109.398 163.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.428 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.4 18.34 20.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -169.7 158.37 7.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.23 -174.19 34.64 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.16 -39.08 63.3 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.494 1.118 . . . . 0.0 110.608 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -74.04 7.94 2.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.29 1.036 . . . . 0.0 113.314 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.428 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.473 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.473 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.319 . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.5 p -128.45 -176.31 3.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.149 1.34 . . . . 0.0 113.371 -162.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -109.53 138.18 46.27 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.588 1.555 . . . . 0.0 109.528 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -72.75 131.74 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -136.16 73.04 1.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 169.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.427 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -94.65 29.03 2.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.797 -1.814 . . . . 0.0 109.907 -174.509 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 21.0 mp0 -132.9 -24.94 1.88 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.377 1.071 . . . . 0.0 111.748 -165.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.71 -62.71 0.45 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.678 1.191 . . . . 0.0 109.5 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.31 37.8 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.3 1.44 . . . . 0.0 110.1 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.83 178.42 17.48 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.97 145.31 85.2 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.631 2.22 . . . . 0.0 110.786 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.26 72.93 2.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -139.8 -169.16 2.65 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.441 1.496 . . . . 0.0 108.184 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.56 -152.07 0.29 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.534 1.534 . . . . 0.0 109.605 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -71.99 76.64 0.92 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.885 0.874 . . . . 0.0 110.916 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.23 -43.34 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.407 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.5 p -75.24 55.16 0.74 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.373 0.669 . . . . 0.0 112.082 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.27 -44.22 71.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.101 0.961 . . . . 0.0 110.708 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.52 36.22 4.49 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.59 38.67 30.28 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.024 0.93 . . . . 0.0 112.264 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 m -52.25 -80.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.399 1.88 . . . . 0.0 114.868 -164.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 t -80.4 -54.18 5.94 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.13 1.71 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.602 1.161 . . . . 0.0 109.766 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -47.71 153.46 1.59 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.695 1.617 . . . . 0.0 110.638 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.77 -175.04 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.651 1.567 . . . . 0.0 112.361 -167.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.5 mp -103.66 27.16 7.71 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.5 p -155.03 171.24 20.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.389 0.675 . . . . 0.0 109.811 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.66 -162.17 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.1 -18.84 65.64 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.455 -1.026 . . . . 0.0 111.916 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -88.06 2.4 51.99 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.417 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 m -138.64 53.36 1.78 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 150.35 20.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.031 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.07 28.43 Favored 'General case' 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.2 -55.05 0.31 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.019 1.328 . . . . 0.0 109.958 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 63.55 -62.45 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.397 1.479 . . . . 0.0 112.305 -167.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.83 116.85 29.52 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.2 m -41.9 -36.45 1.07 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.372 1.469 . . . . 0.0 114.234 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.63 39.61 3.89 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.401 0.68 . . . . 0.0 110.785 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.61 172.9 15.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.699 1.142 . . . . 0.0 110.796 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.99 134.17 38.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.746 2.964 . . . . 0.0 110.783 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.41 -179.91 5.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 68.34 -62.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.327 2.251 . . . . 0.0 111.882 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 98.78 -58.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.818 2.847 . . . . 0.0 109.958 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.92 100.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 111.563 -170.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -85.65 59.83 5.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.333 -0.855 . . . . 0.0 110.126 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 p -60.53 -40.47 91.61 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.427 0.691 . . . . 0.0 111.034 -172.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.19 -18.71 16.83 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.263 1.425 . . . . 0.0 113.583 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.49 82.57 1.49 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.8 t 45.55 63.96 1.6 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.565 1.546 . . . . 0.0 110.946 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.3 t -166.13 84.19 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.771 -0.581 . . . . 0.0 109.819 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.0 m -64.21 98.5 0.23 Allowed 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.014 -1.054 . . . . 0.0 110.146 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.75 -50.63 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 110.978 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.02 145.63 29.69 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.724 1.154 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 -171.13 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.784 2.322 . . . . 0.0 112.483 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 91' ' ' LYS . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp -97.29 15.79 21.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 p -173.66 -162.47 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.89 -71.23 2.62 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -162.27 -58.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -75.47 56.53 0.87 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.442 1.497 . . . . 0.0 111.399 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . 0.251 0.0 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.438 . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 t -161.54 76.2 0.51 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 109.261 -174.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.04 74.57 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.17 145.75 50.64 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.93 -63.66 0.41 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.364 1.066 . . . . 0.0 110.003 -172.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 74.75 -55.6 0.65 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.221 1.408 . . . . 0.0 111.914 177.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -58.92 -20.21 49.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.633 178.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m 74.84 -34.93 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.428 1.891 . . . . 0.0 112.256 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -131.44 18.12 4.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.22 1.008 . . . . 0.0 111.931 172.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.86 -160.36 33.94 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.23 136.2 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.181 1.921 . . . . 0.0 110.875 -178.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.54 -161.04 0.34 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 62.77 -61.5 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.741 2.017 . . . . 0.0 113.3 -171.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 65.56 -81.36 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.081 1.752 . . . . 0.0 110.157 -175.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.95 72.41 0.57 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.479 1.112 . . . . 0.0 110.261 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.91 -47.36 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.573 0.749 . . . . 0.0 110.55 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -82.12 51.62 1.81 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.204 0.526 . . . . 0.0 111.737 -172.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -38.32 -42.85 0.75 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.98 2.112 . . . . 0.0 113.331 -175.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.58 63.72 0.59 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 173.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 53.69 41.44 32.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.678 0.751 . . . . 0.0 109.817 172.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.8 m -107.85 -70.88 0.78 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.701 1.2 . . . . 0.0 109.891 -167.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 m -55.05 -34.33 63.45 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.264 0.626 . . . . 0.0 110.975 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 55.76 52.38 10.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.168 0.587 . . . . 0.0 110.167 170.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -39.18 138.52 0.94 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 126.894 2.188 . . . . 0.0 111.934 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.93 160.04 46.11 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.599 1.699 . . . . 0.0 110.783 -170.363 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.33 20.49 9.26 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 -178.83 0.85 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -165.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.87 -88.83 1.48 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -176.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.34 -63.47 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -172.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -80.43 46.96 0.89 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.082 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.401 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.34 . . . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 116.672 -1.632 . . . . 0.0 107.734 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER 58.0 64.45 1.52 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.376 1.048 . . . . 0.0 113.672 159.165 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.86 54.83 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.637 -0.664 . . . . 0.0 110.652 -176.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -122.01 150.55 41.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -143.11 -59.31 0.43 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 122.664 0.386 . . . . 0.0 110.694 -176.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? 77.22 -43.84 0.44 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.225 1.41 . . . . 0.0 111.075 175.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -14.32 59.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.418 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 76.24 -40.91 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.036 1.334 . . . . 0.0 112.308 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -137.28 34.5 2.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.236 1.415 . . . . 0.0 109.801 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.3 -160.95 10.55 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.279 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.18 119.85 6.96 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 119.75 1.775 . . . . 0.0 111.377 -174.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.24 155.74 39.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 46.74 -162.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.921 2.488 . . . . 0.0 112.487 -168.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.04 -42.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.62 1.568 . . . . 0.0 112.186 -175.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.17 82.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.59 1.556 . . . . 0.0 113.543 -170.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.74 36.68 0.96 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.789 -1.194 . . . . 0.0 112.49 -169.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.2 p -54.49 -46.48 73.43 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.363 1.465 . . . . 0.0 111.726 -175.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.0 -16.55 5.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.936 1.294 . . . . 0.0 113.777 176.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.03 83.11 1.53 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -176.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.0 t 56.22 25.82 9.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.08 . . . . 0.0 112.895 170.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 m -114.77 -64.07 1.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.355 1.462 . . . . 0.0 110.023 -169.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.7 m -47.15 -50.76 19.76 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.731 1.212 . . . . 0.0 112.41 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.46 123.17 3.98 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 123.603 0.564 . . . . 0.0 110.556 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.11 -167.45 11.78 Favored Glycine 0 N--CA 1.445 -0.721 0 O-C-N 125.088 1.493 . . . . 0.0 111.085 -161.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.87 -168.1 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.218 1.279 . . . . 0.0 109.81 170.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.45 10.61 29.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.5 p -153.74 -159.05 0.93 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.365 -0.834 . . . . 0.0 110.203 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.57 -69.61 2.57 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.319 0.961 . . . . 0.0 111.335 174.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.67 -63.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -175.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.35 44.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.63 2.772 . . . . 0.0 112.693 171.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.449 HD22 ' CB ' ' A' ' 133' ' ' GLN . 1.8 t30 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.449 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.419 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.466 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -78.01 58.82 2.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.711 0.804 . . . . 0.0 109.831 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? -154.65 87.0 1.14 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.569 1.548 . . . . 0.0 106.954 176.231 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 -118.26 138.87 52.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -174.97 115.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 129.077 2.951 . . . . 0.0 105.058 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.63 8.8 27.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.378 0.671 . . . . 0.0 111.479 -178.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -132.71 154.86 49.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 107.77 -171.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -75.78 -21.56 57.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.905 -0.497 . . . . 0.0 111.386 174.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.07 21.54 2.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.182 0.593 . . . . 0.0 111.723 -171.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.17 179.51 42.37 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.045 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.36 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.077 2.518 . . . . 0.0 109.569 175.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.87 171.03 7.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 65.11 -176.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.685 1.994 . . . . 0.0 112.401 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -140.46 -86.8 0.19 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 107.228 178.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -94.99 118.41 31.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.469 1.107 . . . . 0.0 109.82 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 174.06 -42.76 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 127.472 2.309 . . . . 0.0 107.722 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.7 t -74.03 49.86 0.35 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.193 1.797 . . . . 0.0 112.732 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -39.02 -53.82 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.81 2.044 . . . . 0.0 110.731 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.32 58.8 0.7 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.87 40.81 5.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 163.056 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.4 t -86.9 55.17 3.45 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.35 -0.844 . . . . 0.0 111.62 -173.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 t 70.72 -63.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.924 -1.11 . . . . 0.0 111.826 -176.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 75.05 -76.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 127.489 2.316 . . . . 0.0 108.731 -170.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.41 170.27 43.18 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.05 -172.45 1.27 Allowed 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.901 2.401 . . . . 0.0 110.207 175.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.29 25.25 7.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.1 p -155.21 174.31 15.39 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.22 -153.54 52.9 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.51 -43.89 75.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.702 0.763 . . . . 0.0 109.176 172.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -49.75 -26.88 4.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.196 2.198 . . . . 0.0 115.148 -174.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.492 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.492 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.381 . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -82.43 156.76 23.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 160.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -145.71 140.8 27.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 10.2 tm-20 -100.57 126.12 47.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -149.43 143.87 25.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 165.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -135.36 16.06 3.44 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.326 1.05 . . . . 0.0 109.929 179.815 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -137.68 154.79 49.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.84 2.056 . . . . 0.0 106.128 -177.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -61.41 -51.46 68.67 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.303 0.573 . . . . 0.0 109.72 171.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -122.18 31.15 6.28 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.285 1.034 . . . . 0.0 110.652 -167.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.97 160.76 24.25 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 175.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.88 118.56 5.53 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.096 2.53 . . . . 0.0 109.714 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.42 -144.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 71.84 -55.81 0.65 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.409 1.459 . . . . 0.0 111.187 -167.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 59.89 -95.97 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.611 1.164 . . . . 0.0 109.404 -169.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -103.61 88.81 3.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.543 0.737 . . . . 0.0 109.033 -178.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -40.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 177.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 t -77.02 42.1 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.899 1.679 . . . . 0.0 112.398 -173.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.18 -38.95 27.56 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.768 1.227 . . . . 0.0 112.808 -170.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.78 38.48 1.87 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 57.88 85.57 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.119 0.967 . . . . 0.0 112.962 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.8 m -124.64 -79.9 0.62 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.515 0.726 . . . . 0.0 109.217 176.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -52.2 -47.46 65.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.557 1.543 . . . . 0.0 112.993 -172.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 54.45 51.44 14.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.27 1.028 . . . . 0.0 113.349 170.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.59 162.72 5.18 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 125.81 1.672 . . . . 0.0 111.541 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.38 -175.16 2.52 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.179 1.919 . . . . 0.0 111.474 -173.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 12.23 16.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.1 -171.89 1.88 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -167.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.7 -73.11 2.46 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.32 -64.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.939 0.896 . . . . 0.0 108.787 -170.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -67.69 8.34 0.38 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.425 HD22 ' CB ' ' A' ' 133' ' ' GLN . 0.1 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.425 ' CB ' HD22 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.533 . . . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -163.1 -179.55 6.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.99 0.814 . . . . 0.0 110.14 -173.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -76.84 125.29 29.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.315 1.846 . . . . 0.0 111.707 168.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 31' ' ' VAL . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -126.27 140.21 52.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -134.96 -63.88 0.68 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.564 0.697 . . . . 0.0 109.846 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt 67.62 -43.2 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 114.253 -177.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.46 157.22 20.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.386 1.448 . . . . 0.0 109.319 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -77.44 -28.84 52.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.02 36.61 0.55 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.448 1.099 . . . . 0.0 108.716 -175.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.43 172.64 24.27 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 177.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -62.25 135.57 54.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.249 1.966 . . . . 0.0 109.657 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.413 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -166.93 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 56.57 -163.66 0.16 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.775 1.23 . . . . 0.0 111.702 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.08 -108.61 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -71.5 97.52 1.68 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.955 1.252 . . . . 0.0 110.158 171.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -157.93 -44.95 0.06 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.855 0.462 . . . . 0.0 111.116 172.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -78.36 48.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.401 -0.812 . . . . 0.0 111.72 -174.434 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.17 -39.47 43.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.638 1.175 . . . . 0.0 112.285 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.14 2.47 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 175.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 57.13 30.76 18.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 117.893 0.847 . . . . 0.0 111.655 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.8 m -48.88 -57.84 5.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.778 2.031 . . . . 0.0 112.191 -175.624 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.41 -51.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.989 1.716 . . . . 0.0 108.921 -175.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.95 -86.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.54 1.136 . . . . 0.0 110.263 -170.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.01 165.69 29.81 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.47 -170.64 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.646 2.231 . . . . 0.0 109.987 173.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.96 33.18 1.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 m -82.47 -103.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -167.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 -86.46 0.23 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.38 -51.52 34.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.671 0.736 . . . . 0.0 110.735 170.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -80.33 -18.2 49.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.9 p -74.23 -175.07 2.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.534 1.534 . . . . 0.0 110.248 -172.885 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -135.89 104.34 5.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 175.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -137.67 157.05 47.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -110.19 -94.82 0.42 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.468 0.707 . . . . 0.0 110.867 -175.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm 148.51 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 128.356 2.662 . . . . 0.0 106.528 -175.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -150.94 141.94 23.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -166.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -39.67 -45.3 1.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.535 1.534 . . . . 0.0 112.356 175.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -116.35 37.36 3.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.296 1.438 . . . . 0.0 109.443 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.83 163.14 16.19 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 172.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.46 138.72 61.33 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.063 1.842 . . . . 0.0 109.712 177.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -147.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.4 -55.08 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.372 2.269 . . . . 0.0 114.869 -174.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 68.16 -83.54 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.26 1.424 . . . . 0.0 109.809 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.43 76.88 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.58 1.152 . . . . 0.0 109.479 -176.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -163.5 -52.45 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 174.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.4 t -77.1 55.18 1.12 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.426 0.691 . . . . 0.0 111.279 -176.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.88 -43.21 49.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.533 1.533 . . . . 0.0 112.482 -177.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.04 -101.2 0.74 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 171.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.64 31.27 0.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.444 -0.445 . . . . 0.0 110.383 168.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.2 m -71.42 -71.46 0.26 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.033 0.933 . . . . 0.0 110.972 -167.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 m -59.97 -48.99 79.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.805 0.842 . . . . 0.0 109.995 -178.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.46 57.49 4.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.003 1.321 . . . . 0.0 112.015 176.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.06 157.94 5.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.206 1.384 . . . . 0.0 110.812 -178.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.51 -174.03 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.222 1.948 . . . . 0.0 112.987 -164.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp -92.74 33.97 1.11 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.2 p -154.52 167.94 28.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.665 0.786 . . . . 0.0 108.898 -173.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.91 -159.56 27.47 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -176.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -64.63 -31.56 72.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.975 1.71 . . . . 0.0 110.352 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.04 -33.18 75.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 -178.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.409 . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 m -71.34 106.95 4.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -124.57 150.8 45.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.612 1.565 . . . . 0.0 107.945 179.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 154.59 24.64 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.35 -59.02 0.74 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 127.171 2.188 . . . . 0.0 108.752 175.164 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt 72.18 -57.68 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.312 1.445 . . . . 0.0 110.925 -171.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.52 -24.16 29.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.634 1.573 . . . . 0.0 111.864 -176.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 78.38 -28.87 0.16 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 -175.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -122.46 25.89 8.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.591 1.157 . . . . 0.0 110.421 174.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.9 -176.68 22.95 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.33 132.18 45.07 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.433 2.089 . . . . 0.0 109.018 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -77.94 72.04 4.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -115.42 -62.14 1.64 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.629 0.371 . . . . 0.0 111.72 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 58.19 -139.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.934 1.294 . . . . 0.0 110.993 171.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.83 71.99 1.52 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.365 -0.834 . . . . 0.0 109.83 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 -38.88 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.638 0.775 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.2 t -66.99 56.29 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.902 1.681 . . . . 0.0 113.395 174.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.11 -31.96 63.74 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.263 -0.898 . . . . 0.0 111.873 178.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.22 53.0 0.53 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 176.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.21 44.56 30.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.609 0.764 . . . . 0.0 111.481 175.2 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -73.77 -170.19 0.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.687 0.795 . . . . 0.0 110.59 -177.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 t -55.53 -40.64 72.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.097 0.959 . . . . 0.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.43 -111.78 0.4 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.641 0.776 . . . . 0.0 111.511 179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.79 145.85 11.62 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.797 -1.002 . . . . 0.0 110.851 176.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo 10.42 154.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 130.747 7.631 . . . . 0.0 122.112 155.453 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.41 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.51 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp -94.05 17.91 11.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -108.07 140.08 41.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.385 1.474 . . . . 0.0 108.737 -178.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -19.75 -60.75 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 127.762 2.601 . . . . 0.0 112.971 -173.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.41 -69.22 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.284 3.033 . . . . 0.0 114.342 173.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -121.43 4.63 10.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 177.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.51 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.48 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.406 . . . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 115.804 -2.046 . . . . 0.0 106.88 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t 176.57 -144.27 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 127.008 2.123 . . . . 0.0 109.169 -174.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.74 126.35 47.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 110.392 172.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -105.41 137.59 42.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -168.1 106.97 0.51 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 175.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.01 28.12 8.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.841 0.856 . . . . 0.0 110.703 -175.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -116.07 -16.83 11.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.546 1.139 . . . . 0.0 111.542 -178.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 t 73.22 -53.11 0.7 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.184 1.394 . . . . 0.0 110.318 -169.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.88 27.92 9.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.223 1.009 . . . . 0.0 111.703 -178.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 169.2 19.57 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.17 130.29 19.78 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.383 2.055 . . . . 0.0 108.679 174.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.72 -112.64 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.273 4.6 pm0 45.91 -108.44 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.819 1.648 . . . . 0.0 112.89 -175.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 70.67 2.6 4.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 112.256 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.64 -168.8 2.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.165 1.386 . . . . 0.0 110.078 175.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -25.98 68.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.805 0.842 . . . . 0.0 111.493 172.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -74.92 59.22 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.405 1.002 . . . . 0.0 110.276 175.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.81 -22.97 62.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.579 0.752 . . . . 0.0 111.247 175.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.85 145.69 45.51 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.92 49.67 0.55 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.448 1.499 . . . . 0.0 111.153 -173.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.4 m -114.38 -100.43 0.43 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.477 1.111 . . . . 0.0 109.356 -172.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 t -71.64 -79.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.231 -2.136 . . . . 0.0 105.231 167.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 50.47 -117.92 1.13 Allowed 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.27 166.17 34.08 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.834 1.197 . . . . 0.0 112.132 177.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.3 -172.28 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.232 2.622 . . . . 0.0 110.039 174.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.36 14.69 2.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.29 -174.23 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -174.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.16 -81.44 1.75 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -170.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -154.28 -55.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.667 1.587 . . . . 0.0 108.405 -177.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 38.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.884 1.674 . . . . 0.0 112.718 -177.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 t -165.12 74.99 0.24 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 120.573 1.533 . . . . 0.0 110.893 -157.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.96 76.0 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.968 0.907 . . . . 0.0 108.657 -176.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.15 124.57 42.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -140.77 71.72 1.37 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.409 1.084 . . . . 0.0 109.165 177.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -65.0 -18.99 65.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.554 -1.341 . . . . 0.0 113.057 -175.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 148.07 30.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.58 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 m -67.33 -50.36 60.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.742 -0.598 . . . . 0.0 109.905 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -129.03 34.01 4.5 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.587 0.755 . . . . 0.0 111.071 -171.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.48 177.36 18.93 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.395 2.73 . . . . 0.0 111.396 -170.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -48.53 -75.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.19 162.83 13.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.132 0.573 . . . . 0.0 110.2 178.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.35 -27.72 13.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.593 1.157 . . . . 0.0 114.058 176.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -73.5 75.25 1.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.032 0.92 . . . . 0.0 110.937 -167.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -108.75 51.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.004 0.921 . . . . 0.0 110.779 -167.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 p -54.02 -27.07 29.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.031 0.932 . . . . 0.0 112.858 -177.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.09 -22.85 52.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.878 0.871 . . . . 0.0 113.289 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.53 -112.05 0.5 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.65 -26.5 5.7 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.559 0.744 . . . . 0.0 112.751 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -152.46 121.69 6.71 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.9 t -168.47 -44.15 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.365 1.866 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.98 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.775 1.63 . . . . 0.0 112.554 -175.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.16 139.69 11.11 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -175.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.61 -163.31 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.942 2.428 . . . . 0.0 111.029 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.44 5.58 51.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.7 m -61.3 171.8 1.29 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.069 0.948 . . . . 0.0 111.273 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -51.19 -89.71 0.01 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.203 0.906 . . . . 0.0 113.684 -172.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -82.84 56.78 3.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.505 1.145 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -154.69 -44.15 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.981 1.312 . . . . 0.0 109.451 -169.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.452 ' C ' HD21 ' A' ' 131' ' ' ASN . 0.1 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.414 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.445 ' ND2' ' HG ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.445 ' HG ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 106' ' ' LEU . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 38' ' ' LEU . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.45 -1.041 0 N-CA-C 109.102 -1.153 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.926 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.653 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 N-CA-C 111.209 -0.343 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 38' ' ' LEU . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD13 ' HA3' ' A' ' 33' ' ' GLY . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HG22 ' A' ' 31' ' ' VAL . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.455 -0.772 0 CA-C-O 120.953 0.314 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 20' ' ' PHE . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.606 HG21 HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 14' ' ' VAL . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.739 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' O ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 110.736 -0.524 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.448 0.642 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 45' ' ' PHE . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD12 ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.488 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.373 0.489 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' HD12 ' A' ' 149' ' ' ILE . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 117' ' ' LEU . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 38' ' ' LEU . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HA3' ' A' ' 33' ' ' GLY . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.557 ' HD2' HG22 ' A' ' 31' ' ' VAL . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.449 -1.109 0 N-CA-C 109.64 -0.946 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' HD2' ' A' ' 20' ' ' PHE . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.779 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 35' ' ' ILE . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 38' ' ' LEU . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 4' ' ' ALA . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 110.051 -0.788 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 20' ' ' PHE . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.7 HD12 ' CE1' ' A' ' 43' ' ' HIS . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.7 ' CE1' HD12 ' A' ' 38' ' ' LEU . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.45 -1.087 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.624 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.527 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 115' ' ' ARG . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 ' HA3' ' A' ' 33' ' ' GLY . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 1.2 tm-20 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.454 -0.85 0 CA-C-O 121.397 0.499 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 49' ' ' GLU . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.449 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' A' ' 31' ' ' VAL . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 N-CA-C 109.647 -0.944 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' HD2' ' A' ' 20' ' ' PHE . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.704 ' CE1' HD12 ' A' ' 38' ' ' LEU . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 CA-C-O 121.449 0.521 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' HD23 ' A' ' 126' ' ' LEU . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 124' ' ' ASP . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD13 ' HA3' ' A' ' 33' ' ' GLY . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 N-CA-C 110.85 -0.481 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 35' ' ' ILE . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.449 -1.091 0 CA-C-O 121.552 0.563 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.631 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.7 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 149' ' ' ILE . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 38' ' ' LEU . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 124' ' ' ASP . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 117' ' ' LEU . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 . . . . . 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.449 -1.105 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 19' ' ' ASN . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.691 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' CE1' HD12 ' A' ' 38' ' ' LEU . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 115' ' ' ARG . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.023 -1.184 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.611 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD22 ' OD2' ' A' ' 101' ' ' ASP . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 97' ' ' VAL . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 87' ' ' VAL . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD2' HD22 ' A' ' 84' ' ' LEU . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.486 ' OD1' HD23 ' A' ' 126' ' ' LEU . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 ' HA3' ' A' ' 73' ' ' GLY . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.718 HG21 HG12 ' A' ' 112' ' ' ILE . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.601 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 43' ' ' HIS . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.634 ' CE1' HD12 ' A' ' 38' ' ' LEU . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 N--CA 1.448 -1.173 0 N-CA-C 109.413 -1.034 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB3' HD23 ' A' ' 126' ' ' LEU . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 124' ' ' ASP . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 6' ' ' ALA . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 35' ' ' ILE . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 N--CA 1.442 -1.526 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.703 ' HB2' HD12 ' A' ' 149' ' ' ILE . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' HD23 ' A' ' 126' ' ' LEU . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD23 ' OD1' ' A' ' 124' ' ' ASP . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 115' ' ' ARG . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 117' ' ' LEU . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.451 -0.974 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CE1' HD12 ' A' ' 38' ' ' LEU . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 122.229 0.845 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.437 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' ALA . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 8' ' ' LEU . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 N--CA 1.45 -1.078 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 43' ' ' HIS . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CG ' HD23 ' A' ' 38' ' ' LEU . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.0 m80 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 121.432 0.513 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.616 ' HG2' HD12 ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' HD11 ' A' ' 149' ' ' ILE . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 38' ' ' LEU . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 38' ' ' LEU . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 33' ' ' GLY . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 111.023 -0.414 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.794 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 35' ' ' ILE . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' HD12 ' A' ' 38' ' ' LEU . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 115' ' ' ARG . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' ILE . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.659 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 47' ' ' VAL . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.535 HG21 HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 64.0 m80 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 112' ' ' ILE . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 HD22 ' A' ' 38' ' ' LEU . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.619 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' HD12 ' A' ' 38' ' ' LEU . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.641 -0.561 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 HG23 ' A' ' 118' ' ' VAL . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 146' ' ' CYS . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' H ' ' HB3' ' A' ' 86' ' ' ASN . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' CYS . . . . . 0.495 ' HA ' HG22 ' A' ' 118' ' ' VAL . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 HG12 ' A' ' 18' ' ' ILE . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 145' ' ' ALA . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 HD13 ' A' ' 8' ' ' LEU . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 121.292 0.455 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CG ' HD21 ' A' ' 38' ' ' LEU . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 117' ' ' LEU . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.45 -1.067 0 N-CA-C 109.699 -0.923 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 104' ' ' ILE . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' ILE . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.718 HG22 HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 45' ' ' PHE . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 120' ' ' HIS . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.416 ' H ' HG12 ' A' ' 118' ' ' VAL . 50.5 m80 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 119' ' ' VAL . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 HD13 ' HA3' ' A' ' 33' ' ' GLY . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 N--CA 1.454 -0.828 0 N-CA-C 109.09 -1.158 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 35' ' ' ILE . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE2' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.795 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 HD11 ' A' ' 113' ' ' ILE . 7.7 mt . . . . . 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 4' ' ' ALA . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ARG . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD21 ' CG ' ' A' ' 43' ' ' HIS . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CG ' HD21 ' A' ' 38' ' ' LEU . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 149' ' ' ILE . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 115' ' ' ARG . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 N-CA-C 110.786 -0.505 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 35' ' ' ILE . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 38' ' ' LEU . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 CA-C-O 121.496 0.54 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 97' ' ' VAL . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 HG11 ' A' ' 87' ' ' VAL . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD11 HD11 ' A' ' 112' ' ' ILE . 9.5 mp . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 106' ' ' LEU . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' HD12 ' A' ' 117' ' ' LEU . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HD13 ' HA3' ' A' ' 33' ' ' GLY . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 110.783 -0.506 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 CA-C-O 122.667 1.028 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 67' ' ' LEU . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 66' ' ' PRO . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.512 ' CA ' HD22 ' A' ' 126' ' ' LEU . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 120.454 0.169 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 4' ' ' ALA . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.512 HD22 ' CA ' ' A' ' 73' ' ' GLY . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 117' ' ' LEU . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 117' ' ' LEU . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 HD22 ' A' ' 38' ' ' LEU . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 110.875 -0.471 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG11 ' CD1' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 35' ' ' ILE . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 38' ' ' LEU . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' NE2' ' OD2' ' A' ' 124' ' ' ASP . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 118' ' ' VAL . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 N-CA-C 110.783 -0.507 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.517 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 29' ' ' VAL . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 8' ' ' LEU . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 48' ' ' HIS . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' OD2' ' NE2' ' A' ' 46' ' ' HIS . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.024 0.44 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 N-CA-C 111.377 -0.278 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.476 ' CG ' HD21 ' A' ' 38' ' ' LEU . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.444 -1.438 0 N-CA-C 109.81 -0.881 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 35' ' ' ILE . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.545 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.436 ' HB2' HD12 ' A' ' 149' ' ' ILE . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.725 HD11 ' CD1' ' A' ' 117' ' ' LEU . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 N-CA-C 109.569 -0.973 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 104' ' ' ILE . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' A' ' 35' ' ' ILE . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CG ' HD21 ' A' ' 38' ' ' LEU . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.448 -1.152 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 29' ' ' VAL . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 149' ' ' ILE . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 115' ' ' ARG . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.701 HD11 HD23 ' A' ' 117' ' ' LEU . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 38' ' ' LEU . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 35' ' ' ILE . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.511 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.445 -1.359 0 CA-C-O 120.8 0.25 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 35' ' ' ILE . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.541 HD12 HG11 ' A' ' 29' ' ' VAL . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.701 HD23 HD11 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 137' ' ' THR . 2.2 tm0? -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.405 HG21 ' NE2' ' A' ' 133' ' ' GLN . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.45 -1.059 0 N-CA-C 109.657 -0.94 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 109.987 -0.813 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' THR . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 104' ' ' ILE . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.3 mp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 70' ' ' LYS . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 109.712 -0.919 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB2' HG21 ' A' ' 35' ' ' ILE . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 38' ' ' LEU . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.705 0.627 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 80' ' ' HIS . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 65' ' ' ASN . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 31' ' ' VAL . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 101' ' ' ASP . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 38' ' ' LEU . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 109.018 -1.185 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 20' ' ' PHE . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 35' ' ' ILE . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.562 ' CE1' HD12 ' A' ' 38' ' ' LEU . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 122.112 3.851 . . . . 0.0 122.112 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 149' ' ' ILE . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 38' ' ' LEU . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.792 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.597 ' CE1' HD12 ' A' ' 38' ' ' LEU . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 135' ' ' THR . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 149' ' ' ILE . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 117' ' ' LEU . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 70' ' ' LYS . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 115' ' ' ARG . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 111.396 -0.271 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 CA-C-O 121.251 0.438 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 35' ' ' ILE . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 118.545 -0.741 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.402 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.407 . . . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -99.76 13.56 33.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.979 0.809 . . . . 0.0 111.792 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.39 88.98 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.538 1.135 . . . . 0.0 109.585 -173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 106' ' ' LEU . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 38' ' ' LEU . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -123.73 124.69 43.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -112.32 -65.86 1.14 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.432 1.093 . . . . 0.0 108.801 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 tttp 66.66 -60.99 0.33 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.12 1.368 . . . . 0.0 112.081 -166.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -77.66 137.15 38.37 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.239 1.016 . . . . 0.0 110.654 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -53.67 -42.6 68.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.445 -0.784 . . . . 0.0 112.065 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -133.34 34.4 3.52 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.348 0.659 . . . . 0.0 110.682 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.05 174.69 27.84 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 118.77 5.81 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.391 2.727 . . . . 0.0 109.102 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.926 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.653 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -34.05 -82.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -148.93 -178.37 6.32 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.41 68.64 2.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.554 1.142 . . . . 0.0 108.571 -170.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.75 84.48 1.94 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.799 1.639 . . . . 0.0 110.546 -165.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -51.91 -43.36 63.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.59 1.156 . . . . 0.0 112.262 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -53.65 -23.41 11.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.91 -13.45 62.44 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.51 -86.62 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 118.889 0.768 . . . . 0.0 112.884 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.7 p -70.96 179.27 2.79 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -35.03 -38.75 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.982 1.713 . . . . 0.0 113.499 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -168.2 125.71 1.11 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.675 1.19 . . . . 0.0 110.532 163.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.67 74.22 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.26 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.28 -178.68 0.58 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.434 1.492 . . . . 0.0 111.161 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.82 167.75 20.48 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 CA-C-N 120.279 2.04 . . . . 0.0 111.209 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER 66.92 -4.33 0.81 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.69 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 107.224 -168.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.5 -165.48 30.01 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 105.95 -2.86 . . . . 0.0 105.95 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.96 -53.45 12.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.247 1.419 . . . . 0.0 109.993 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -94.52 45.57 1.13 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.345 . . . . . . . 0 C--O 1.242 0.677 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.1 p -54.66 136.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 160.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 132.34 54.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 165.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 38' ' ' LEU . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD13 ' HA3' ' A' ' 33' ' ' GLY . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HG22 ' A' ' 31' ' ' VAL . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.74 126.67 55.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 29' ' ' VAL . 8.3 tp60 -91.26 -54.64 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.108 0.963 . . . . 0.0 108.408 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 tttt 74.25 -58.64 0.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 110.615 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -113.69 113.41 24.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.823 1.649 . . . . 0.0 109.554 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -46.61 -34.3 4.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.804 1.642 . . . . 0.0 112.762 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.932 0.893 . . . . 0.0 111.365 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.79 179.76 16.7 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.83 131.67 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.369 2.713 . . . . 0.0 111.61 -169.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 22' ' ' GLN . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 20' ' ' PHE . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.606 HG21 HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 14' ' ' VAL . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.739 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' O ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -153.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 69.11 -62.82 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.379 1.872 . . . . 0.0 110.296 -168.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 69.0 154.18 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.573 1.949 . . . . 0.0 110.168 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.9 t0 8.5 73.2 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.496 2.318 . . . . 0.0 115.782 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.33 -41.31 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.259 0.623 . . . . 0.0 111.794 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.657 HG21 HG21 ' A' ' 116' ' ' THR . 8.0 t -75.52 50.2 0.52 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.042 0.937 . . . . 0.0 112.282 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.73 10.59 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 126.027 1.731 . . . . 0.0 112.505 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.1 52.83 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.85 18.31 7.28 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.731 0.813 . . . . 0.0 112.197 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -71.59 -75.45 0.13 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.31 1.844 . . . . 0.0 113.207 -163.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -36.3 70.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.457 1.103 . . . . 0.0 111.503 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.68 52.07 5.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.999 0.92 . . . . 0.0 111.076 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.79 142.54 12.21 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.02 174.28 9.97 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 119.056 1.428 . . . . 0.0 110.736 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' SER . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -23.83 0.2 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 105' ' ' SER . 1.4 p -169.0 89.11 0.2 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 106.184 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 165.64 -142.38 7.65 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -67.67 -59.47 3.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -84.26 48.57 1.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.403 -0.811 . . . . 0.0 111.237 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.657 HG21 HG21 ' A' ' 54' ' ' THR . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.358 . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 117.224 -1.369 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -77.67 57.72 1.68 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.383 1.447 . . . . 0.0 111.203 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -159.3 78.0 0.72 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.714 2.006 . . . . 0.0 106.093 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 45' ' ' PHE . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.37 145.91 46.69 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -166.96 -67.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.357 1.463 . . . . 0.0 111.711 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 67.45 -52.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.766 2.026 . . . . 0.0 112.731 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -70.32 142.83 52.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.341 1.056 . . . . 0.0 110.028 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -56.86 -42.65 80.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.532 0.333 . . . . 0.0 110.772 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -136.8 21.55 3.08 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.152 1.381 . . . . 0.0 110.354 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.5 172.32 44.65 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.92 134.8 51.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.895 2.396 . . . . 0.0 110.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD12 ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.488 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.33 172.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 80.65 168.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.079 2.151 . . . . 0.0 111.161 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.37 -103.08 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.696 2.398 . . . . 0.0 106.129 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -80.16 78.9 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.427 -0.796 . . . . 0.0 110.581 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -162.18 -40.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.167 0.587 . . . . 0.0 112.212 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -75.2 46.43 0.32 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.725 1.61 . . . . 0.0 113.041 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.73 -41.61 3.23 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.785 2.034 . . . . 0.0 113.153 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.0 51.43 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 32.61 17.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 m -66.09 -66.26 0.57 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.441 1.096 . . . . 0.0 112.059 -168.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 p -78.2 -59.14 2.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.633 1.173 . . . . 0.0 107.901 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.99 66.1 1.3 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.821 1.248 . . . . 0.0 109.991 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.34 160.82 5.84 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.28 -171.05 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.72 1.613 . . . . 0.0 111.456 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.15 43.52 1.06 Allowed 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 p -175.29 169.49 3.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.707 1.603 . . . . 0.0 107.104 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.1 -152.99 46.06 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -85.04 -10.11 57.29 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.333 0.587 . . . . 0.0 111.689 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -13.62 31.19 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' HD12 ' A' ' 149' ' ' ILE . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 117' ' ' LEU . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -53.11 112.37 0.85 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.687 0.676 . . . . 0.0 109.71 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -129.8 143.56 50.87 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.707 1.603 . . . . 0.0 110.436 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 38' ' ' LEU . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HA3' ' A' ' 33' ' ' GLY . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.557 ' HD2' HG22 ' A' ' 31' ' ' VAL . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.18 148.67 43.36 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -117.72 -63.58 1.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.906 1.283 . . . . 0.0 109.035 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 71.29 -50.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.958 1.703 . . . . 0.0 112.235 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.15 -11.31 19.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.372 1.469 . . . . 0.0 112.817 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.21 -58.61 0.54 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.671 1.588 . . . . 0.0 110.749 -168.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -125.89 37.93 4.25 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.469 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.35 -159.91 13.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.759 0.695 . . . . 0.0 111.508 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.2 119.19 5.49 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.218 2.612 . . . . 0.0 109.64 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' HD2' ' A' ' 20' ' ' PHE . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.779 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 35' ' ' ILE . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 38' ' ' LEU . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.58 113.31 17.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 164.5 -47.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.603 2.761 . . . . 0.0 108.872 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 68.69 -68.01 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.266 1.426 . . . . 0.0 110.823 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -61.99 101.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.832 0.853 . . . . 0.0 111.732 -168.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -80.77 42.88 0.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.936 -1.102 . . . . 0.0 112.625 -169.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 49.6 p -56.11 -42.07 76.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.578 1.551 . . . . 0.0 112.419 -169.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -15.0 8.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.461 1.104 . . . . 0.0 113.072 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.04 51.88 1.05 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.75 32.93 22.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.558 0.743 . . . . 0.0 111.303 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 m -135.86 157.07 47.75 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.646 2.379 . . . . 0.0 105.903 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m 60.46 -79.56 0.02 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.894 0.878 . . . . 0.0 110.777 -169.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 45.8 -137.33 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -155.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.64 177.73 17.28 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 167.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.25 -174.07 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.708 2.939 . . . . 0.0 110.998 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.17 29.71 4.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 m -76.76 -135.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.352 1.061 . . . . 0.0 112.702 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.93 -73.94 0.9 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.89 -58.86 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.341 1.067 . . . . 0.0 109.936 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -73.19 -13.83 61.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 4' ' ' ALA . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.5 m 57.16 51.16 10.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.698 0.761 . . . . 0.0 110.631 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -75.61 156.98 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.21 138.42 40.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -126.02 -47.83 1.63 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.566 0.541 . . . . 0.0 111.04 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 67.91 -60.89 0.39 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.988 1.715 . . . . 0.0 110.859 -168.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.63 -22.97 60.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.375 1.07 . . . . 0.0 111.653 -165.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 74.31 -36.52 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.331 1.452 . . . . 0.0 111.681 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.05 -8.43 19.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.376 1.87 . . . . 0.0 112.205 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.33 -174.01 34.14 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.202 0.906 . . . . 0.0 112.144 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.17 118.64 5.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.251 1.967 . . . . 0.0 110.051 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 20' ' ' PHE . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.7 HD12 ' CE1' ' A' ' 43' ' ' HIS . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.7 ' CE1' HD12 ' A' ' 38' ' ' LEU . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -162.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 63.7 -175.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.179 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.41 -53.73 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.504 1.522 . . . . 0.0 109.151 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.52 89.17 1.54 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.127 0.971 . . . . 0.0 108.645 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -161.88 -47.66 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.028 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -69.43 65.82 0.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.407 1.083 . . . . 0.0 110.893 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.63 -29.5 17.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 0.0 112.398 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.54 -108.17 0.2 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.0 t -178.07 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.67 1.188 . . . . 0.0 110.717 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.5 m -51.64 136.81 26.22 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.925 -0.484 . . . . 0.0 110.118 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 68.2 -72.92 0.09 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.825 1.25 . . . . 0.0 109.448 -170.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.47 18.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.558 1.143 . . . . 0.0 110.818 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.11 142.44 0.53 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.46 175.45 5.99 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-N 119.789 1.795 . . . . 0.0 109.193 166.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.32 -13.52 58.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.4 m -70.16 141.72 52.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.827 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.59 146.19 0.16 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.779 1.181 . . . . 0.0 112.692 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.0 t70 78.76 -61.75 0.34 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.348 1.859 . . . . 0.0 110.495 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -77.06 -23.36 52.01 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.624 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 115' ' ' ARG . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.448 . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -139.99 39.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.946 0.779 . . . . 0.0 109.806 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -77.13 101.42 6.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 ' HA3' ' A' ' 33' ' ' GLY . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -144.03 145.23 32.06 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -109.77 -42.25 4.31 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.641 1.176 . . . . 0.0 110.323 172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 74.49 -49.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.064 1.346 . . . . 0.0 111.51 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.89 176.73 8.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.264 0.938 . . . . 0.0 110.447 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 m -99.94 -6.77 26.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.166 1.387 . . . . 0.0 111.901 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.01 34.04 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.713 -0.617 . . . . 0.0 111.02 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.63 177.81 22.94 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 142.84 48.46 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.809 2.339 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 1.2 tm-20 -76.77 68.25 2.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -148.3 177.39 9.46 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 109.719 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -139.97 -66.67 0.45 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.002 1.721 . . . . 0.0 110.245 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.76 90.24 3.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.029 0.931 . . . . 0.0 110.556 -173.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 60' ' ' ALA . 9.6 t-20 -77.39 46.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.6 0.76 . . . . 0.0 112.353 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p -59.41 -30.56 68.54 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.293 1.437 . . . . 0.0 112.039 -168.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.26 -17.82 5.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.923 1.289 . . . . 0.0 113.97 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 62.97 1.78 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m 45.05 28.23 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.342 2.257 . . . . 0.0 114.297 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -98.6 -66.6 0.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.472 1.109 . . . . 0.0 108.878 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -85.25 0.04 OUTLIER 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.44 ' HB2' HD22 ' A' ' 53' ' ' ASN . . . 52.06 -143.31 0.69 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -168.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.46 168.92 30.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.4 -177.99 3.93 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.31 2.673 . . . . 0.0 111.068 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 49' ' ' GLU . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.26 19.59 12.85 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -173.71 178.24 2.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.323 1.849 . . . . 0.0 106.3 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.13 56.02 9.6 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.36 -60.49 0.32 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 127.006 2.123 . . . . 0.0 112.338 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -73.74 42.49 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.468 1.507 . . . . 0.0 112.298 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.354 . . . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 3' ' ' LYS . 1.0 OUTLIER 68.02 -147.89 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.616 1.098 . . . . 0.0 112.224 150.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' H ' HG22 ' A' ' 2' ' ' THR . 1.0 OUTLIER -142.46 127.34 18.27 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.547 1.939 . . . . 0.0 108.982 -173.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.449 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' A' ' 31' ' ' VAL . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.52 143.57 45.94 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -128.76 -55.04 1.22 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.851 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttm 70.25 -53.14 0.64 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.632 1.173 . . . . 0.0 112.729 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -78.49 144.41 35.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.661 1.184 . . . . 0.0 108.834 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -59.24 -51.87 68.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.481 0.712 . . . . 0.0 109.554 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -126.25 38.31 4.16 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.153 0.981 . . . . 0.0 109.901 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.36 171.98 18.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 128.74 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.523 2.149 . . . . 0.0 109.647 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' HD2' ' A' ' 20' ' ' PHE . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.704 ' CE1' HD12 ' A' ' 38' ' ' LEU . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.61 -24.07 66.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 54' ' ' THR . 6.1 pt-20 -48.4 -45.88 36.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.764 0.826 . . . . 0.0 113.012 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 51.22 -133.48 1.76 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.989 1.315 . . . . 0.0 108.062 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.3 86.0 6.73 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.083 0.953 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -157.27 -51.59 0.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 50' ' ' GLU . 5.7 t -76.43 63.9 2.07 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.616 -0.678 . . . . 0.0 109.554 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.18 -45.48 22.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.18 0.992 . . . . 0.0 111.23 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.49 118.51 4.74 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 161.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.6 m -63.73 106.35 0.97 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.5 m -149.21 -68.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 m -58.46 -49.37 77.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.06 66.12 1.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.24 1.016 . . . . 0.0 109.853 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -40.12 149.12 0.16 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 128.509 2.957 . . . . 0.0 112.105 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.06 176.69 4.3 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 CA-C-N 118.232 1.016 . . . . 0.0 111.562 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.98 25.19 10.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 p -110.94 154.78 23.62 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.546 1.938 . . . . 0.0 108.842 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -27.09 -56.73 0.09 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.237 1.875 . . . . 0.0 112.092 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.71 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.085 2.954 . . . . 0.0 114.976 169.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -117.45 12.0 14.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' HD23 ' A' ' 126' ' ' LEU . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 124' ' ' ASP . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.398 . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 117.071 -1.442 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -158.66 -172.01 3.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.512 1.525 . . . . 0.0 108.119 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -129.08 148.22 51.01 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.75 0.82 . . . . 0.0 112.321 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD13 ' HA3' ' A' ' 33' ' ' GLY . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.34 126.42 33.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' HB2' HD13 ' A' ' 106' ' ' LEU . 1.4 tp60 -90.44 -66.77 0.9 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.8 -49.03 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.593 1.557 . . . . 0.0 112.702 -170.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -73.03 -7.97 53.64 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.995 1.318 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.05 -50.43 0.66 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.431 1.492 . . . . 0.0 111.896 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.93 41.93 1.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.298 0.639 . . . . 0.0 109.331 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.92 -170.33 11.85 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.46 130.01 35.34 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.148 2.565 . . . . 0.0 110.85 -166.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 35' ' ' ILE . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -150.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.318 2.8 pp20? 37.07 -143.71 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 164.85 -82.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.879 3.672 . . . . 0.0 106.74 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -77.55 77.1 4.07 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.411 -0.805 . . . . 0.0 110.796 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -158.1 -42.53 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.545 1.138 . . . . 0.0 111.219 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -73.68 51.05 0.35 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.35 -38.14 40.6 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.362 1.065 . . . . 0.0 111.922 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.9 0.95 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.132 0.872 . . . . 0.0 111.115 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -55.23 0.68 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.817 1.647 . . . . 0.0 112.439 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -53.3 154.5 3.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.977 1.311 . . . . 0.0 110.078 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m 83.76 4.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.698 1.999 . . . . 0.0 112.168 -173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 117.69 7.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 176.87 24.29 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.53 -179.3 3.15 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.955 1.77 . . . . 0.0 112.541 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.631 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 22' ' ' GLN . 6.7 mp -107.71 31.65 5.3 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 p -151.92 155.53 38.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.376 1.07 . . . . 0.0 108.905 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.97 -167.84 3.24 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -171.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.8 -16.78 30.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 122.066 -0.667 . . . . 0.0 112.332 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.12 -7.66 53.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 149' ' ' ILE . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 38' ' ' LEU . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 124' ' ' ASP . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 117' ' ' LEU . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 t -63.76 156.42 27.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.33 0.968 . . . . 0.0 109.147 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -157.42 117.8 3.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -138.72 147.15 42.36 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -99.26 -56.58 2.37 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.301 1.041 . . . . 0.0 109.622 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? 73.13 -52.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.16 114.38 28.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.44 1.096 . . . . 0.0 110.594 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -47.5 -31.44 4.27 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -124.7 32.61 5.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.339 0.518 . . . . 0.0 111.166 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.49 -179.66 21.05 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.84 0.733 . . . . 0.0 112.755 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.11 143.46 20.25 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.435 2.757 . . . . 0.0 109.228 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 19' ' ' ASN . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.691 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' CE1' HD12 ' A' ' 38' ' ' LEU . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 115' ' ' ARG . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -74.52 70.67 1.79 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 2.6 mm-40 -150.66 -179.95 7.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.733 0.813 . . . . 0.0 109.635 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.41 -73.86 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 125.941 2.026 . . . . 0.0 109.077 171.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.75 13.83 27.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 112.732 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.83 52.96 12.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.629 1.572 . . . . 0.0 110.151 -176.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.6 p -45.3 -35.71 3.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -165.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.1 -14.89 41.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 48.43 1.59 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.084 1.326 . . . . 0.0 111.624 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.05 12.91 8.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.436 1.094 . . . . 0.0 112.971 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -96.76 -59.9 1.71 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 126.879 2.071 . . . . 0.0 111.09 -168.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.39 88.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.503 2.321 . . . . 0.0 108.075 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . . . -94.0 -88.4 0.24 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 160.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.32 125.29 31.41 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.63 -174.16 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.343 1.571 . . . . 0.0 109.023 165.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.611 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD22 ' OD2' ' A' ' 101' ' ' ASP . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 97' ' ' VAL . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 87' ' ' VAL . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD2' HD22 ' A' ' 84' ' ' LEU . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -97.29 10.21 40.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.46 6.73 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 123.878 0.871 . . . . 0.0 110.098 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.91 -84.18 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.578 1.085 . . . . 0.0 114.371 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.84 -26.64 60.7 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.292 0.568 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -58.05 -48.78 79.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.486 ' OD1' HD23 ' A' ' 126' ' ' LEU . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 ' HA3' ' A' ' 73' ' ' GLY . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.718 HG21 HG12 ' A' ' 112' ' ' ILE . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.405 . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -152.64 69.66 0.87 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 149.01 41.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.601 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 167.75 9.92 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -152.87 -43.81 0.1 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.098 0.559 . . . . 0.0 110.233 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.17 -50.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.87 1.668 . . . . 0.0 110.89 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -77.47 -17.7 57.8 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.802 1.241 . . . . 0.0 112.814 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 74.94 -39.87 0.42 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.027 0.831 . . . . 0.0 111.734 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -127.46 33.46 4.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.918 -1.114 . . . . 0.0 111.049 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.23 -164.64 13.93 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.63 1.11 . . . . 0.0 111.339 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.49 134.02 34.29 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.47 2.113 . . . . 0.0 109.435 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 43' ' ' HIS . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.634 ' CE1' HD12 ' A' ' 38' ' ' LEU . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.66 63.03 1.09 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -131.24 173.48 11.01 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.968 1.307 . . . . 0.0 108.957 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.74 101.95 1.03 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.141 2.576 . . . . 0.0 104.776 168.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 t0 29.85 66.78 0.11 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.71 2.004 . . . . 0.0 114.515 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 -54.61 0.67 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.04 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -69.64 67.06 0.23 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.103 0.865 . . . . 0.0 112.015 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.1 66.56 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.544 -1.347 . . . . 0.0 111.595 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.89 -8.41 73.11 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.998 -0.335 . . . . 0.0 113.057 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.5 t 41.09 45.71 2.39 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.854 2.462 . . . . 0.0 114.141 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -80.48 -60.34 2.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.049 0.54 . . . . 0.0 111.04 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.6 p 176.45 51.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.8 -1.188 . . . . 0.0 110.118 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.2 -115.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.82 121.23 26.0 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.839 1.2 . . . . 0.0 112.121 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.97 -165.14 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.99 1.794 . . . . 0.0 109.413 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.25 7.98 38.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 p -146.4 174.62 11.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.488 1.515 . . . . 0.0 108.545 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.05 -162.18 27.75 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -67.36 -20.54 65.58 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 122.583 1.183 . . . . 0.0 111.724 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.6 -15.48 54.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB3' HD23 ' A' ' 126' ' ' LEU . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 124' ' ' ASP . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 6' ' ' ALA . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 p -79.07 -162.7 0.41 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -165.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -77.99 114.96 17.37 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 9.4 tm-20 -122.23 154.53 37.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 29' ' ' VAL . 43.6 tt0 -149.45 -56.08 0.19 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.094 0.95 . . . . 0.0 111.576 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER 69.58 -50.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.34 2.656 . . . . 0.0 111.966 -173.195 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -45.86 -22.71 0.21 Allowed 'General case' 0 C--N 1.342 0.26 0 C-N-CA 128.365 2.666 . . . . 0.0 114.638 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t 81.31 -44.03 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.537 1.135 . . . . 0.0 110.727 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -128.31 10.5 6.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.13 1.372 . . . . 0.0 112.44 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.75 -167.68 42.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.8 131.4 18.37 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.438 2.092 . . . . 0.0 110.465 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 35' ' ' ILE . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 166.65 8.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 80.25 174.92 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.049 2.54 . . . . 0.0 110.797 -174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -178.22 162.03 1.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.904 2.882 . . . . 0.0 107.138 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t0 27.51 65.59 0.08 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.753 3.221 . . . . 0.0 114.682 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -161.86 -47.58 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.22 1.008 . . . . 0.0 109.363 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.9 p -82.07 51.58 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.858 0.863 . . . . 0.0 111.673 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.14 -41.96 1.91 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 112.491 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.98 58.3 0.67 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 56.1 57.96 4.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.241 0.616 . . . . 0.0 112.115 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.9 p -89.68 -87.28 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.677 -0.639 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.9 m -84.22 18.33 2.2 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.896 0.879 . . . . 0.0 112.7 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.43 111.48 0.23 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.908 1.283 . . . . 0.0 111.109 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.8 171.24 22.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.11 173.99 9.59 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 120.903 1.069 . . . . 0.0 109.988 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.22 15.81 4.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 p -165.86 174.34 9.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.425 1.09 . . . . 0.0 108.109 -167.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.0 59.15 8.93 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 69.88 -35.63 0.32 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.418 2.287 . . . . 0.0 113.562 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -86.95 5.62 36.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.703 ' HB2' HD12 ' A' ' 149' ' ' ILE . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' HD23 ' A' ' 126' ' ' LEU . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD23 ' OD1' ' A' ' 124' ' ' ASP . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 115' ' ' ARG . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.357 . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 116.683 -1.627 . . . . 0.0 108.122 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.4 p -159.31 -160.5 0.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.733 2.013 . . . . 0.0 105.814 163.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -47.37 122.08 4.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.325 0.511 . . . . 0.0 110.181 155.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 117' ' ' LEU . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -99.26 149.33 23.22 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.491 ' HB2' HG22 ' A' ' 29' ' ' VAL . 3.3 tp60 -163.63 -66.31 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 67.37 -50.87 0.5 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.748 1.619 . . . . 0.0 112.244 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.51 158.95 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.897 1.279 . . . . 0.0 113.01 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.9 t -73.23 -40.88 64.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.674 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -140.58 38.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.85 1.26 . . . . 0.0 109.576 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.94 49.94 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.65 116.98 4.61 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.689 2.26 . . . . 0.0 109.113 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 22' ' ' GLN . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CE1' HD12 ' A' ' 38' ' ' LEU . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -62.14 179.32 0.3 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 76.12 -175.96 0.12 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.942 2.097 . . . . 0.0 109.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -152.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.62 92.0 3.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.936 1.695 . . . . 0.0 107.852 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -168.58 -54.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.07 0.948 . . . . 0.0 109.365 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 t -70.02 60.93 0.18 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.61 1.164 . . . . 0.0 111.133 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.19 -36.29 51.47 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.45 -1.406 . . . . 0.0 112.031 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 -9.97 67.28 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.965 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 48.29 50.38 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.98 1.712 . . . . 0.0 111.979 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.2 -60.64 1.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.141 0.976 . . . . 0.0 108.907 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.4 -38.22 58.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.525 2.33 . . . . 0.0 112.967 -171.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.07 118.14 1.4 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.965 0.791 . . . . 0.0 108.961 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.33 -131.58 2.55 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.36 -160.91 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.992 1.795 . . . . 0.0 113.092 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD13 ' CB ' ' A' ' 22' ' ' GLN . 7.6 mp -98.84 21.04 12.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.5 p -172.74 -169.23 0.56 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.017 1.327 . . . . 0.0 108.843 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.01 -71.77 2.7 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.73 -53.06 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 107.181 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -69.57 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.29 1.436 . . . . 0.0 113.214 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' ALA . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 8' ' ' LEU . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.397 . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.3 p -78.93 83.93 5.0 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.065 0.848 . . . . 0.0 109.126 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 97.4 5.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 167.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -123.2 155.77 36.44 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 29' ' ' VAL . 1.9 tm0? -135.88 -56.58 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.177 1.791 . . . . 0.0 108.779 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 72.8 -52.61 0.71 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.685 1.994 . . . . 0.0 110.035 -169.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.75 166.67 19.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.479 1.512 . . . . 0.0 111.874 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 m -86.04 -34.44 20.73 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -133.28 44.71 2.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.559 1.144 . . . . 0.0 109.461 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.33 -174.24 32.75 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.77 132.43 15.74 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.417 2.078 . . . . 0.0 109.123 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 22' ' ' GLN . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 43' ' ' HIS . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CG ' HD23 ' A' ' 38' ' ' LEU . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -173.74 2.44 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 69.98 -47.38 0.61 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.192 2.597 . . . . 0.0 114.324 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 73.15 -63.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.31 1.444 . . . . 0.0 111.041 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.25 67.79 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.41 1.484 . . . . 0.0 112.724 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.8 57.16 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 120.798 -1.189 . . . . 0.0 110.083 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.5 p -55.27 -34.48 64.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.196 1.398 . . . . 0.0 112.225 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.07 -18.75 26.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.773 1.229 . . . . 0.0 113.772 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.04 -92.36 0.26 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.0 t -142.42 15.21 2.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.297 0.57 . . . . 0.0 111.899 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -137.44 103.12 4.98 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m 178.19 -51.16 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 127.455 2.302 . . . . 0.0 108.485 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.54 -78.1 0.02 OUTLIER 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.533 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.25 30.31 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.18 -161.6 0.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.817 3.012 . . . . 0.0 110.774 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.37 36.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -176.63 178.14 1.3 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.636 1.174 . . . . 0.0 108.443 -168.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.67 -72.02 2.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.02 -53.87 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.512 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -70.83 28.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.695 1.198 . . . . 0.0 113.591 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.616 ' HG2' HD12 ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' HD11 ' A' ' 149' ' ' ILE . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 38' ' ' LEU . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.7 m -51.27 128.37 22.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.141 0.901 . . . . 0.0 109.347 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -142.33 151.84 42.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.964 0.906 . . . . 0.0 109.014 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 38' ' ' LEU . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 33' ' ' GLY . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.84 134.99 50.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HB2' HG23 ' A' ' 29' ' ' VAL . 2.4 tt0 -153.89 77.25 1.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 108.713 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -57.4 -40.62 78.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.764 -0.585 . . . . 0.0 109.921 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -87.51 111.35 21.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.0 108.262 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -42.22 -47.61 4.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.086 1.354 . . . . 0.0 112.974 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.55 45.94 1.93 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.65 0.78 . . . . 0.0 109.725 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.27 176.58 16.18 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 171.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.43 127.17 16.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.761 2.974 . . . . 0.0 111.023 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.794 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 35' ' ' ILE . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' HD12 ' A' ' 38' ' ' LEU . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 115' ' ' ARG . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.25 -55.68 2.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -146.4 178.21 8.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.494 1.518 . . . . 0.0 107.774 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.9 -46.8 89.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.015 0.37 . . . . 0.0 110.153 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -42.41 106.84 0.07 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.193 1.397 . . . . 0.0 112.325 -165.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -141.65 76.77 1.56 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.8 p -50.79 -37.54 43.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 112.82 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.03 -16.78 47.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.183 0.993 . . . . 0.0 113.655 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 67.71 1.07 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.699 1.142 . . . . 0.0 112.275 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 9.6 m 42.36 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.549 1.94 . . . . 0.0 112.107 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.1 m -152.03 -51.46 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.121 -0.987 . . . . 0.0 111.024 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -148.72 -77.88 0.15 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.716 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 53' ' ' ASN . . . 30.81 -105.74 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.419 1.488 . . . . 0.0 112.052 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.54 112.97 5.4 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.5 -169.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.531 1.487 . . . . 0.0 109.144 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' ILE . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.659 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.34 6.08 44.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.8 p -160.54 -158.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.613 -0.68 . . . . 0.0 109.232 -169.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.45 -71.77 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -165.56 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.452 1.596 . . . . 0.0 107.247 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -70.47 10.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 47' ' ' VAL . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.535 HG21 HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.412 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.1 m-70 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 112' ' ' ILE . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.37 . . . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 t -79.33 174.85 11.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 130.9 12.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 HD22 ' A' ' 38' ' ' LEU . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -100.17 120.69 40.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -106.11 66.51 0.72 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 63.72 3.75 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.01 -1.056 . . . . 0.0 109.539 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 178.39 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.336 2.254 . . . . 0.0 111.554 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t 81.82 -51.87 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.696 1.598 . . . . 0.0 109.843 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -112.56 6.6 18.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.647 0.779 . . . . 0.0 111.877 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.17 -164.91 26.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -174.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.36 118.61 5.76 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.106 1.871 . . . . 0.0 110.88 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.619 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' HD12 ' A' ' 38' ' ' LEU . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -136.64 177.03 8.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.754 1.615 . . . . 0.0 110.269 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.2 65.34 5.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 64.43 8.38 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.612 1.196 . . . . 0.0 112.07 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -23.26 63.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.774 -1.204 . . . . 0.0 110.932 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.95 -38.78 17.52 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 128.563 2.745 . . . . 0.0 112.329 172.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.78 -10.23 59.07 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.08 41.6 2.07 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.777 1.656 . . . . 0.0 111.78 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.51 -64.12 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.522 1.929 . . . . 0.0 113.137 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.7 p -79.46 54.85 1.81 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.419 1.487 . . . . 0.0 110.342 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 m -167.98 -67.57 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.927 1.691 . . . . 0.0 108.105 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.82 -128.05 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.812 1.245 . . . . 0.0 110.852 -171.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.51 159.29 24.9 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.04 -166.24 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.18 2.587 . . . . 0.0 110.641 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.53 19.97 15.86 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.0 p -172.4 -165.24 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 109.364 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 -73.28 2.7 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.03 -60.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -74.35 53.81 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.972 0.909 . . . . 0.0 109.985 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 HG23 ' A' ' 118' ' ' VAL . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 146' ' ' CYS . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' H ' ' HB3' ' A' ' 86' ' ' ASN . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . 0.495 ' HA ' HG22 ' A' ' 118' ' ' VAL . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.43 . . . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.8 t -117.83 54.32 0.91 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.239 1.019 . . . . 0.0 108.535 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -80.53 121.98 26.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 HG12 ' A' ' 18' ' ' ILE . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 145' ' ' ALA . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 HD13 ' A' ' 8' ' ' LEU . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -114.67 151.45 33.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -155.36 54.69 0.63 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.662 1.185 . . . . 0.0 108.453 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 32.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.093 -1.005 . . . . 0.0 113.302 -177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -119.63 -14.03 9.11 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.498 1.919 . . . . 0.0 111.069 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m 73.24 -52.14 0.7 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.639 1.576 . . . . 0.0 112.601 176.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -135.42 45.58 2.45 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 124.088 0.955 . . . . 0.0 108.6 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.15 -179.46 16.14 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.27 151.58 80.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.632 2.221 . . . . 0.0 111.402 -171.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CG ' HD21 ' A' ' 38' ' ' LEU . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 117' ' ' LEU . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.78 84.09 3.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' OE2' ' HB1' ' A' ' 60' ' ' ALA . 1.5 pt-20 -177.22 -159.7 0.05 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.611 1.964 . . . . 0.0 107.384 175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 -165.54 2.09 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.966 1.706 . . . . 0.0 109.219 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.06 83.26 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.507 1.123 . . . . 0.0 110.868 172.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -144.38 -54.14 0.33 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 124.534 1.134 . . . . 0.0 110.36 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p -74.57 62.96 1.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.5 -36.86 16.07 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.759 -1.213 . . . . 0.0 113.407 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -27.17 62.22 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.482 0.563 . . . . 0.0 113.321 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.5 t 59.72 45.34 13.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.927 1.691 . . . . 0.0 111.288 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.3 m -98.93 -81.56 0.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.963 1.305 . . . . 0.0 110.05 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -66.47 -51.52 55.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB1' ' OE2' ' A' ' 50' ' ' GLU . . . 65.62 -102.61 0.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.98 35.19 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.15 168.57 23.73 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.502 1.651 . . . . 0.0 109.699 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 104' ' ' ILE . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' ILE . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.718 HG22 HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -99.45 24.55 7.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -155.16 166.85 32.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.733 1.213 . . . . 0.0 110.151 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 -149.6 51.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.83 -34.64 71.89 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.986 -0.714 . . . . 0.0 110.469 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.61 -22.8 67.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 45' ' ' PHE . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 120' ' ' HIS . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.416 ' H ' HG12 ' A' ' 118' ' ' VAL . 80.1 m-70 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 119' ' ' VAL . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 106' ' ' LEU . 2.1 m -166.55 135.88 3.03 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -176.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.98 84.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.288 1.435 . . . . 0.0 107.924 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 HD13 ' HA3' ' A' ' 33' ' ' GLY . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -126.09 138.05 53.67 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.408 ' OE1' HG23 ' A' ' 29' ' ' VAL . 10.2 tt0 -161.71 80.85 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.921 2.088 . . . . 0.0 106.244 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -28.67 67.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.912 -1.117 . . . . 0.0 108.946 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.7 mp0 -59.4 124.47 20.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.088 2.555 . . . . 0.0 110.064 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 m -50.32 -42.01 52.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.349 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -139.83 42.0 1.98 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.406 0.683 . . . . 0.0 109.363 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.22 52.27 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.42 139.93 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.528 2.819 . . . . 0.0 109.09 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.408 HG23 ' OE1' ' A' ' 22' ' ' GLN . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 35' ' ' ILE . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE2' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -74.03 70.76 1.56 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -149.01 177.93 9.14 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.32 -111.9 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.829 1.252 . . . . 0.0 108.901 168.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -104.71 103.5 13.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.185 0.994 . . . . 0.0 108.7 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -165.9 -41.56 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.345 1.058 . . . . 0.0 109.75 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 t -77.17 59.06 1.68 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.642 0.734 . . . . 0.0 110.34 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -40.17 66.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.006 1.323 . . . . 0.0 112.608 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.98 -101.11 0.33 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.054 -2.019 . . . . 0.0 108.054 170.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.13 34.51 0.1 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.904 0.859 . . . . 0.0 110.36 165.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -119.94 139.66 52.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.215 1.806 . . . . 0.0 106.687 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 m 108.6 -45.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.519 3.128 . . . . 0.0 111.307 -169.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -24.46 102.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.225 1.81 . . . . 0.0 113.098 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.84 -176.34 12.19 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.57 -174.83 1.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.398 1.399 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.795 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.812 ' CD1' HG23 ' A' ' 2' ' ' THR . 7.7 mt -76.28 38.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -156.11 146.35 21.54 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.936 1.294 . . . . 0.0 108.608 -174.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.25 -177.93 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -161.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.61 -14.81 55.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.155 0.982 . . . . 0.0 112.818 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -72.03 -17.77 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.341 1.056 . . . . 0.0 112.726 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 4' ' ' ALA . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ARG . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.442 . . . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.446 HG21 ' N ' ' A' ' 23' ' ' LYS . 5.2 t -120.63 97.52 5.6 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.926 0.89 . . . . 0.0 109.638 -169.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 90.19 1.72 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.95 157.61 30.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.78 -65.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.103 0.561 . . . . 0.0 110.811 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 2' ' ' THR . 12.4 tmtt? 72.84 -44.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 113.857 168.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.72 -10.93 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.849 0.86 . . . . 0.0 112.676 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 t 74.86 -55.46 0.65 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.817 2.047 . . . . 0.0 109.161 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -129.49 48.22 2.4 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.06 -167.86 12.24 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.72 129.14 18.16 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.597 2.198 . . . . 0.0 111.306 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD21 ' CG ' ' A' ' 43' ' ' HIS . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CG ' HD21 ' A' ' 38' ' ' LEU . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -63.85 -179.43 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.64 -163.92 0.22 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.101 1.76 . . . . 0.0 112.106 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -152.42 -110.17 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.35 137.72 57.69 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 120.428 1.467 . . . . 0.0 110.595 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 164.86 -38.31 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 127.969 2.508 . . . . 0.0 109.714 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -79.43 44.14 0.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.055 0.942 . . . . 0.0 112.681 -166.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.47 -40.16 1.71 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.757 2.023 . . . . 0.0 113.313 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.51 51.59 0.74 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.19 40.34 28.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.826 0.822 . . . . 0.0 110.795 173.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 p -73.06 -84.96 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -170.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -104.8 -50.37 3.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.527 1.131 . . . . 0.0 109.773 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 68.17 -65.65 0.25 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 125.161 1.384 . . . . 0.0 111.574 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.42 171.49 20.03 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.2 179.71 6.25 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.49 . . . . 0.0 109.398 163.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.4 18.34 20.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -169.7 158.37 7.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.23 -174.19 34.64 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.16 -39.08 63.3 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.494 1.118 . . . . 0.0 110.608 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -74.04 7.94 2.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.29 1.036 . . . . 0.0 113.314 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 149' ' ' ILE . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 115' ' ' ARG . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 22' ' ' GLN 2.319 . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.5 p -128.45 -176.31 3.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.149 1.34 . . . . 0.0 113.371 -162.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -109.53 138.18 46.27 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.588 1.555 . . . . 0.0 109.528 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -72.75 131.74 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 3.4 tm0? -136.16 73.04 1.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 169.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -94.65 29.03 2.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.797 -1.814 . . . . 0.0 109.907 -174.509 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 21.0 mp0 -132.9 -24.94 1.88 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.377 1.071 . . . . 0.0 111.748 -165.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.71 -62.71 0.45 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.678 1.191 . . . . 0.0 109.5 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.31 37.8 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.3 1.44 . . . . 0.0 110.1 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.83 178.42 17.48 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.97 145.31 85.2 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.631 2.22 . . . . 0.0 110.786 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 35' ' ' ILE . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 38' ' ' LEU . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.26 72.93 2.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -139.8 -169.16 2.65 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.441 1.496 . . . . 0.0 108.184 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.56 -152.07 0.29 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.534 1.534 . . . . 0.0 109.605 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -71.99 76.64 0.92 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.885 0.874 . . . . 0.0 110.916 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.23 -43.34 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.407 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.5 p -75.24 55.16 0.74 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.373 0.669 . . . . 0.0 112.082 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.27 -44.22 71.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.101 0.961 . . . . 0.0 110.708 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.52 36.22 4.49 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.59 38.67 30.28 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.024 0.93 . . . . 0.0 112.264 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 m -52.25 -80.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.399 1.88 . . . . 0.0 114.868 -164.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 t -80.4 -54.18 5.94 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.13 1.71 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.602 1.161 . . . . 0.0 109.766 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -47.71 153.46 1.59 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.695 1.617 . . . . 0.0 110.638 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.77 -175.04 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.651 1.567 . . . . 0.0 112.361 -167.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 97' ' ' VAL . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 HG11 ' A' ' 87' ' ' VAL . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD11 HD11 ' A' ' 112' ' ' ILE . 9.5 mp -103.66 27.16 7.71 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.5 p -155.03 171.24 20.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.389 0.675 . . . . 0.0 109.811 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.66 -162.17 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.1 -18.84 65.64 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.455 -1.026 . . . . 0.0 111.916 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -88.06 2.4 51.99 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 106' ' ' LEU . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' HD12 ' A' ' 117' ' ' LEU . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 m -138.64 53.36 1.78 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 150.35 20.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.031 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HD13 ' HA3' ' A' ' 33' ' ' GLY . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.07 28.43 Favored 'General case' 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.2 -55.05 0.31 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.019 1.328 . . . . 0.0 109.958 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 63.55 -62.45 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.397 1.479 . . . . 0.0 112.305 -167.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.83 116.85 29.52 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.2 m -41.9 -36.45 1.07 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.372 1.469 . . . . 0.0 114.234 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.63 39.61 3.89 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.401 0.68 . . . . 0.0 110.785 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.61 172.9 15.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.699 1.142 . . . . 0.0 110.796 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.99 134.17 38.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.746 2.964 . . . . 0.0 110.783 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.41 -179.91 5.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 68.34 -62.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.327 2.251 . . . . 0.0 111.882 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 98.78 -58.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.818 2.847 . . . . 0.0 109.958 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.92 100.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 111.563 -170.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -85.65 59.83 5.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.333 -0.855 . . . . 0.0 110.126 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 p -60.53 -40.47 91.61 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.427 0.691 . . . . 0.0 111.034 -172.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.19 -18.71 16.83 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.263 1.425 . . . . 0.0 113.583 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.49 82.57 1.49 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.8 t 45.55 63.96 1.6 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.565 1.546 . . . . 0.0 110.946 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.3 t -166.13 84.19 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.771 -0.581 . . . . 0.0 109.819 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.0 m -64.21 98.5 0.23 Allowed 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.014 -1.054 . . . . 0.0 110.146 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.75 -50.63 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 110.978 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.02 145.63 29.69 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.724 1.154 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 -171.13 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.784 2.322 . . . . 0.0 112.483 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 67' ' ' LEU . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 66' ' ' PRO . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.512 ' CA ' HD22 ' A' ' 126' ' ' LEU . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp -97.29 15.79 21.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 p -173.66 -162.47 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.89 -71.23 2.62 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -162.27 -58.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -75.47 56.53 0.87 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.442 1.497 . . . . 0.0 111.399 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 4' ' ' ALA . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.512 HD22 ' CA ' ' A' ' 73' ' ' GLY . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . 0.251 0.2 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 117' ' ' LEU . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.438 . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 2' ' ' THR . 7.2 t -161.54 76.2 0.51 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 109.261 -174.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.04 74.57 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 117' ' ' LEU . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 HD22 ' A' ' 38' ' ' LEU . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.17 145.75 50.64 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.401 ' CG ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -142.93 -63.66 0.41 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.364 1.066 . . . . 0.0 110.003 -172.565 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 74.75 -55.6 0.65 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.221 1.408 . . . . 0.0 111.914 177.224 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -58.92 -20.21 49.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.633 178.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m 74.84 -34.93 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.428 1.891 . . . . 0.0 112.256 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -131.44 18.12 4.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.22 1.008 . . . . 0.0 111.931 172.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.86 -160.36 33.94 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.23 136.2 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.181 1.921 . . . . 0.0 110.875 -178.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG23 ' CG ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 35' ' ' ILE . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 38' ' ' LEU . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' NE2' ' OD2' ' A' ' 124' ' ' ASP . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 118' ' ' VAL . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.54 -161.04 0.34 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 62.77 -61.5 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.741 2.017 . . . . 0.0 113.3 -171.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 65.56 -81.36 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.081 1.752 . . . . 0.0 110.157 -175.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.95 72.41 0.57 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.479 1.112 . . . . 0.0 110.261 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -166.91 -47.36 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.573 0.749 . . . . 0.0 110.55 -179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -82.12 51.62 1.81 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.204 0.526 . . . . 0.0 111.737 -172.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -38.32 -42.85 0.75 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.98 2.112 . . . . 0.0 113.331 -175.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.58 63.72 0.59 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 173.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 53.69 41.44 32.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.678 0.751 . . . . 0.0 109.817 172.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.8 m -107.85 -70.88 0.78 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.701 1.2 . . . . 0.0 109.891 -167.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 m -55.05 -34.33 63.45 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.264 0.626 . . . . 0.0 110.975 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 55.76 52.38 10.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.168 0.587 . . . . 0.0 110.167 170.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -39.18 138.52 0.94 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 126.894 2.188 . . . . 0.0 111.934 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.93 160.04 46.11 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.599 1.699 . . . . 0.0 110.783 -170.363 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.517 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 29' ' ' VAL . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.33 20.49 9.26 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 -178.83 0.85 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -165.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.87 -88.83 1.48 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -176.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.34 -63.47 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -172.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -80.43 46.96 0.89 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.082 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 8' ' ' LEU . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 48' ' ' HIS . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' OD2' ' NE2' ' A' ' 46' ' ' HIS . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.34 . . . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 116.672 -1.632 . . . . 0.0 107.734 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER 58.0 64.45 1.52 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.376 1.048 . . . . 0.0 113.672 159.165 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.86 54.83 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.637 -0.664 . . . . 0.0 110.652 -176.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -122.01 150.55 41.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -143.11 -59.31 0.43 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 122.664 0.386 . . . . 0.0 110.694 -176.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? 77.22 -43.84 0.44 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.225 1.41 . . . . 0.0 111.075 175.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -14.32 59.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.418 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 76.24 -40.91 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.036 1.334 . . . . 0.0 112.308 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -137.28 34.5 2.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.236 1.415 . . . . 0.0 109.801 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.3 -160.95 10.55 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.279 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.18 119.85 6.96 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 119.75 1.775 . . . . 0.0 111.377 -174.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' CG ' HD21 ' A' ' 38' ' ' LEU . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.24 155.74 39.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 46.74 -162.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.921 2.488 . . . . 0.0 112.487 -168.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.04 -42.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.62 1.568 . . . . 0.0 112.186 -175.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.17 82.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.59 1.556 . . . . 0.0 113.543 -170.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -91.74 36.68 0.96 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.789 -1.194 . . . . 0.0 112.49 -169.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.2 p -54.49 -46.48 73.43 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.363 1.465 . . . . 0.0 111.726 -175.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.0 -16.55 5.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.936 1.294 . . . . 0.0 113.777 176.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.03 83.11 1.53 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -176.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.0 t 56.22 25.82 9.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.08 . . . . 0.0 112.895 170.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 m -114.77 -64.07 1.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.355 1.462 . . . . 0.0 110.023 -169.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.7 m -47.15 -50.76 19.76 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.731 1.212 . . . . 0.0 112.41 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.46 123.17 3.98 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 123.603 0.564 . . . . 0.0 110.556 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.11 -167.45 11.78 Favored Glycine 0 N--CA 1.445 -0.721 0 O-C-N 125.088 1.493 . . . . 0.0 111.085 -161.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.87 -168.1 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.218 1.279 . . . . 0.0 109.81 170.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 35' ' ' ILE . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.545 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.45 10.61 29.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.5 p -153.74 -159.05 0.93 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.365 -0.834 . . . . 0.0 110.203 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.57 -69.61 2.57 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.319 0.961 . . . . 0.0 111.335 174.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.67 -63.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -175.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 44.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.63 2.772 . . . . 0.0 112.693 171.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.436 ' HB2' HD12 ' A' ' 149' ' ' ILE . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.725 HD11 ' CD1' ' A' ' 117' ' ' LEU . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -78.01 58.82 2.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.711 0.804 . . . . 0.0 109.831 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? -154.65 87.0 1.14 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.569 1.548 . . . . 0.0 106.954 176.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 -118.26 138.87 52.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' A' ' 29' ' ' VAL . 3.7 tp60 -174.97 115.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 129.077 2.951 . . . . 0.0 105.058 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.63 8.8 27.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.378 0.671 . . . . 0.0 111.479 -178.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -132.71 154.86 49.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 107.77 -171.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -75.78 -21.56 57.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.905 -0.497 . . . . 0.0 111.386 174.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.07 21.54 2.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.182 0.593 . . . . 0.0 111.723 -171.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.17 179.51 42.37 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.36 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.077 2.518 . . . . 0.0 109.569 175.074 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 104' ' ' ILE . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' A' ' 35' ' ' ILE . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CG ' HD21 ' A' ' 38' ' ' LEU . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.87 171.03 7.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 65.11 -176.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.685 1.994 . . . . 0.0 112.401 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -140.46 -86.8 0.19 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 107.228 178.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -94.99 118.41 31.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.469 1.107 . . . . 0.0 109.82 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 174.06 -42.76 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 127.472 2.309 . . . . 0.0 107.722 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.421 ' HA ' HG22 ' A' ' 58' ' ' THR . 7.7 t -74.03 49.86 0.35 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.193 1.797 . . . . 0.0 112.732 -177.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -39.02 -53.82 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.81 2.044 . . . . 0.0 110.731 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.32 58.8 0.7 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.87 40.81 5.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 163.056 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 t -86.9 55.17 3.45 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.35 -0.844 . . . . 0.0 111.62 -173.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 t 70.72 -63.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.924 -1.11 . . . . 0.0 111.826 -176.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 75.05 -76.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 127.489 2.316 . . . . 0.0 108.731 -170.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.41 170.27 43.18 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.05 -172.45 1.27 Allowed 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.901 2.401 . . . . 0.0 110.207 175.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 29' ' ' VAL . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.29 25.25 7.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.1 p -155.21 174.31 15.39 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.22 -153.54 52.9 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.51 -43.89 75.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.702 0.763 . . . . 0.0 109.176 172.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -49.75 -26.88 4.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.196 2.198 . . . . 0.0 115.148 -174.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 149' ' ' ILE . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 115' ' ' ARG . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.381 . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -82.43 156.76 23.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 160.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -145.71 140.8 27.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.701 HD11 HD23 ' A' ' 117' ' ' LEU . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 38' ' ' LEU . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 10.2 tm-20 -100.57 126.12 47.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 29' ' ' VAL . 6.4 tt0 -149.43 143.87 25.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 165.666 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -135.36 16.06 3.44 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.326 1.05 . . . . 0.0 109.929 179.815 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -137.68 154.79 49.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.84 2.056 . . . . 0.0 106.128 -177.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -61.41 -51.46 68.67 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.303 0.573 . . . . 0.0 109.72 171.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -122.18 31.15 6.28 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.285 1.034 . . . . 0.0 110.652 -167.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.97 160.76 24.25 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 175.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.88 118.56 5.53 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.096 2.53 . . . . 0.0 109.714 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 35' ' ' ILE . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.511 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.42 -144.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 71.84 -55.81 0.65 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.409 1.459 . . . . 0.0 111.187 -167.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 59.89 -95.97 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.611 1.164 . . . . 0.0 109.404 -169.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -103.61 88.81 3.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.543 0.737 . . . . 0.0 109.033 -178.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -40.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 177.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 54' ' ' THR . 7.0 t -77.02 42.1 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.899 1.679 . . . . 0.0 112.398 -173.523 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.18 -38.95 27.56 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.768 1.227 . . . . 0.0 112.808 -170.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.78 38.48 1.87 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 57.88 85.57 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.119 0.967 . . . . 0.0 112.962 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.8 m -124.64 -79.9 0.62 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.515 0.726 . . . . 0.0 109.217 176.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -52.2 -47.46 65.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.557 1.543 . . . . 0.0 112.993 -172.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 54.45 51.44 14.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.27 1.028 . . . . 0.0 113.349 170.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.59 162.72 5.18 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 125.81 1.672 . . . . 0.0 111.541 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.38 -175.16 2.52 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.179 1.919 . . . . 0.0 111.474 -173.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 35' ' ' ILE . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.541 HD12 HG11 ' A' ' 29' ' ' VAL . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 12.23 16.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.1 -171.89 1.88 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -167.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.7 -73.11 2.46 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.32 -64.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.939 0.896 . . . . 0.0 108.787 -170.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -67.69 8.34 0.38 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.701 HD23 HD11 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.405 ' NE2' HG21 ' A' ' 137' ' ' THR . 2.2 tm0? -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.405 HG21 ' NE2' ' A' ' 133' ' ' GLN . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.533 . . . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -163.1 -179.55 6.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.99 0.814 . . . . 0.0 110.14 -173.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -76.84 125.29 29.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.315 1.846 . . . . 0.0 111.707 168.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -126.27 140.21 52.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -134.96 -63.88 0.68 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.564 0.697 . . . . 0.0 109.846 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt 67.62 -43.2 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 114.253 -177.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.46 157.22 20.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.386 1.448 . . . . 0.0 109.319 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -77.44 -28.84 52.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.02 36.61 0.55 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.448 1.099 . . . . 0.0 108.716 -175.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.43 172.64 24.27 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 177.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -62.25 135.57 54.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.249 1.966 . . . . 0.0 109.657 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -166.93 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 56.57 -163.66 0.16 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.775 1.23 . . . . 0.0 111.702 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.08 -108.61 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -71.5 97.52 1.68 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.955 1.252 . . . . 0.0 110.158 171.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -157.93 -44.95 0.06 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.855 0.462 . . . . 0.0 111.116 172.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 1.5 t -78.36 48.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.401 -0.812 . . . . 0.0 111.72 -174.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.17 -39.47 43.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.638 1.175 . . . . 0.0 112.285 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.14 2.47 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 175.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 57.13 30.76 18.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 117.893 0.847 . . . . 0.0 111.655 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.8 m -48.88 -57.84 5.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.778 2.031 . . . . 0.0 112.191 -175.624 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.41 -51.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.989 1.716 . . . . 0.0 108.921 -175.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . 59.95 -86.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.54 1.136 . . . . 0.0 110.263 -170.282 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.01 165.69 29.81 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.47 -170.64 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.646 2.231 . . . . 0.0 109.987 173.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' THR . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 104' ' ' ILE . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.3 mp -93.96 33.18 1.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 m -82.47 -103.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -167.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 -86.46 0.23 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.38 -51.52 34.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.671 0.736 . . . . 0.0 110.735 170.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -80.33 -18.2 49.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.521 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 70' ' ' LYS . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.9 p -74.23 -175.07 2.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.534 1.534 . . . . 0.0 110.248 -172.885 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -135.89 104.34 5.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 175.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -137.67 157.05 47.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -110.19 -94.82 0.42 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.468 0.707 . . . . 0.0 110.867 -175.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm 148.51 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 128.356 2.662 . . . . 0.0 106.528 -175.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -150.94 141.94 23.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -166.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -39.67 -45.3 1.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.535 1.534 . . . . 0.0 112.356 175.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -116.35 37.36 3.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.296 1.438 . . . . 0.0 109.443 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.83 163.14 16.19 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 172.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.46 138.72 61.33 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.063 1.842 . . . . 0.0 109.712 177.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB2' HG21 ' A' ' 35' ' ' ILE . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 38' ' ' LEU . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -147.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.4 -55.08 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.372 2.269 . . . . 0.0 114.869 -174.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 68.16 -83.54 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.26 1.424 . . . . 0.0 109.809 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.43 76.88 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.58 1.152 . . . . 0.0 109.479 -176.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -163.5 -52.45 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 174.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.4 t -77.1 55.18 1.12 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.426 0.691 . . . . 0.0 111.279 -176.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.88 -43.21 49.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.533 1.533 . . . . 0.0 112.482 -177.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.04 -101.2 0.74 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 171.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.64 31.27 0.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.444 -0.445 . . . . 0.0 110.383 168.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.2 m -71.42 -71.46 0.26 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.033 0.933 . . . . 0.0 110.972 -167.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 m -59.97 -48.99 79.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.805 0.842 . . . . 0.0 109.995 -178.112 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.46 57.49 4.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.003 1.321 . . . . 0.0 112.015 176.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.06 157.94 5.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.206 1.384 . . . . 0.0 110.812 -178.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.51 -174.03 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.222 1.948 . . . . 0.0 112.987 -164.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 80' ' ' HIS . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 65' ' ' ASN . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 31' ' ' VAL . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 101' ' ' ASP . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp -92.74 33.97 1.11 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.2 p -154.52 167.94 28.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.665 0.786 . . . . 0.0 108.898 -173.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.91 -159.56 27.47 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -176.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -64.63 -31.56 72.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.975 1.71 . . . . 0.0 110.352 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.04 -33.18 75.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 -178.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.409 . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 m -71.34 106.95 4.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -124.57 150.8 45.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.612 1.565 . . . . 0.0 107.945 179.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 38' ' ' LEU . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 154.59 24.64 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' CG ' HD13 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -136.35 -59.02 0.74 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 127.171 2.188 . . . . 0.0 108.752 175.164 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt 72.18 -57.68 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.312 1.445 . . . . 0.0 110.925 -171.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.52 -24.16 29.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.634 1.573 . . . . 0.0 111.864 -176.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 78.38 -28.87 0.16 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 -175.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -122.46 25.89 8.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.591 1.157 . . . . 0.0 110.421 174.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.9 -176.68 22.95 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.33 132.18 45.07 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.433 2.089 . . . . 0.0 109.018 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 20' ' ' PHE . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 35' ' ' ILE . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.562 ' CE1' HD12 ' A' ' 38' ' ' LEU . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -77.94 72.04 4.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 8.1 mt-10 -115.42 -62.14 1.64 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.629 0.371 . . . . 0.0 111.72 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 58.19 -139.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.934 1.294 . . . . 0.0 110.993 171.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.83 71.99 1.52 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.365 -0.834 . . . . 0.0 109.83 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 -38.88 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.638 0.775 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' HG22 ' A' ' 58' ' ' THR . 10.2 t -66.99 56.29 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.902 1.681 . . . . 0.0 113.395 174.388 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.11 -31.96 63.74 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.263 -0.898 . . . . 0.0 111.873 178.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.22 53.0 0.53 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 176.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.21 44.56 30.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.609 0.764 . . . . 0.0 111.481 175.2 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.4 t -73.77 -170.19 0.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.687 0.795 . . . . 0.0 110.59 -177.234 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 t -55.53 -40.64 72.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.097 0.959 . . . . 0.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.43 -111.78 0.4 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.641 0.776 . . . . 0.0 111.511 179.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.79 145.85 11.62 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.797 -1.002 . . . . 0.0 110.851 176.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo 10.42 154.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 130.747 7.631 . . . . 0.0 122.112 155.453 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.503 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD13 ' CG ' ' A' ' 22' ' ' GLN . 6.3 mp -94.05 17.91 11.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -108.07 140.08 41.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.385 1.474 . . . . 0.0 108.737 -178.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -19.75 -60.75 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 127.762 2.601 . . . . 0.0 112.971 -173.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.41 -69.22 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.284 3.033 . . . . 0.0 114.342 173.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -121.43 4.63 10.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 177.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.503 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 106' ' ' LEU 2.406 . . . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 115.804 -2.046 . . . . 0.0 106.88 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t 176.57 -144.27 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 127.008 2.123 . . . . 0.0 109.169 -174.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.74 126.35 47.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 110.392 172.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 149' ' ' ILE . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 38' ' ' LEU . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -105.41 137.59 42.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.62 ' HB2' HG23 ' A' ' 29' ' ' VAL . 1.5 tm0? -168.1 106.97 0.51 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 175.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.01 28.12 8.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.841 0.856 . . . . 0.0 110.703 -175.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -116.07 -16.83 11.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.546 1.139 . . . . 0.0 111.542 -178.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 t 73.22 -53.11 0.7 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.184 1.394 . . . . 0.0 110.318 -169.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.88 27.92 9.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.223 1.009 . . . . 0.0 111.703 -178.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 169.2 19.57 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.17 130.29 19.78 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.383 2.055 . . . . 0.0 108.679 174.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.792 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.597 ' CE1' HD12 ' A' ' 38' ' ' LEU . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.408 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.72 -112.64 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' HB3' ' A' ' 48' ' ' HIS 0.273 4.6 pm0 45.91 -108.44 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.819 1.648 . . . . 0.0 112.89 -175.372 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 70.67 2.6 4.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 112.256 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.64 -168.8 2.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.165 1.386 . . . . 0.0 110.078 175.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -25.98 68.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.805 0.842 . . . . 0.0 111.493 172.417 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -74.92 59.22 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.405 1.002 . . . . 0.0 110.276 175.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.81 -22.97 62.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.579 0.752 . . . . 0.0 111.247 175.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.85 145.69 45.51 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.92 49.67 0.55 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.448 1.499 . . . . 0.0 111.153 -173.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.4 m -114.38 -100.43 0.43 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.477 1.111 . . . . 0.0 109.356 -172.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 t -71.64 -79.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.231 -2.136 . . . . 0.0 105.231 167.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 50.47 -117.92 1.13 Allowed 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.27 166.17 34.08 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.834 1.197 . . . . 0.0 112.132 177.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.3 -172.28 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.232 2.622 . . . . 0.0 110.039 174.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 135' ' ' THR . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -82.36 14.69 2.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.29 -174.23 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -174.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.16 -81.44 1.75 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -170.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -154.28 -55.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.667 1.587 . . . . 0.0 108.405 -177.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 38.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.884 1.674 . . . . 0.0 112.718 -177.507 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 149' ' ' ILE . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 117' ' ' LEU . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.436 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 70' ' ' LYS . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 115' ' ' ARG . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 t -165.12 74.99 0.24 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 120.573 1.533 . . . . 0.0 110.893 -157.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.96 76.0 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.968 0.907 . . . . 0.0 108.657 -176.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.15 124.57 42.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.668 ' HB2' HG23 ' A' ' 29' ' ' VAL . 1.6 tt0 -140.77 71.72 1.37 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.409 1.084 . . . . 0.0 109.165 177.448 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -65.0 -18.99 65.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.554 -1.341 . . . . 0.0 113.057 -175.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 148.07 30.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.58 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 m -67.33 -50.36 60.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.742 -0.598 . . . . 0.0 109.905 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -129.03 34.01 4.5 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.587 0.755 . . . . 0.0 111.071 -171.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.48 177.36 18.93 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.395 2.73 . . . . 0.0 111.396 -170.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.668 HG23 ' HB2' ' A' ' 22' ' ' GLN . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -48.53 -75.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.19 162.83 13.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.132 0.573 . . . . 0.0 110.2 178.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.35 -27.72 13.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.593 1.157 . . . . 0.0 114.058 176.268 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -73.5 75.25 1.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.032 0.92 . . . . 0.0 110.937 -167.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -108.75 51.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.004 0.921 . . . . 0.0 110.779 -167.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 p -54.02 -27.07 29.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.031 0.932 . . . . 0.0 112.858 -177.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.09 -22.85 52.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.878 0.871 . . . . 0.0 113.289 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.53 -112.05 0.5 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.65 -26.5 5.7 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.559 0.744 . . . . 0.0 112.751 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -152.46 121.69 6.71 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.9 t -168.47 -44.15 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.365 1.866 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.98 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.775 1.63 . . . . 0.0 112.554 -175.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.16 139.69 11.11 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -175.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.61 -163.31 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.942 2.428 . . . . 0.0 111.029 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 35' ' ' ILE . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.44 5.58 51.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.7 m -61.3 171.8 1.29 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.069 0.948 . . . . 0.0 111.273 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -51.19 -89.71 0.01 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.203 0.906 . . . . 0.0 113.684 -172.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -82.84 56.78 3.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.505 1.145 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -154.69 -44.15 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.981 1.312 . . . . 0.0 109.451 -169.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.402 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.452 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 106' ' ' LEU . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 38' ' ' LEU . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 N--CA 1.45 -1.041 0 N-CA-C 109.102 -1.153 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.926 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.653 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 N--CA 1.452 -0.942 0 N-CA-C 111.209 -0.343 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 38' ' ' LEU . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 HD13 ' HA3' ' A' ' 33' ' ' GLY . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HG22 ' A' ' 31' ' ' VAL . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.455 -0.772 0 CA-C-O 120.953 0.314 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 20' ' ' PHE . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.606 HG21 HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 14' ' ' VAL . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.739 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.553 ' O ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.448 -1.184 0 N-CA-C 110.736 -0.524 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.448 0.642 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.493 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 45' ' ' PHE . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 . . . . . 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 HD12 ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.488 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.448 -1.194 0 CA-C-O 121.373 0.489 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' HD12 ' A' ' 149' ' ' ILE . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.48 HD21 ' CB ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.48 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 117' ' ' LEU . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.834 0.35 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 38' ' ' LEU . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HA3' ' A' ' 33' ' ' GLY . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.557 ' HD2' HG22 ' A' ' 31' ' ' VAL . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.449 -1.109 0 N-CA-C 109.64 -0.946 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' HD2' ' A' ' 20' ' ' PHE . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.779 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 35' ' ' ILE . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 38' ' ' LEU . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 N--CA 1.454 -0.847 0 N-CA-C 110.998 -0.424 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 4' ' ' ALA . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 110.051 -0.788 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 20' ' ' PHE . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.7 HD12 ' CE1' ' A' ' 43' ' ' HIS . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.7 ' CE1' HD12 ' A' ' 38' ' ' LEU . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 N--CA 1.45 -1.087 0 N-CA-C 109.193 -1.118 . . . . 0.0 109.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.624 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.527 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 115' ' ' ARG . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 ' HA3' ' A' ' 33' ' ' GLY . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 . . . . . 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 N--CA 1.453 -0.875 0 N-CA-C 110.102 -0.768 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 1.2 tm-20 . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.454 -0.85 0 CA-C-O 121.397 0.499 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 49' ' ' GLU . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.453 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.449 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' A' ' 31' ' ' VAL . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.057 0 N-CA-C 109.647 -0.944 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' HD2' ' A' ' 20' ' ' PHE . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.704 ' CE1' HD12 ' A' ' 38' ' ' LEU . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo . . . . . 0 N--CA 1.445 -1.372 0 CA-C-O 121.449 0.521 . . . . 0.0 111.562 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' HD23 ' A' ' 126' ' ' LEU . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 124' ' ' ASP . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.515 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD13 ' HA3' ' A' ' 33' ' ' GLY . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo . . . . . 0 N--CA 1.454 -0.795 0 N-CA-C 110.85 -0.481 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 35' ' ' ILE . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.449 -1.091 0 CA-C-O 121.552 0.563 . . . . 0.0 112.541 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.631 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.7 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 149' ' ' ILE . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 38' ' ' LEU . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 124' ' ' ASP . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 117' ' ' LEU . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 . . . . . 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo . . . . . 0 N--CA 1.449 -1.105 0 N-CA-C 109.228 -1.105 . . . . 0.0 109.228 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 19' ' ' ASN . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.691 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.578 ' CE1' HD12 ' A' ' 38' ' ' LEU . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 115' ' ' ARG . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 . . . . . 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.448 -1.148 0 N-CA-C 109.023 -1.184 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.611 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD22 ' OD2' ' A' ' 101' ' ' ASP . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 97' ' ' VAL . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 87' ' ' VAL . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD2' HD22 ' A' ' 84' ' ' LEU . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.486 ' OD1' HD23 ' A' ' 126' ' ' LEU . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 ' HA3' ' A' ' 73' ' ' GLY . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.577 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.718 HG21 HG12 ' A' ' 112' ' ' ILE . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.601 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.456 -0.716 0 N-CA-C 109.435 -1.025 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 43' ' ' HIS . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.634 ' CE1' HD12 ' A' ' 38' ' ' LEU . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 N--CA 1.448 -1.173 0 N-CA-C 109.413 -1.034 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB3' HD23 ' A' ' 126' ' ' LEU . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 124' ' ' ASP . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.54 HD22 ' H ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.47 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.54 ' H ' HD22 ' A' ' 131' ' ' ASN . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 6' ' ' ALA . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.453 -0.903 0 N-CA-C 110.465 -0.629 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 35' ' ' ILE . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo . . . . . 0 N--CA 1.442 -1.526 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.703 ' HB2' HD12 ' A' ' 149' ' ' ILE . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' HD23 ' A' ' 126' ' ' LEU . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD23 ' OD1' ' A' ' 124' ' ' ASP . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.436 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 115' ' ' ARG . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 117' ' ' LEU . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.451 -0.974 0 N-CA-C 109.113 -1.149 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CE1' HD12 ' A' ' 38' ' ' LEU . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 . . . . . 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 122.229 0.845 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.437 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' ALA . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 8' ' ' LEU . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.505 HD21 ' CB ' ' A' ' 133' ' ' GLN . 1.3 t30 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.505 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.491 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 . . . . . 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo . . . . . 0 N--CA 1.45 -1.078 0 N-CA-C 109.123 -1.145 . . . . 0.0 109.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 43' ' ' HIS . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CG ' HD23 ' A' ' 38' ' ' LEU . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.448 -1.153 0 CA-C-O 121.432 0.513 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.447 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.616 ' HG2' HD12 ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' HD11 ' A' ' 149' ' ' ILE . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 38' ' ' LEU . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt . . . . . 0 N--CA 1.447 -0.595 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 38' ' ' LEU . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 33' ' ' GLY . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 111.023 -0.414 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.794 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 35' ' ' ILE . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' HD12 ' A' ' 38' ' ' LEU . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.412 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 115' ' ' ARG . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.453 -0.893 0 N-CA-C 109.144 -1.137 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' ILE . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.659 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 47' ' ' VAL . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.535 HG21 HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.412 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.1 m-70 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.464 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 112' ' ' ILE . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 HD22 ' A' ' 38' ' ' LEU . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 110.88 -0.469 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.619 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' HD12 ' A' ' 38' ' ' LEU . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.453 -0.907 0 N-CA-C 110.641 -0.561 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 HG23 ' A' ' 118' ' ' VAL . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 146' ' ' CYS . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.449 ' H ' ' HB3' ' A' ' 86' ' ' ASN . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 134' ' ' SER . 4.9 t30 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.438 ' HB3' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.471 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . 0.495 ' HA ' HG22 ' A' ' 118' ' ' VAL . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 HG12 ' A' ' 18' ' ' ILE . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 145' ' ' ALA . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 HD13 ' A' ' 8' ' ' LEU . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 . . . . . 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 121.292 0.455 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CG ' HD21 ' A' ' 38' ' ' LEU . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 117' ' ' LEU . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.45 -1.067 0 N-CA-C 109.699 -0.923 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 104' ' ' ILE . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' ILE . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.718 HG22 HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 45' ' ' PHE . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 120' ' ' HIS . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.416 ' H ' HG12 ' A' ' 118' ' ' VAL . 80.1 m-70 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 119' ' ' VAL . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 HD13 ' HA3' ' A' ' 33' ' ' GLY . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 N--CA 1.454 -0.828 0 N-CA-C 109.09 -1.158 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 35' ' ' ILE . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE2' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.449 -1.128 0 N-CA-C 110.819 -0.493 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.795 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 HD11 ' A' ' 113' ' ' ILE . 7.7 mt . . . . . 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 . . . . . 0 CA--C 1.529 0.157 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 4' ' ' ALA . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ARG . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.14 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo . . . . . 0 N--CA 1.452 -0.967 0 N-CA-C 111.306 -0.305 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD21 ' CG ' ' A' ' 43' ' ' HIS . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CG ' HD21 ' A' ' 38' ' ' LEU . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 . . . . . 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.453 -0.887 0 N-CA-C 109.398 -1.039 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.498 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 149' ' ' ILE . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.517 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 115' ' ' ARG . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.448 -1.187 0 N-CA-C 110.786 -0.505 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 35' ' ' ILE . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 38' ' ' LEU . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 N--CA 1.449 -1.124 0 CA-C-O 121.496 0.54 . . . . 0.0 112.361 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 97' ' ' VAL . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.742 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 HG11 ' A' ' 87' ' ' VAL . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD11 HD11 ' A' ' 112' ' ' ILE . 9.5 mp . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 . . . . . 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 106' ' ' LEU . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.457 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' HD12 ' A' ' 117' ' ' LEU . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HD13 ' HA3' ' A' ' 33' ' ' GLY . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 110.783 -0.506 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.446 -1.307 0 CA-C-O 122.667 1.028 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 67' ' ' LEU . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 66' ' ' PRO . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.512 ' CA ' HD22 ' A' ' 126' ' ' LEU . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.525 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 120.454 0.169 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 4' ' ' ALA . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.512 HD22 ' CA ' ' A' ' 73' ' ' GLY . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.426 HE21 ' C ' ' A' ' 133' ' ' GLN 0.251 0.0 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.436 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 117' ' ' LEU . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 117' ' ' LEU . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 HD22 ' A' ' 38' ' ' LEU . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 110.875 -0.471 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG11 ' CD1' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 35' ' ' ILE . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.428 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 38' ' ' LEU . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.408 ' NE2' ' OD2' ' A' ' 124' ' ' ASP . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 118' ' ' VAL . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.446 -1.299 0 N-CA-C 110.783 -0.507 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.517 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 29' ' ' VAL . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.618 -0.23 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 8' ' ' LEU . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 48' ' ' HIS . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' OD2' ' NE2' ' A' ' 46' ' ' HIS . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.491 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 121.024 0.44 . . . . 0.0 110.652 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 N--CA 1.455 -0.783 0 N-CA-C 111.377 -0.278 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.476 ' CG ' HD21 ' A' ' 38' ' ' LEU . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.444 -1.438 0 N-CA-C 109.81 -0.881 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 35' ' ' ILE . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.545 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.436 ' HB2' HD12 ' A' ' 149' ' ' ILE . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 134' ' ' SER . 1.8 t30 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.463 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.725 HD11 ' CD1' ' A' ' 117' ' ' LEU . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? . . . . . 0 N--CA 1.455 -0.2 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.862 0 N-CA-C 109.569 -0.973 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 104' ' ' ILE . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' A' ' 35' ' ' ILE . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CG ' HD21 ' A' ' 38' ' ' LEU . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo . . . . . 0 N--CA 1.448 -1.152 0 N-CA-C 110.207 -0.728 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 29' ' ' VAL . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 149' ' ' ILE . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.4 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.633 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 115' ' ' ARG . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.701 HD11 HD23 ' A' ' 117' ' ' LEU . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 38' ' ' LEU . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 . . . . . 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.714 -0.918 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 104' ' ' ILE . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 35' ' ' ILE . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.511 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 N--CA 1.445 -1.359 0 CA-C-O 120.8 0.25 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 35' ' ' ILE . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.541 HD12 HG11 ' A' ' 29' ' ' VAL . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 . . . . . 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.701 HD23 HD11 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.442 HD21 ' CB ' ' A' ' 133' ' ' GLN . 0.1 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.442 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 121.615 0.721 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo . . . . . 0 N--CA 1.45 -1.059 0 N-CA-C 109.657 -0.94 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo . . . . . 0 N--CA 1.451 -1.01 0 N-CA-C 109.987 -0.813 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' THR . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 104' ' ' ILE . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.3 mp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 70' ' ' LYS . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo . . . . . 0 N--CA 1.45 -1.053 0 N-CA-C 109.712 -0.919 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB2' HG21 ' A' ' 35' ' ' ILE . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 38' ' ' LEU . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 N--CA 1.45 -1.036 0 CA-C-O 121.705 0.627 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 80' ' ' HIS . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 65' ' ' ASN . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 31' ' ' VAL . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 101' ' ' ASP . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 . . . . . 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.433 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 38' ' ' LEU . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 109.018 -1.185 . . . . 0.0 109.018 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 20' ' ' PHE . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 35' ' ' ILE . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.562 ' CE1' HD12 ' A' ' 38' ' ' LEU . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo . . . . . 0 CA--C 1.542 0.899 0 N-CA-C 122.112 3.851 . . . . 0.0 122.112 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.473 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.562 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 121.55 0.69 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 149' ' ' ILE . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 38' ' ' LEU . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? . . . . . 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.451 -0.997 0 N-CA-C 108.679 -1.316 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.792 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.597 ' CE1' HD12 ' A' ' 38' ' ' LEU . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 0 N--CA 1.448 -1.16 0 N-CA-C 110.039 -0.793 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 135' ' ' THR . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 149' ' ' ILE . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 117' ' ' LEU . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.438 HD22 ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.438 ' H ' HD22 ' A' ' 131' ' ' ASN . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 70' ' ' LYS . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 115' ' ' ARG . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 N-CA-C 111.396 -0.271 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 . . . . . 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.54 0.803 0 CA-C-O 121.251 0.438 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 35' ' ' ILE . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 118.545 -0.741 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.402 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.494 HD22 ' H ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 131' ' ' ASN . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.446 -1.288 0 N-CA-C 110.328 -0.681 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.45 -1.048 0 CA-C-O 121.375 0.49 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.407 . . . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.2 t -99.76 13.56 33.24 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.979 0.809 . . . . 0.0 111.792 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.39 88.98 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.538 1.135 . . . . 0.0 109.585 -173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.501 ' CB ' HD21 ' A' ' 106' ' ' LEU . . . -122.99 158.11 31.2 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.582 1.153 . . . . 0.0 108.926 176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 p -139.4 153.73 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -174.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.81 111.43 8.14 Favored 'General case' 0 CA--C 1.523 -0.082 0 CA-C-N 118.909 0.777 . . . . 0.0 108.933 165.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -85.81 100.05 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.768 0.794 . . . . 0.0 109.333 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.63 142.75 55.02 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.301 1.04 . . . . 0.0 109.87 171.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -157.93 146.67 19.25 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.198 1.799 . . . . 0.0 107.587 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -126.96 -163.0 11.36 Favored Glycine 0 C--N 1.333 0.394 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.52 -39.52 93.93 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.243 0.617 . . . . 0.0 110.091 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.92 -167.97 33.38 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.93 -2.66 12.61 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.473 2.782 . . . . 0.0 112.468 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG23 HD22 ' A' ' 38' ' ' LEU . 3.6 p -44.06 116.15 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 123.929 0.892 . . . . 0.0 110.071 164.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -148.41 154.56 40.08 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.199 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.42 129.85 2.55 Favored Glycine 0 C--O 1.222 -0.653 0 CA-C-N 119.516 1.053 . . . . 0.0 113.481 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.9 mp -88.59 106.6 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.81 150.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.68 141.41 50.92 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.769 2.028 . . . . 0.0 107.503 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.57 130.84 38.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 109.447 173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -123.73 124.69 43.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.15 0.98 . . . . 0.0 109.83 170.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.0 tp60 -112.32 -65.86 1.14 Allowed 'General case' 0 C--N 1.343 0.284 0 C-N-CA 124.432 1.093 . . . . 0.0 108.801 174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 tttp 66.66 -60.99 0.33 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.12 1.368 . . . . 0.0 112.081 -166.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -77.66 137.15 38.37 Favored 'General case' 0 C--O 1.227 -0.125 0 C-N-CA 124.239 1.016 . . . . 0.0 110.654 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.1 p -53.67 -42.6 68.08 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.445 -0.784 . . . . 0.0 112.065 178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -133.34 34.4 3.52 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.348 0.659 . . . . 0.0 110.682 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.05 174.69 27.84 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.934 -0.467 . . . . 0.0 111.934 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.76 118.77 5.81 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.391 2.727 . . . . 0.0 109.102 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 104' ' ' ILE . 0.3 OUTLIER -70.91 152.13 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -108.28 128.85 55.1 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 164.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -125.12 138.78 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 3.7 p90 -160.49 169.36 23.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.49 -171.19 43.46 Favored Glycine 0 CA--C 1.508 -0.359 0 CA-C-O 118.433 -1.204 . . . . 0.0 110.41 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.0 p -161.03 103.21 1.29 Allowed 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.926 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -71.82 167.9 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 C-N-CA 119.804 -0.758 . . . . 0.0 109.457 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -154.17 95.22 1.81 Allowed 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 170.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.62 10.92 0.65 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-N 115.055 -0.975 . . . . 0.0 113.753 168.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.926 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -73.45 177.11 5.49 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.48 1.14 . . . . 0.0 109.309 167.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.5 t -88.95 166.04 14.19 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 160.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.58 157.19 4.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.402 0.681 . . . . 0.0 111.7 172.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.44 -175.72 21.22 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -78.75 135.86 37.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.831 -0.217 . . . . 0.0 110.541 -173.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.653 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.6 m-70 -126.64 119.88 28.12 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.189 1.396 . . . . 0.0 109.379 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.03 142.35 42.13 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.63 121.55 16.62 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 123.789 0.835 . . . . 0.0 108.8 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -147.73 157.22 43.44 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.274 -0.571 . . . . 0.0 112.531 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.05 98.79 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -71.99 155.53 40.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -34.05 -82.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.165 2.186 . . . . 0.0 112.098 -171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -148.93 -178.37 6.32 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -75.41 68.64 2.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.554 1.142 . . . . 0.0 108.571 -170.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.75 84.48 1.94 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.799 1.639 . . . . 0.0 110.546 -165.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -51.91 -43.36 63.36 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.59 1.156 . . . . 0.0 112.262 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.8 t -53.65 -23.41 11.16 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.91 -13.45 62.44 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.51 -86.62 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-N 118.889 0.768 . . . . 0.0 112.884 168.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.7 p -70.96 179.27 2.79 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.6 t -35.03 -38.75 0.09 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.982 1.713 . . . . 0.0 113.499 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.3 m -168.2 125.71 1.11 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.675 1.19 . . . . 0.0 110.532 163.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -170.67 74.22 0.06 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.98 -0.534 . . . . 0.0 111.26 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.28 -178.68 0.58 Allowed Glycine 0 C--N 1.341 0.811 0 C-N-CA 125.434 1.492 . . . . 0.0 111.161 173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.82 167.75 20.48 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 CA-C-N 120.279 2.04 . . . . 0.0 111.209 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -49.85 116.17 1.69 Allowed 'General case' 0 C--N 1.344 0.362 0 O-C-N 121.846 -0.534 . . . . 0.0 109.603 169.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.31 132.14 50.05 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -146.78 73.51 12.45 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.615 1.166 . . . . 0.0 112.543 -171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.65 -35.77 5.63 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.994 2.463 . . . . 0.0 111.12 -172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.06 -5.38 57.91 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.815 0.446 . . . . 0.0 110.828 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.72 57.67 3.6 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.619 0.768 . . . . 0.0 110.878 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.68 175.16 5.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 173.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -82.98 166.49 18.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 121.014 -1.054 . . . . 0.0 109.512 168.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 63.7 t60 -72.69 155.2 40.23 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.103 0.961 . . . . 0.0 110.749 -175.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.56 -141.85 3.79 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 164.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.37 -178.38 15.36 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.82 1.2 . . . . 0.0 110.243 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -57.66 -32.86 95.65 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.419 2.079 . . . . 0.0 112.04 -177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -89.83 5.01 48.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 117.835 -1.079 . . . . 0.0 113.432 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -96.39 161.02 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.907 1.231 . . . . 0.0 110.387 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -39.9 71.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.942 175.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -105.99 108.22 19.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -145.38 131.79 19.67 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -73.87 171.89 12.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.46 -48.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 C-N-CA 123.228 0.611 . . . . 0.0 111.518 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -110.11 38.77 3.16 Favored Glycine 0 C--N 1.337 0.61 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.87 -174.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -88.45 75.09 8.47 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 117.724 0.762 . . . . 0.0 110.868 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -83.89 44.18 0.98 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.446 0.698 . . . . 0.0 109.722 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.97 -107.83 0.01 OUTLIER Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.392 1.949 . . . . 0.0 113.698 -171.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -141.3 162.91 34.34 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.8 1.24 . . . . 0.0 110.007 -177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -116.37 176.27 2.58 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 C-N-CA 125.438 1.495 . . . . 0.0 107.188 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 89.7 m -121.76 122.87 40.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.63 1.172 . . . . 0.0 108.498 -178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -92.36 140.44 29.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.067 0.547 . . . . 0.0 110.699 173.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -67.11 170.64 6.63 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.499 1.92 . . . . 0.0 110.847 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -19.7 9.55 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.782 2.033 . . . . 0.0 113.064 166.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.62 1.49 46.41 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.008 0.923 . . . . 0.0 110.361 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 77.71 31.07 51.05 Favored Glycine 0 CA--C 1.526 0.776 0 O-C-N 121.564 -0.71 . . . . 0.0 112.548 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 55.4 t -113.71 122.0 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 126.467 1.907 . . . . 0.0 107.24 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.565 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -111.65 105.35 13.86 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 174.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.62 109.36 17.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 124.799 1.312 . . . . 0.0 108.122 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -87.42 148.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.5 m -168.86 95.62 0.35 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 125.456 1.502 . . . . 0.0 108.479 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 tt -146.02 -174.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 124.043 0.937 . . . . 0.0 108.538 178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.54 148.97 29.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.203 1.401 . . . . 0.0 107.224 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -147.73 160.66 42.47 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.0 m -127.96 5.71 5.98 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.691 1.596 . . . . 0.0 112.887 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.41 -47.49 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 119.428 1.013 . . . . 0.0 109.356 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 HG11 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -76.15 -169.33 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.206 1.002 . . . . 0.0 111.833 -177.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -148.03 -19.53 0.35 Allowed 'General case' 0 C--N 1.341 0.229 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 4' ' ' ALA . 0.4 OUTLIER 66.92 -4.33 0.81 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 121.078 1.763 . . . . 0.0 112.701 176.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 170.69 85.91 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 107.224 -168.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 150.5 -165.48 30.01 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 105.95 -2.86 . . . . 0.0 105.95 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.96 -53.45 12.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.247 1.419 . . . . 0.0 109.993 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -94.52 45.57 1.13 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.255 0.55 . . . . 0.0 111.162 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.7 t -46.06 109.24 0.17 Allowed 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 154.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.8 pt -82.19 -9.51 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 122.567 0.347 . . . . 0.0 111.665 170.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.2 mm -56.78 121.54 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.07 -17.18 41.62 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 124.006 0.816 . . . . 0.0 112.542 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -76.8 174.83 10.04 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.125 0.962 . . . . 0.0 111.305 -175.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 96.8 m -118.86 99.03 6.5 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 125.069 1.347 . . . . 0.0 109.155 -169.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -91.45 122.26 33.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.7 t -132.51 142.17 43.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.07 149.43 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -113.17 153.15 28.74 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 111.061 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -57.81 -58.6 7.65 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 123.294 0.371 . . . . 0.0 110.552 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -92.8 173.22 7.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.983 0.897 . . . . 0.0 109.986 -170.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.77 141.18 58.41 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.85 174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 12.6 t0 -60.49 128.02 34.59 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 162.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -79.48 14.64 1.53 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.548 1.939 . . . . 0.0 112.324 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.27 38.87 18.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 36.81 40.04 0.45 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.875 2.179 . . . . 0.0 115.07 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 6.03 19.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.65 0.725 . . . . 0.0 112.498 -178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.01 -2.78 19.58 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 114.918 0.727 . . . . 0.0 114.918 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 33.43 85.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 118.548 1.174 . . . . 0.0 112.16 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.18 133.16 15.12 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 mp0 -31.33 -67.55 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 126.868 2.067 . . . . 0.0 111.703 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.0 -67.06 0.29 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 124.373 1.069 . . . . 0.0 111.233 -177.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.99 -57.68 2.75 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 128.157 2.583 . . . . 0.0 113.247 167.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.9 p -72.36 0.32 10.4 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.646 -0.659 . . . . 0.0 112.209 -174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -112.82 -32.46 6.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.39 2.276 . . . . 0.0 109.814 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 68.7 p -125.67 -28.88 3.22 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.52 14.1 45.4 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 125.846 1.689 . . . . 0.0 110.006 -170.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.5 t30 55.89 26.81 10.17 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.698 1.749 . . . . 0.0 111.018 176.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.24 -0.45 28.64 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.648 -168.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.19 -167.83 54.03 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 121.346 -0.846 . . . . 0.0 111.363 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.1 m -61.14 156.83 17.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 122.643 1.211 . . . . 0.0 111.694 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -92.18 99.58 12.35 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.934 -171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.02 -51.19 62.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.384 0.674 . . . . 0.0 109.983 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.45 156.8 48.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.778 0.831 . . . . 0.0 110.852 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 59.1 m -132.57 168.36 18.37 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.482 1.913 . . . . 0.0 106.399 -175.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.76 171.47 43.05 Favored Glycine 0 CA--C 1.52 0.371 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -176.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.05 141.62 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.914 1.286 . . . . 0.0 108.526 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.9 mt -90.62 126.83 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 124.656 1.182 . . . . 0.0 107.911 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.29 -174.87 16.93 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.3 mt -74.82 140.03 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.12 112.53 7.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 166.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.345 . . . . . . . 0 C--O 1.242 0.677 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.1 p -54.66 136.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 160.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.92 132.34 54.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 165.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.96 22.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 170.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.0 p -132.18 149.89 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 125.938 1.695 . . . . 0.0 107.263 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -129.92 109.53 10.97 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 162.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.4 m -82.58 93.07 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -56.92 130.96 48.17 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -155.03 122.32 5.58 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.36 -165.77 23.73 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -52.09 -47.82 65.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.205 1.002 . . . . 0.0 110.691 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.99 -149.95 26.31 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -82.69 -15.15 8.6 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 122.907 2.405 . . . . 0.0 111.606 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG23 HD22 ' A' ' 38' ' ' LEU . 2.9 p -41.19 107.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 124.748 1.219 . . . . 0.0 110.173 167.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -149.73 169.6 20.66 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.809 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.99 134.35 3.08 Favored Glycine 0 C--O 1.223 -0.558 0 CA-C-N 118.618 0.644 . . . . 0.0 112.992 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.2 mm -93.02 89.95 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 HD13 ' HA3' ' A' ' 33' ' ' GLY . 38.5 mm -80.04 154.75 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 175.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.42 139.53 29.99 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.275 1.83 . . . . 0.0 107.423 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' CD2' HG22 ' A' ' 31' ' ' VAL . 86.2 m-85 -134.36 126.01 28.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.241 1.416 . . . . 0.0 108.383 174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.74 126.67 55.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 160.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 29' ' ' VAL . 8.3 tp60 -91.26 -54.64 3.84 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.108 0.963 . . . . 0.0 108.408 174.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.8 tttt 74.25 -58.64 0.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.435 1.094 . . . . 0.0 110.615 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -113.69 113.41 24.97 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.823 1.649 . . . . 0.0 109.554 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -46.61 -34.3 4.87 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.804 1.642 . . . . 0.0 112.762 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -121.9 33.06 5.61 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.932 0.893 . . . . 0.0 111.365 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.79 179.76 16.7 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.83 131.67 16.07 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.369 2.713 . . . . 0.0 111.61 -169.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 22' ' ' GLN . 38.5 t -84.2 152.4 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.918 1.687 . . . . 0.0 109.369 176.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -108.83 124.62 50.91 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.816 1.247 . . . . 0.0 107.647 163.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' CD2' ' A' ' 20' ' ' PHE . 45.8 t -112.63 134.21 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 C-N-CA 126.256 1.822 . . . . 0.0 106.984 176.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.1 p90 -162.57 156.9 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.175 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.46 179.58 41.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.926 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.3 m -157.59 95.05 1.41 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 -175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.606 HG21 HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -68.68 162.66 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 171.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -158.08 96.14 1.43 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 169.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.03 9.3 0.82 Allowed Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.087 -0.96 . . . . 0.0 113.619 174.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.826 HD22 HG23 ' A' ' 14' ' ' VAL . 3.4 mm? -78.32 173.78 11.95 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.871 1.335 . . . . 0.0 108.893 167.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -90.81 163.15 14.54 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.66 155.44 9.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.3 1.04 . . . . 0.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.1 -169.53 21.92 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 170.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 mp -81.68 136.13 35.5 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.599 -0.354 . . . . 0.0 111.218 -169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.739 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.0 m-70 -127.31 122.16 33.04 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.632 1.973 . . . . 0.0 109.041 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.39 144.82 48.03 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CZ ' HD22 ' A' ' 117' ' ' LEU . 15.3 t80 -145.26 120.39 10.12 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.543 0.672 . . . . 0.0 109.41 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.553 ' O ' HD23 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -154.66 160.83 41.65 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -169.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -79.19 116.21 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 169.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -87.31 154.72 20.46 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.083 1.353 . . . . 0.0 109.742 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.77 -153.57 0.07 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.704 0.802 . . . . 0.0 110.647 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 69.11 -62.82 0.39 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.379 1.872 . . . . 0.0 110.296 -168.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 69.0 154.18 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.573 1.949 . . . . 0.0 110.168 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.9 t0 8.5 73.2 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.496 2.318 . . . . 0.0 115.782 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.33 -41.31 0.07 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.259 0.623 . . . . 0.0 111.794 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.657 HG21 HG21 ' A' ' 116' ' ' THR . 8.0 t -75.52 50.2 0.52 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.042 0.937 . . . . 0.0 112.282 -174.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -45.41 -42.73 10.59 Favored 'General case' 0 C--N 1.338 0.08 0 C-N-CA 126.027 1.731 . . . . 0.0 112.505 -173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.1 52.83 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.4 m 59.85 18.31 7.28 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.731 0.813 . . . . 0.0 112.197 174.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 m -71.59 -75.45 0.13 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.31 1.844 . . . . 0.0 113.207 -163.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -36.3 70.64 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.457 1.103 . . . . 0.0 111.503 -169.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.68 52.07 5.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.999 0.92 . . . . 0.0 111.076 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -49.79 142.54 12.21 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.02 174.28 9.97 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 119.056 1.428 . . . . 0.0 110.736 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -50.24 130.57 23.11 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.66 120.82 16.01 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -96.24 144.16 27.36 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.033 1.333 . . . . 0.0 109.801 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -84.82 -70.94 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.79 2.326 . . . . 0.0 109.108 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -120.6 41.32 3.29 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.526 1.53 . . . . 0.0 107.847 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.8 m 63.21 34.05 13.75 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -78.32 168.43 19.83 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -82.78 169.43 16.15 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.448 0.642 . . . . 0.0 110.102 172.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -73.99 150.69 40.57 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.903 0.881 . . . . 0.0 110.203 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.71 -158.62 19.23 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.26 172.49 30.56 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 -177.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -61.19 -22.2 73.94 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.836 2.357 . . . . 0.0 112.204 -175.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -113.51 16.71 18.72 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 174.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -81.03 161.92 24.01 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.795 1.18 . . . . 0.0 109.231 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -61.82 -42.88 99.57 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.557 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.63 111.09 23.65 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -131.65 141.08 49.52 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 176.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -82.25 176.02 9.81 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.663 1.12 . . . . 0.0 110.52 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.0 p -57.39 -43.95 83.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 O-C-N 121.958 -0.464 . . . . 0.0 111.004 -173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -123.09 48.06 0.98 Allowed Glycine 0 C--N 1.336 0.564 0 CA-C-O 119.104 -0.831 . . . . 0.0 111.291 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -85.96 82.68 8.03 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.735 0.768 . . . . 0.0 109.534 170.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.1 mt -84.12 50.01 1.76 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 23.89 -111.51 0.01 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.505 2.003 . . . . 0.0 113.733 -166.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -138.7 162.21 35.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.985 1.314 . . . . 0.0 109.586 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.0 m -117.89 164.43 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 125.415 1.486 . . . . 0.0 107.761 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.2 m -115.41 115.57 26.78 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.239 1.016 . . . . 0.0 108.903 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.64 139.27 31.53 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 123.347 0.404 . . . . 0.0 110.537 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -70.66 171.59 10.11 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.418 1.487 . . . . 0.0 110.748 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.2 -21.84 49.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.909 1.284 . . . . 0.0 111.951 171.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.35 2.65 55.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.874 0.869 . . . . 0.0 110.361 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.81 27.04 52.11 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.095 0.855 . . . . 0.0 112.842 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 46.4 t -111.49 114.72 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.824 1.65 . . . . 0.0 107.904 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.469 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -97.67 106.54 18.86 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 169.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.99 140.96 58.34 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 161.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.1 t -119.73 141.72 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 170.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.33 98.06 0.91 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.3 tt -152.16 -177.57 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.78 150.43 44.74 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.918 1.287 . . . . 0.0 108.502 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.26 159.73 40.05 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 124.351 1.06 . . . . 0.0 108.547 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -137.52 32.21 2.54 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.774 0.83 . . . . 0.0 110.437 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 78.4 t -100.36 -57.46 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.89 165.95 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.393 0.677 . . . . 0.0 112.643 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' SER . 42.7 m -126.54 -21.8 4.07 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.141 0.576 . . . . 0.0 112.232 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 72.52 -23.83 0.2 Allowed 'General case' 0 C--N 1.343 0.305 0 C-N-CA 124.747 1.219 . . . . 0.0 112.907 174.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 105' ' ' SER . 1.4 p -169.0 89.11 0.2 Allowed 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 106.184 -171.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 165.64 -142.38 7.65 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -67.67 -59.47 3.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 168.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -84.26 48.57 1.51 Allowed 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.403 -0.811 . . . . 0.0 111.237 -177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.0 m -57.98 100.56 0.06 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.235 1.014 . . . . 0.0 110.614 162.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.3 pt -60.99 -28.37 43.48 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 O-C-N 121.792 -0.568 . . . . 0.0 110.916 169.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.8 mm -53.84 113.42 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 114.76 -35.47 4.39 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.077 0.846 . . . . 0.0 112.566 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -71.16 165.37 23.72 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.28 -0.541 . . . . 0.0 110.787 -175.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.657 HG21 HG21 ' A' ' 54' ' ' THR . 98.7 m -101.54 121.4 41.91 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 124.076 0.95 . . . . 0.0 109.925 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.568 HD22 ' CZ ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -101.29 139.99 36.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.996 0.817 . . . . 0.0 108.971 168.389 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.88 144.57 26.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 p -108.89 146.88 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.481 1.112 . . . . 0.0 109.605 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -110.84 154.39 24.06 Favored 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 125.906 1.682 . . . . 0.0 110.398 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.41 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 33.4 tt0 -59.67 -54.34 47.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 O-C-N 123.214 0.321 . . . . 0.0 111.151 177.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.54 171.88 8.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.625 0.726 . . . . 0.0 110.457 -169.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.05 142.47 57.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.605 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -64.76 108.45 1.74 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 168.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.67 -2.91 10.24 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 128.759 2.824 . . . . 0.0 112.473 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.2 mt 46.39 35.48 2.83 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.268 1.827 . . . . 0.0 112.503 -177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.62 -3.34 34.61 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 123.591 0.615 . . . . 0.0 114.264 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -63.89 -30.76 71.82 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.491 1.146 . . . . 0.0 111.439 -165.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.92 -23.85 47.42 Favored Glycine 0 CA--C 1.533 1.217 0 CA-C-O 119.477 -0.624 . . . . 0.0 113.152 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.89 55.47 10.95 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 118.728 1.264 . . . . 0.0 111.61 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -151.74 153.55 34.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.344 1.058 . . . . 0.0 108.428 173.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -46.11 -41.8 12.85 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 119.706 1.139 . . . . 0.0 112.2 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.14 -72.27 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.74 0.7 . . . . 0.0 111.103 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.493 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 26.7 m -41.46 -58.08 2.0 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 125.889 1.675 . . . . 0.0 112.124 168.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 m -70.33 -4.13 20.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.503 1.121 . . . . 0.0 111.33 -169.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -110.47 -32.93 6.75 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.301 1.84 . . . . 0.0 111.214 167.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 52.5 p -129.01 -24.45 2.91 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -165.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.67 26.05 30.87 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.0 t30 57.03 22.36 7.23 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.193 1.497 . . . . 0.0 110.99 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.83 -4.14 55.74 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.434 -158.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.33 -167.4 46.97 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 m -56.58 152.82 11.23 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.392 1.077 . . . . 0.0 112.498 -174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.12 102.62 14.62 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.643 1.577 . . . . 0.0 108.763 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.744 ' HB3' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -59.38 -47.63 84.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.352 0.524 . . . . 0.0 109.959 -178.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB2' HG22 ' A' ' 14' ' ' VAL . . . -142.07 155.22 45.38 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.544 0.738 . . . . 0.0 112.17 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -124.38 153.92 41.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 128.779 2.832 . . . . 0.0 107.058 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.85 127.81 1.98 Allowed Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 175.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 98.1 t -74.05 141.93 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 171.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.86 125.52 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.6 -179.02 17.23 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 83.2 mt -75.48 143.61 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.4 109.7 16.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.574 0.75 . . . . 0.0 110.376 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 125.946 1.699 . . . . 0.0 110.484 179.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.358 . . . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 117.224 -1.369 . . . . 0.0 108.097 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -77.67 57.72 1.68 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 120.383 1.447 . . . . 0.0 111.203 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -159.3 78.0 0.72 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.714 2.006 . . . . 0.0 106.093 -173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -128.32 153.36 47.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 168.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.5 p -148.83 150.02 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.836 1.254 . . . . 0.0 107.883 -170.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.41 112.83 10.63 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 166.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.1 m -83.34 99.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-O 121.825 0.821 . . . . 0.0 109.309 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.37 144.59 57.05 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.867 0.867 . . . . 0.0 109.829 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -145.22 143.27 30.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.085 1.754 . . . . 0.0 107.043 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.63 -167.13 12.89 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 118.889 0.768 . . . . 0.0 111.244 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.18 -43.72 92.18 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.673 0.789 . . . . 0.0 109.744 171.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.34 -167.51 30.1 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -80.13 14.99 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.655 2.904 . . . . 0.0 112.029 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.4 t -58.99 101.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -109.84 156.51 20.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.02 114.77 0.66 Allowed Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.416 -1.373 . . . . 0.0 114.334 173.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.29 87.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 45' ' ' PHE . 9.9 mm -75.69 147.96 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -138.96 135.93 34.87 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 82.1 m-85 -124.03 126.18 45.83 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.074 0.949 . . . . 0.0 108.835 177.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -120.37 145.91 46.69 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.215 0.947 . . . . 0.0 109.933 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -166.96 -67.72 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.357 1.463 . . . . 0.0 111.711 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? 67.45 -52.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.766 2.026 . . . . 0.0 112.731 -167.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -70.32 142.83 52.16 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.341 1.056 . . . . 0.0 110.028 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.0 p -56.86 -42.65 80.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 122.532 0.333 . . . . 0.0 110.772 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -136.8 21.55 3.08 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.152 1.381 . . . . 0.0 110.354 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.5 172.32 44.65 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -61.92 134.8 51.88 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.895 2.396 . . . . 0.0 110.54 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -94.2 137.0 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -103.41 119.19 38.41 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 170.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.3 t -100.98 110.56 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.819 2.048 . . . . 0.0 106.964 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -116.25 162.26 17.76 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.98 179.68 42.14 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.357 170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -163.12 101.75 0.97 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -69.25 155.55 7.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 165.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -147.34 101.8 3.41 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 167.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.47 -8.03 1.16 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.881 -0.4 . . . . 0.0 113.746 167.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 HD12 ' CE1' ' A' ' 43' ' ' HIS . 0.5 OUTLIER -70.69 -167.19 0.17 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.481 0.658 . . . . 0.0 110.912 176.366 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 t -118.36 167.66 11.35 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 160.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.62 160.28 0.44 Allowed 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.024 1.73 . . . . 0.0 112.979 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.47 177.96 29.9 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mp -84.46 144.5 28.7 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.728 0.299 . . . . 0.0 110.638 -164.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.488 ' CE1' HD12 ' A' ' 38' ' ' LEU . 69.6 m-70 -134.23 117.13 16.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.886 1.275 . . . . 0.0 109.437 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.13 141.62 40.29 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 174.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -137.47 120.06 16.09 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 -177.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -146.52 158.04 43.84 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.585 -174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' HB ' ' HA3' ' A' ' 82' ' ' GLY . 11.1 t -89.68 105.17 15.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -74.98 165.57 25.05 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.394 0.616 . . . . 0.0 110.077 174.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.33 172.65 1.85 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.259 162.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 80.65 168.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.079 2.151 . . . . 0.0 111.161 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -154.37 -103.08 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 127.696 2.398 . . . . 0.0 106.129 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -80.16 78.9 6.79 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.427 -0.796 . . . . 0.0 110.581 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -162.18 -40.67 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.167 0.587 . . . . 0.0 112.212 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.8 t -75.2 46.43 0.32 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.725 1.61 . . . . 0.0 113.041 -171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -42.73 -41.61 3.23 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 126.785 2.034 . . . . 0.0 113.153 -174.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -138.0 51.43 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 32.61 17.21 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.209 0.528 . . . . 0.0 110.941 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 m -66.09 -66.26 0.57 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.441 1.096 . . . . 0.0 112.059 -168.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.5 p -78.2 -59.14 2.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.633 1.173 . . . . 0.0 107.901 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 51.99 66.1 1.3 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.821 1.248 . . . . 0.0 109.991 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.34 160.82 5.84 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.28 -171.05 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.72 1.613 . . . . 0.0 111.456 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -54.38 126.39 23.12 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.262 0.625 . . . . 0.0 109.824 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.52 110.51 4.23 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -83.89 132.98 46.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 117.455 -1.259 . . . . 0.0 109.23 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -81.53 -66.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.958 1.772 . . . . 0.0 109.884 -173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.75 17.17 13.55 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.088 0.955 . . . . 0.0 111.169 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.4 t 77.66 99.48 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.59 1.156 . . . . 0.0 111.177 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -149.45 176.76 10.31 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.311 1.845 . . . . 0.0 107.986 171.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -82.07 170.77 15.14 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.695 0.759 . . . . 0.0 110.726 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.502 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 44.5 t60 -74.22 155.71 38.03 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.344 1.058 . . . . 0.0 111.5 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.41 -144.54 5.42 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 166.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -129.0 -179.82 16.19 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.743 1.163 . . . . 0.0 111.454 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.55 -7.9 15.72 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.603 2.869 . . . . 0.0 112.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -112.99 1.48 15.4 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.729 -1.129 . . . . 0.0 113.1 176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -92.83 166.35 12.46 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.998 1.272 . . . . 0.0 108.916 173.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -80.12 -35.59 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.567 1.547 . . . . 0.0 109.964 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -101.61 108.17 19.65 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 ptp85 -147.45 130.67 16.49 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -70.58 177.91 3.25 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.3 -40.18 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 O-C-N 121.448 -0.782 . . . . 0.0 110.629 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 47' ' ' VAL . . . -113.82 42.82 1.84 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.013 -173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -99.29 83.6 2.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.964 0.882 . . . . 0.0 111.11 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.0 mm? -95.08 38.96 1.12 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.787 1.235 . . . . 0.0 109.305 177.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 42.31 -113.59 0.6 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.042 1.306 . . . . 0.0 113.71 -178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -147.83 168.55 21.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.762 1.225 . . . . 0.0 110.174 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.0 m -127.46 170.79 16.76 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 26.2 m -113.59 119.54 37.85 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.578 1.151 . . . . 0.0 108.689 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.9 141.77 35.78 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.444 0.566 . . . . 0.0 110.223 169.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -77.96 173.71 11.87 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.121 1.368 . . . . 0.0 110.832 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.68 -19.19 37.35 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.475 1.51 . . . . 0.0 111.99 175.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -85.92 -15.43 41.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.309 0.576 . . . . 0.0 110.691 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 31.08 32.62 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 51.8 t -109.57 123.16 65.23 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 125.899 1.68 . . . . 0.0 106.864 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.27 104.07 13.38 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 169.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -71.74 141.65 49.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.1 t -121.73 148.06 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.7 p -166.32 81.47 0.27 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.51 1.524 . . . . 0.0 107.878 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -130.63 171.79 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -142.34 140.52 32.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.46 160.71 38.34 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.38 1.072 . . . . 0.0 109.137 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 m -117.36 -2.29 11.6 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.664 1.186 . . . . 0.0 112.491 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 86.9 t -94.24 -63.09 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.52 154.84 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.6 m -163.54 158.63 20.99 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 125.547 1.539 . . . . 0.0 107.314 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.15 43.52 1.06 Allowed 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.5 p -175.29 169.49 3.22 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.707 1.603 . . . . 0.0 107.104 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.1 -152.99 46.06 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.001 -1.239 . . . . 0.0 110.001 -174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -85.04 -10.11 57.29 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.333 0.587 . . . . 0.0 111.689 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.79 -13.62 31.19 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-O 117.878 -1.058 . . . . 0.0 113.383 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.6 m -17.8 91.44 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.895 2.478 . . . . 0.0 114.699 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.27 -17.17 19.72 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.6 mm -50.65 113.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 115.3 -28.44 7.91 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.293 0.473 . . . . 0.0 113.664 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.515 ' HB2' HD12 ' A' ' 149' ' ' ILE . 41.2 mmt-85 -67.25 158.06 32.34 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.63 1.215 . . . . 0.0 112.976 -171.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.9 m -89.53 113.41 24.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.852 0.861 . . . . 0.0 111.102 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -95.82 145.59 25.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.945 0.898 . . . . 0.0 110.066 172.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.35 142.72 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.921 0.889 . . . . 0.0 109.533 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.19 145.76 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.127 1.371 . . . . 0.0 110.379 173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -118.31 164.93 14.48 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.477 1.111 . . . . 0.0 113.663 -169.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -74.4 -56.88 4.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.861 -172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -90.91 175.53 6.95 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.003 0.906 . . . . 0.0 109.925 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.81 149.57 46.62 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.673 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 18.3 t0 -66.84 125.0 24.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 160.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -68.78 5.68 1.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.11 1.764 . . . . 0.0 112.632 173.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 53.41 33.73 16.55 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 120.569 -1.332 . . . . 0.0 108.992 -172.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.52 8.14 0.77 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 126.17 1.843 . . . . 0.0 116.179 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.91 20.42 13.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.899 1.349 . . . . 0.0 110.684 -173.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.58 -11.93 69.38 Favored Glycine 0 CA--C 1.533 1.171 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 171.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.17 41.12 92.53 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 117.954 0.877 . . . . 0.0 111.262 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.48 HD21 ' CB ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -155.84 132.38 10.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -175.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -42.08 -49.36 4.77 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.733 1.213 . . . . 0.0 112.058 -174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.48 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -50.59 -73.72 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 118.523 -0.751 . . . . 0.0 110.613 176.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 53.9 p -39.8 -51.89 2.37 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.852 1.661 . . . . 0.0 112.543 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.0 m -77.22 1.32 18.85 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.807 0.843 . . . . 0.0 111.551 -172.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -112.22 -36.55 5.28 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.104 2.162 . . . . 0.0 110.489 169.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.7 p -121.95 -20.87 6.2 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.729 1.604 . . . . 0.0 114.716 -171.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.46 11.31 66.65 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 60.58 20.21 10.07 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 119.32 1.56 . . . . 0.0 112.063 173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.84 9.14 2.01 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.885 0.874 . . . . 0.0 111.668 -172.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 77.9 -148.71 33.64 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.6 t -70.94 -171.5 0.55 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.785 0.802 . . . . 0.0 111.205 -177.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 106.84 17.5 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.92 -44.3 90.0 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.74 157.79 38.56 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 122.885 0.474 . . . . 0.0 109.987 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 23.9 p -146.91 154.75 41.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.281 1.832 . . . . 0.0 108.058 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.51 162.44 35.55 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.87 137.67 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 109.023 -175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.613 HD11 HD12 ' A' ' 117' ' ' LEU . 55.3 mt -79.49 134.55 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.04 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -142.9 179.82 20.21 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -68.16 144.35 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 124.911 1.284 . . . . 0.0 108.656 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -92.6 148.57 21.97 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 124.271 1.028 . . . . 0.0 110.548 174.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 117.456 -1.259 . . . . 0.0 108.533 164.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.475 0.791 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -53.11 112.37 0.85 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.687 0.676 . . . . 0.0 109.71 176.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -129.8 143.56 50.87 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.707 1.603 . . . . 0.0 110.436 -174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -136.96 162.04 34.39 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.977 1.311 . . . . 0.0 109.664 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.23 149.01 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.206 1.802 . . . . 0.0 107.728 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.81 117.67 15.18 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 163.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.35 95.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.849 0.833 . . . . 0.0 108.879 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.02 139.13 57.15 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.681 0.793 . . . . 0.0 109.253 167.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -153.07 141.22 20.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 174.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.52 -165.74 12.38 Favored Glycine 0 C--N 1.335 0.473 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.48 -44.42 93.05 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.882 0.873 . . . . 0.0 109.952 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -98.21 -157.97 30.0 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.72 -4.66 15.22 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.706 2.271 . . . . 0.0 111.682 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.508 HG13 HD22 ' A' ' 38' ' ' LEU . 6.9 t -43.56 102.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.299 0 C-N-CA 125.436 1.494 . . . . 0.0 108.948 168.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -131.67 164.22 26.39 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.26 138.81 5.73 Favored Glycine 0 C--O 1.221 -0.686 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.481 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.59 105.68 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HA3' ' A' ' 33' ' ' GLY . 41.3 mm -91.53 142.55 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 168.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -129.79 147.61 51.58 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 166.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.557 ' HD2' HG22 ' A' ' 31' ' ' VAL . 6.9 m-85 -128.31 131.27 48.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.18 148.67 43.36 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.986 0.812 . . . . 0.0 109.966 165.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -117.72 -63.58 1.41 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.906 1.283 . . . . 0.0 109.035 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 71.29 -50.6 0.69 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.958 1.703 . . . . 0.0 112.235 -176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.15 -11.31 19.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.372 1.469 . . . . 0.0 112.817 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.21 -58.61 0.54 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.671 1.588 . . . . 0.0 110.749 -168.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -125.89 37.93 4.25 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.608 0.763 . . . . 0.0 110.469 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.35 -159.91 13.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 123.759 0.695 . . . . 0.0 111.508 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.2 119.19 5.49 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 123.218 2.612 . . . . 0.0 109.64 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.25 138.51 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 175.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -95.68 121.48 37.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' HD2' ' A' ' 20' ' ' PHE . 54.6 t -99.63 135.69 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 126.696 1.998 . . . . 0.0 106.466 173.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.6 p90 -155.61 168.99 25.37 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 170.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -178.46 -176.77 46.64 Favored Glycine 0 CA--C 1.501 -0.793 0 C-N-CA 119.152 -1.499 . . . . 0.0 110.716 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.6 t -152.9 110.48 3.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.779 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -76.56 169.34 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.144 173.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -157.35 100.07 1.8 Allowed 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 168.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.0 -5.17 1.25 Allowed Glycine 0 CA--C 1.528 0.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.255 166.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.779 HD23 HG21 ' A' ' 35' ' ' ILE . 1.5 mm? -70.23 179.54 2.36 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.115 0.957 . . . . 0.0 110.106 171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -102.08 153.55 19.82 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.978 1.711 . . . . 0.0 108.86 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.2 152.74 4.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.697 1.199 . . . . 0.0 111.98 178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.21 -109.9 1.68 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 104.929 -3.268 . . . . 0.0 104.929 174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.759 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.6 pt? -163.9 151.67 12.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.405 1.102 . . . . 0.0 108.874 -171.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.563 ' CE1' HD12 ' A' ' 38' ' ' LEU . 89.4 m-70 -144.16 135.82 25.97 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.39 1.076 . . . . 0.0 109.074 -170.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.71 142.51 48.21 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.45 109.69 7.81 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 125.004 1.321 . . . . 0.0 109.391 -173.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.51 161.4 42.75 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 119.714 -0.795 . . . . 0.0 112.529 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.1 t -88.17 119.58 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.555 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.8 m-70 -90.18 127.2 36.06 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.685 1.194 . . . . 0.0 109.398 172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -79.58 113.31 17.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 164.5 -47.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 128.603 2.761 . . . . 0.0 108.872 172.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 68.69 -68.01 0.19 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.266 1.426 . . . . 0.0 110.823 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -61.99 101.67 0.23 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.832 0.853 . . . . 0.0 111.732 -168.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -80.77 42.88 0.65 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.936 -1.102 . . . . 0.0 112.625 -169.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 49.6 p -56.11 -42.07 76.23 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 125.578 1.551 . . . . 0.0 112.419 -169.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.27 -15.0 8.45 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.461 1.104 . . . . 0.0 113.072 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.04 51.88 1.05 Allowed Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.75 32.93 22.11 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.558 0.743 . . . . 0.0 111.303 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 m -135.86 157.07 47.75 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 127.646 2.379 . . . . 0.0 105.903 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.9 m 60.46 -79.56 0.02 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 123.894 0.878 . . . . 0.0 110.777 -169.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 45.8 -137.33 0.61 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -155.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -115.64 177.73 17.28 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 167.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.25 -174.07 1.83 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.708 2.939 . . . . 0.0 110.998 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -52.3 130.58 31.31 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.27 104.51 0.4 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.502 0.668 . . . . 0.0 109.357 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -131.74 93.39 28.05 Favored Pre-proline 0 N--CA 1.452 -0.366 0 C-N-CA 126.118 1.767 . . . . 0.0 109.139 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.44 -48.14 0.1 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.653 0 C-N-CA 120.788 0.992 . . . . 0.0 111.288 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.88 20.49 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.466 1.906 . . . . 0.0 109.254 -174.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 65.9 m -97.12 44.58 1.05 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 122.122 0.963 . . . . 0.0 111.936 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 68.62 -152.16 0.15 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.319 1.448 . . . . 0.0 109.212 164.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -91.44 -176.22 4.46 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.521 1.055 . . . . 0.0 110.544 173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 31.0 t60 -65.73 153.28 42.2 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.851 -0.53 . . . . 0.0 109.732 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.91 -166.68 38.04 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 107.009 -2.436 . . . . 0.0 107.009 173.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.86 160.64 13.66 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.92 -17.27 59.01 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.637 2.225 . . . . 0.0 112.476 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -83.19 -11.36 57.93 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 174.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -105.29 166.93 10.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.74 1.216 . . . . 0.0 109.568 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -67.21 -34.73 78.11 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.563 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -96.9 139.6 32.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? 169.47 123.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.538 2.335 . . . . 0.0 108.035 -171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -68.96 -177.88 1.12 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.743 0.417 . . . . 0.0 110.543 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -57.92 -62.04 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.544 -0.723 . . . . 0.0 109.995 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.28 50.47 0.94 Allowed Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.94 69.58 0.74 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 124.462 1.105 . . . . 0.0 109.996 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.2 mt -86.66 53.94 2.99 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -171.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.78 -102.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.052 0 C-N-CA 127.155 2.312 . . . . 0.0 113.316 -168.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -141.01 171.63 13.8 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.816 1.646 . . . . 0.0 111.108 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.2 m -117.1 -158.33 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.165 0.986 . . . . 0.0 109.308 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.4 m -148.46 104.69 3.53 Favored 'General case' 0 CA--C 1.523 -0.075 0 O-C-N 120.857 -1.152 . . . . 0.0 108.852 176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.81 140.29 36.91 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 123.039 0.212 . . . . 0.0 111.119 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.87 171.93 7.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.516 1.527 . . . . 0.0 110.55 172.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -53.41 -24.91 13.81 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.176 2.19 . . . . 0.0 112.576 169.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.1 -7.89 47.29 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.799 1.64 . . . . 0.0 110.05 -177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 83.35 31.48 27.81 Favored Glycine 0 CA--C 1.527 0.792 0 O-C-N 122.068 -0.395 . . . . 0.0 112.61 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 52.4 t -113.6 116.09 51.59 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 C-N-CA 126.075 1.75 . . . . 0.0 107.54 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.51 107.3 18.08 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 174.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -83.14 105.73 14.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.638 1.211 . . . . 0.0 108.312 175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.58 145.04 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.6 t -164.7 99.64 0.79 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.7 tt -150.47 178.81 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.707 1.203 . . . . 0.0 108.519 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -146.27 157.85 43.84 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.267 -0.896 . . . . 0.0 108.772 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -146.64 155.8 42.73 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 175.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.0 p -97.28 -22.24 16.78 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.754 2.022 . . . . 0.0 111.506 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.6 t -75.64 -68.56 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 118.473 0.579 . . . . 0.0 109.835 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -67.23 155.24 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 O-C-N 121.501 -0.75 . . . . 0.0 110.336 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 m -160.88 -178.47 6.84 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.0 mt -101.17 29.71 4.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.162 1.385 . . . . 0.0 108.891 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 m -76.76 -135.55 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.352 1.061 . . . . 0.0 112.702 -173.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -105.93 -73.94 0.9 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 108.894 -1.683 . . . . 0.0 108.894 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -58.89 -58.86 6.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.341 1.067 . . . . 0.0 109.936 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -73.19 -13.83 61.23 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.96 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -36.18 117.57 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.495 1.118 . . . . 0.0 113.147 176.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 27.0 pt -79.61 -15.32 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.163 0.585 . . . . 0.0 111.789 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' A' ' 4' ' ' ALA . 31.7 mm -55.25 122.43 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 170.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.52 14.28 58.67 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.477 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -104.05 173.69 6.2 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.397 1.098 . . . . 0.0 108.809 167.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.5 m -125.6 119.14 27.29 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.097 0.959 . . . . 0.0 110.795 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -91.22 131.49 36.72 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -128.01 141.78 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.19 0.996 . . . . 0.0 108.394 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.58 146.05 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 124.126 0.97 . . . . 0.0 109.441 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -112.64 158.81 19.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 124.861 1.264 . . . . 0.0 111.625 -171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -59.59 -55.88 28.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.051 0.541 . . . . 0.0 111.424 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -98.44 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.759 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -61.07 155.39 20.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 162.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.49 145.53 50.86 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.371 166.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.06 26.74 1.31 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.917 1.687 . . . . 0.0 111.371 -177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 mm? 52.98 29.54 8.06 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 119.94 -1.725 . . . . 0.0 111.128 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.28 -0.02 1.05 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 126.619 2.056 . . . . 0.0 115.789 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -91.65 11.93 22.79 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.854 1.327 . . . . 0.0 112.272 -164.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.69 -13.63 63.81 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.838 -0.423 . . . . 0.0 112.366 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.71 41.3 99.85 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.008 0.904 . . . . 0.0 110.914 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.3 130.66 8.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -37.98 -60.5 0.74 Allowed 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.089 0.859 . . . . 0.0 112.997 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.86 -64.14 0.77 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 119.255 0.934 . . . . 0.0 112.083 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.3 t -46.54 -59.5 2.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 121.041 1.746 . . . . 0.0 112.447 166.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.9 m -70.41 -0.47 8.35 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.289 -0.882 . . . . 0.0 112.117 -171.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.95 -34.64 5.68 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.769 2.828 . . . . 0.0 111.114 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.5 p -127.93 -26.24 2.94 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 9.71 53.72 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 125.558 1.551 . . . . 0.0 110.09 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 52.76 31.24 10.11 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 119.41 1.605 . . . . 0.0 110.025 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.6 0.04 21.6 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.416 -169.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 75.47 -168.64 54.8 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.2 t -64.83 164.39 12.47 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.135 0.969 . . . . 0.0 111.621 -169.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -79.31 114.47 18.28 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.771 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.65 -35.22 60.49 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.32 0.509 . . . . 0.0 109.833 175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.55 33.08 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 123.037 0.535 . . . . 0.0 110.451 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -137.43 144.08 42.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 127.289 2.236 . . . . 0.0 106.704 -171.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.19 132.12 2.95 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 118.625 0.648 . . . . 0.0 113.057 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.83 144.28 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.559 1.143 . . . . 0.0 110.799 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.4 mt -96.26 125.01 49.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.688 1.595 . . . . 0.0 108.801 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.47 169.5 24.54 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.4 mp -65.33 139.02 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.269 1.028 . . . . 0.0 108.899 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.03 149.08 24.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 123.104 0.562 . . . . 0.0 111.154 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 . . . . . 0 C--O 1.251 1.16 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 167.642 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.5 m 57.16 51.16 10.66 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.698 0.761 . . . . 0.0 110.631 171.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -75.61 156.98 34.39 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.748 0.785 . . . . 0.0 112.102 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.608 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -88.29 164.5 15.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.595 1.158 . . . . 0.0 108.131 165.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.59 151.11 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 126.313 1.845 . . . . 0.0 107.773 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.86 118.65 16.15 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.376 0.989 . . . . 0.0 109.432 163.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.78 97.52 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 122.044 0.926 . . . . 0.0 109.691 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -65.36 133.86 52.28 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.62 1.168 . . . . 0.0 108.773 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.49 114.04 0.45 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.815 1.646 . . . . 0.0 109.34 174.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.36 32.21 0.26 Allowed Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.294 -0.879 . . . . 0.0 114.387 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.95 -70.36 0.46 Allowed 'General case' 0 C--N 1.335 -0.043 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.94 -104.69 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 107.905 -2.078 . . . . 0.0 107.905 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.47 -16.84 21.45 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.959 1.773 . . . . 0.0 112.252 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.03 113.06 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 119.517 1.053 . . . . 0.0 108.936 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.89 160.15 29.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 167.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -148.95 128.35 2.75 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-N 119.344 0.975 . . . . 0.0 114.094 165.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.99 94.37 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -79.85 153.51 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 123.761 0.824 . . . . 0.0 109.15 169.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.23 137.22 35.77 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.871 1.668 . . . . 0.0 108.818 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.608 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 62.0 m-85 -120.74 104.92 10.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.0 0.92 . . . . 0.0 109.503 171.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -103.21 138.42 40.04 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -126.02 -47.83 1.63 Allowed 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 123.566 0.541 . . . . 0.0 111.04 170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.6 tttt 67.91 -60.89 0.39 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.988 1.715 . . . . 0.0 110.859 -168.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -72.63 -22.97 60.87 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.375 1.07 . . . . 0.0 111.653 -165.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t 74.31 -36.52 0.33 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.331 1.452 . . . . 0.0 111.681 -175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -104.05 -8.43 19.54 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.376 1.87 . . . . 0.0 112.205 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.33 -174.01 34.14 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.202 0.906 . . . . 0.0 112.144 -168.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.17 118.64 5.71 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.251 1.967 . . . . 0.0 110.051 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -76.39 134.48 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -90.25 118.94 30.14 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG22 ' CE2' ' A' ' 20' ' ' PHE . 88.5 t -91.18 108.74 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.931 2.092 . . . . 0.0 106.8 170.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -113.09 157.24 21.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.47 175.86 42.4 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.523 165.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -154.83 98.98 2.1 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.678 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.05 163.09 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 171.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -153.72 100.77 2.41 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 165.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.03 -13.32 0.47 Allowed Glycine 0 CA--C 1.528 0.875 0 O-C-N 124.539 1.149 . . . . 0.0 113.244 167.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.7 HD12 ' CE1' ' A' ' 43' ' ' HIS . 1.1 mm? -68.8 -174.45 0.58 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.187 0.993 . . . . 0.0 110.929 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.5 p -114.69 149.26 37.06 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.765 1.626 . . . . 0.0 108.969 175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -49.39 144.4 5.57 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.59 1.556 . . . . 0.0 112.012 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.13 -131.63 9.17 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 104.898 -3.281 . . . . 0.0 104.898 -175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.8 pt? -149.93 151.31 33.18 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 118.869 1.334 . . . . 0.0 109.865 -167.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.7 ' CE1' HD12 ' A' ' 38' ' ' LEU . 71.6 m-70 -140.7 139.76 34.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.604 1.162 . . . . 0.0 109.261 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.97 145.84 37.17 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 108.784 -1.727 . . . . 0.0 108.784 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -143.02 110.21 5.66 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 117.267 0.533 . . . . 0.0 110.629 -162.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.428 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -147.15 152.84 39.11 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 119.935 -0.706 . . . . 0.0 111.846 -171.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.2 t -89.71 105.35 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 166.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -76.71 171.42 14.73 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.971 0.908 . . . . 0.0 109.737 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -162.43 0.08 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.012 173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 63.7 -175.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.14 0.976 . . . . 0.0 111.179 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -161.41 -53.73 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.504 1.522 . . . . 0.0 109.151 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -150.52 89.17 1.54 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.127 0.971 . . . . 0.0 108.645 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -161.88 -47.66 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 124.575 1.15 . . . . 0.0 110.028 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -69.43 65.82 0.18 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.407 1.083 . . . . 0.0 110.893 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.63 -29.5 17.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.929 0.892 . . . . 0.0 112.398 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.54 -108.17 0.2 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 172.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 10.0 t -178.07 -34.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.67 1.188 . . . . 0.0 110.717 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.5 m -51.64 136.81 26.22 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.925 -0.484 . . . . 0.0 110.118 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.5 t 68.2 -72.92 0.09 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.825 1.25 . . . . 0.0 109.448 -170.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 48.59 49.47 18.44 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.558 1.143 . . . . 0.0 110.818 -171.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 73.11 142.44 0.53 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.46 175.45 5.99 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 CA-C-N 119.789 1.795 . . . . 0.0 109.193 166.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -48.36 118.62 2.54 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.999 -0.438 . . . . 0.0 110.536 167.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.16 118.05 6.85 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 123.982 0.801 . . . . 0.0 108.847 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -121.27 46.88 1.13 Allowed Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.284 1.034 . . . . 0.0 113.288 -171.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.82 -20.49 22.51 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.526 1.484 . . . . 0.0 111.356 -171.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mt -82.78 -9.44 59.34 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.398 0.545 . . . . 0.0 111.572 173.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 29.8 t 59.53 51.91 6.14 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.87 0.759 . . . . 0.0 112.197 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.9 -176.87 3.51 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.157 0.983 . . . . 0.0 109.589 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -86.37 160.9 18.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.824 0.85 . . . . 0.0 111.565 173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -67.25 151.17 48.0 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.94 -150.15 8.15 Favored Glycine 0 N--CA 1.44 -1.044 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 166.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.39 25.66 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -60.15 -28.56 87.21 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.705 2.27 . . . . 0.0 112.22 -170.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -67.27 -28.48 68.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.885 0.311 . . . . 0.0 111.803 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -103.68 162.6 12.94 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -36.72 63.02 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -76.35 146.8 38.54 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.801 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt180 167.19 142.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 C-N-CA 128.681 2.792 . . . . 0.0 104.837 -168.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -76.72 -122.41 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 23.6 t -107.57 -65.26 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 158.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -80.74 45.16 3.08 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.811 -169.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -110.49 87.78 2.61 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.11 1.455 . . . . 0.0 111.458 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.46 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -95.4 50.55 1.25 Allowed 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.43 -120.96 0.04 OUTLIER Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.375 1.464 . . . . 0.0 114.039 -167.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -125.01 175.67 7.19 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 125.647 1.579 . . . . 0.0 110.394 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.2 m -119.48 -156.16 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -151.9 103.18 2.89 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 119.247 0.93 . . . . 0.0 108.77 176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.39 140.35 42.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.737 0.303 . . . . 0.0 111.083 174.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -74.38 168.98 18.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.782 2.033 . . . . 0.0 110.294 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -53.31 -26.92 20.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.286 1.434 . . . . 0.0 112.427 169.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -78.11 -9.1 59.01 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.027 0.918 . . . . 0.0 109.84 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.96 27.98 51.55 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 123.748 0.689 . . . . 0.0 111.629 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.0 t -109.72 116.74 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 125.112 1.365 . . . . 0.0 108.906 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.603 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.53 108.83 20.51 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 171.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -92.2 121.02 33.33 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 145.38 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 52.6 p -163.46 87.84 0.55 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.71 1.604 . . . . 0.0 107.108 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.0 tt -141.08 172.79 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.15 142.26 34.08 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.92 0.888 . . . . 0.0 110.005 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.22 153.02 46.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.664 0.786 . . . . 0.0 109.524 176.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.21 8.73 23.77 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.055 1.342 . . . . 0.0 111.203 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.21 -65.0 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.125 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 5.3 pt -62.76 142.44 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.408 0.683 . . . . 0.0 109.493 174.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 30.2 m -158.81 174.6 14.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.32 -13.52 58.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.227 1.811 . . . . 0.0 109.385 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.4 m -70.16 141.72 52.6 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.827 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.59 146.19 0.16 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.779 1.181 . . . . 0.0 112.692 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.0 t70 78.76 -61.75 0.34 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 126.348 1.859 . . . . 0.0 110.495 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -77.06 -23.36 52.01 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.424 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -32.2 102.75 0.02 OUTLIER 'General case' 0 C--N 1.343 0.294 0 C-N-CA 127.358 2.263 . . . . 0.0 112.458 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -18.97 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.509 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 34.4 mm -59.85 114.68 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.57 -21.06 22.01 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 123.864 0.727 . . . . 0.0 113.396 -178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.624 ' HB2' HD12 ' A' ' 149' ' ' ILE . 2.0 mmm180 -71.67 153.6 41.95 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 119.172 1.486 . . . . 0.0 112.061 -171.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -89.1 117.06 27.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.952 1.301 . . . . 0.0 110.248 175.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tt -107.79 136.35 47.67 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.78 1.173 . . . . 0.0 110.114 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.1 t -141.88 142.08 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.561 0.744 . . . . 0.0 110.58 -169.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.1 p -111.22 150.4 13.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.401 1.48 . . . . 0.0 109.886 175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -113.16 159.36 19.34 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.837 1.255 . . . . 0.0 112.418 -176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -61.72 -42.06 98.45 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 3.0 mtpm? -115.73 173.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -67.89 147.29 52.7 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 169.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 19.1 p-10 -75.61 134.18 40.71 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.522 168.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -75.63 18.21 0.25 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.035 1.734 . . . . 0.0 113.193 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 mt 39.17 45.63 1.12 Allowed 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.248 1.419 . . . . 0.0 112.721 -169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 0.74 53.22 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.108 1.337 . . . . 0.0 113.816 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -65.97 -16.14 63.62 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.509 1.155 . . . . 0.0 113.288 -169.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.09 -23.51 24.67 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.166 0.894 . . . . 0.0 113.036 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.61 30.0 76.73 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-N 119.004 1.402 . . . . 0.0 111.702 176.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.75 150.25 51.48 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 126.232 1.813 . . . . 0.0 107.837 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -50.41 -54.49 21.53 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 119.785 1.175 . . . . 0.0 112.025 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -70.93 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 118.684 0.675 . . . . 0.0 111.527 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 42.6 p -38.92 -55.09 1.59 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.942 2.097 . . . . 0.0 112.534 168.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.8 m -73.21 -3.04 24.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.935 0.494 . . . . 0.0 111.503 -173.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -104.94 -39.56 6.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 126.345 1.858 . . . . 0.0 110.213 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.5 p -123.56 -33.06 3.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.133 1.333 . . . . 0.0 114.134 -168.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 114.89 -2.86 22.9 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 124.207 0.908 . . . . 0.0 112.252 -175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.1 t30 65.83 13.04 8.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.888 0.844 . . . . 0.0 111.951 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -59.49 -55.38 35.38 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 123.731 0.812 . . . . 0.0 109.873 -174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.21 24.23 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.23 173.91 2.91 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.847 0.832 . . . . 0.0 111.601 -177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.91 109.38 22.11 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.01 1.724 . . . . 0.0 108.635 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.52 -36.8 76.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.79 144.56 22.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.387 -0.821 . . . . 0.0 110.77 178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.0 p -126.19 156.1 40.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.778 1.631 . . . . 0.0 107.391 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.15 173.34 42.36 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 54.3 t -120.17 141.13 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.577 1.151 . . . . 0.0 108.769 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 115' ' ' ARG . 20.6 mt -83.1 127.06 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 124.224 1.01 . . . . 0.0 109.915 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.54 179.05 18.85 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 175.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -60.55 136.62 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.711 1.204 . . . . 0.0 109.114 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.82 162.16 28.45 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.09 0.471 . . . . 0.0 112.047 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 117.461 -1.257 . . . . 0.0 107.724 170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.448 . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 t -139.99 39.33 1.97 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.946 0.779 . . . . 0.0 109.806 -169.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -77.13 101.42 6.12 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -117.14 160.76 20.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.421 0.688 . . . . 0.0 109.825 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -146.11 149.59 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 125.165 1.386 . . . . 0.0 107.724 -170.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.0 109.79 8.66 Favored 'General case' 0 C--N 1.338 0.082 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 166.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.0 m -84.53 94.7 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-O 121.786 0.803 . . . . 0.0 109.443 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 mp -63.17 135.94 57.45 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.797 0.839 . . . . 0.0 109.338 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -154.19 157.79 39.34 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 125.546 1.538 . . . . 0.0 109.312 166.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.6 -160.92 8.73 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.38 -38.84 88.5 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.298 0.639 . . . . 0.0 111.171 -178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.01 -170.6 33.79 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -79.35 -6.17 14.58 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.265 2.643 . . . . 0.0 112.131 -173.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 p -44.98 109.77 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 123.677 0.791 . . . . 0.0 109.271 167.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -137.19 151.98 49.38 Favored 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -151.18 114.45 0.64 Allowed Glycine 0 C--O 1.222 -0.594 0 CA-C-N 119.672 1.124 . . . . 0.0 113.026 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 27.1 mt -85.59 92.08 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 ' HA3' ' A' ' 33' ' ' GLY . 7.1 mm -74.76 146.65 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 170.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -127.4 143.68 51.17 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.736 1.615 . . . . 0.0 108.084 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.38 131.42 48.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.947 1.299 . . . . 0.0 108.03 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -144.03 145.23 32.06 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 124.076 0.86 . . . . 0.0 110.168 166.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -109.77 -42.25 4.31 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.641 1.176 . . . . 0.0 110.323 172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? 74.49 -49.05 0.66 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.064 1.346 . . . . 0.0 111.51 -175.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -76.89 176.73 8.29 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.264 0.938 . . . . 0.0 110.447 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 m -99.94 -6.77 26.11 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.166 1.387 . . . . 0.0 111.901 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.01 34.04 0.14 Allowed 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.713 -0.617 . . . . 0.0 111.02 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.63 177.81 22.94 Favored Glycine 0 CA--C 1.531 1.064 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 175.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.88 142.84 48.46 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.809 2.339 . . . . 0.0 110.102 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.94 128.07 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 173.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -90.06 125.35 35.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -116.45 132.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -149.93 167.15 27.47 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.68 -176.32 41.25 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.289 -0.958 . . . . 0.0 111.024 -175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -160.42 92.45 0.97 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.83 158.23 3.55 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 170.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -147.87 98.21 2.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.38 35.59 0.16 Allowed Glycine 0 CA--C 1.523 0.539 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.382 164.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tp -111.17 -149.75 0.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -171.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -137.15 139.36 41.1 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -52.52 148.61 6.74 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 124.956 1.41 . . . . 0.0 111.392 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.56 -126.41 6.91 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 104.847 -3.301 . . . . 0.0 104.847 176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -146.45 147.88 31.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.085 1.443 . . . . 0.0 112.052 -177.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 29.7 m-70 -136.28 131.38 34.35 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.308 1.443 . . . . 0.0 109.751 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.09 149.98 50.57 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' CZ ' HD11 ' A' ' 18' ' ' ILE . 5.4 t80 -150.63 111.25 4.24 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 117.993 0.896 . . . . 0.0 111.588 -165.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.75 161.88 41.94 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -170.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -89.65 109.91 21.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.221 171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -82.47 146.86 29.04 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 172.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' HG2' ' CD1' ' A' ' 64' ' ' PHE . 1.2 tm-20 -76.77 68.25 2.97 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.937 0.495 . . . . 0.0 109.882 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -148.3 177.39 9.46 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.82 1.248 . . . . 0.0 109.719 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -139.97 -66.67 0.45 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.002 1.721 . . . . 0.0 110.245 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.76 90.24 3.95 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.029 0.931 . . . . 0.0 110.556 -173.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.39 46.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.6 0.76 . . . . 0.0 112.353 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.4 p -59.41 -30.56 68.54 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.293 1.437 . . . . 0.0 112.039 -168.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.26 -17.82 5.17 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.923 1.289 . . . . 0.0 113.97 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.99 62.97 1.78 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 18.9 m 45.05 28.23 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 127.342 2.257 . . . . 0.0 114.297 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -98.6 -66.6 0.89 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.472 1.109 . . . . 0.0 108.878 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.1 t -73.45 -85.25 0.04 OUTLIER 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 174.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 52.06 -143.31 0.69 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -168.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.46 168.92 30.37 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.4 -177.99 3.93 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.31 2.673 . . . . 0.0 111.068 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -56.46 130.4 44.75 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.676 0.79 . . . . 0.0 109.704 174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HG2' ' A' ' 49' ' ' GLU . 10.4 t80 -67.0 109.26 2.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 119.318 -0.372 . . . . 0.0 110.218 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -126.5 56.27 16.44 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 124.565 1.146 . . . . 0.0 113.723 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -65.35 -21.73 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.514 2.809 . . . . 0.0 112.439 -175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.5 mt -72.31 -9.31 58.32 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.736 -0.602 . . . . 0.0 111.293 175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.4 t 65.39 54.99 1.1 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.04 1.336 . . . . 0.0 111.499 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -121.54 175.67 6.09 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.484 0.714 . . . . 0.0 109.352 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 78' ' ' GLU . 2.0 mtmp? -91.33 177.59 6.2 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 125.353 1.461 . . . . 0.0 108.139 175.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 75.5 t60 -74.42 141.46 45.04 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.642 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.21 -174.12 41.55 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.94 160.13 23.08 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 124.527 1.06 . . . . 0.0 110.772 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -58.04 -21.1 48.72 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.937 1.758 . . . . 0.0 111.493 170.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -94.95 -1.15 53.08 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.95 1.3 . . . . 0.0 113.879 177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -103.63 170.04 8.17 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 119.627 1.103 . . . . 0.0 109.6 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -63.22 -40.31 97.11 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.199 0.599 . . . . 0.0 110.068 169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 9.6 mm-40 -91.98 149.21 21.66 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 124.783 1.233 . . . . 0.0 109.121 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 164.79 133.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.468 1.907 . . . . 0.0 107.456 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -74.49 179.4 4.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.722 0.809 . . . . 0.0 109.505 167.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.4 m -66.76 -53.88 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 O-C-N 121.047 -1.033 . . . . 0.0 109.521 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.02 41.31 2.82 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.076 -175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.49 73.12 1.3 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.967 1.307 . . . . 0.0 109.502 -176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.7 mt -88.27 47.44 1.5 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 17.82 -122.28 0.01 OUTLIER Glycine 0 CA--C 1.532 1.155 0 C-N-CA 126.658 2.075 . . . . 0.0 114.615 -162.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.83 156.86 24.15 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.847 1.259 . . . . 0.0 110.929 -176.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.6 m -107.22 161.35 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 m -110.13 119.78 40.37 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.73 141.08 29.03 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.376 0.67 . . . . 0.0 109.735 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -76.98 173.69 11.49 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.88 2.072 . . . . 0.0 110.055 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.49 -23.23 9.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.405 2.282 . . . . 0.0 111.831 172.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.35 -1.31 48.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.307 1.443 . . . . 0.0 110.164 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 68.9 36.82 82.69 Favored Glycine 0 CA--C 1.529 0.924 0 O-C-N 121.688 -0.633 . . . . 0.0 111.598 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.7 t -110.7 129.89 65.05 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 C-N-CA 126.883 2.073 . . . . 0.0 106.572 171.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.62 103.9 9.51 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 119.238 0.926 . . . . 0.0 108.847 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.45 115.22 17.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.19 1.396 . . . . 0.0 108.033 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.26 146.02 7.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 175.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t -163.79 96.68 0.83 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.451 1.1 . . . . 0.0 108.838 169.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.0 tt -141.6 -176.89 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.29 159.81 42.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -134.07 149.86 51.15 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.358 1.036 . . . . 0.0 109.227 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.7 m -116.84 40.79 2.87 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.957 1.703 . . . . 0.0 109.631 172.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -144.48 -58.7 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 124.027 0.931 . . . . 0.0 111.065 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.2 pp -69.83 158.44 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 121.795 -0.566 . . . . 0.0 109.684 174.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.9 m -156.63 -177.05 6.31 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.26 19.59 12.85 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -173.71 178.24 2.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.323 1.849 . . . . 0.0 106.3 -172.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.13 56.02 9.6 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.7 t70 66.36 -60.49 0.32 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 127.006 2.123 . . . . 0.0 112.338 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -73.74 42.49 0.14 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.468 1.507 . . . . 0.0 112.298 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t -63.42 104.46 0.63 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.803 2.041 . . . . 0.0 108.811 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 34.4 pt -62.63 -23.99 34.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.7 0.8 . . . . 0.0 111.854 170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.61 117.28 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.33 21.35 52.15 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 123.835 0.709 . . . . 0.0 113.016 -175.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.5 mmt-85 -102.39 167.29 10.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.39 1.095 . . . . 0.0 110.222 164.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.1 m -110.6 118.73 37.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.232 1.413 . . . . 0.0 109.816 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.82 129.09 45.2 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.751 1.221 . . . . 0.0 108.122 177.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.5 t -135.15 139.02 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.5 148.97 6.34 Favored 'Isoleucine or valine' 0 C--N 1.343 0.293 0 C-N-CA 124.4 1.08 . . . . 0.0 108.645 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -111.12 156.82 20.78 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 124.794 1.237 . . . . 0.0 110.323 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.53 -66.09 0.59 Allowed 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.46 170.57 16.13 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.292 1.044 . . . . 0.0 110.569 -178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 153.25 37.07 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.442 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.9 OUTLIER -78.93 140.01 38.15 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.624 164.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 -12.65 61.72 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.004 2.122 . . . . 0.0 112.173 172.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 45.22 45.96 9.75 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.49 1.041 . . . . 0.0 111.144 -168.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.34 -14.69 27.45 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 118.823 -0.987 . . . . 0.0 113.67 175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -54.31 -31.58 54.49 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.917 1.359 . . . . 0.0 111.98 -171.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.91 -25.28 56.11 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.706 0.669 . . . . 0.0 113.292 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.03 48.13 78.72 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.663 1.231 . . . . 0.0 112.384 173.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.464 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.9 156.5 41.87 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 117.041 -1.457 . . . . 0.0 107.769 171.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -43.49 -48.28 7.31 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 120.339 1.427 . . . . 0.0 112.431 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.56 -71.05 0.07 Allowed 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 118.159 0.436 . . . . 0.0 111.115 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.453 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.4 t -40.3 -56.04 2.06 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.269 1.827 . . . . 0.0 111.719 167.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 12.8 m -73.05 1.44 8.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.037 0.935 . . . . 0.0 111.471 -171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -119.03 -28.53 5.48 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.069 2.148 . . . . 0.0 110.858 171.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -132.53 -29.59 1.54 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.048 1.295 . . . . 0.0 114.22 -172.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.82 16.89 34.56 Favored Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 54.1 t30 55.37 24.21 6.4 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.47 1.635 . . . . 0.0 110.936 178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -2.86 22.92 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 111.277 -170.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 71.18 -162.68 54.17 Favored Glycine 0 N--CA 1.441 -1.015 0 O-C-N 121.293 -0.879 . . . . 0.0 110.996 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 81.2 p -61.23 154.37 23.68 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 113.972 -1.114 . . . . 0.0 111.524 -169.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -89.2 96.03 10.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.61 1.164 . . . . 0.0 109.491 -175.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.55 -48.02 75.4 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.142 0.577 . . . . 0.0 110.886 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.7 156.51 46.2 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.171 0.588 . . . . 0.0 111.638 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.04 135.84 27.78 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.245 2.218 . . . . 0.0 106.229 -164.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.93 151.41 23.49 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 119.431 1.014 . . . . 0.0 110.566 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.5 p -94.52 141.2 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.69 123.27 42.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.603 1.161 . . . . 0.0 108.106 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.91 -179.3 22.03 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.671 -0.972 . . . . 0.0 110.671 -175.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 24.5 mm -74.56 140.24 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.03 142.81 39.72 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.533 0.333 . . . . 0.0 111.064 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.424 -1.275 . . . . 0.0 108.428 165.716 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.354 . . . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 3' ' ' LYS . 1.0 OUTLIER 68.02 -147.89 0.14 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.616 1.098 . . . . 0.0 112.224 150.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' H ' HG22 ' A' ' 2' ' ' THR . 1.0 OUTLIER -142.46 127.34 18.27 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.547 1.939 . . . . 0.0 108.982 -173.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 163.9 19.47 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 125.896 1.678 . . . . 0.0 109.797 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -134.49 150.16 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.002 1.721 . . . . 0.0 107.58 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.88 115.76 13.98 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 161.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -87.12 97.96 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.7 mp -62.96 142.83 58.19 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 121.744 -0.598 . . . . 0.0 109.443 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -154.24 140.85 18.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.869 1.667 . . . . 0.0 107.428 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.29 -160.64 10.3 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.44 -38.52 87.56 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.056 0.542 . . . . 0.0 110.103 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.46 -165.43 33.45 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.83 -6.48 16.84 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.989 2.459 . . . . 0.0 111.964 -176.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.8 m -38.52 106.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 125.611 1.564 . . . . 0.0 110.843 169.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -123.22 159.12 29.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.01 115.91 0.75 Allowed Glycine 0 C--O 1.222 -0.62 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.2 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -84.94 92.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.449 HD13 ' HA3' ' A' ' 33' ' ' GLY . 6.2 mm -82.63 142.79 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 170.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -134.81 136.52 42.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 173.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' A' ' 31' ' ' VAL . 15.7 m-85 -119.98 127.8 52.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -117.52 143.57 45.94 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 172.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -128.76 -55.04 1.22 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.851 168.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.4 tttm 70.25 -53.14 0.64 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.632 1.173 . . . . 0.0 112.729 -173.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -78.49 144.41 35.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.661 1.184 . . . . 0.0 108.834 -176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 p -59.24 -51.87 68.12 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.481 0.712 . . . . 0.0 109.554 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -126.25 38.31 4.16 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.153 0.981 . . . . 0.0 109.901 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.36 171.98 18.12 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.69 128.74 19.57 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.523 2.149 . . . . 0.0 109.647 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.16 145.27 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 168.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 100' ' ' GLU . 4.5 mptp? -99.88 123.56 44.26 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 160.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' HD2' ' A' ' 20' ' ' PHE . 55.9 t -100.59 116.17 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 126.757 2.023 . . . . 0.0 106.925 169.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -118.9 160.88 21.14 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.069 0.948 . . . . 0.0 109.306 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -167.68 178.31 41.65 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.528 169.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.4 p -165.02 94.8 0.67 Allowed 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -73.54 164.37 3.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 176.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -154.26 97.38 2.03 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 170.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.99 -15.55 0.89 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.02 163.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.2 mm? -65.28 174.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 117.585 0.692 . . . . 0.0 109.568 -177.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 t -95.3 161.38 14.12 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 165.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.6 153.59 3.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.654 1.182 . . . . 0.0 111.477 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.37 -176.77 24.56 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 10.5 mp -85.44 144.32 28.06 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.676 -0.308 . . . . 0.0 110.971 -164.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.704 ' CE1' HD12 ' A' ' 38' ' ' LEU . 80.1 m-70 -132.98 116.49 16.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.846 1.258 . . . . 0.0 109.147 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.8 145.65 45.43 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.809 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.37 116.75 10.13 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.95 0.9 . . . . 0.0 110.317 -173.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.75 159.21 43.12 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 118.569 0.622 . . . . 0.0 112.352 -173.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.54 116.84 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.78 0.675 . . . . 0.0 109.7 166.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -87.34 148.3 25.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.025 0.93 . . . . 0.0 110.991 171.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -61.61 -24.07 66.45 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.996 2.118 . . . . 0.0 112.83 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 54' ' ' THR . 6.1 pt-20 -48.4 -45.88 36.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.764 0.826 . . . . 0.0 113.012 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 51.22 -133.48 1.76 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.989 1.315 . . . . 0.0 108.062 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.3 86.0 6.73 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.083 0.953 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -157.27 -51.59 0.07 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.428 HG22 ' HB2' ' A' ' 50' ' ' GLU . 5.7 t -76.43 63.9 2.07 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.616 -0.678 . . . . 0.0 109.554 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.18 -45.48 22.96 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.18 0.992 . . . . 0.0 111.23 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.49 118.51 4.74 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 161.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 86.6 m -63.73 106.35 0.97 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.5 m -149.21 -68.51 0.21 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -174.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.1 m -58.46 -49.37 77.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.06 66.12 1.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.24 1.016 . . . . 0.0 109.853 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -40.12 149.12 0.16 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 128.509 2.957 . . . . 0.0 112.105 -173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -67.06 176.69 4.3 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 CA-C-N 118.232 1.016 . . . . 0.0 111.562 -171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -47.63 129.33 13.63 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.63 171.61 4.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -155.28 135.13 8.15 Favored Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-O 117.448 -1.263 . . . . 0.0 108.38 -175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.46 -56.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.789 1.66 . . . . 0.0 109.523 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 tp -112.32 8.06 19.5 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.993 2.117 . . . . 0.0 110.111 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.4 m 69.24 53.03 0.46 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.048 -1.032 . . . . 0.0 110.829 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.1 mtt180 -91.35 173.52 7.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.937 1.295 . . . . 0.0 109.099 173.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.1 mttp -82.08 169.62 16.47 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 122.077 0.942 . . . . 0.0 110.492 169.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -73.63 153.63 40.08 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.146 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.45 -158.76 21.75 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.14 169.57 16.7 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -59.33 -25.36 78.1 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.638 2.225 . . . . 0.0 111.844 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -84.33 -15.79 45.25 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.897 1.279 . . . . 0.0 111.974 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -86.65 161.46 18.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 122.597 1.189 . . . . 0.0 109.127 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.41 -47.38 73.45 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.262 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -92.97 121.99 34.88 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.38 126.2 5.18 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -68.46 177.59 2.34 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.027 0.441 . . . . 0.0 109.976 175.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.29 -46.67 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 O-C-N 121.872 -0.517 . . . . 0.0 111.454 -169.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -119.67 54.84 0.63 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.96 73.29 9.15 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.314 1.445 . . . . 0.0 109.751 171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -86.62 53.27 2.75 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.76 -0.588 . . . . 0.0 109.515 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.59 -108.66 0.01 OUTLIER Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.06 1.79 . . . . 0.0 114.315 -171.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -144.85 170.53 15.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.796 1.238 . . . . 0.0 110.675 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.4 m -120.56 173.91 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 C-N-CA 125.175 1.39 . . . . 0.0 107.417 172.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.5 m -120.31 119.01 31.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.146 1.378 . . . . 0.0 108.53 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.8 139.77 32.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.106 0.412 . . . . 0.0 110.821 170.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -70.28 172.09 8.78 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.436 1.894 . . . . 0.0 110.692 172.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -52.86 -26.94 16.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.139 1.776 . . . . 0.0 112.176 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.56 -7.37 57.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.257 1.023 . . . . 0.0 109.756 -176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.56 29.42 48.69 Favored Glycine 0 CA--C 1.527 0.818 0 O-C-N 121.922 -0.486 . . . . 0.0 112.213 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.9 t -111.49 126.82 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.22 104.38 12.28 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 171.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -82.94 129.39 35.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.96 152.74 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 p -170.47 81.26 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.322 1.449 . . . . 0.0 107.645 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.3 tt -132.51 171.05 18.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 30' ' ' LYS . 53.5 mp0 -135.43 149.28 49.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.619 1.168 . . . . 0.0 108.75 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.99 152.62 50.35 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 20.2 m -116.14 26.7 9.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.829 1.252 . . . . 0.0 110.953 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 p -127.23 -58.42 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.763 1.225 . . . . 0.0 110.702 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.57 152.66 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.4 m -163.1 169.25 19.73 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 mp -104.98 25.19 10.81 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.923 1.289 . . . . 0.0 108.143 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.9 p -110.94 154.78 23.62 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.546 1.938 . . . . 0.0 108.842 176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -27.09 -56.73 0.09 OUTLIER Glycine 0 C--N 1.342 0.896 0 C-N-CA 126.237 1.875 . . . . 0.0 112.092 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.71 -86.38 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.085 2.954 . . . . 0.0 114.976 169.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -117.45 12.0 14.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.481 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.4 t -17.75 93.1 0.01 OUTLIER 'General case' 0 C--N 1.347 0.472 0 C-N-CA 125.237 1.415 . . . . 0.0 114.703 -175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.3 pt -69.19 -10.26 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.558 -0.714 . . . . 0.0 111.835 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.1 mm -58.22 130.41 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.85 -21.96 43.34 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.552 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -78.98 164.59 24.27 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.112 0.956 . . . . 0.0 110.19 -171.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 92.0 m -117.67 104.78 11.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.4 tp -89.41 72.91 7.96 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.939 0.896 . . . . 0.0 109.478 -169.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.6 t -74.03 144.7 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.942 0.497 . . . . 0.0 110.266 -173.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.13 153.15 5.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 109.577 173.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.448 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 75.5 m-70 -116.05 158.94 22.38 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.923 1.289 . . . . 0.0 112.741 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -61.46 -66.34 0.55 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.699 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -85.92 174.33 9.34 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.166 0.984 . . . . 0.0 109.635 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -62.31 146.36 51.28 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.417 174.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' OD1' HD23 ' A' ' 126' ' ' LEU . 44.8 t0 -70.24 115.38 9.37 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 162.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -75.27 -2.95 30.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 129.557 3.143 . . . . 0.0 113.074 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.453 HD23 ' OD1' ' A' ' 124' ' ' ASP . 8.3 mt 48.09 38.65 10.04 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.033 1.333 . . . . 0.0 111.934 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.1 -0.38 39.26 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.045 -0.864 . . . . 0.0 114.273 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 3.4 mttp -68.53 -20.07 64.54 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.714 1.257 . . . . 0.0 112.536 -167.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.29 -28.65 62.01 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 123.415 0.531 . . . . 0.0 112.269 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.94 60.38 5.3 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 118.269 1.035 . . . . 0.0 111.798 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.515 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -160.22 152.76 20.96 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 117.346 -1.312 . . . . 0.0 107.549 177.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -47.32 -44.75 23.91 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-N 120.753 1.615 . . . . 0.0 111.36 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.46 -71.95 0.06 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.342 0.519 . . . . 0.0 112.101 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.515 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.1 p -49.02 -53.42 20.15 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 120.777 -1.202 . . . . 0.0 111.991 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 13.5 m -68.43 -1.5 6.63 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.867 1.267 . . . . 0.0 111.948 -171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -116.11 -35.55 4.35 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.186 2.194 . . . . 0.0 110.843 169.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 43.0 p -125.3 -36.86 2.44 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.946 1.248 . . . . 0.0 114.098 -166.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.17 28.29 6.19 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 126.316 1.912 . . . . 0.0 110.98 -177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 51.48 25.93 2.94 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.99 1.895 . . . . 0.0 110.637 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -79.15 -6.01 55.51 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.247 -170.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.72 -163.67 51.72 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.68 168.6 10.96 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.348 1.071 . . . . 0.0 111.15 -175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -96.46 103.17 15.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.472 -169.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -37.29 79.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.89 -0.576 . . . . 0.0 110.466 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.51 153.0 36.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.797 0.726 . . . . 0.0 110.917 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -127.47 147.85 50.3 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 127.328 2.251 . . . . 0.0 107.309 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.64 122.4 1.08 Allowed Glycine 0 CA--C 1.525 0.697 0 O-C-N 121.724 -0.61 . . . . 0.0 112.533 -176.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.8 t -75.66 144.97 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.355 1.062 . . . . 0.0 109.97 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 58.9 mt -95.09 127.37 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 126.324 1.85 . . . . 0.0 109.208 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.36 175.12 22.54 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 13.6 mt -62.32 144.09 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 124.528 1.131 . . . . 0.0 108.557 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.2 60.19 3.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 122.472 0.309 . . . . 0.0 110.553 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.251 1.175 0 CA-C-O 116.206 -1.854 . . . . 0.0 106.496 175.604 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.398 . . . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 117.071 -1.442 . . . . 0.0 107.45 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 p -158.66 -172.01 3.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.512 1.525 . . . . 0.0 108.119 -170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -129.08 148.22 51.01 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 123.75 0.82 . . . . 0.0 112.321 169.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -87.69 170.91 10.84 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.64 1.176 . . . . 0.0 109.293 169.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.41 148.34 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.828 1.651 . . . . 0.0 107.525 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.81 110.67 8.76 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 119.501 1.046 . . . . 0.0 108.889 165.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 m -86.22 99.73 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 121.673 0.749 . . . . 0.0 109.236 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -65.98 143.53 57.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.648 0.779 . . . . 0.0 109.563 170.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -148.8 144.09 26.76 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.947 1.299 . . . . 0.0 108.208 170.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.91 -165.72 13.03 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.17 -36.43 83.07 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.646 0.778 . . . . 0.0 110.519 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.72 -158.97 27.7 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.56 2.15 8.07 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.177 2.585 . . . . 0.0 111.925 -177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -52.19 106.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.192 0.997 . . . . 0.0 108.648 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -127.98 155.14 44.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.75 122.94 1.32 Allowed Glycine 0 C--O 1.223 -0.556 0 C-N-CA 119.714 -1.231 . . . . 0.0 114.396 172.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.66 90.57 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 123.951 0.9 . . . . 0.0 108.765 -178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD13 ' HA3' ' A' ' 33' ' ' GLY . 14.6 mm -83.47 152.22 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 C-N-CA 123.807 0.843 . . . . 0.0 109.363 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.62 128.42 14.35 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 123.808 0.843 . . . . 0.0 109.103 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.403 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 m-85 -111.09 99.49 8.34 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -85.34 126.42 33.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.44 0.563 . . . . 0.0 109.526 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.498 ' HB2' HD13 ' A' ' 106' ' ' LEU . 1.4 tp60 -90.44 -66.77 0.9 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 170.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.8 -49.03 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.593 1.557 . . . . 0.0 112.702 -170.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -73.03 -7.97 53.64 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.995 1.318 . . . . 0.0 112.51 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.05 -50.43 0.66 Allowed 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.431 1.492 . . . . 0.0 111.896 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.93 41.93 1.55 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.298 0.639 . . . . 0.0 109.331 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.92 -170.33 11.85 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -58.46 130.01 35.34 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.148 2.565 . . . . 0.0 110.85 -166.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 t -93.66 129.26 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 24.2 mmtt -90.09 116.51 28.16 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.785 1.234 . . . . 0.0 107.907 171.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.1 p -101.25 127.35 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.8 m-90 -123.89 158.55 31.65 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.932 2.093 . . . . 0.0 108.275 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -164.6 176.62 40.43 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 170.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.7 m -163.12 87.25 0.56 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 -177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -67.08 159.56 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -152.08 89.44 1.45 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 157.76 -11.19 0.24 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 114.424 -1.262 . . . . 0.0 113.426 170.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 35' ' ' ILE . 1.6 mp -59.86 -178.84 0.08 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.545 1.138 . . . . 0.0 112.116 170.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -119.47 145.63 46.12 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.044 2.138 . . . . 0.0 108.425 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -47.9 134.47 13.38 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.914 1.286 . . . . 0.0 111.142 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.38 -169.67 13.35 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.08 134.51 33.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 122.606 0.363 . . . . 0.0 110.964 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' CE1' ' HG ' ' A' ' 38' ' ' LEU . 43.7 m-70 -128.21 130.28 47.74 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.973 1.709 . . . . 0.0 109.649 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.53 150.27 49.44 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 118.57 -1.128 . . . . 0.0 111.959 -178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.08 121.61 10.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.293 1.046 . . . . 0.0 111.699 -173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 2.4 m80 -148.01 162.44 39.35 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -90.84 108.01 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 160.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -74.26 175.42 7.61 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.61 -150.16 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 119.147 -0.454 . . . . 0.0 111.24 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.318 2.8 pp20? 37.07 -143.71 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 164.85 -82.06 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 130.879 3.672 . . . . 0.0 106.74 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -77.55 77.1 4.07 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.411 -0.805 . . . . 0.0 110.796 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -158.1 -42.53 0.06 Allowed 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.545 1.138 . . . . 0.0 111.219 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -73.68 51.05 0.35 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -171.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.35 -38.14 40.6 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.362 1.065 . . . . 0.0 111.922 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.9 0.95 Allowed Glycine 0 C--N 1.34 0.766 0 C-N-CA 124.132 0.872 . . . . 0.0 111.115 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 72.74 -55.23 0.68 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.817 1.647 . . . . 0.0 112.439 174.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.4 m -53.3 154.5 3.24 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.977 1.311 . . . . 0.0 110.078 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 m 83.76 4.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.698 1.999 . . . . 0.0 112.168 -173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.56 117.69 7.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -67.81 176.87 24.29 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.53 -179.3 3.15 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.955 1.77 . . . . 0.0 112.541 -174.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -53.48 128.57 29.3 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.377 0.671 . . . . 0.0 109.645 173.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -71.03 113.8 8.44 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -135.37 69.57 68.19 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.555 1.142 . . . . 0.0 111.593 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.53 -24.48 63.39 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.71 2.274 . . . . 0.0 112.202 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.71 -4.45 40.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.429 0.692 . . . . 0.0 111.635 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.9 t 59.48 43.99 15.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.393 1.477 . . . . 0.0 112.023 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -99.14 167.73 10.51 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.441 0.696 . . . . 0.0 109.373 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 mttp -80.17 170.18 16.79 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.823 0.849 . . . . 0.0 109.657 169.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -75.37 145.0 42.02 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.687 0.795 . . . . 0.0 110.569 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.77 -168.81 33.06 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 165.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -105.35 165.52 14.22 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -58.41 -26.24 76.89 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.095 2.53 . . . . 0.0 112.435 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.38 -6.03 59.26 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.9 1.28 . . . . 0.0 113.884 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -107.95 161.3 15.06 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.733 1.213 . . . . 0.0 108.241 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.97 -42.67 99.39 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.13 143.68 27.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.42 -1.264 . . . . 0.0 108.329 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.1 ptt180 174.68 123.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.233 1.813 . . . . 0.0 106.339 -175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -70.31 -178.42 1.7 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.265 0.626 . . . . 0.0 110.029 170.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 p -65.68 -51.02 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 O-C-N 121.333 -0.855 . . . . 0.0 110.226 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.01 50.24 0.81 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.94 75.16 1.26 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.699 1.599 . . . . 0.0 109.108 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -84.37 43.29 0.94 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.46 -0.775 . . . . 0.0 110.352 -174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.18 -131.97 0.44 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.164 1.364 . . . . 0.0 112.969 -169.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -123.07 159.35 28.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.13 1.372 . . . . 0.0 109.621 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 15.1 m -114.91 162.51 12.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.356 0 C-N-CA 124.846 1.258 . . . . 0.0 107.919 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.2 m -112.74 109.08 18.35 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 108.995 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.95 147.8 31.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 118.461 0.573 . . . . 0.0 110.083 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -80.63 179.01 7.97 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.983 1.713 . . . . 0.0 111.515 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.63 -3.67 16.03 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.852 2.061 . . . . 0.0 112.957 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.33 -8.3 23.53 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.889 0.876 . . . . 0.0 110.255 170.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.11 25.61 39.9 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 121.635 -0.665 . . . . 0.0 112.027 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.2 t -114.21 124.79 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.815 1.246 . . . . 0.0 108.449 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.631 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -115.05 109.95 18.85 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 172.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -75.14 152.81 38.45 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 166.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.17 150.21 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.4 t -167.67 64.74 0.08 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.742 1.217 . . . . 0.0 109.089 -175.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.7 tt -124.58 -176.61 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -142.99 165.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.191 -0.943 . . . . 0.0 109.605 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -141.37 154.66 45.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.83 0.852 . . . . 0.0 109.36 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 13.5 p -101.08 -24.47 14.29 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 127.841 2.456 . . . . 0.0 111.44 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.06 -59.57 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.471 0.578 . . . . 0.0 110.9 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.17 167.49 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-N 119.322 0.964 . . . . 0.0 110.937 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.37 178.59 8.53 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.498 HD13 ' HB2' ' A' ' 22' ' ' GLN . 6.7 mp -107.71 31.65 5.3 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 166.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 p -151.92 155.53 38.26 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.376 1.07 . . . . 0.0 108.905 -173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.97 -167.84 3.24 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 -171.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.8 -16.78 30.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 122.066 -0.667 . . . . 0.0 112.332 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -74.12 -7.66 53.38 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 117.768 -1.11 . . . . 0.0 113.164 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -44.27 106.82 0.08 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.055 0.843 . . . . 0.0 111.874 177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -71.24 -11.63 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 O-C-N 121.643 -0.661 . . . . 0.0 112.527 177.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -61.33 116.17 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.85 44.54 6.34 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 115.95 -0.568 . . . . 0.0 113.143 -175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.05 153.98 31.76 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.541 1.136 . . . . 0.0 109.855 160.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -76.52 132.31 39.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.411 1.085 . . . . 0.0 109.705 165.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 149' ' ' ILE . 2.5 tt -121.62 133.03 54.98 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.886 1.275 . . . . 0.0 108.374 174.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.26 146.28 24.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 123.195 0.598 . . . . 0.0 110.421 -167.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 38' ' ' LEU . 10.7 p -110.31 152.29 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.748 1.219 . . . . 0.0 109.532 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -116.82 159.38 22.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.289 1.435 . . . . 0.0 111.813 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -71.75 -60.92 1.98 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.906 0.384 . . . . 0.0 111.585 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -79.0 172.33 13.96 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 120.61 -1.306 . . . . 0.0 109.594 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.79 142.03 46.21 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.387 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.545 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.2 m-20 -60.05 129.51 42.12 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.314 166.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -80.83 -2.59 47.87 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 127.604 2.362 . . . . 0.0 112.341 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 124' ' ' ASP . 9.3 mt 49.72 36.91 11.81 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.939 1.295 . . . . 0.0 111.05 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 4.81 51.95 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.479 1.99 . . . . 0.0 115.394 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -68.94 -18.64 64.12 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 118.467 1.133 . . . . 0.0 110.774 -169.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.87 -19.65 44.88 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.537 1.541 . . . . 0.0 111.7 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.18 84.5 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.33 137.25 12.46 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 -169.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.45 -55.96 3.23 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 119.357 0.981 . . . . 0.0 112.1 -174.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.1 -74.63 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 118.001 -0.999 . . . . 0.0 111.463 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.7 p -36.83 -51.95 0.91 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.214 2.205 . . . . 0.0 112.334 169.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.2 m -82.47 9.19 9.7 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.834 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -124.34 -36.19 2.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 127.56 2.344 . . . . 0.0 110.555 170.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.6 p -118.33 -24.04 7.03 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 120.092 1.314 . . . . 0.0 113.565 -172.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.81 14.14 55.55 Favored Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 125.245 1.402 . . . . 0.0 110.556 -172.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.5 t30 53.84 27.63 7.39 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.802 1.301 . . . . 0.0 109.934 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.92 5.34 11.79 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.815 -171.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.84 -167.06 42.55 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.6 t -67.44 171.91 5.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 123.063 1.411 . . . . 0.0 111.213 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -91.95 105.73 17.91 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.486 -2.143 . . . . 0.0 108.813 -170.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.9 -32.95 74.91 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.309 0.504 . . . . 0.0 110.772 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.57 153.03 29.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.35 0.523 . . . . 0.0 109.767 178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.5 m -130.99 162.1 30.5 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.91 176.98 44.15 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 175.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.47 150.88 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 117' ' ' LEU . 16.6 mt -94.57 127.65 46.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.047 0.539 . . . . 0.0 109.735 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -136.14 -178.92 16.13 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.2 mm -68.54 139.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 121.69 -0.888 . . . . 0.0 109.008 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.58 77.09 1.99 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.781 0.432 . . . . 0.0 110.711 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 170.835 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.4 t -63.76 156.42 27.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.33 0.968 . . . . 0.0 109.147 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.5 mttp -157.42 117.8 3.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -116.38 153.25 32.36 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.989 0.916 . . . . 0.0 108.777 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 p -136.93 151.06 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 108.133 -174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.69 115.71 14.09 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 m -85.35 112.96 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.0 143.9 37.15 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.142 0.977 . . . . 0.0 108.705 173.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.93 134.72 13.72 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.412 1.885 . . . . 0.0 107.857 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.93 -177.15 17.21 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -46.71 -43.18 17.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.742 1.617 . . . . 0.0 111.471 171.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.16 -161.55 36.59 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.99 -8.64 16.68 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 122.107 1.871 . . . . 0.0 111.229 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 7.0 t -43.85 114.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.251 0 C-N-CA 124.983 1.313 . . . . 0.0 109.967 170.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -142.62 169.66 17.16 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 124.185 0.928 . . . . 0.0 108.688 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -155.12 164.32 31.82 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.38 112.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 126.43 1.892 . . . . 0.0 107.067 170.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.3 mm -101.69 147.42 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 125.165 1.386 . . . . 0.0 107.729 172.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.412 ' HB2' ' CE2' ' A' ' 32' ' ' TRP . 16.1 m120 -126.36 146.32 50.09 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.999 1.32 . . . . 0.0 108.679 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 73.8 m-85 -127.69 128.38 45.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.137 1.775 . . . . 0.0 107.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -138.72 147.15 42.36 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.619 0.767 . . . . 0.0 109.372 172.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -99.26 -56.58 2.37 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 124.301 1.041 . . . . 0.0 109.622 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? 73.13 -52.14 0.71 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 111.563 -176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.16 114.38 28.27 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.44 1.096 . . . . 0.0 110.594 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.8 m -47.5 -31.44 4.27 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -124.7 32.61 5.41 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.339 0.518 . . . . 0.0 111.166 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.49 -179.66 21.05 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.84 0.733 . . . . 0.0 112.755 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.11 143.46 20.25 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 123.435 2.757 . . . . 0.0 109.228 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -77.78 141.66 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -85.26 125.87 33.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.834 1.254 . . . . 0.0 108.222 165.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.1 t -109.09 128.35 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 126.756 2.022 . . . . 0.0 106.534 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.412 ' CE2' ' HB2' ' A' ' 19' ' ' ASN . 6.2 p90 -155.68 166.95 31.94 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 174.37 -170.31 43.41 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 119.221 -1.466 . . . . 0.0 112.314 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 65.6 p -157.3 130.93 8.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.691 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -93.29 172.32 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 C-N-CA 123.231 0.612 . . . . 0.0 109.657 175.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -154.99 94.19 1.62 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 170.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 151.09 -4.15 0.51 Allowed Glycine 0 CA--C 1.526 0.72 0 O-C-N 123.9 0.75 . . . . 0.0 113.99 162.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.691 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.33 -179.6 2.08 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.516 1.158 . . . . 0.0 109.095 173.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 p -109.34 156.71 19.66 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.987 1.315 . . . . 0.0 108.495 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -46.78 144.0 2.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.157 0.983 . . . . 0.0 111.965 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.9 -175.56 18.66 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mp -83.05 138.52 33.69 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.186 0.594 . . . . 0.0 110.875 -168.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.578 ' CE1' HD12 ' A' ' 38' ' ' LEU . 81.7 m-70 -131.37 125.24 32.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 123.452 0.701 . . . . 0.0 110.728 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.37 140.08 45.77 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.61 114.67 13.0 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 125.299 1.44 . . . . 0.0 107.969 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -147.23 158.94 44.13 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.585 0.63 . . . . 0.0 112.051 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 115' ' ' ARG . 12.7 t -90.44 114.33 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.936 0.894 . . . . 0.0 108.593 166.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -84.31 155.26 22.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 110.191 172.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -74.52 70.67 1.79 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.176 0.99 . . . . 0.0 109.822 176.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 60' ' ' ALA . 2.6 mm-40 -150.66 -179.95 7.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.733 0.813 . . . . 0.0 109.635 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.41 -73.86 0.63 Allowed 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 125.941 2.026 . . . . 0.0 109.077 171.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.75 13.83 27.16 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.372 0.669 . . . . 0.0 112.732 -178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.83 52.96 12.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.629 1.572 . . . . 0.0 110.151 -176.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.6 p -45.3 -35.71 3.64 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -165.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.1 -14.89 41.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.13 48.43 1.59 Allowed Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.084 1.326 . . . . 0.0 111.624 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.05 12.91 8.8 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.436 1.094 . . . . 0.0 112.971 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -96.76 -59.9 1.71 Allowed 'General case' 0 C--N 1.339 0.123 0 C-N-CA 126.879 2.071 . . . . 0.0 111.09 -168.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 169.39 88.21 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 127.503 2.321 . . . . 0.0 108.075 177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.495 ' HB3' ' HG3' ' A' ' 50' ' ' GLU . . . -94.0 -88.4 0.24 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 160.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.32 125.29 31.41 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -71.63 -174.16 1.2 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 CA-C-N 119.343 1.571 . . . . 0.0 109.023 165.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -50.9 118.53 3.22 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 168.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.94 125.55 24.02 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.27 62.25 63.99 Favored Pre-proline 0 CA--C 1.529 0.162 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.45 -27.04 13.58 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.513 2.142 . . . . 0.0 111.578 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.77 -15.22 40.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.722 0.692 . . . . 0.0 111.986 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.0 t 71.5 12.72 6.51 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -77.89 154.31 31.82 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -75.18 173.7 10.45 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 120.879 1.672 . . . . 0.0 111.28 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.3 t60 -61.89 153.39 29.17 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.668 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.99 -153.17 12.01 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 106.503 -2.639 . . . . 0.0 106.503 170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.611 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -152.6 -179.39 28.13 Favored Glycine 0 CA--C 1.52 0.357 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.68 -20.34 64.83 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.262 2.642 . . . . 0.0 113.797 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -79.99 -23.41 41.6 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.798 0.726 . . . . 0.0 112.409 176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -105.26 159.28 16.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.525 1.13 . . . . 0.0 108.337 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -73.8 -31.81 63.45 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.216 0.606 . . . . 0.0 110.261 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -80.99 156.23 26.02 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 154.28 120.26 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.758 2.823 . . . . 0.0 106.223 -164.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.426 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.0 m80 -62.37 -80.95 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.513 1.125 . . . . 0.0 109.741 -170.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -137.81 -64.31 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 147.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.24 44.39 3.04 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 119.33 -0.706 . . . . 0.0 112.806 -166.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -107.12 78.09 1.2 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.045 1.338 . . . . 0.0 109.624 -171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD22 ' OD2' ' A' ' 101' ' ' ASP . 14.7 mt -89.01 50.33 1.94 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -171.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 25.4 -110.54 0.01 OUTLIER Glycine 0 CA--C 1.53 0.975 0 C-N-CA 126.285 1.898 . . . . 0.0 113.421 -166.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 0.4 OUTLIER -144.71 159.56 42.65 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 124.452 1.101 . . . . 0.0 110.761 -177.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 97' ' ' VAL . 20.2 m -103.46 -165.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 79.5 m -144.04 119.52 10.34 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.7 142.64 27.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.728 0.643 . . . . 0.0 110.736 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.59 170.82 9.97 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.066 1.746 . . . . 0.0 110.623 169.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -50.92 -27.63 7.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.23 2.212 . . . . 0.0 112.181 168.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.22 -10.69 54.18 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.112 0.965 . . . . 0.0 109.944 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.85 28.48 37.97 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 116.444 -0.344 . . . . 0.0 112.485 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.34 123.67 66.44 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 C-N-CA 126.257 1.823 . . . . 0.0 107.064 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -113.61 103.6 11.41 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -80.91 116.12 20.72 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.526 1.141 . . . . 0.0 108.08 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 87' ' ' VAL . 5.0 t -92.61 148.05 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.3 p -172.14 86.54 0.08 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.375 1.07 . . . . 0.0 109.666 -176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.6 tt -146.72 -175.83 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -137.57 159.07 42.99 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.909 1.284 . . . . 0.0 109.281 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' OD2' HD22 ' A' ' 84' ' ' LEU . 1.4 m-20 -133.29 148.83 51.94 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.063 0.945 . . . . 0.0 110.472 176.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.8 p -99.98 -22.58 15.2 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.447 1.899 . . . . 0.0 111.552 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.75 -62.11 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.892 0.477 . . . . 0.0 110.232 -173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -69.83 166.1 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 122.019 -0.425 . . . . 0.0 110.154 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.0 m 177.97 -179.92 0.29 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -172.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mp -97.29 10.21 40.19 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.677 2.391 . . . . 0.0 109.704 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 168.46 6.73 Favored 'General case' 0 C--O 1.22 -0.488 0 C-N-CA 123.878 0.871 . . . . 0.0 110.098 173.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -38.91 -84.18 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.578 1.085 . . . . 0.0 114.371 -170.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.84 -26.64 60.7 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 121.292 0.568 . . . . 0.0 111.727 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -58.05 -48.78 79.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.3 t -25.38 106.94 0.03 OUTLIER 'General case' 0 C--N 1.342 0.247 0 C-N-CA 127.724 2.409 . . . . 0.0 112.246 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -70.57 -12.95 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.929 178.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 20.7 mm -57.06 117.79 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.06 -2.78 55.24 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.07 -0.85 . . . . 0.0 113.603 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -84.46 151.83 24.38 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.932 1.366 . . . . 0.0 110.597 176.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.6 m -93.88 113.77 25.87 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.787 0.835 . . . . 0.0 111.051 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.2 127.73 44.3 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.017 0.927 . . . . 0.0 108.764 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.9 t -132.26 142.8 41.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 123.589 0.756 . . . . 0.0 109.552 -168.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.71 147.92 13.02 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 C-N-CA 124.463 1.105 . . . . 0.0 109.784 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -119.35 161.6 20.19 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.736 1.214 . . . . 0.0 112.245 -176.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.8 tt0 -66.13 -55.09 18.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.27 0.628 . . . . 0.0 112.142 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -89.68 171.71 9.46 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.139 0.971 . . . . 0.0 110.482 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.24 148.98 48.92 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.441 171.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.486 ' OD1' HD23 ' A' ' 126' ' ' LEU . 38.9 t0 -74.83 118.42 17.77 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.726 0.774 . . . . 0.0 109.152 167.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -75.01 -0.92 20.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.883 2.873 . . . . 0.0 112.77 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 ' HA3' ' A' ' 73' ' ' GLY . 8.9 mt 43.45 41.22 3.13 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.076 1.35 . . . . 0.0 112.068 -177.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 76.11 -8.48 23.7 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.402 1.001 . . . . 0.0 114.292 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.76 -27.48 69.23 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.364 1.082 . . . . 0.0 113.622 -162.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.87 -22.78 42.7 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.475 1.036 . . . . 0.0 113.086 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.05 83.93 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 118.706 1.253 . . . . 0.0 112.353 173.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.577 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -126.26 161.45 27.73 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 125.23 1.412 . . . . 0.0 109.785 170.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -49.83 -52.35 33.01 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 118.833 0.742 . . . . 0.0 109.337 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.56 -63.75 0.93 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.247 0.619 . . . . 0.0 111.701 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.577 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 36.2 m -49.65 -59.85 3.42 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.414 1.486 . . . . 0.0 112.212 170.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.3 p -66.61 -7.86 23.23 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.99 -29.89 9.66 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.997 2.519 . . . . 0.0 111.409 173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 34.4 p -139.4 -29.01 0.76 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -171.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.12 25.12 9.77 Favored Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 125.07 1.319 . . . . 0.0 110.839 -175.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 61.8 t30 50.49 29.35 3.92 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 119.097 1.448 . . . . 0.0 110.951 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.53 52.46 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.103 -166.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.27 -168.24 52.54 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 t -72.15 171.63 11.64 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.811 0.815 . . . . 0.0 111.857 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 117.35 28.73 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 113.793 -1.548 . . . . 0.0 108.7 -173.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.25 -29.96 54.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.136 176.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 154.64 21.61 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.401 0.546 . . . . 0.0 110.215 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 21.9 p -128.02 150.37 49.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 126.532 1.933 . . . . 0.0 107.262 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.57 159.42 28.13 Favored Glycine 0 CA--C 1.518 0.276 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 19.5 t -116.02 131.08 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 -174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.718 HG21 HG12 ' A' ' 112' ' ' ILE . 8.3 mt -84.04 127.31 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -141.07 177.34 21.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.542 1.544 . . . . 0.0 109.269 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.6 mm -70.98 141.89 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -88.34 47.57 1.52 Allowed 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 123.223 0.609 . . . . 0.0 111.589 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.177 -1.868 . . . . 0.0 106.912 178.155 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.405 . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -152.64 69.66 0.87 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -167.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.34 149.01 41.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.864 0.364 . . . . 0.0 111.304 174.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -85.43 163.23 18.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 168.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.16 149.17 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 126.191 1.796 . . . . 0.0 107.519 168.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.83 112.22 12.29 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 162.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -85.0 102.26 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-O 121.732 0.777 . . . . 0.0 108.947 176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.38 145.14 56.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 O-C-N 121.705 -0.622 . . . . 0.0 109.556 170.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -148.64 143.26 26.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 126.362 1.865 . . . . 0.0 107.016 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.72 -165.07 11.57 Favored Glycine 0 C--N 1.337 0.604 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.52 -41.35 96.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.302 0.573 . . . . 0.0 109.785 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.68 -166.38 27.3 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -79.82 14.41 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.791 2.994 . . . . 0.0 111.956 -174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -61.03 101.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -111.34 159.18 18.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 172.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.44 119.57 0.96 Allowed Glycine 0 C--O 1.22 -0.723 0 C-N-CA 119.871 -1.157 . . . . 0.0 113.754 173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.2 mp -88.18 83.01 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 117.745 0.772 . . . . 0.0 109.025 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 33.1 mm -72.45 149.98 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.97 133.9 22.5 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.031 0.932 . . . . 0.0 108.645 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.601 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.7 m-85 -117.54 101.98 8.81 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 118.001 -1.0 . . . . 0.0 108.521 175.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.61 167.75 9.92 Favored 'General case' 0 N--CA 1.461 0.086 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -152.87 -43.81 0.1 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.098 0.559 . . . . 0.0 110.233 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.17 -50.56 0.6 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.87 1.668 . . . . 0.0 110.89 -178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -77.47 -17.7 57.8 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.802 1.241 . . . . 0.0 112.814 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 74.94 -39.87 0.42 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 119.027 0.831 . . . . 0.0 111.734 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -127.46 33.46 4.84 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.918 -1.114 . . . . 0.0 111.049 174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.23 -164.64 13.93 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.63 1.11 . . . . 0.0 111.339 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.49 134.02 34.29 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.47 2.113 . . . . 0.0 109.435 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.95 135.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 174.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' HB3' ' CZ3' ' A' ' 32' ' ' TRP . 21.3 mmtt -99.27 121.75 41.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.965 1.306 . . . . 0.0 108.015 169.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.3 t -98.72 118.37 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.887 1.675 . . . . 0.0 107.394 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CZ3' ' HB3' ' A' ' 30' ' ' LYS . 1.6 m-90 -121.34 159.52 25.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.33 1.052 . . . . 0.0 108.471 175.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -165.36 175.43 41.15 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 168.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.9 p -162.9 94.81 0.86 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -66.32 162.39 2.93 Favored 'Isoleucine or valine' 0 C--N 1.342 0.242 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -150.88 98.64 2.62 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 167.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 152.92 -11.46 0.59 Allowed Glycine 0 CA--C 1.529 0.946 0 O-C-N 123.66 0.6 . . . . 0.0 113.924 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.634 HD12 ' CE1' ' A' ' 43' ' ' HIS . 3.2 mm? -72.13 -170.23 0.58 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.009 0.904 . . . . 0.0 111.174 178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.0 t -127.24 166.78 17.11 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 162.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 55.0 tt0 -56.82 155.85 7.32 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.986 1.714 . . . . 0.0 111.96 -172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.11 -137.4 12.67 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 104.523 -3.431 . . . . 0.0 104.523 -177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -142.63 156.61 45.09 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 118.176 0.988 . . . . 0.0 111.629 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.634 ' CE1' HD12 ' A' ' 38' ' ' LEU . 91.8 m-70 -144.89 131.31 19.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.566 0.747 . . . . 0.0 110.514 -172.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.84 153.39 50.09 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-O 118.784 -1.009 . . . . 0.0 110.96 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.33 121.27 5.11 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.194 0.997 . . . . 0.0 112.876 -171.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.441 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 1.8 m80 -149.7 163.41 38.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -173.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.3 t -83.02 107.95 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.015 165.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -81.63 149.17 28.7 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.118 -0.364 . . . . 0.0 110.623 169.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -74.66 63.03 1.09 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.813 . . . . 0.0 110.404 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -131.24 173.48 11.01 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.968 1.307 . . . . 0.0 108.957 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -162.74 101.95 1.03 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.141 2.576 . . . . 0.0 104.776 168.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.7 t0 29.85 66.78 0.11 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 126.71 2.004 . . . . 0.0 114.515 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.75 -54.61 0.67 Allowed 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.04 -176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 t -69.64 67.06 0.23 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.103 0.865 . . . . 0.0 112.015 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.65 -45.1 66.56 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.544 -1.347 . . . . 0.0 111.595 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.89 -8.41 73.11 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 119.998 -0.335 . . . . 0.0 113.057 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.5 t 41.09 45.71 2.39 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.854 2.462 . . . . 0.0 114.141 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.9 t -80.48 -60.34 2.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.049 0.54 . . . . 0.0 111.04 -175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.6 p 176.45 51.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.8 -1.188 . . . . 0.0 110.118 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -81.2 -115.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.82 121.23 26.0 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 119.839 1.2 . . . . 0.0 112.121 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -79.97 -165.14 0.32 Allowed 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.99 1.794 . . . . 0.0 109.413 170.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -58.33 136.13 57.32 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.763 0.825 . . . . 0.0 110.797 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.66 102.65 0.2 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.379 1.072 . . . . 0.0 111.991 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -131.33 79.68 69.52 Favored Pre-proline 0 N--CA 1.468 0.44 0 C-N-CA 125.672 1.589 . . . . 0.0 111.314 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -87.58 -30.67 0.27 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.529 1.486 . . . . 0.0 112.258 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.7 31.94 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 t -97.0 -128.3 0.16 Allowed 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -143.36 162.74 34.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -57.55 166.71 1.21 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.489 0.716 . . . . 0.0 111.334 174.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -57.4 145.45 32.62 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -170.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.29 -171.52 38.66 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.07 152.41 21.29 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 125.008 1.29 . . . . 0.0 111.935 -170.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -58.78 -30.91 93.99 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.017 2.478 . . . . 0.0 110.106 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.02 -7.9 59.64 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -108.09 162.24 14.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.927 1.291 . . . . 0.0 110.319 -173.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.54 -36.78 79.3 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.414 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -75.8 142.02 42.38 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 18.7 ptt-85 165.09 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 128.214 2.606 . . . . 0.0 106.141 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -66.88 179.44 1.11 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 109.244 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.28 -29.26 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 120.647 -1.283 . . . . 0.0 111.282 -170.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.71 61.5 0.64 Allowed Glycine 0 CA--C 1.53 0.971 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.22 90.33 3.26 Favored 'General case' 0 C--N 1.338 0.107 0 C-N-CA 126.489 1.916 . . . . 0.0 109.848 176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -93.86 43.39 1.11 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.8 -124.53 0.55 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 125.74 1.638 . . . . 0.0 112.817 -173.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -123.33 164.16 19.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.164 1.385 . . . . 0.0 109.128 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 m -118.43 166.57 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.4 m -108.91 121.12 44.44 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.879 1.272 . . . . 0.0 108.571 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.26 147.49 27.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.1 0.56 . . . . 0.0 110.351 171.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -78.35 166.83 22.21 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.269 1.828 . . . . 0.0 109.836 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -55.01 -25.32 29.29 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.396 1.879 . . . . 0.0 112.529 167.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.29 -3.61 58.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.609 1.163 . . . . 0.0 109.557 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.67 31.08 30.83 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 121.916 -0.49 . . . . 0.0 112.543 172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.4 t -118.23 122.03 68.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 126.088 1.755 . . . . 0.0 107.196 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -107.83 100.92 10.25 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 171.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.17 125.25 32.68 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 124.968 1.417 . . . . 0.0 108.479 175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -107.16 154.47 8.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 125.237 1.415 . . . . 0.0 107.653 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.9 t -167.58 91.39 0.36 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.475 1.51 . . . . 0.0 107.112 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -136.3 175.81 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.47 155.94 45.12 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.715 0.806 . . . . 0.0 108.996 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -146.73 141.2 26.51 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.26 1.15 21.8 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.686 1.194 . . . . 0.0 110.756 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.03 -46.69 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.427 0.558 . . . . 0.0 109.789 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -80.15 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 122.732 0.413 . . . . 0.0 110.356 173.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.1 t -162.45 169.1 20.98 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mp -91.25 7.98 38.15 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.841 1.256 . . . . 0.0 109.876 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.1 p -146.4 174.62 11.21 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.488 1.515 . . . . 0.0 108.545 -174.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.05 -162.18 27.75 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -67.36 -20.54 65.58 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 122.583 1.183 . . . . 0.0 111.724 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.6 -15.48 54.54 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -174.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -19.97 92.97 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.938 2.895 . . . . 0.0 114.244 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.88 -28.3 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.766 1.227 . . . . 0.0 111.157 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 4' ' ' ALA . 43.8 mm -58.05 119.66 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.16 -15.81 46.73 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 123.395 0.434 . . . . 0.0 112.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.3 mmt-85 -72.8 174.09 8.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.538 1.169 . . . . 0.0 110.59 177.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 93.8 m -117.24 127.38 54.03 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.796 1.238 . . . . 0.0 109.581 171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.55 142.53 30.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 118.619 0.645 . . . . 0.0 109.664 170.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.77 140.9 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 p -101.86 153.56 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.642 1.177 . . . . 0.0 109.355 177.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 78.4 m-70 -115.27 153.02 31.67 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.04 1.336 . . . . 0.0 113.023 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -60.08 -55.52 32.88 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.853 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -99.38 -171.3 2.05 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.27 150.59 28.48 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.792 0.837 . . . . 0.0 110.069 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' HB3' HD23 ' A' ' 126' ' ' LEU . 3.4 m-20 -64.76 131.67 47.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.076 0.55 . . . . 0.0 111.673 165.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -72.14 -1.58 15.46 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 127.412 2.285 . . . . 0.0 112.539 170.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.481 HD23 ' HB3' ' A' ' 124' ' ' ASP . 11.0 mt 43.94 39.83 2.93 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.959 1.303 . . . . 0.0 111.764 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.84 3.66 16.95 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.534 1.54 . . . . 0.0 114.799 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -72.23 -11.72 60.85 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.6 1.2 . . . . 0.0 111.612 -175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.6 -10.56 54.7 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 119.292 -0.727 . . . . 0.0 113.148 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 48.92 83.73 Favored Glycine 0 C--N 1.341 0.852 0 CA-C-N 118.787 1.293 . . . . 0.0 111.526 172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.54 HD22 ' H ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -164.93 127.83 2.28 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -168.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -27.91 -64.71 0.09 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.645 1.578 . . . . 0.0 113.225 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.47 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -50.68 -53.57 30.08 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.849 -1.157 . . . . 0.0 113.659 179.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.54 ' H ' HD22 ' A' ' 131' ' ' ASN . 52.2 p -56.33 -46.72 79.79 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 119.152 -2.218 . . . . 0.0 111.635 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.3 m -81.52 -1.74 47.27 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.205 1.402 . . . . 0.0 111.977 -170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -119.26 -46.2 2.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 128.629 2.772 . . . . 0.0 109.904 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.97 -27.58 12.07 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 119.993 -0.683 . . . . 0.0 112.606 -175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.07 12.07 60.63 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.176 -1.347 . . . . 0.0 110.898 -164.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 64.33 10.4 5.62 Favored 'General case' 0 C--N 1.342 0.267 0 CA-C-N 119.613 1.707 . . . . 0.0 110.933 174.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.18 15.51 1.16 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.843 0.857 . . . . 0.0 111.782 -162.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 69.47 -165.55 49.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.4 t -65.29 171.41 3.85 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.38 1.086 . . . . 0.0 110.636 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.9 111.52 23.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.996 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.23 -40.5 67.74 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.75 0.82 . . . . 0.0 110.403 175.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.05 155.9 30.11 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.418 0.554 . . . . 0.0 111.386 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.2 m -140.03 142.78 36.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.371 1.869 . . . . 0.0 107.167 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -159.22 142.82 8.61 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 118.901 0.773 . . . . 0.0 113.394 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.0 p -85.65 148.44 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.183 0.993 . . . . 0.0 110.503 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.465 HG12 ' HB2' ' A' ' 6' ' ' ALA . 45.7 mt -97.81 122.93 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.779 1.232 . . . . 0.0 110.046 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -138.7 -178.26 16.12 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 174.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.7 141.28 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 124.734 1.214 . . . . 0.0 109.13 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.97 64.84 1.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.475 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.9 p -79.07 -162.7 0.41 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -165.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 pttp -77.99 114.96 17.37 Favored 'General case' 0 C--N 1.347 0.49 0 CA-C-O 121.952 0.882 . . . . 0.0 110.333 177.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -93.71 165.99 12.44 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.29 1.436 . . . . 0.0 108.645 167.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.93 146.53 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 126.846 2.059 . . . . 0.0 107.394 174.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -126.27 115.61 19.97 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 160.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.4 m -82.61 96.81 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 122.361 1.077 . . . . 0.0 108.673 170.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 mp -67.11 140.97 57.59 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 109.013 169.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -148.48 149.34 31.49 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.664 0.786 . . . . 0.0 109.751 168.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.61 -165.32 12.97 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -60.43 -42.41 95.98 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.659 0.784 . . . . 0.0 110.282 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -94.54 -164.84 35.91 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.42 6.18 4.96 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.294 2.662 . . . . 0.0 111.645 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.4 t -52.75 115.81 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 124.423 1.089 . . . . 0.0 108.132 166.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -140.78 160.75 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.69 128.49 2.5 Favored Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.275 172.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 36.2 mm -93.47 100.81 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 mm -88.81 150.95 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -135.72 147.42 48.46 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.033 1.333 . . . . 0.0 109.311 173.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -139.86 113.26 8.43 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 117.297 -1.335 . . . . 0.0 110.784 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.451 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 9.4 tm-20 -122.23 154.53 37.39 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 120.33 1.423 . . . . 0.0 110.274 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.404 ' HB2' HG23 ' A' ' 29' ' ' VAL . 43.6 tt0 -149.45 -56.08 0.19 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 122.094 0.95 . . . . 0.0 111.576 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 0.1 OUTLIER 69.58 -50.97 0.62 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 128.34 2.656 . . . . 0.0 111.966 -173.195 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -45.86 -22.71 0.21 Allowed 'General case' 0 C--N 1.342 0.26 0 C-N-CA 128.365 2.666 . . . . 0.0 114.638 -176.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 t 81.31 -44.03 0.19 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.537 1.135 . . . . 0.0 110.727 175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -128.31 10.5 6.28 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.13 1.372 . . . . 0.0 112.44 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.75 -167.68 42.59 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.8 131.4 18.37 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.438 2.092 . . . . 0.0 110.465 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -79.5 131.98 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 170.592 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -93.15 118.49 31.29 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 168.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.85 135.04 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 C-N-CA 125.732 1.613 . . . . 0.0 106.942 -176.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -159.94 168.41 25.77 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -172.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.54 -170.1 43.02 Favored Glycine 0 C--O 1.227 -0.312 0 C-N-CA 119.239 -1.458 . . . . 0.0 113.08 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.8 m -156.45 102.32 2.07 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 -174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.709 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.3 OUTLIER -68.33 168.04 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 170.075 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -155.76 87.0 1.07 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.02 2.41 0.29 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.157 0.884 . . . . 0.0 114.71 170.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.651 HD22 HG21 ' A' ' 35' ' ' ILE . 2.2 mp -72.02 -168.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.357 1.079 . . . . 0.0 110.006 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 t -133.75 152.14 51.79 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 171.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -43.99 135.83 4.01 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.855 2.462 . . . . 0.0 111.49 -176.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.67 -172.11 14.2 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.35 135.74 33.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.695 0.398 . . . . 0.0 110.858 -165.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -128.5 123.83 34.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.011 1.724 . . . . 0.0 109.118 -177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -63.45 145.66 50.04 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 118.692 -1.06 . . . . 0.0 111.035 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.86 120.98 16.75 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.058 0.943 . . . . 0.0 110.067 -175.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -152.02 166.16 32.42 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.2 m -92.19 116.95 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.828 167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -91.97 159.05 15.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.503 1.121 . . . . 0.0 109.407 172.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 166.65 8.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.831 166.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 80.25 174.92 0.12 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.049 2.54 . . . . 0.0 110.797 -174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -178.22 162.03 1.51 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 128.904 2.882 . . . . 0.0 107.138 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t0 27.51 65.59 0.08 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 129.753 3.221 . . . . 0.0 114.682 -177.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -161.86 -47.58 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.22 1.008 . . . . 0.0 109.363 -175.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 39.9 p -82.07 51.58 1.8 Allowed 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.858 0.863 . . . . 0.0 111.673 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.14 -41.96 1.91 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.843 1.657 . . . . 0.0 112.491 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.98 58.3 0.67 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 170.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 56.1 57.96 4.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.241 0.616 . . . . 0.0 112.115 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.9 p -89.68 -87.28 0.18 Allowed 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.677 -0.639 . . . . 0.0 109.305 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.9 m -84.22 18.33 2.2 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 123.896 0.879 . . . . 0.0 112.7 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.43 111.48 0.23 Allowed 'General case' 0 C--N 1.342 0.266 0 C-N-CA 124.908 1.283 . . . . 0.0 111.109 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.8 171.24 22.35 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -170.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.11 173.99 9.59 Favored 'Trans proline' 0 N--CA 1.442 -1.526 0 C-N-CA 120.903 1.069 . . . . 0.0 109.988 173.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -43.25 121.89 2.35 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.174 0.59 . . . . 0.0 109.976 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.87 118.82 13.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -130.95 75.14 79.06 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.679 1.192 . . . . 0.0 111.741 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.68 -13.21 22.23 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.333 2.022 . . . . 0.0 111.074 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.75 -9.85 59.16 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.387 1.075 . . . . 0.0 112.154 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.7 m 53.98 62.23 2.7 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.85 1.66 . . . . 0.0 112.658 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -142.11 168.29 20.1 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -75.05 165.6 24.98 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 121.234 -0.916 . . . . 0.0 109.833 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.426 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 77.5 t60 -66.55 146.96 53.94 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.078 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.62 -158.11 11.52 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 173.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -117.52 170.84 13.66 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.261 0.934 . . . . 0.0 112.122 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.3 -4.98 10.26 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.681 2.921 . . . . 0.0 112.682 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -125.27 22.59 7.79 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.817 1.247 . . . . 0.0 112.276 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -113.04 162.96 15.29 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.718 0.807 . . . . 0.0 109.572 171.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.39 -45.83 90.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.84 152.1 18.68 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.632 0.73 . . . . 0.0 109.725 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 173.76 138.56 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.781 2.032 . . . . 0.0 107.466 176.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -77.47 -177.59 4.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.754 1.222 . . . . 0.0 109.991 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.63 -53.42 39.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.297 0 O-C-N 121.376 -0.828 . . . . 0.0 110.28 -178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.94 22.66 11.12 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.059 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -80.94 68.1 7.09 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 119.67 1.735 . . . . 0.0 111.177 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.2 mt -85.92 43.63 1.06 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.664 1.186 . . . . 0.0 109.205 178.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.41 -110.79 0.02 OUTLIER Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.053 1.787 . . . . 0.0 114.039 -170.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 23.4 p30 -144.85 163.92 32.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.418 1.087 . . . . 0.0 110.234 -172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -123.19 166.45 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 C-N-CA 124.688 1.195 . . . . 0.0 108.343 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 86.8 m -112.97 109.08 18.27 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.518 0.727 . . . . 0.0 109.61 -174.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.16 143.53 47.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 118.129 0.422 . . . . 0.0 109.934 170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -80.73 177.79 8.8 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.147 1.379 . . . . 0.0 110.307 174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.43 -14.78 31.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.688 1.595 . . . . 0.0 112.084 174.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.95 -3.75 55.51 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.607 0.763 . . . . 0.0 110.056 177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.83 31.08 65.11 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 121.546 -0.721 . . . . 0.0 111.929 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.85 119.71 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.948 2.099 . . . . 0.0 106.202 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.709 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.83 106.01 16.33 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 174.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.68 112.57 17.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -94.2 144.55 9.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.3 p -164.96 95.9 0.7 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.07 0.948 . . . . 0.0 109.209 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.17 -178.72 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -150.69 149.0 29.26 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -137.3 157.94 45.52 Favored 'General case' 0 CA--C 1.52 -0.177 0 O-C-N 123.385 0.428 . . . . 0.0 110.371 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.0 m -113.19 36.55 3.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.489 1.516 . . . . 0.0 110.496 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 11.6 p -134.1 -55.41 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.217 0.607 . . . . 0.0 109.776 172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.4 pt -67.2 134.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.3 m -149.75 173.83 13.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -86.22 15.81 4.9 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.515 0.726 . . . . 0.0 109.629 173.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.4 p -165.86 174.34 9.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.425 1.09 . . . . 0.0 108.109 -167.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.0 59.15 8.93 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 69.88 -35.63 0.32 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 127.418 2.287 . . . . 0.0 113.562 174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -86.95 5.62 36.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.549 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.6 t -33.58 104.2 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.286 1.434 . . . . 0.0 113.3 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.4 pt -66.82 -20.8 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 123.296 0.638 . . . . 0.0 112.067 177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.445 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.9 mm -59.95 116.41 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 171.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.29 42.69 5.8 Favored Glycine 0 N--CA 1.439 -1.163 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.43 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.703 ' HB2' HD12 ' A' ' 149' ' ' ILE . 13.0 mmt85 -117.26 139.71 50.47 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.748 0.819 . . . . 0.0 109.677 167.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 89.7 m -72.31 102.73 3.2 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 tp -87.68 136.04 33.12 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 142.07 33.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 122.408 0.283 . . . . 0.0 110.509 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.68 145.74 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.794 1.238 . . . . 0.0 109.545 175.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -112.3 158.27 19.95 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.935 1.294 . . . . 0.0 111.0 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.25 -65.9 0.62 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -79.52 170.12 17.04 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 122.432 1.111 . . . . 0.0 110.572 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.98 143.73 56.63 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.038 174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' OD1' HD23 ' A' ' 126' ' ' LEU . 35.5 t0 -63.2 123.26 18.18 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 165.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -83.64 0.96 44.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 129.621 3.168 . . . . 0.0 112.479 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD23 ' OD1' ' A' ' 124' ' ' ASP . 3.5 mt 44.25 37.02 1.74 Allowed 'General case' 0 CA--C 1.54 0.568 0 O-C-N 120.495 -1.378 . . . . 0.0 112.444 -178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 65.7 7.72 36.45 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.298 0.951 . . . . 0.0 114.959 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.6 -16.69 63.44 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.249 1.525 . . . . 0.0 111.712 -174.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.8 -6.76 64.1 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-O 118.748 -1.029 . . . . 0.0 114.415 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.89 50.59 64.41 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 119.344 1.572 . . . . 0.0 112.793 172.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.18 133.55 5.23 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 -174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -28.27 -65.64 0.08 Allowed 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 126.823 2.049 . . . . 0.0 113.13 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.436 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -49.53 -55.43 13.43 Favored 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 123.397 0.679 . . . . 0.0 111.645 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.82 -59.31 3.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 128.623 2.769 . . . . 0.0 113.523 163.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 38.4 p -77.05 5.73 7.61 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.129 0.971 . . . . 0.0 112.034 -172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -120.04 -36.36 3.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 127.192 2.197 . . . . 0.0 109.198 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -123.79 -22.27 4.96 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -173.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 91.67 20.99 35.42 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -170.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 53.18 27.41 5.93 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.243 1.521 . . . . 0.0 110.393 174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.9 -2.01 41.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.983 -164.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.65 -168.7 52.85 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -66.49 165.27 14.77 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.285 1.04 . . . . 0.0 111.624 -171.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.06 110.89 20.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 113.657 -1.611 . . . . 0.0 108.584 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -37.16 76.37 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.895 0.77 . . . . 0.0 110.07 177.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.28 155.33 33.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.072 0.396 . . . . 0.0 110.585 -178.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.3 p -141.68 152.19 43.68 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.415 1.886 . . . . 0.0 108.066 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.95 177.5 38.99 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.71 140.47 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.703 HD12 ' HB2' ' A' ' 115' ' ' ARG . 58.4 mt -85.21 124.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 123.58 0.752 . . . . 0.0 109.635 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.96 169.79 26.06 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -64.97 141.89 17.63 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 C-N-CA 124.369 1.068 . . . . 0.0 109.981 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -99.78 161.35 13.67 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 123.636 0.774 . . . . 0.0 112.095 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 . . . . . 0 C--O 1.238 0.491 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 156.099 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.357 . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 116.683 -1.627 . . . . 0.0 108.122 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.4 p -159.31 -160.5 0.84 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.733 2.013 . . . . 0.0 105.814 163.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -47.37 122.08 4.38 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 118.325 0.511 . . . . 0.0 110.181 155.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -104.87 166.55 10.31 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.772 2.029 . . . . 0.0 106.872 163.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.81 154.21 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.432 1.493 . . . . 0.0 107.659 175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.61 19.65 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 159.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -85.79 96.98 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.981 0.896 . . . . 0.0 108.909 172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.549 HD11 HD23 ' A' ' 117' ' ' LEU . 5.6 mp -60.62 139.09 57.95 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.863 0.865 . . . . 0.0 109.417 165.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.1 mtpt -151.6 152.06 32.37 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 126.708 2.003 . . . . 0.0 108.531 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.63 -163.79 11.24 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.63 -41.03 98.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.405 0.682 . . . . 0.0 110.222 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.15 -165.12 33.81 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.44 5.05 5.79 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.43 2.753 . . . . 0.0 112.008 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 20.6 t -46.59 121.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 124.739 1.216 . . . . 0.0 108.797 164.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.54 160.63 41.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.31 135.45 4.74 Favored Glycine 0 C--O 1.221 -0.68 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.618 172.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -94.94 110.6 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 173.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -100.29 151.1 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.894 1.278 . . . . 0.0 107.856 172.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -132.78 140.29 47.95 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 127.539 2.335 . . . . 0.0 107.072 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.0 m-85 -134.03 110.61 9.76 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 118.377 -0.82 . . . . 0.0 110.517 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -99.26 149.33 23.22 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 119.559 1.072 . . . . 0.0 109.95 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.491 ' HB2' HG22 ' A' ' 29' ' ' VAL . 3.3 tp60 -163.63 -66.31 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 67.37 -50.87 0.5 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.748 1.619 . . . . 0.0 112.244 -168.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -63.51 158.95 19.66 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.897 1.279 . . . . 0.0 113.01 -173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.9 t -73.23 -40.88 64.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.851 -1.522 . . . . 0.0 109.674 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -140.58 38.91 1.86 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.85 1.26 . . . . 0.0 109.576 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.06 -177.94 49.94 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -75.65 116.98 4.61 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.689 2.26 . . . . 0.0 109.113 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 22' ' ' GLN . 2.3 t -68.84 138.43 22.38 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 169.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -104.29 129.92 52.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 158.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.92 135.26 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 174.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -160.91 166.74 27.92 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -176.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.68 -169.9 43.01 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 119.168 -1.491 . . . . 0.0 112.386 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 p -153.7 108.51 3.12 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.437 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -76.21 164.68 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.113 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.51 92.48 1.31 Allowed 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.2 -6.01 0.93 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.122 0.868 . . . . 0.0 113.778 167.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.475 HD12 ' CE1' ' A' ' 43' ' ' HIS . 4.3 mm? -64.26 169.51 4.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.437 1.118 . . . . 0.0 108.981 170.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.9 p -83.92 167.32 17.08 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.902 1.281 . . . . 0.0 108.002 169.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -55.41 155.53 5.19 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.256 0.48 . . . . 0.0 111.226 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -173.69 26.8 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 165.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 mp -77.8 133.77 38.15 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.587 -0.306 . . . . 0.0 110.448 -170.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' CE1' HD12 ' A' ' 38' ' ' LEU . 76.3 m-70 -127.45 121.66 31.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.852 1.661 . . . . 0.0 108.762 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -53.51 137.73 38.13 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 173.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 39.7 t80 -135.69 113.28 10.84 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 124.73 1.212 . . . . 0.0 107.861 -175.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -150.9 163.89 37.61 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 118.741 0.701 . . . . 0.0 112.69 -170.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.1 t -96.26 105.73 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -74.17 168.23 20.01 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.057 0.543 . . . . 0.0 111.29 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -62.14 179.32 0.3 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.006 165.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 76.12 -175.96 0.12 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.942 2.097 . . . . 0.0 109.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -152.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.62 92.0 3.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.936 1.695 . . . . 0.0 107.852 175.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -168.58 -54.02 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.07 0.948 . . . . 0.0 109.365 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.8 t -70.02 60.93 0.18 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.61 1.164 . . . . 0.0 111.133 177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.19 -36.29 51.47 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.45 -1.406 . . . . 0.0 112.031 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.94 -9.97 67.28 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-O 119.377 -0.679 . . . . 0.0 113.965 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.3 m 48.29 50.38 16.54 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.98 1.712 . . . . 0.0 111.979 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.2 -60.64 1.55 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.141 0.976 . . . . 0.0 108.907 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.4 -38.22 58.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.525 2.33 . . . . 0.0 112.967 -171.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -44.07 118.14 1.4 Allowed 'General case' 0 C--O 1.234 0.275 0 O-C-N 123.965 0.791 . . . . 0.0 108.961 173.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -85.33 -131.58 2.55 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 107.886 -2.086 . . . . 0.0 107.886 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.36 -160.91 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.992 1.795 . . . . 0.0 113.092 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -74.12 136.41 42.95 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 108.537 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -46.22 117.58 1.61 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.32 1.048 . . . . 0.0 109.852 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -125.76 57.94 20.66 Favored Pre-proline 0 CA--C 1.53 0.204 0 C-N-CA 124.546 1.139 . . . . 0.0 112.308 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.27 -28.41 33.59 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 120.857 1.038 . . . . 0.0 110.824 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.14 -32.36 68.87 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.292 0.951 . . . . 0.0 110.281 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.3 m 82.24 52.91 0.02 OUTLIER 'General case' 0 CA--C 1.526 0.031 0 C-N-CA 124.772 1.229 . . . . 0.0 110.214 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -120.14 157.82 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -76.06 174.88 9.47 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.887 0.767 . . . . 0.0 109.558 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.434 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 26.2 t60 -64.41 148.99 49.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.725 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.77 -150.14 7.39 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 165.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.11 171.62 13.99 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 124.419 1.009 . . . . 0.0 111.834 -175.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.17 -26.98 78.21 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.802 2.335 . . . . 0.0 111.431 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -109.23 22.35 15.96 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -86.65 168.46 13.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.81 1.186 . . . . 0.0 108.804 166.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -73.61 -43.05 60.65 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 165.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.82 120.72 38.71 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.57 131.45 3.59 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 103.406 -2.813 . . . . 0.0 103.406 175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -53.83 -76.14 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.529 1.059 . . . . 0.0 110.569 -170.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.6 t -152.66 -71.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 129.088 2.955 . . . . 0.0 105.997 162.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -81.79 39.73 2.58 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 122.06 -0.4 . . . . 0.0 113.401 -169.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.48 71.32 5.1 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.664 1.586 . . . . 0.0 109.366 -174.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 37.4 mt -85.17 50.27 1.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 121.319 -0.863 . . . . 0.0 109.297 -175.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.88 -111.22 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 127.657 2.551 . . . . 0.0 112.473 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 p30 -141.19 159.5 42.08 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.132 0.973 . . . . 0.0 109.507 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.21 165.8 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 173.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 95.3 m -115.0 120.22 39.12 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 141.27 28.89 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 123.534 0.521 . . . . 0.0 110.419 175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.86 171.03 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.928 1.691 . . . . 0.0 111.112 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -14.37 53.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.245 1.418 . . . . 0.0 112.256 175.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.36 3.41 37.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.708 1.603 . . . . 0.0 109.777 177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.11 32.06 30.01 Favored Glycine 0 C--N 1.341 0.841 0 O-C-N 121.204 -0.935 . . . . 0.0 113.537 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.23 117.43 55.27 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 125.51 1.524 . . . . 0.0 108.837 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.83 113.86 27.63 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -85.46 98.5 10.63 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.735 1.614 . . . . 0.0 108.405 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.4 t -75.11 145.59 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.8 p -170.3 90.07 0.16 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.988 0.915 . . . . 0.0 109.823 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.9 tt -146.88 179.1 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.158 0.983 . . . . 0.0 108.551 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -148.8 156.49 42.41 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.508 1.523 . . . . 0.0 108.771 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -143.75 161.58 38.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.743 1.217 . . . . 0.0 108.138 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 p -115.78 -13.65 11.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.122 2.169 . . . . 0.0 113.268 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.06 -49.61 14.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 119.606 1.094 . . . . 0.0 110.346 -174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.81 161.5 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 C-N-CA 122.83 0.452 . . . . 0.0 109.916 175.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 2.7 m -155.64 -177.44 6.56 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 176.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.422 HD13 ' CB ' ' A' ' 22' ' ' GLN . 7.6 mp -98.84 21.04 12.06 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.5 p -172.74 -169.23 0.56 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.017 1.327 . . . . 0.0 108.843 -166.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.01 -71.77 2.7 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.73 -53.06 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.376 1.47 . . . . 0.0 107.181 176.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -69.57 34.75 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.29 1.436 . . . . 0.0 113.214 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.0 t -56.88 105.42 0.21 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.217 1.007 . . . . 0.0 109.135 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.7 pt -68.76 -22.01 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 119.114 -0.469 . . . . 0.0 110.725 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' ALA . 41.5 mm -57.43 116.62 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 173.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 109.32 -30.25 8.76 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 119.105 -0.83 . . . . 0.0 112.336 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -70.05 158.62 35.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.121 1.461 . . . . 0.0 112.401 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.1 m -88.49 105.24 17.49 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.724 1.21 . . . . 0.0 110.325 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 8' ' ' LEU . 15.2 tp -83.63 134.79 34.78 Favored 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.1 146.8 21.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 110.156 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.09 176.13 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 C-N-CA 123.516 0.726 . . . . 0.0 110.992 171.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -138.18 159.96 40.67 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.14 -64.63 0.82 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 122.663 0.385 . . . . 0.0 110.954 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -80.25 174.15 11.89 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.88 155.38 40.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.813 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.434 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 46.4 t0 -82.15 113.95 20.34 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 169.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -72.77 6.17 2.7 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 126.483 1.913 . . . . 0.0 112.814 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.9 mt 46.0 41.18 7.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.168 1.387 . . . . 0.0 111.321 -174.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 68.48 4.75 39.92 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.539 -0.755 . . . . 0.0 114.005 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -73.28 -8.53 56.21 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.765 1.282 . . . . 0.0 111.368 -174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.72 -6.88 60.35 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-O 119.405 -0.664 . . . . 0.0 113.952 -176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.84 34.55 83.2 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 118.751 1.276 . . . . 0.0 112.188 176.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.505 HD21 ' CB ' ' A' ' 133' ' ' GLN . 1.3 t30 -136.41 155.6 49.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.807 1.643 . . . . 0.0 108.461 -174.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -61.12 -58.63 7.57 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.505 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -47.95 -41.28 24.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.264 1.026 . . . . 0.0 112.778 178.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.491 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 89.2 p -66.33 -57.02 8.37 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 124.573 1.149 . . . . 0.0 111.722 173.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 57.4 p -69.17 -5.22 21.14 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.825 -0.547 . . . . 0.0 112.105 -177.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -105.41 -35.73 7.4 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 127.491 2.317 . . . . 0.0 111.517 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.3 p -136.19 -23.99 1.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.51 22.12 10.74 Favored Glycine 0 C--O 1.222 -0.648 0 C-N-CA 124.914 1.245 . . . . 0.0 111.358 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 64.29 17.25 10.63 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 118.09 0.945 . . . . 0.0 110.431 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.05 -4.07 30.21 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 122.06 -0.4 . . . . 0.0 111.244 -168.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.88 -158.68 53.75 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.7 t -70.31 174.61 5.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 122.667 1.222 . . . . 0.0 111.891 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 72.6 mtm180 -98.69 98.17 9.34 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 127.292 2.237 . . . . 0.0 109.354 -169.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.83 -39.02 76.67 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.548 0.613 . . . . 0.0 110.884 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.09 151.91 29.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.157 0.583 . . . . 0.0 110.329 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.7 p -130.83 160.82 33.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.538 1.935 . . . . 0.0 108.329 178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.54 173.92 37.99 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.14 139.33 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 60.5 mt -84.2 125.44 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.08 -178.52 23.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -64.9 140.02 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 121.938 -0.743 . . . . 0.0 109.504 -177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.69 50.02 1.6 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 123.262 0.625 . . . . 0.0 111.773 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 . . . . . 0 C--O 1.254 1.326 0 C-N-CA 127.01 2.124 . . . . 0.0 105.777 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.397 . . . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 64.3 p -78.93 83.93 5.0 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 119.065 0.848 . . . . 0.0 109.126 -176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 97.4 5.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 167.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.64 162.19 13.97 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 171.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 p -147.82 150.21 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.523 1.529 . . . . 0.0 108.835 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -131.17 121.8 25.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 160.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m -84.36 94.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-O 122.147 0.975 . . . . 0.0 108.722 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -64.5 106.37 1.13 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 117.397 -1.287 . . . . 0.0 109.114 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -119.14 145.27 46.11 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.953 1.251 . . . . 0.0 107.839 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.16 10.47 Favored Glycine 0 C--N 1.333 0.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 171.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.12 -42.95 93.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.094 0.958 . . . . 0.0 110.436 176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.9 -168.34 40.68 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.31 16.06 1.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 123.411 2.741 . . . . 0.0 111.944 -174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 t -60.73 113.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.2 137.39 54.53 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -138.84 113.86 0.98 Allowed Glycine 0 C--O 1.222 -0.648 0 CA-C-N 120.527 1.512 . . . . 0.0 112.096 172.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.51 96.68 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.9 mm -81.45 149.59 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 170.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -131.36 142.62 50.1 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.267 1.427 . . . . 0.0 107.972 173.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -126.91 134.34 50.47 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.715 0.634 . . . . 0.0 110.698 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -123.2 155.77 36.44 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.274 1.429 . . . . 0.0 110.873 172.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.479 ' HG2' HG22 ' A' ' 29' ' ' VAL . 1.9 tm0? -135.88 -56.58 0.77 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.177 1.791 . . . . 0.0 108.779 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 tttm 72.8 -52.61 0.71 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.685 1.994 . . . . 0.0 110.035 -169.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -81.75 166.67 19.85 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.479 1.512 . . . . 0.0 111.874 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 m -86.04 -34.44 20.73 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -133.28 44.71 2.78 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.559 1.144 . . . . 0.0 109.461 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.33 -174.24 32.75 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.77 132.43 15.74 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.417 2.078 . . . . 0.0 109.123 168.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 22' ' ' GLN . 13.0 t -71.44 147.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 169.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -105.95 118.26 36.14 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 164.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.0 t -100.99 130.82 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 C-N-CA 126.703 2.001 . . . . 0.0 106.429 172.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.41 166.54 32.94 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 118.993 0.815 . . . . 0.0 109.26 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 179.68 -171.79 43.46 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.638 178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.2 p -160.57 100.21 1.3 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -68.92 162.29 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 4.0 tttm -147.7 103.31 3.51 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 161.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.63 -1.27 0.7 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.136 1.35 . . . . 0.0 114.071 171.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 43' ' ' HIS . 5.2 mp -70.48 -170.57 0.4 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.528 1.164 . . . . 0.0 109.792 172.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.6 t -131.1 154.72 47.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -47.37 137.81 8.11 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.082 1.353 . . . . 0.0 111.881 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.51 -172.93 14.68 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.7 136.84 34.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.922 0.489 . . . . 0.0 110.174 -174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.502 ' CG ' HD23 ' A' ' 38' ' ' LEU . 53.3 m-70 -126.87 123.85 38.23 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.604 1.162 . . . . 0.0 109.194 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.57 146.91 49.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-O 118.672 -1.071 . . . . 0.0 111.309 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.28 119.07 10.52 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.943 0.872 . . . . 0.0 110.71 -173.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.55 161.77 41.47 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -173.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.5 t -82.72 105.67 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.969 172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -80.72 149.11 29.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 119.535 1.062 . . . . 0.0 110.975 171.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -173.74 2.44 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.256 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 69.98 -47.38 0.61 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 128.192 2.597 . . . . 0.0 114.324 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 73.15 -63.15 0.45 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.31 1.444 . . . . 0.0 111.041 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.25 67.79 0.32 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.41 1.484 . . . . 0.0 112.724 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.8 57.16 3.97 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 120.798 -1.189 . . . . 0.0 110.083 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.5 p -55.27 -34.48 64.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.196 1.398 . . . . 0.0 112.225 -173.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.07 -18.75 26.85 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.773 1.229 . . . . 0.0 113.772 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.04 -92.36 0.26 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 8.0 t -142.42 15.21 2.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.297 0.57 . . . . 0.0 111.899 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.6 m -137.44 103.12 4.98 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.1 m 178.19 -51.16 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 127.455 2.302 . . . . 0.0 108.485 170.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -42.54 -78.1 0.02 OUTLIER 'General case' 0 C--N 1.341 0.198 0 C-N-CA 125.059 1.344 . . . . 0.0 112.533 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.22 -165.25 30.31 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -83.18 -161.6 0.15 Allowed 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.817 3.012 . . . . 0.0 110.774 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -69.23 144.86 53.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.739 0.816 . . . . 0.0 109.825 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.03 120.98 10.71 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.586 0.754 . . . . 0.0 109.203 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -128.99 63.26 66.26 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.477 1.111 . . . . 0.0 112.188 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -73.89 -26.43 13.3 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.129 1.886 . . . . 0.0 110.663 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.84 -24.91 52.67 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.044 0.938 . . . . 0.0 110.595 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.3 m 71.58 59.68 0.16 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.222 1.009 . . . . 0.0 111.674 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.79 161.58 26.15 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 164.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -77.64 179.93 6.28 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.848 1.658 . . . . 0.0 110.894 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.3 t60 -65.27 151.37 46.36 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.821 178.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.86 -165.74 33.78 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.15 175.61 21.26 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 118.368 1.084 . . . . 0.0 110.45 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.65 -22.64 70.13 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.279 2.653 . . . . 0.0 112.766 -171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -70.82 -28.64 64.77 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 119.149 -0.453 . . . . 0.0 111.222 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -102.43 162.84 12.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.193 0.997 . . . . 0.0 108.485 -172.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -77.23 -37.29 53.55 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -80.53 150.03 29.76 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 159.32 138.72 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 128.733 2.813 . . . . 0.0 105.29 -165.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -68.73 -99.64 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.891 0.876 . . . . 0.0 108.899 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.2 t -124.94 -72.57 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 158.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.82 51.69 4.48 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -171.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -98.31 81.15 2.73 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.239 1.416 . . . . 0.0 109.959 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.8 mt -87.29 54.55 3.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 21.42 -107.4 0.01 OUTLIER Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.655 2.074 . . . . 0.0 114.007 -167.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -138.51 161.36 37.24 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.859 1.263 . . . . 0.0 109.761 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 m -110.64 179.89 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 171.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 61.6 m -126.36 114.34 18.1 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 124.188 0.995 . . . . 0.0 109.143 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.52 142.5 37.36 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 118.335 0.516 . . . . 0.0 110.912 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -70.32 173.91 6.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.338 1.855 . . . . 0.0 110.117 173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -16.79 48.89 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.724 1.61 . . . . 0.0 111.795 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.447 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 2.4 t70 -90.5 0.02 57.48 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.654 0.782 . . . . 0.0 110.549 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 71.14 32.97 65.25 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 -176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.3 t -112.62 109.45 28.61 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 125.718 1.607 . . . . 0.0 109.125 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -94.08 108.27 20.12 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 166.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -78.08 123.96 27.47 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.29 142.23 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.0 p -164.5 95.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 108.571 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.78 175.65 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -139.48 152.8 47.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.699 1.2 . . . . 0.0 109.266 175.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -128.22 151.47 49.22 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 124.282 1.033 . . . . 0.0 108.517 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.2 m -119.61 31.42 6.57 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.918 1.287 . . . . 0.0 111.121 173.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.67 -57.05 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 C-N-CA 123.411 0.684 . . . . 0.0 110.292 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.46 156.06 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 O-C-N 121.864 -0.522 . . . . 0.0 109.882 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -165.83 165.45 18.34 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.37 36.26 1.07 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.8 p -176.63 178.14 1.3 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.636 1.174 . . . . 0.0 108.443 -168.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.67 -72.02 2.76 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.02 -53.87 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.512 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -70.83 28.56 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.695 1.198 . . . . 0.0 113.591 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.5 m -38.09 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.771 2.829 . . . . 0.0 112.951 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 29.4 pt -63.54 -24.17 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.171 0.588 . . . . 0.0 112.568 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 36.4 mm -61.46 114.41 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 172.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.71 28.5 32.01 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 123.28 0.362 . . . . 0.0 113.448 -173.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.616 ' HG2' HD12 ' A' ' 149' ' ' ILE . 26.6 ptt180 -106.21 154.34 20.84 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 157.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 m -97.12 129.68 44.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.137 0.575 . . . . 0.0 110.039 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB2' HD11 ' A' ' 149' ' ' ILE . 54.5 tp -110.92 130.41 55.59 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.5 143.11 36.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG21 HD21 ' A' ' 38' ' ' LEU . 8.9 p -107.18 151.9 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 124.247 1.019 . . . . 0.0 109.005 175.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 86.4 m-70 -113.8 160.24 18.93 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 125.415 1.486 . . . . 0.0 111.066 -176.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -65.54 -70.15 0.25 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 59.1 mmtt -74.1 170.5 15.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 122.909 1.338 . . . . 0.0 110.486 -173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.34 141.93 55.64 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.932 175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -67.12 122.73 18.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 166.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.71 0.66 25.83 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 129.706 3.202 . . . . 0.0 112.63 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.6 mt 45.35 41.4 6.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.391 1.477 . . . . 0.0 110.952 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.66 8.39 9.81 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.613 1.102 . . . . 0.0 114.435 175.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -77.32 -16.38 58.96 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-N 119.134 1.467 . . . . 0.0 112.384 -169.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.77 1.02 8.39 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-O 119.256 -0.747 . . . . 0.0 114.056 -175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.35 44.63 93.42 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 118.809 1.305 . . . . 0.0 111.942 171.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.0 151.09 32.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.156 0.982 . . . . 0.0 108.355 -175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -51.01 -59.46 4.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.527 0.603 . . . . 0.0 111.187 -176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.32 -64.66 0.7 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.13 0.572 . . . . 0.0 112.36 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.5 p -42.59 -60.91 1.37 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.264 1.826 . . . . 0.0 112.931 166.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.2 p -65.85 -10.98 42.95 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.305 0.957 . . . . 0.0 112.348 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -102.36 -30.39 11.08 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 126.989 2.116 . . . . 0.0 111.424 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -141.1 -23.4 0.76 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 -173.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.63 19.93 18.69 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 125.206 1.384 . . . . 0.0 111.075 -176.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.4 t30 53.33 25.9 4.87 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.673 1.236 . . . . 0.0 111.388 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -77.63 -7.97 57.18 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.279 -171.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.53 -158.86 53.42 Favored Glycine 0 N--CA 1.444 -0.781 0 O-C-N 120.976 -1.078 . . . . 0.0 110.9 175.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.6 t -69.72 169.27 13.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.088 0.947 . . . . 0.0 111.322 -174.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.75 107.5 19.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.491 1.516 . . . . 0.0 110.172 -171.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -30.72 70.51 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 118.698 -0.668 . . . . 0.0 111.081 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 153.53 20.66 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.886 0.767 . . . . 0.0 110.192 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.73 145.6 25.89 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.666 1.586 . . . . 0.0 107.793 -165.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.43 31.3 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 111.951 -0.46 . . . . 0.0 111.951 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 20.0 t -94.2 144.05 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.502 1.121 . . . . 0.0 108.399 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.616 HD12 ' HG2' ' A' ' 115' ' ' ARG . 64.9 mt -88.66 123.08 40.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.41 177.67 20.54 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -68.49 143.84 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.808 1.243 . . . . 0.0 109.959 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.91 94.87 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 123.945 0.898 . . . . 0.0 111.102 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.427 1.491 . . . . 0.0 110.031 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.732 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.7 m -51.27 128.37 22.06 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 124.141 0.901 . . . . 0.0 109.347 171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -142.33 151.84 42.34 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.964 0.906 . . . . 0.0 109.014 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -109.0 168.26 9.5 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.285 1.034 . . . . 0.0 109.186 173.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 7.3 p -144.0 147.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.909 1.683 . . . . 0.0 106.772 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.4 111.22 8.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 168.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.8 m -83.28 88.68 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.49 137.45 42.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 169.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -146.62 139.24 25.16 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -123.32 -171.72 13.68 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.33 -42.26 66.55 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.394 1.077 . . . . 0.0 110.421 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.52 -141.95 12.28 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -170.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -81.24 -9.22 12.75 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.896 2.397 . . . . 0.0 111.113 174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG13 HD22 ' A' ' 38' ' ' LEU . 48.0 t -43.19 103.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.357 0 C-N-CA 125.173 1.389 . . . . 0.0 108.873 171.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -140.03 149.36 43.07 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.98 125.74 2.03 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 118.694 0.679 . . . . 0.0 113.046 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -88.09 92.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.45 HD13 ' HA3' ' A' ' 33' ' ' GLY . 8.6 mm -73.04 145.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 169.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -131.12 135.6 47.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.328 1.451 . . . . 0.0 107.448 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 75.0 m-85 -116.5 121.73 42.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 117.463 -1.256 . . . . 0.0 108.01 172.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -107.84 134.99 50.0 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.97 1.259 . . . . 0.0 110.417 172.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.559 ' HB2' HG23 ' A' ' 29' ' ' VAL . 2.4 tt0 -153.89 77.25 1.09 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 108.713 176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -57.4 -40.62 78.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.764 -0.585 . . . . 0.0 109.921 174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -87.51 111.35 21.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.775 1.23 . . . . 0.0 108.262 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.8 m -42.22 -47.61 4.73 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.086 1.354 . . . . 0.0 112.974 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -118.55 45.94 1.93 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.65 0.78 . . . . 0.0 109.725 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.27 176.58 16.18 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 171.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.43 127.17 16.04 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.761 2.974 . . . . 0.0 111.023 -171.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.559 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -76.15 131.53 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 175.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -98.02 115.0 27.31 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 172.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.4 t -90.95 108.79 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 126.946 2.099 . . . . 0.0 107.622 177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -111.4 158.1 19.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.057 0.943 . . . . 0.0 109.551 170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.89 176.97 43.53 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.152 -1.023 . . . . 0.0 111.382 166.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.4 m -159.59 97.16 1.31 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.794 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.16 165.01 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -155.09 88.17 1.16 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.95 -7.6 0.22 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.146 -0.808 . . . . 0.0 114.119 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.794 HD23 HG21 ' A' ' 35' ' ' ILE . 1.4 mm? -69.97 -178.81 1.68 Allowed 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.779 1.289 . . . . 0.0 110.174 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.6 p -102.92 154.89 18.77 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.057 1.343 . . . . 0.0 109.006 169.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.01 145.55 5.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.085 1.754 . . . . 0.0 111.673 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.34 -173.88 18.35 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -80.6 141.48 34.99 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.154 0.581 . . . . 0.0 110.256 -169.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' HD12 ' A' ' 38' ' ' LEU . 58.9 m-70 -132.03 124.47 29.34 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 0.0 110.14 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.37 126.12 9.87 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 118.96 0.8 . . . . 0.0 111.34 -173.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -117.89 120.32 37.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 119.172 1.486 . . . . 0.0 109.378 -168.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.412 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -153.17 154.71 35.29 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-N 119.725 1.148 . . . . 0.0 110.851 -175.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' HB3' ' A' ' 115' ' ' ARG . 0.5 OUTLIER -88.54 112.72 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 114.536 -1.211 . . . . 0.0 108.853 174.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -79.4 155.98 28.13 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.228 173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.25 -55.68 2.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.072 1.349 . . . . 0.0 112.561 -165.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -146.4 178.21 8.43 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.494 1.518 . . . . 0.0 107.774 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.9 -46.8 89.19 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.015 0.37 . . . . 0.0 110.153 168.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -42.41 106.84 0.07 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.193 1.397 . . . . 0.0 112.325 -165.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -141.65 76.77 1.56 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -178.07 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.8 p -50.79 -37.54 43.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.755 1.222 . . . . 0.0 112.82 -177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.03 -16.78 47.38 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.183 0.993 . . . . 0.0 113.655 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 67.71 1.07 Allowed Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.699 1.142 . . . . 0.0 112.275 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 9.6 m 42.36 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.549 1.94 . . . . 0.0 112.107 -172.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.1 m -152.03 -51.46 0.11 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.121 -0.987 . . . . 0.0 111.024 -174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.5 t -148.72 -77.88 0.15 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.716 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 53' ' ' ASN . . . 30.81 -105.74 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.419 1.488 . . . . 0.0 112.052 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.54 112.97 5.4 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 173.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.5 -169.51 0.55 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.531 1.487 . . . . 0.0 109.144 171.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -52.59 123.98 12.52 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 122.069 -0.394 . . . . 0.0 110.011 172.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -63.4 121.38 13.65 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -134.99 49.35 3.64 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.0 -20.51 71.77 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.302 2.002 . . . . 0.0 113.425 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.13 -18.12 47.51 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 119.364 0.984 . . . . 0.0 112.204 172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.4 m 67.93 74.65 0.29 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.855 0.836 . . . . 0.0 112.092 172.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -144.73 152.66 40.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 169.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.51 168.96 9.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.596 1.089 . . . . 0.0 110.115 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 46.1 t60 -56.75 148.22 20.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.996 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.46 -174.7 45.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.7 161.35 28.32 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 123.986 0.803 . . . . 0.0 112.576 -165.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -55.2 -38.71 93.46 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.58 2.187 . . . . 0.0 110.272 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -93.49 12.41 25.17 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -102.72 163.22 12.35 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.542 1.065 . . . . 0.0 109.551 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -65.93 -38.4 88.54 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.014 0.525 . . . . 0.0 110.023 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -99.81 145.52 27.63 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.568 0.699 . . . . 0.0 110.079 175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 172.36 134.82 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.015 2.926 . . . . 0.0 103.258 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.6 m80 -64.66 -95.03 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.332 1.053 . . . . 0.0 110.537 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.98 -72.53 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.125 0 C-N-CA 125.465 1.506 . . . . 0.0 108.616 157.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -85.11 50.92 4.46 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.4 76.23 5.18 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.416 1.886 . . . . 0.0 107.517 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.45 52.76 2.45 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.7 -122.26 0.05 OUTLIER Glycine 0 C--N 1.342 0.868 0 C-N-CA 126.865 2.174 . . . . 0.0 112.218 -165.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -126.28 164.94 19.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.135 1.374 . . . . 0.0 109.14 176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 m -102.92 -162.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 168.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.6 m -149.08 114.81 5.65 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.94 142.17 30.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.0 p30 -74.45 -179.97 4.3 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.013 1.325 . . . . 0.0 111.488 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.436 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 6.4 pttp -64.66 -13.2 53.01 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.459 1.504 . . . . 0.0 112.465 176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -92.76 -12.19 31.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.54 26.4 32.93 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' ILE . 88.2 t -109.3 120.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.056 1.342 . . . . 0.0 108.254 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.659 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.93 110.77 21.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.32 126.37 34.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -107.81 143.12 18.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.206 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 31.9 t -163.98 81.38 0.42 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.214 1.406 . . . . 0.0 108.499 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.8 tt -138.48 177.18 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.919 1.287 . . . . 0.0 108.409 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.87 157.42 43.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.889 0.876 . . . . 0.0 109.831 174.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 157.47 44.65 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.172 0.989 . . . . 0.0 109.363 172.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 m -102.1 -0.13 33.91 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.906 1.282 . . . . 0.0 111.861 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.69 -55.28 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.405 0.682 . . . . 0.0 110.141 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 pt -72.34 132.18 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 172.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 70.2 m -141.34 176.97 8.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.9 mp -90.34 6.08 44.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.88 0.872 . . . . 0.0 109.912 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.8 p -160.54 -158.95 0.65 Allowed 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.613 -0.68 . . . . 0.0 109.232 -169.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.45 -71.77 2.25 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 176.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -165.56 -60.15 0.03 OUTLIER 'General case' 0 C--O 1.235 0.324 0 CA-C-O 123.452 1.596 . . . . 0.0 107.247 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -70.47 10.05 0.53 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 116.887 -1.53 . . . . 0.0 112.984 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.0 t -26.77 97.49 0.01 OUTLIER 'General case' 0 C--N 1.344 0.365 0 C-N-CA 127.708 2.403 . . . . 0.0 112.386 173.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.442 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -65.54 -18.23 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 O-C-N 121.755 -0.591 . . . . 0.0 111.515 -177.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 mm -57.27 113.61 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 110.94 -26.2 12.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.513 0.578 . . . . 0.0 112.76 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 47' ' ' VAL . 2.1 mpt_? -80.35 162.74 24.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.268 1.034 . . . . 0.0 110.009 -178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.83 127.47 51.33 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 110.729 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 127.39 37.18 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 172.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 34.5 t -112.05 148.32 15.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.894 1.677 . . . . 0.0 108.397 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.535 HG21 HD21 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -105.45 -19.96 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.081 2.152 . . . . 0.0 114.063 -174.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.412 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.1 m-70 52.55 161.51 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 128.49 2.716 . . . . 0.0 115.438 -173.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -72.17 -47.86 47.69 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.132 -1.394 . . . . 0.0 110.765 -176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -114.18 -178.02 3.27 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.016 0.927 . . . . 0.0 110.037 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -59.09 151.63 22.01 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.005 1.322 . . . . 0.0 108.597 168.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB2' ' HA3' ' A' ' 138' ' ' GLY . 16.5 p-10 -95.63 125.02 39.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.377 0.608 . . . . 0.0 109.981 169.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.46 21.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.818 1.647 . . . . 0.0 112.489 -172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.2 mt 42.32 42.3 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.762 1.225 . . . . 0.0 112.051 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.32 -5.03 16.46 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.273 0.939 . . . . 0.0 114.008 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -66.87 -14.7 63.02 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.953 0.877 . . . . 0.0 112.021 -168.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -60.3 -25.36 62.48 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-N 118.487 0.585 . . . . 0.0 111.819 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.32 44.26 66.35 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 118.033 0.916 . . . . 0.0 111.104 175.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.468 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -149.19 154.42 39.11 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 117.613 -1.184 . . . . 0.0 110.019 171.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -39.57 -52.1 2.2 Favored 'General case' 0 C--O 1.224 -0.24 0 O-C-N 124.867 1.354 . . . . 0.0 109.843 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.91 -82.18 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.615 1.166 . . . . 0.0 111.056 176.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.464 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 7.0 t -33.31 -57.12 0.41 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.913 2.085 . . . . 0.0 112.976 168.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.6 p -71.46 -7.59 48.4 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.286 0.493 . . . . 0.0 111.429 -170.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -110.89 -33.53 6.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 125.288 1.435 . . . . 0.0 110.495 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -122.14 -32.12 3.74 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.715 1.143 . . . . 0.0 113.242 -171.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 124' ' ' ASP . . . 108.84 -7.49 33.47 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-O 118.531 -1.15 . . . . 0.0 112.379 -161.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 t30 72.53 5.12 5.18 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.499 1.65 . . . . 0.0 111.119 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.21 -58.31 9.07 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.023 1.329 . . . . 0.0 111.135 -168.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.2 -156.37 25.58 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -168.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.4 t -75.3 -169.13 0.91 Allowed 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.752 0.787 . . . . 0.0 111.663 -171.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -109.11 91.5 3.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.618 1.967 . . . . 0.0 108.723 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.75 -41.86 44.9 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.347 0.659 . . . . 0.0 111.174 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.4 163.37 36.71 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 123.264 0.626 . . . . 0.0 109.783 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.0 p -142.08 150.1 40.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.57 1.948 . . . . 0.0 105.808 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.08 132.18 2.64 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.239 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.36 141.93 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 124.408 1.083 . . . . 0.0 110.622 176.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.442 HG21 HG12 ' A' ' 112' ' ' ILE . 15.1 mt -95.72 133.56 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.363 1.065 . . . . 0.0 108.619 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.34 170.87 25.33 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -65.76 141.99 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.389 1.076 . . . . 0.0 108.483 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -104.47 -175.64 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.955 0.902 . . . . 0.0 111.013 177.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.685 -1.15 . . . . 0.0 109.039 176.816 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.37 . . . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.5 t -79.33 174.85 11.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 163.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 130.9 12.81 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 173.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -106.0 167.18 9.97 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.771 1.228 . . . . 0.0 108.979 170.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.73 148.1 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 C-N-CA 126.569 1.948 . . . . 0.0 107.244 -174.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.32 110.86 10.35 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 164.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 m -81.93 102.19 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -67.01 133.12 49.29 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.748 0.819 . . . . 0.0 108.795 170.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -166.1 113.31 0.9 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.342 1.857 . . . . 0.0 108.219 170.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -155.67 18.97 0.51 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.437 -1.202 . . . . 0.0 114.823 174.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -130.15 -65.72 0.81 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.67 -95.71 0.1 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.56 -31.02 27.76 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.705 2.27 . . . . 0.0 111.002 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.572 HG13 HD22 ' A' ' 38' ' ' LEU . 93.2 t -52.97 98.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.874 173.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -125.17 155.87 39.3 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -149.79 122.03 1.36 Allowed Glycine 0 C--O 1.221 -0.658 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.577 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 mp -91.29 85.14 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -75.17 150.92 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.018 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -141.93 136.15 30.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.644 1.178 . . . . 0.0 108.612 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 59.2 m-85 -124.5 105.9 9.75 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 125.562 1.545 . . . . 0.0 110.277 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -100.17 120.69 40.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.163 0.892 . . . . 0.0 109.889 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -106.11 66.51 0.72 Allowed 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.01 63.72 3.75 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.01 -1.056 . . . . 0.0 109.539 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 178.39 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.336 2.254 . . . . 0.0 111.554 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.9 t 81.82 -51.87 0.25 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.696 1.598 . . . . 0.0 109.843 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -112.56 6.6 18.52 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.647 0.779 . . . . 0.0 111.877 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.17 -164.91 26.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -174.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.36 118.61 5.76 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.106 1.871 . . . . 0.0 110.88 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.94 136.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -87.49 116.49 25.64 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.5 t -96.05 107.5 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 127.068 2.147 . . . . 0.0 107.414 176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -113.13 158.87 19.85 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.987 0.915 . . . . 0.0 108.895 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.59 173.93 42.0 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.633 167.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 70.3 m -161.29 99.87 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.619 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -72.91 161.06 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 170.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -151.95 102.24 2.8 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.237 -2.135 . . . . 0.0 105.237 166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.71 -8.0 1.3 Allowed Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.667 167.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.619 HD23 HG21 ' A' ' 35' ' ' ILE . 2.2 mm? -70.37 -177.72 1.53 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.193 0.997 . . . . 0.0 109.631 172.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -112.02 159.78 18.12 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 164.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -48.7 146.11 3.31 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.228 1.811 . . . . 0.0 111.268 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.54 -179.51 16.64 Favored Glycine 0 CA--C 1.521 0.436 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.7 mp -85.24 134.9 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.761 0.424 . . . . 0.0 110.197 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.6 ' CE1' HD12 ' A' ' 38' ' ' LEU . 59.8 m-70 -123.59 122.1 37.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.451 1.1 . . . . 0.0 108.941 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.64 142.6 42.45 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.04 124.38 19.21 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -175.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.413 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -149.78 157.02 42.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.558 -177.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 76.7 t -85.7 104.06 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 164.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -71.15 164.02 26.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 169.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -41.82 -87.97 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.207 1.803 . . . . 0.0 111.349 -176.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -136.64 177.03 8.17 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.754 1.615 . . . . 0.0 110.269 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.2 65.34 5.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -169.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 64.43 8.38 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 122.612 1.196 . . . . 0.0 112.07 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -23.26 63.57 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.774 -1.204 . . . . 0.0 110.932 172.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -47.95 -38.78 17.52 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 128.563 2.745 . . . . 0.0 112.329 172.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.78 -10.23 59.07 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 177.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.08 41.6 2.07 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.777 1.656 . . . . 0.0 111.78 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.4 t 62.51 -64.12 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.522 1.929 . . . . 0.0 113.137 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.7 p -79.46 54.85 1.81 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.419 1.487 . . . . 0.0 110.342 -177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 m -167.98 -67.57 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 125.927 1.691 . . . . 0.0 108.105 174.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 33.82 -128.05 0.07 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.812 1.245 . . . . 0.0 110.852 -171.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -92.51 159.29 24.9 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.04 -166.24 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 123.18 2.587 . . . . 0.0 110.641 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -50.78 129.08 22.38 Favored 'General case' 0 C--N 1.343 0.283 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 167.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -75.33 161.75 29.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -139.88 143.27 33.92 Favored Pre-proline 0 CA--C 1.531 0.225 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 175.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -84.42 -54.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.713 2.275 . . . . 0.0 109.092 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.9 24.48 10.81 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.326 1.85 . . . . 0.0 109.988 -178.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.1 m 60.59 36.92 19.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.87 -0.519 . . . . 0.0 111.037 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.8 mtp-105 -72.33 166.87 21.63 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -75.03 166.13 24.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.707 0.685 . . . . 0.0 110.052 168.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -68.48 154.88 40.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.496 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.2 -159.01 22.6 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 106.787 -2.525 . . . . 0.0 106.787 164.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -114.39 173.28 14.77 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -59.03 -22.11 62.11 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.386 2.057 . . . . 0.0 111.704 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.98 -5.16 58.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 176.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -111.98 159.67 18.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.408 1.083 . . . . 0.0 110.026 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -68.31 -41.09 81.4 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 122.379 1.085 . . . . 0.0 109.852 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.43 140.46 29.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 173.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.3 126.62 0.02 OUTLIER 'General case' 0 C--O 1.239 0.539 0 N-CA-C 103.425 -2.806 . . . . 0.0 103.425 -171.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 19.1 m170 -78.69 -173.73 3.57 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.452 1.101 . . . . 0.0 109.499 174.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.0 p -65.48 -53.56 38.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 123.067 0.547 . . . . 0.0 110.475 -177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -98.61 28.78 13.39 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.455 -0.636 . . . . 0.0 112.713 -176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -83.38 73.98 10.11 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.109 0.954 . . . . 0.0 110.266 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.4 mt -86.26 49.34 1.77 Allowed 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.894 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.16 -116.56 0.08 OUTLIER Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.733 1.635 . . . . 0.0 113.609 -171.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 124' ' ' ASP . 20.9 p30 -140.81 165.07 28.51 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.303 1.441 . . . . 0.0 108.752 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.9 m -113.46 176.04 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 87.8 m -122.51 120.3 33.45 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.501 1.12 . . . . 0.0 108.515 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.48 142.35 34.33 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.98 173.92 9.31 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 124.199 0.999 . . . . 0.0 110.75 173.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -13.48 45.75 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.559 1.544 . . . . 0.0 112.203 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -89.94 -12.02 40.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.375 1.07 . . . . 0.0 110.316 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 86.14 27.34 31.23 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 122.15 -0.344 . . . . 0.0 112.315 -176.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 64.9 t -113.31 115.8 50.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 C-N-CA 125.397 1.479 . . . . 0.0 109.096 179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -102.78 108.96 20.38 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -84.33 149.13 26.26 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.146 0.904 . . . . 0.0 108.936 171.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 t -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.4 p -169.91 75.14 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.029 1.332 . . . . 0.0 108.818 -171.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.1 tt -131.63 171.31 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -146.19 128.09 15.43 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.933 0.788 . . . . 0.0 109.532 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -121.95 143.52 49.41 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.81 0.844 . . . . 0.0 110.313 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 m -105.43 29.92 6.1 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.853 2.061 . . . . 0.0 110.954 178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.19 -48.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.043 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.7 pt -81.89 137.19 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.58 -174.71 3.96 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.045 0.938 . . . . 0.0 108.613 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.53 19.97 15.86 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 171.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.0 p -172.4 -165.24 0.32 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 109.364 -173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.16 -73.28 2.7 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 174.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -163.03 -60.02 0.04 OUTLIER 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.2 m170 -74.35 53.81 0.54 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.972 0.909 . . . . 0.0 109.985 170.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.0 t -68.04 114.22 6.38 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 166.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -19.69 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.977 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.5 mm -59.27 114.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 106.22 -20.36 35.55 Favored Glycine 0 CA--C 1.53 1.025 0 O-C-N 123.369 0.418 . . . . 0.0 113.079 -178.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -69.66 162.19 28.19 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.418 1.109 . . . . 0.0 110.637 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.401 HG22 HG23 ' A' ' 118' ' ' VAL . 1.1 m -103.22 114.7 29.19 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.846 1.258 . . . . 0.0 109.823 169.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 5.5 tt -100.62 124.32 46.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.495 HG22 ' HA ' ' A' ' 146' ' ' CYS . 38.2 t -128.82 144.63 37.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -168.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.1 p -107.65 146.31 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 O-C-N 124.269 0.98 . . . . 0.0 109.077 171.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -108.21 161.49 14.94 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 125.258 1.423 . . . . 0.0 110.361 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -61.3 -68.75 0.28 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -81.36 173.61 12.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.153 0.978 . . . . 0.0 110.889 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.08 146.28 54.46 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.73 176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.449 ' H ' ' HB3' ' A' ' 86' ' ' ASN . 21.7 t70 -72.19 107.78 5.02 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 167.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -80.9 10.31 5.23 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 127.388 2.275 . . . . 0.0 112.168 -175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 mt 44.7 33.21 0.91 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.655 1.582 . . . . 0.0 113.566 172.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.15 1.34 33.62 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 115.323 0.889 . . . . 0.0 115.323 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -11.42 60.9 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.397 1.599 . . . . 0.0 112.378 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.15 -14.46 73.85 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 118.991 0.814 . . . . 0.0 112.703 -176.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.05 24.45 68.65 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 118.251 1.026 . . . . 0.0 111.527 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 134' ' ' SER . 4.9 t30 -116.04 131.05 57.05 Favored 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 125.153 1.381 . . . . 0.0 108.668 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -40.23 -52.68 2.6 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 119.77 1.168 . . . . 0.0 110.924 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.438 ' HB3' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -69.47 -28.8 66.4 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.577 -175.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.471 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 16.7 p -61.9 -51.59 67.53 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.588 1.155 . . . . 0.0 110.121 164.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.4 p -75.22 -5.41 44.36 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -109.49 -34.67 6.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.858 1.663 . . . . 0.0 110.705 172.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.1 p -133.05 -9.88 3.0 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 -174.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.37 23.73 46.47 Favored Glycine 0 C--O 1.221 -0.706 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 59.01 22.25 10.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.829 0.815 . . . . 0.0 110.778 171.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.68 -5.25 49.84 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.505 -162.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.25 -163.86 52.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.7 t -65.52 165.99 11.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 122.842 1.306 . . . . 0.0 111.848 -171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.63 90.99 5.91 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 112.937 -1.938 . . . . 0.0 107.836 -167.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.35 -42.14 66.5 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 118.301 0.501 . . . . 0.0 109.97 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.52 145.17 26.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 120.792 -1.192 . . . . 0.0 112.522 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . 0.495 ' HA ' HG22 ' A' ' 118' ' ' VAL . 32.1 p -117.12 148.55 41.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.981 2.112 . . . . 0.0 107.188 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.54 140.95 7.42 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 39.5 t -91.22 138.17 20.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.5 mt -89.81 129.9 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -147.84 177.4 26.13 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 178.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -66.05 141.96 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.401 1.08 . . . . 0.0 109.665 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -93.52 62.55 3.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.628 1.171 . . . . 0.0 109.586 177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 173.425 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.43 . . . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.8 t -117.83 54.32 0.91 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.239 1.019 . . . . 0.0 108.535 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 152' ' ' ALA . 0.0 OUTLIER -80.53 121.98 26.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 174.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -119.77 155.47 32.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.784 0.833 . . . . 0.0 109.368 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.59 152.93 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.71 111.46 6.33 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.777 0.717 . . . . 0.0 109.58 171.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -87.1 94.83 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD13 HG12 ' A' ' 18' ' ' ILE . 10.0 mp -57.79 137.33 56.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.388 1.075 . . . . 0.0 109.074 169.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -152.37 163.09 40.19 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 168.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.12 -165.92 12.98 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -36.62 84.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.259 0.552 . . . . 0.0 110.417 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.67 -165.23 29.35 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -74.98 -15.07 21.0 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.808 2.339 . . . . 0.0 111.986 -172.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 145' ' ' ALA . 8.8 p -41.69 100.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.265 0 C-N-CA 124.766 1.227 . . . . 0.0 111.095 174.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -140.25 156.23 46.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.49 127.11 1.6 Allowed Glycine 0 C--O 1.222 -0.634 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.512 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mp -86.13 100.41 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 175.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 HD13 ' A' ' 8' ' ' LEU . 33.3 mm -79.44 147.83 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -128.19 140.71 51.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.924 2.09 . . . . 0.0 106.952 177.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 29.7 m-85 -131.36 120.89 23.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.049 1.74 . . . . 0.0 108.475 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -114.67 151.45 33.57 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.156 0.982 . . . . 0.0 110.381 166.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -155.36 54.69 0.63 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.662 1.185 . . . . 0.0 108.453 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 32.45 0.07 Allowed 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.093 -1.005 . . . . 0.0 113.302 -177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -119.63 -14.03 9.11 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 126.498 1.919 . . . . 0.0 111.069 -171.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 m 73.24 -52.14 0.7 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.639 1.576 . . . . 0.0 112.601 176.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -135.42 45.58 2.45 Favored 'General case' 0 CA--C 1.527 0.058 0 C-N-CA 124.088 0.955 . . . . 0.0 108.6 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -131.15 -179.46 16.14 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 174.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.27 151.58 80.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.632 2.221 . . . . 0.0 111.402 -171.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.23 131.36 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 168.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -96.25 121.49 38.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 167.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.82 137.95 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 125.26 1.424 . . . . 0.0 107.196 -176.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 16.3 p90 -158.51 167.31 29.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.18 -173.55 43.68 Favored Glycine 0 C--O 1.227 -0.339 0 CA-C-O 118.435 -1.203 . . . . 0.0 110.223 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 82.6 p -158.12 93.65 1.25 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -66.08 158.6 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -145.28 97.87 3.07 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 170.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 144.35 38.07 0.06 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.117 166.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.623 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.6 tp -110.58 -150.02 0.45 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.431 1.092 . . . . 0.0 109.425 -171.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 15.0 p -140.19 148.55 41.74 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.528 1.531 . . . . 0.0 107.085 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -53.85 131.84 40.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.247 0.967 . . . . 0.0 110.253 174.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 136.71 -145.12 16.95 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 107.128 -2.389 . . . . 0.0 107.128 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 0.8 OUTLIER -142.36 140.2 32.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.995 0.918 . . . . 0.0 109.324 -172.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.486 ' CG ' HD21 ' A' ' 38' ' ' LEU . 8.0 m-70 -130.83 137.67 49.51 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.495 1.518 . . . . 0.0 108.608 -171.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.79 117.78 4.99 Favored Glycine 0 C--O 1.219 -0.817 0 CA-C-O 118.768 -1.018 . . . . 0.0 111.251 -170.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.608 ' CE1' HD12 ' A' ' 117' ' ' LEU . 1.1 t80 -108.18 120.5 42.52 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 120.415 2.108 . . . . 0.0 108.773 -174.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.28 170.47 17.83 Favored 'General case' 0 C--N 1.343 0.319 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.9 m -102.43 121.88 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.518 1.527 . . . . 0.0 109.938 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -95.25 141.8 28.42 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.201 1.8 . . . . 0.0 110.709 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -76.78 84.09 3.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.061 0.545 . . . . 0.0 110.056 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.445 ' OE2' ' HB1' ' A' ' 60' ' ' ALA . 1.5 pt-20 -177.22 -159.7 0.05 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.611 1.964 . . . . 0.0 107.384 175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 -165.54 2.09 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.966 1.706 . . . . 0.0 109.219 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -64.06 83.26 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.507 1.123 . . . . 0.0 110.868 172.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -144.38 -54.14 0.33 Allowed 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 124.534 1.134 . . . . 0.0 110.36 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.1 p -74.57 62.96 1.06 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.5 -36.86 16.07 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.759 -1.213 . . . . 0.0 113.407 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -27.17 62.22 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 123.482 0.563 . . . . 0.0 113.321 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.5 t 59.72 45.34 13.0 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.927 1.691 . . . . 0.0 111.288 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.3 m -98.93 -81.56 0.45 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.963 1.305 . . . . 0.0 110.05 -176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.0 p -66.47 -51.52 55.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' HB1' ' OE2' ' A' ' 50' ' ' GLU . . . 65.62 -102.61 0.08 Allowed 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -172.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -159.83 166.98 35.19 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 106.081 -2.808 . . . . 0.0 106.081 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.15 168.57 23.73 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 CA-C-N 119.502 1.651 . . . . 0.0 109.699 171.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -52.42 126.02 18.0 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 171.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -70.5 111.5 6.08 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -131.37 62.46 65.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 124.061 0.944 . . . . 0.0 113.145 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -63.81 -19.26 66.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.851 2.367 . . . . 0.0 111.977 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.37 -10.24 59.53 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.691 0.796 . . . . 0.0 111.549 173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t 60.21 40.1 18.44 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.967 1.307 . . . . 0.0 112.504 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 77' ' ' GLU . 7.8 mtp180 -106.65 167.0 10.16 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.785 1.234 . . . . 0.0 108.456 173.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -74.7 171.58 13.66 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.414 0.626 . . . . 0.0 110.957 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -70.56 153.08 43.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.333 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.24 -148.84 6.74 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 168.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -128.7 175.69 18.59 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -61.85 -24.32 77.06 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.381 2.721 . . . . 0.0 112.583 -173.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -83.9 -11.85 56.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.125 0.97 . . . . 0.0 112.394 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -107.78 153.63 22.7 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -168.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 69' ' ' ARG . 17.6 tp10 -82.62 -30.24 29.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.294 -171.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -96.06 94.15 7.39 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 174.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -140.53 137.84 34.08 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -75.04 173.88 10.13 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.239 0.616 . . . . 0.0 110.852 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.718 HG13 HG22 ' A' ' 104' ' ' ILE . 2.1 t -50.97 -59.52 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.276 1.03 . . . . 0.0 110.679 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -87.73 23.79 12.32 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 118.176 -1.347 . . . . 0.0 114.276 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -80.32 72.44 7.18 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 120.996 2.398 . . . . 0.0 111.398 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.4 mt -87.6 43.99 1.15 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.235 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 26.03 -113.36 0.02 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 128.072 2.749 . . . . 0.0 113.266 -172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.62 156.7 47.39 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 109.992 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 27.2 m -95.26 -160.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.8 m -149.59 114.25 5.31 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 170.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -88.43 141.15 28.78 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 122.878 0.471 . . . . 0.0 110.193 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.35 175.36 6.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.925 1.69 . . . . 0.0 110.547 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -66.23 -14.92 62.7 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 123.953 0.901 . . . . 0.0 112.059 175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.41 0.58 56.08 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.224 0.61 . . . . 0.0 109.956 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 66.49 42.78 93.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 35' ' ' ILE . 92.6 t -119.77 119.03 59.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -106.75 105.67 15.81 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.68 108.73 16.94 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 124.74 1.275 . . . . 0.0 108.308 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.69 145.54 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.06 101.02 0.76 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 172.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 tt -151.11 -179.59 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -142.58 163.96 31.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.3 157.38 41.27 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 123.767 0.667 . . . . 0.0 110.508 170.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.8 p -112.02 4.37 18.05 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.443 1.497 . . . . 0.0 112.244 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.654 1.181 . . . . 0.0 109.211 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.718 HG22 HG13 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -70.95 171.3 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-O 121.082 0.467 . . . . 0.0 111.246 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.59 167.62 11.4 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 mp -99.45 24.55 7.98 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.937 0.895 . . . . 0.0 109.324 172.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p -155.16 166.85 32.27 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.733 1.213 . . . . 0.0 110.151 -172.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.15 -149.6 51.24 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -70.83 -34.64 71.89 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.986 -0.714 . . . . 0.0 110.469 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -64.61 -22.8 67.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.9 m -22.35 91.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 127.577 2.351 . . . . 0.0 114.954 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.6 pt -65.09 -24.74 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 122.78 0.432 . . . . 0.0 111.705 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 4' ' ' ALA . 37.3 mm -55.29 116.03 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 111.59 -34.59 5.18 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 124.109 0.862 . . . . 0.0 111.874 -178.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -63.4 143.71 57.58 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 118.352 1.076 . . . . 0.0 111.383 -174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.4 m -78.45 141.26 38.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 45' ' ' PHE . 1.3 pt? -123.79 153.1 41.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.769 0.428 . . . . 0.0 110.366 172.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 120' ' ' HIS . 46.4 t -142.99 138.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -170.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.514 ' CG1' ' HB3' ' A' ' 145' ' ' ALA . 0.5 OUTLIER -92.59 -20.96 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 127.266 2.226 . . . . 0.0 112.18 -177.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.416 ' H ' HG12 ' A' ' 118' ' ' VAL . 80.1 m-70 60.5 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.935 2.094 . . . . 0.0 113.858 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.494 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.5 tm-20 -70.71 -28.32 64.65 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.79 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -133.43 -176.76 4.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -66.36 160.3 24.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.931 176.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.42 138.95 31.0 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -66.3 14.22 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.73 1.612 . . . . 0.0 114.122 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 54.42 34.34 20.63 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.083 -1.635 . . . . 0.0 109.85 -174.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 43.51 32.4 1.91 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 126.263 1.887 . . . . 0.0 115.032 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -126.07 30.11 5.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.163 0.982 . . . . 0.0 111.553 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -87.42 32.81 4.05 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 30.8 51.79 0.23 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 128.1 2.762 . . . . 0.0 116.843 174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 137.24 5.5 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -42.79 -53.35 4.63 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.646 1.112 . . . . 0.0 112.134 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -74.02 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.633 177.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 54.1 p -39.96 -46.36 2.04 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 122.036 2.198 . . . . 0.0 113.35 172.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.3 m -76.31 1.92 14.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.778 1.231 . . . . 0.0 112.048 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -117.79 -43.82 2.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.349 2.26 . . . . 0.0 110.162 172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 p -108.51 -30.5 8.23 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.658 1.117 . . . . 0.0 111.935 -169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.93 12.2 58.06 Favored Glycine 0 N--CA 1.438 -1.178 0 CA-C-O 118.392 -1.227 . . . . 0.0 110.488 -170.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 68.91 -3.83 1.37 Allowed 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.688 1.744 . . . . 0.0 113.928 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -47.13 -40.96 16.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.148 1.379 . . . . 0.0 112.016 -165.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 113.51 -127.54 7.91 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 174.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.0 m -68.93 169.34 11.82 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.676 1.227 . . . . 0.0 111.412 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -99.54 98.31 9.21 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.721 1.608 . . . . 0.0 107.537 173.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 1.5 mt -52.51 -51.16 60.88 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.965 0.802 . . . . 0.0 109.575 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.514 ' HB3' ' CG1' ' A' ' 119' ' ' VAL . . . -137.27 168.0 20.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.291 1.437 . . . . 0.0 109.374 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.26 152.91 24.76 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.91 2.084 . . . . 0.0 106.273 -173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.94 178.33 37.83 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.63 146.82 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.216 0 CA-C-N 118.038 0.919 . . . . 0.0 109.625 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 42.8 mt -88.23 120.71 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -134.54 -177.64 15.09 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.9 139.13 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 3' ' ' LYS . . . -81.65 96.3 7.47 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 116.112 -1.899 . . . . 0.0 106.742 170.6 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.812 HG23 ' CD1' ' A' ' 106' ' ' LEU . 2.1 m -166.55 135.88 3.03 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -176.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.98 84.25 0.59 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.288 1.435 . . . . 0.0 107.924 171.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -117.31 165.85 12.98 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.172 0.589 . . . . 0.0 110.16 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -138.85 144.36 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.11 1.764 . . . . 0.0 107.164 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -128.73 108.45 10.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 165.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 m -83.1 90.74 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.085 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -58.37 138.63 56.39 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 169.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.18 141.47 26.26 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 167.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.19 -170.16 16.17 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 175.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -56.74 -43.82 81.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.638 0.732 . . . . 0.0 109.413 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.26 -151.51 24.5 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.1 -11.68 14.75 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 122.193 1.929 . . . . 0.0 111.197 178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.9 t -43.66 111.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.363 0 C-N-CA 124.856 1.263 . . . . 0.0 110.187 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -130.47 154.19 48.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.004 1.322 . . . . 0.0 107.817 177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.07 112.17 0.52 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 119.176 0.898 . . . . 0.0 113.601 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.3 mt -84.27 86.35 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 HD13 ' HA3' ' A' ' 33' ' ' GLY . 10.9 mm -77.98 152.92 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.7 134.36 22.2 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.802 2.041 . . . . 0.0 106.441 -174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -119.02 122.89 43.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -126.09 138.05 53.67 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.664 1.186 . . . . 0.0 108.814 172.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.408 ' OE1' HG23 ' A' ' 29' ' ' VAL . 10.2 tt0 -161.71 80.85 0.58 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.921 2.088 . . . . 0.0 106.244 171.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -28.67 67.64 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.912 -1.117 . . . . 0.0 108.946 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 24' ' ' GLU . 1.7 mp0 -59.4 124.47 20.13 Favored 'General case' 0 N--CA 1.438 -1.055 0 C-N-CA 128.088 2.555 . . . . 0.0 110.064 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 m -50.32 -42.01 52.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.635 1.174 . . . . 0.0 112.349 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -139.83 42.0 1.98 Allowed 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.406 0.683 . . . . 0.0 109.363 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.63 -178.22 52.27 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 168.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -83.42 139.93 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.528 2.819 . . . . 0.0 109.09 170.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.408 HG23 ' OE1' ' A' ' 22' ' ' GLN . 10.0 t -65.09 126.19 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -85.43 113.98 22.13 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 124.92 1.387 . . . . 0.0 107.585 168.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 75.9 t -94.89 118.2 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 C-N-CA 126.246 1.819 . . . . 0.0 106.254 175.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.54 156.42 48.13 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 118.442 0.564 . . . . 0.0 111.121 172.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -169.73 -176.6 39.61 Favored Glycine 0 C--O 1.226 -0.382 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.443 -177.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.2 m -159.09 97.38 1.38 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.795 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -71.41 164.9 3.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -147.44 93.11 2.18 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 153.41 -3.33 0.29 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.996 0.808 . . . . 0.0 114.637 169.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 35' ' ' ILE . 6.2 mp -72.22 -171.06 0.7 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.415 1.108 . . . . 0.0 109.839 174.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 p -133.21 149.88 52.0 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.211 1.805 . . . . 0.0 107.167 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.2 144.65 9.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 125.419 1.7 . . . . 0.0 112.662 -172.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.57 -115.03 2.91 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 104.267 -3.533 . . . . 0.0 104.267 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.702 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 2.3 pt? -162.43 154.78 19.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 118.785 1.293 . . . . 0.0 112.129 -171.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -146.24 136.54 23.81 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.112 1.365 . . . . 0.0 111.242 -168.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.03 145.63 45.1 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.627 1.108 . . . . 0.0 110.848 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' CE2' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -142.51 110.5 5.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.366 1.066 . . . . 0.0 110.185 -168.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.38 157.19 36.69 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.5 t -83.85 115.96 26.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.045 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -92.77 154.18 18.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.794 1.238 . . . . 0.0 111.634 177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -74.03 70.76 1.56 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.467 1.107 . . . . 0.0 110.159 176.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -149.01 177.93 9.14 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 165.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -131.32 -111.9 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.829 1.252 . . . . 0.0 108.901 168.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -104.71 103.5 13.15 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.185 0.994 . . . . 0.0 108.7 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.9 -41.56 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.345 1.058 . . . . 0.0 109.75 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.5 t -77.17 59.06 1.68 Allowed 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.642 0.734 . . . . 0.0 110.34 -176.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.95 -40.17 66.58 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.006 1.323 . . . . 0.0 112.608 -174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.98 -101.11 0.33 Allowed Glycine 0 CA--C 1.525 0.679 0 N-CA-C 108.054 -2.019 . . . . 0.0 108.054 170.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.13 34.51 0.1 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.904 0.859 . . . . 0.0 110.36 165.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -119.94 139.66 52.11 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.215 1.806 . . . . 0.0 106.687 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 m 108.6 -45.27 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 129.519 3.128 . . . . 0.0 111.307 -169.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -24.46 102.36 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.225 1.81 . . . . 0.0 113.098 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -68.84 -176.34 12.19 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.57 -174.83 1.58 Allowed 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 121.398 1.399 . . . . 0.0 110.819 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -55.47 145.23 23.28 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -70.03 -175.6 0.97 Allowed 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -142.28 140.67 19.51 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-O 118.002 -0.999 . . . . 0.0 108.535 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -86.86 -70.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.835 2.356 . . . . 0.0 108.915 175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.8 45.26 2.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.098 1.359 . . . . 0.0 108.175 173.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m 63.72 43.88 5.35 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.016 0.526 . . . . 0.0 112.285 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -88.41 168.89 12.27 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 109.588 176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -81.64 174.5 11.33 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.789 0.804 . . . . 0.0 110.065 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -70.99 150.63 45.46 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.564 1.546 . . . . 0.0 110.747 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.47 -155.58 10.49 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -122.1 -179.99 16.08 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 175.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -64.99 -17.02 58.25 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.074 2.516 . . . . 0.0 112.243 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -18.23 29.81 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.355 173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 128' ' ' LYS . 13.6 m-20 -78.16 157.58 29.35 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 119.812 1.187 . . . . 0.0 109.404 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -80.62 -31.66 36.53 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 112.939 -1.937 . . . . 0.0 109.019 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -111.6 95.43 5.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -137.09 150.53 48.08 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -76.73 165.38 24.81 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.623 0.647 . . . . 0.0 110.781 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 p -50.38 -37.23 14.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.245 0 C-N-CA 124.434 1.094 . . . . 0.0 112.124 -173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.88 52.21 0.83 Allowed Glycine 0 C--N 1.337 0.619 0 CA-C-O 119.33 -0.705 . . . . 0.0 111.563 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -88.29 86.04 7.0 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 117.83 0.815 . . . . 0.0 110.289 166.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.74 40.14 1.01 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.998 0.919 . . . . 0.0 109.15 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 36.75 -121.85 0.76 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.914 1.721 . . . . 0.0 112.859 -171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.6 168.0 17.09 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 125.674 1.589 . . . . 0.0 110.523 -177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.1 166.61 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 3.9 m -119.65 100.63 7.38 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.218 1.007 . . . . 0.0 109.572 -171.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.78 143.71 43.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.024 0.375 . . . . 0.0 111.87 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -71.6 172.37 9.75 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.535 1.934 . . . . 0.0 110.522 169.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -54.51 -24.84 22.28 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.56 1.944 . . . . 0.0 112.211 168.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.1 -1.34 57.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.885 1.274 . . . . 0.0 109.585 -177.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 75.94 29.86 58.39 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 121.816 -0.553 . . . . 0.0 112.115 176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.09 116.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.367 1.867 . . . . 0.0 107.451 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.795 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.21 106.18 16.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 170.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -77.15 120.88 22.83 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 168.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.74 141.63 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -164.09 82.23 0.42 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -129.95 174.11 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.298 1.439 . . . . 0.0 108.097 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.61 133.54 29.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.317 1.847 . . . . 0.0 107.812 -171.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.4 152.4 50.67 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 171.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 t -107.67 9.17 29.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.045 1.338 . . . . 0.0 111.298 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 92.9 t -100.76 -53.38 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.048 0.939 . . . . 0.0 109.565 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 13.4 pt -69.37 158.57 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.206 0.602 . . . . 0.0 110.356 174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.9 m 176.12 127.43 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.812 ' CD1' HG23 ' A' ' 2' ' ' THR . 7.7 mt -76.28 38.74 0.18 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.05 1.34 . . . . 0.0 110.497 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.7 p -156.11 146.35 21.54 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.936 1.294 . . . . 0.0 108.608 -174.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 62.25 -177.93 5.37 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -161.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.61 -14.81 55.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.155 0.982 . . . . 0.0 112.818 -172.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -72.03 -17.77 62.0 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.341 1.056 . . . . 0.0 112.726 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.8 t -44.28 109.71 0.17 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -6.1 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.386 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.563 HD11 ' HB2' ' A' ' 4' ' ' ALA . 47.5 mm -50.49 118.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 168.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.81 -37.83 3.43 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 124.369 0.985 . . . . 0.0 111.906 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -70.27 169.06 14.54 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 117.351 0.576 . . . . 0.0 111.818 -169.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.8 m -96.21 115.67 27.79 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.965 0.906 . . . . 0.0 110.593 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.3 123.54 34.82 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.01 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.5 p -101.55 157.58 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.384 1.074 . . . . 0.0 108.983 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -116.11 160.07 20.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 124.429 1.092 . . . . 0.0 113.02 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -64.64 -38.43 90.97 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.111 1.364 . . . . 0.0 112.143 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 9.8 mtpp -122.33 176.89 5.63 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.702 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -63.39 153.71 34.31 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.441 0.639 . . . . 0.0 109.977 169.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.1 142.28 33.45 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.614 172.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -81.89 32.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.533 1.133 . . . . 0.0 112.664 -175.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 50.05 32.43 5.78 Favored 'General case' 0 C--N 1.345 0.4 0 O-C-N 120.652 -1.28 . . . . 0.0 111.067 178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 39.91 43.27 2.42 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 126.113 1.816 . . . . 0.0 113.585 -173.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.428 ' NZ ' ' OD1' ' A' ' 76' ' ' ASP . 8.3 mmtp -117.58 7.95 12.77 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 117.563 0.682 . . . . 0.0 112.396 -176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -79.73 18.4 7.43 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.419 -0.801 . . . . 0.0 113.383 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.94 45.21 19.23 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 125.495 1.521 . . . . 0.0 114.421 171.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.62 138.71 9.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -175.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -37.8 -62.97 0.5 Allowed 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 125.946 1.699 . . . . 0.0 112.15 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.86 -63.27 1.01 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.399 0.68 . . . . 0.0 112.375 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.5 t -45.04 -58.84 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.404 1.882 . . . . 0.0 112.21 166.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 71.3 p -71.82 0.27 9.46 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 120.993 -1.067 . . . . 0.0 112.073 -173.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -110.89 -32.55 6.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.556 2.342 . . . . 0.0 110.392 172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 71.2 p -131.88 -29.97 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.94 3.59 54.74 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 125.745 1.64 . . . . 0.0 110.448 -171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.55 18.36 8.25 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-N 119.471 1.635 . . . . 0.0 113.007 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.15 -51.08 71.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.028 0.931 . . . . 0.0 109.514 -175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.94 -162.88 22.98 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -66.86 169.18 8.48 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.844 0.831 . . . . 0.0 111.342 -168.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -89.01 110.24 20.97 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.661 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.07 -38.75 92.43 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.545 0.611 . . . . 0.0 110.327 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.88 157.65 33.6 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 123.256 0.622 . . . . 0.0 110.823 -174.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.8 p -135.91 143.98 45.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 126.555 1.942 . . . . 0.0 107.854 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.7 167.2 28.19 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 173.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.1 m -120.93 142.67 36.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 115' ' ' ARG . 1.8 mp -89.92 126.91 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -173.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.72 174.48 24.85 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.18 135.38 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 125.262 1.425 . . . . 0.0 110.139 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.24 87.85 7.54 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 . . . . . 0 C--O 1.253 1.26 0 CA-C-O 116.002 -1.951 . . . . 0.0 106.616 161.049 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.442 . . . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.446 HG21 ' N ' ' A' ' 23' ' ' LYS . 5.2 t -120.63 97.52 5.6 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.926 0.89 . . . . 0.0 109.638 -169.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 90.19 1.72 Allowed 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -120.23 152.48 37.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.693 0.797 . . . . 0.0 109.061 178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -146.99 153.22 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.973 1.309 . . . . 0.0 108.092 -171.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -139.66 111.58 7.4 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.315 0.507 . . . . 0.0 110.324 167.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.6 m -86.65 97.55 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.646 0.736 . . . . 0.0 110.612 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.14 145.86 55.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.529 1.132 . . . . 0.0 109.891 169.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -155.23 142.25 19.19 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.426 1.89 . . . . 0.0 107.409 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.82 -157.84 11.03 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 119.226 0.921 . . . . 0.0 111.428 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -65.26 -43.47 91.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.916 1.286 . . . . 0.0 109.067 168.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.67 23.68 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.72 -4.25 13.91 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 121.987 1.792 . . . . 0.0 111.808 -176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 t -48.04 106.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.356 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 170.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -144.95 157.11 44.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.34 122.15 1.07 Allowed Glycine 0 C--O 1.222 -0.603 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.214 -178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 mp -87.69 93.16 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 10.6 mm -70.48 145.04 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 170.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -127.1 137.67 53.05 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.516 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 67.1 m-85 -121.8 122.38 39.36 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -121.95 157.61 30.87 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.78 -65.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.103 0.561 . . . . 0.0 110.811 -178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 2' ' ' THR . 12.4 tmtt? 72.84 -44.89 0.61 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.363 1.865 . . . . 0.0 113.857 168.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.72 -10.93 22.08 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.849 0.86 . . . . 0.0 112.676 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.1 t 74.86 -55.46 0.65 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.817 2.047 . . . . 0.0 109.161 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -129.49 48.22 2.4 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.06 -167.86 12.24 Favored Glycine 0 CA--C 1.531 1.049 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.72 129.14 18.16 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.597 2.198 . . . . 0.0 111.306 -172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.1 t -68.11 138.95 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 167.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -94.43 120.75 35.13 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 125.58 1.552 . . . . 0.0 107.241 163.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.08 113.72 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.463 1.905 . . . . 0.0 107.447 169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -116.53 160.99 19.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 170.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -169.99 -179.64 41.73 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-O 118.217 -1.324 . . . . 0.0 110.921 163.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.6 m -159.59 90.83 0.96 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.498 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.71 166.47 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.333 170.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.0 82.55 0.79 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 159.24 -11.72 0.19 Allowed Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.915 -0.38 . . . . 0.0 113.619 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD21 ' CG ' ' A' ' 43' ' ' HIS . 9.5 tp -72.65 -152.07 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.332 1.853 . . . . 0.0 110.124 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 p -142.73 141.06 31.7 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 125.109 1.364 . . . . 0.0 108.531 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -52.11 152.69 3.08 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 125.548 1.78 . . . . 0.0 111.504 -177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.32 -112.36 2.36 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -154.87 151.07 28.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.043 1.421 . . . . 0.0 111.621 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' CG ' HD21 ' A' ' 38' ' ' LEU . 54.7 m-70 -139.68 136.46 34.27 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.487 1.115 . . . . 0.0 110.354 -173.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.52 145.13 49.65 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CE1' HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -146.17 119.4 8.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 118.415 -0.802 . . . . 0.0 110.342 -171.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.415 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.4 OUTLIER -153.53 165.42 35.93 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -172.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG22 ' HA3' ' A' ' 82' ' ' GLY . 1.5 m -91.34 121.76 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.206 1.002 . . . . 0.0 108.703 167.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -98.15 166.01 11.61 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.564 1.946 . . . . 0.0 110.657 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -63.85 -179.43 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.866 171.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 59.64 -163.92 0.22 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.101 1.76 . . . . 0.0 112.106 -174.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -152.42 -110.17 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.35 137.72 57.69 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 120.428 1.467 . . . . 0.0 110.595 168.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 164.86 -38.31 0.0 OUTLIER 'General case' 0 C--N 1.341 0.21 0 C-N-CA 127.969 2.508 . . . . 0.0 109.714 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.9 t -79.43 44.14 0.59 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.055 0.942 . . . . 0.0 112.681 -166.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -41.47 -40.16 1.71 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 126.757 2.023 . . . . 0.0 113.313 -173.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -139.51 51.59 0.74 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 172.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.19 40.34 28.16 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.826 0.822 . . . . 0.0 110.795 173.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.6 p -73.06 -84.96 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.182 1.393 . . . . 0.0 110.23 -170.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.2 m -104.8 -50.37 3.29 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.527 1.131 . . . . 0.0 109.773 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 68.17 -65.65 0.25 Allowed 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 125.161 1.384 . . . . 0.0 111.574 -178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.42 171.49 20.03 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 178.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.2 179.71 6.25 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.036 2.49 . . . . 0.0 109.398 163.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -54.88 145.97 18.63 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 169.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -65.38 173.37 2.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.781 0.432 . . . . 0.0 110.428 173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -136.04 135.71 21.82 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 0.0 109.608 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -85.55 -71.88 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.25 2.634 . . . . 0.0 109.387 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.26 33.91 5.39 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.813 1.645 . . . . 0.0 108.62 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.3 t 60.26 49.73 6.89 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.485 0.659 . . . . 0.0 111.984 174.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -91.71 167.44 12.19 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 169.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -75.29 176.04 7.79 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 122.291 1.043 . . . . 0.0 110.632 168.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -70.25 158.43 35.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.089 1.356 . . . . 0.0 110.954 176.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.14 -147.59 8.09 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 108.042 -2.023 . . . . 0.0 108.042 164.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.7 167.81 14.46 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -60.46 -34.1 93.3 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.637 2.225 . . . . 0.0 111.207 -173.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -71.4 -28.25 63.88 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 125.272 1.429 . . . . 0.0 111.619 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 87.6 m-20 -81.24 159.77 24.45 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -70.51 -40.44 73.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.94 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.31 136.01 37.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.02 134.06 0.02 OUTLIER 'General case' 0 C--O 1.233 0.212 0 C-N-CA 126.206 1.802 . . . . 0.0 107.596 -167.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -76.21 174.57 9.96 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.913 0.885 . . . . 0.0 110.89 175.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.74 -48.25 81.26 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.034 0.534 . . . . 0.0 110.779 -175.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.554 ' HA3' HG22 ' A' ' 47' ' ' VAL . . . -96.77 26.52 21.85 Favored Glycine 0 C--N 1.336 0.573 0 CA-C-O 118.496 -1.169 . . . . 0.0 112.431 -178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -82.71 72.39 9.78 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 119.826 1.813 . . . . 0.0 109.927 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 mt -84.6 44.96 1.09 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.34 1.456 . . . . 0.0 107.912 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.23 -101.61 0.01 OUTLIER Glycine 0 CA--C 1.53 0.986 0 C-N-CA 127.142 2.306 . . . . 0.0 114.2 -165.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -143.19 161.46 38.18 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.495 1.518 . . . . 0.0 108.652 -173.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 m -121.23 164.25 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 124.946 1.298 . . . . 0.0 107.81 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 m -111.34 109.46 19.47 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.301 1.44 . . . . 0.0 108.543 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.97 146.8 33.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.96 171.35 14.23 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.354 1.862 . . . . 0.0 110.05 168.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -53.98 -22.38 10.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 128.818 2.847 . . . . 0.0 112.782 168.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.83 -6.43 58.12 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.213 1.405 . . . . 0.0 110.384 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.79 32.62 58.91 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.773 0.701 . . . . 0.0 111.547 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.6 117.82 54.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.802 1.641 . . . . 0.0 107.449 175.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.498 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.6 103.21 12.83 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -83.38 117.66 23.18 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 124.836 1.335 . . . . 0.0 108.101 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -100.09 150.3 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.792 1.237 . . . . 0.0 107.695 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -170.53 76.2 0.07 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.568 1.547 . . . . 0.0 108.082 -174.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -135.53 170.02 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -136.14 141.73 44.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.255 1.022 . . . . 0.0 109.256 -176.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.92 159.11 40.88 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.859 0.863 . . . . 0.0 110.157 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 65.3 m -110.94 -6.41 14.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.803 1.241 . . . . 0.0 112.632 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 8.9 p -88.38 -45.44 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 118.963 0.802 . . . . 0.0 111.0 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pt -75.73 144.31 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 123.573 0.749 . . . . 0.0 109.572 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.0 m -134.03 174.58 10.33 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.498 1.119 . . . . 0.0 109.441 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.4 18.34 20.36 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.688 1.195 . . . . 0.0 109.024 172.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.1 p -169.7 158.37 7.53 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -165.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.23 -174.19 34.64 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.16 -39.08 63.3 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.494 1.118 . . . . 0.0 110.608 178.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -74.04 7.94 2.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.29 1.036 . . . . 0.0 113.314 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -59.46 115.76 3.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.278 0.944 . . . . 0.0 109.5 171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG12 HG21 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.15 -17.45 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 175.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 28.0 mm -58.74 120.32 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 174.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.76 26.41 24.79 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 113.422 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 149' ' ' ILE . 17.1 mmp_? -105.27 166.76 10.19 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.226 1.013 . . . . 0.0 109.808 165.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 50.1 m -102.5 110.42 22.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.93 1.692 . . . . 0.0 108.536 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 tt -97.24 130.04 44.5 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 119.726 1.148 . . . . 0.0 108.75 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.1 t -140.31 145.35 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.215 0.606 . . . . 0.0 110.119 -166.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.7 p -112.49 153.72 14.07 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 C-N-CA 125.577 1.551 . . . . 0.0 109.623 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.415 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 89.6 m-70 -114.42 158.93 20.89 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 125.15 1.38 . . . . 0.0 112.042 -174.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -61.1 -59.18 5.76 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.717 175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -96.23 177.99 5.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 109.913 -172.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.59 155.31 38.17 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.598 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -83.01 118.22 23.36 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 167.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -77.34 10.82 2.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.371 1.469 . . . . 0.0 112.707 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 14.4 mt 45.23 42.43 7.05 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 125.87 1.668 . . . . 0.0 112.092 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.26 -11.34 55.62 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.467 1.032 . . . . 0.0 113.354 171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.411 ' NZ ' ' OD2' ' A' ' 76' ' ' ASP . 17.0 mttm -71.55 -14.12 62.0 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -158.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.84 -43.58 23.4 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 119.527 1.058 . . . . 0.0 111.923 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 98.32 52.06 1.38 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 111.799 -0.521 . . . . 0.0 111.799 167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -159.55 162.26 35.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-O 117.586 -1.197 . . . . 0.0 108.799 178.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -44.15 -42.23 6.23 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 119.222 0.919 . . . . 0.0 111.829 175.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.458 0.703 . . . . 0.0 111.116 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.517 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 80.8 p -41.6 -55.92 2.75 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.919 1.687 . . . . 0.0 111.514 168.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 46.5 p -71.91 2.03 6.2 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.982 0.81 . . . . 0.0 111.992 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -111.98 -35.71 5.6 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.49 1.916 . . . . 0.0 109.831 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.2 t -130.58 -23.48 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -168.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.06 35.05 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.43 25.54 9.73 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.262 1.031 . . . . 0.0 112.5 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.12 -16.78 45.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.728 0.811 . . . . 0.0 111.754 -170.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 80.13 -159.16 43.05 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 171.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.7 m -54.32 151.35 7.56 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.701 1.2 . . . . 0.0 113.133 -173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -87.5 115.67 25.09 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.407 -1.269 . . . . 0.0 109.148 -175.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.05 -34.44 76.47 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.302 0.501 . . . . 0.0 110.656 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.87 157.15 32.67 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.68 0.673 . . . . 0.0 111.249 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 2.5 p -135.22 145.93 48.15 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.746 2.418 . . . . 0.0 107.503 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.23 170.16 31.51 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.01 140.99 42.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.484 HD12 ' HB2' ' A' ' 115' ' ' ARG . 16.1 mt -93.77 123.66 45.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -175.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.92 178.86 21.69 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 21.9 mt -70.68 140.04 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 175.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.28 94.55 6.12 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 . . . . . 0 C--O 1.248 1.013 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 170.135 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 22' ' ' GLN 2.319 . . . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.5 p -128.45 -176.31 3.78 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 120.149 1.34 . . . . 0.0 113.371 -162.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -109.53 138.18 46.27 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.588 1.555 . . . . 0.0 109.528 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.43 169.59 8.38 Favored 'General case' 0 N--CA 1.461 0.096 0 C-N-CA 124.832 1.253 . . . . 0.0 109.861 170.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.32 149.41 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 128.255 2.622 . . . . 0.0 107.333 176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -137.77 114.22 10.3 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 166.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.57 92.01 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 CA-C-O 122.189 0.995 . . . . 0.0 109.825 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 mp -58.98 126.97 29.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.253 1.021 . . . . 0.0 109.679 169.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -169.22 119.81 0.71 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.959 1.704 . . . . 0.0 106.496 168.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.71 27.14 0.2 Allowed Glycine 0 CA--C 1.526 0.764 0 C-N-CA 120.132 -1.032 . . . . 0.0 115.079 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.95 -73.5 0.48 Allowed 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 174.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.85 -115.53 0.36 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -170.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -81.91 13.33 2.51 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 123.238 2.625 . . . . 0.0 112.138 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.0 t -83.11 122.55 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 125.407 1.483 . . . . 0.0 107.142 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -145.18 146.49 31.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.722 170.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.78 129.11 3.99 Favored Glycine 0 C--N 1.34 0.799 0 CA-C-N 119.017 0.826 . . . . 0.0 112.018 173.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.71 104.72 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 mm -91.38 159.45 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -139.94 143.39 36.57 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.179 1.792 . . . . 0.0 108.871 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 20.9 m-85 -127.13 99.68 5.79 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 126.607 1.963 . . . . 0.0 110.076 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -72.75 131.74 42.72 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.267 1.427 . . . . 0.0 110.015 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' O ' ' HB1' ' A' ' 1' ' ' ALA . 3.4 tm0? -136.16 73.04 1.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 169.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' NZ ' ' OE2' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -94.65 29.03 2.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 119.797 -1.814 . . . . 0.0 109.907 -174.509 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 21.0 mp0 -132.9 -24.94 1.88 Allowed 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.377 1.071 . . . . 0.0 111.748 -165.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.71 -62.71 0.45 Allowed 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.678 1.191 . . . . 0.0 109.5 -172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.31 37.8 4.33 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.3 1.44 . . . . 0.0 110.1 -174.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -129.83 178.42 17.48 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 174.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.97 145.31 85.2 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.631 2.22 . . . . 0.0 110.786 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -77.77 147.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.74 110.81 21.38 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.241 1.416 . . . . 0.0 108.706 170.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -92.69 148.61 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 CA-C-N 119.013 0.824 . . . . 0.0 109.167 175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -162.29 162.72 28.19 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 168.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.65 -171.28 43.49 Favored Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.525 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.2 p -164.98 105.51 0.8 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.807 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.37 169.15 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.227 -0.095 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.296 175.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 100.2 2.98 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 164.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.53 -15.65 0.39 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 124.334 1.021 . . . . 0.0 113.92 165.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.807 HD23 HG21 ' A' ' 35' ' ' ILE . 1.2 mm? -67.14 174.42 3.16 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.319 1.059 . . . . 0.0 111.368 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 t -98.88 154.7 17.84 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 165.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -51.23 158.48 0.78 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 127.311 2.244 . . . . 0.0 112.664 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.42 -172.49 26.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.76 138.43 35.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.766 0.426 . . . . 0.0 110.565 -170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.55 ' CE1' HD12 ' A' ' 38' ' ' LEU . 34.3 m-70 -130.42 118.96 21.96 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.557 2.343 . . . . 0.0 109.178 -178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.75 121.38 25.7 Favored Glycine 0 C--O 1.218 -0.883 0 CA-C-N 118.783 0.719 . . . . 0.0 111.693 -177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -118.17 114.33 22.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 119.601 1.7 . . . . 0.0 108.84 -170.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -156.56 160.49 39.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.833 1.197 . . . . 0.0 112.435 -170.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.37 120.19 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 124.571 1.148 . . . . 0.0 109.113 175.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -93.61 150.2 20.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.4 1.88 . . . . 0.0 111.499 174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -75.26 72.93 2.35 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.843 0.457 . . . . 0.0 110.837 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -139.8 -169.16 2.65 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.441 1.496 . . . . 0.0 108.184 175.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.56 -152.07 0.29 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.534 1.534 . . . . 0.0 109.605 170.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -71.99 76.64 0.92 Allowed 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.885 0.874 . . . . 0.0 110.916 -176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.23 -43.34 0.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.407 -177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.5 p -75.24 55.16 0.74 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.373 0.669 . . . . 0.0 112.082 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.27 -44.22 71.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.101 0.961 . . . . 0.0 110.708 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.52 36.22 4.49 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 173.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 54.59 38.67 30.28 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.024 0.93 . . . . 0.0 112.264 175.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.8 m -52.25 -80.0 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.399 1.88 . . . . 0.0 114.868 -164.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.6 t -80.4 -54.18 5.94 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.13 1.71 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.602 1.161 . . . . 0.0 109.766 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -47.71 153.46 1.59 Allowed Glycine 0 CA--C 1.528 0.867 0 C-N-CA 125.695 1.617 . . . . 0.0 110.638 175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.77 -175.04 1.47 Allowed 'Trans proline' 0 N--CA 1.449 -1.124 0 C-N-CA 121.651 1.567 . . . . 0.0 112.361 -167.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.464 ' CE1' ' CE1' ' A' ' 46' ' ' HIS . 19.8 m170 -48.94 121.79 5.1 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.296 1.038 . . . . 0.0 109.838 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.71 122.3 12.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.956 0.902 . . . . 0.0 108.897 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.92 135.75 19.64 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 117.461 -1.257 . . . . 0.0 108.933 -172.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -82.59 -65.76 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 CA-C-N 121.786 1.674 . . . . 0.0 109.187 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.8 mt -122.15 41.47 3.39 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.353 1.461 . . . . 0.0 108.175 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.9 t 61.41 45.48 8.47 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.166 0.586 . . . . 0.0 111.691 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.8 mtt85 -90.04 172.54 8.76 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.177 0.991 . . . . 0.0 109.746 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -86.19 171.49 11.25 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.894 0.854 . . . . 0.0 110.219 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.44 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 57.1 t60 -76.83 146.58 37.68 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.909 -176.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.99 -154.83 8.41 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 167.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -112.96 -177.61 19.62 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.059 1.314 . . . . 0.0 110.002 -178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.13 -2.84 12.21 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.935 2.424 . . . . 0.0 113.116 -167.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -126.38 7.22 7.03 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.137 1.375 . . . . 0.0 111.26 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -87.69 159.43 18.51 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 119.445 1.02 . . . . 0.0 109.876 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.49 -32.34 66.12 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.877 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -112.03 98.13 7.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -127.57 140.3 52.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 173.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -74.7 174.09 9.6 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.013 0.525 . . . . 0.0 110.405 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -43.45 90.42 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 O-C-N 121.876 -0.515 . . . . 0.0 111.016 -172.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -112.69 37.01 3.82 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-O 119.276 -0.735 . . . . 0.0 111.868 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.96 75.98 5.46 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.479 1.139 . . . . 0.0 110.02 174.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.1 mt -85.64 43.86 1.06 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.048 177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 34.24 -120.78 0.35 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.754 2.121 . . . . 0.0 113.141 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.41 152.95 52.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.663 1.185 . . . . 0.0 110.131 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.406 HG11 HG22 ' A' ' 97' ' ' VAL . 32.8 m -108.11 164.44 5.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 124.911 1.284 . . . . 0.0 107.935 175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 91.6 m -117.74 110.91 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.97 0.908 . . . . 0.0 109.142 -168.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.44 140.63 38.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.987 0.179 . . . . 0.0 111.079 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -70.97 169.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.199 1.8 . . . . 0.0 109.87 170.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -13.57 25.16 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.291 1.836 . . . . 0.0 112.954 168.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.89 -1.45 52.61 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.992 0.917 . . . . 0.0 110.235 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 79.34 32.84 37.26 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.569 -0.707 . . . . 0.0 112.623 175.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 81.4 t -118.17 114.89 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 126.077 1.751 . . . . 0.0 107.535 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.742 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.85 105.62 16.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.03 141.17 57.64 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 164.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.406 HG22 HG11 ' A' ' 87' ' ' VAL . 11.0 t -118.84 143.31 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.4 t -164.26 99.3 0.83 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 171.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.47 -176.67 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -143.24 153.77 43.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.611 1.165 . . . . 0.0 108.403 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -138.89 157.93 45.15 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.2 t -99.17 -26.21 14.27 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.923 2.089 . . . . 0.0 110.413 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 44.3 t -78.72 -56.89 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.389 0.54 . . . . 0.0 111.778 -169.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.6 162.14 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 122.846 0.458 . . . . 0.0 111.328 -177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 40.8 t -157.01 177.76 11.14 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 120.89 -1.131 . . . . 0.0 108.292 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD11 HD11 ' A' ' 112' ' ' ILE . 9.5 mp -103.66 27.16 7.71 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 167.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 91.5 p -155.03 171.24 20.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.389 0.675 . . . . 0.0 109.811 -177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.66 -162.17 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -176.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.1 -18.84 65.64 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.455 -1.026 . . . . 0.0 111.916 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -88.06 2.4 51.99 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.5 m -41.23 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.363 1.465 . . . . 0.0 112.551 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 106' ' ' LEU . 45.2 pt -58.61 -32.04 45.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 C-N-CA 124.312 1.045 . . . . 0.0 111.115 177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 47.3 mm -58.8 121.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 -175.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.1 32.35 58.59 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 121.041 -0.599 . . . . 0.0 114.255 -171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -105.68 -172.19 2.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.023 1.329 . . . . 0.0 107.841 154.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 m -135.04 131.9 37.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.343 1.057 . . . . 0.0 110.791 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD11 ' CZ ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -93.28 158.76 15.58 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 124.35 1.06 . . . . 0.0 111.513 171.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.3 147.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 126.74 2.016 . . . . 0.0 108.589 173.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.0 p -104.43 -17.08 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.835 2.054 . . . . 0.0 113.955 177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 70.0 m-70 60.06 162.16 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 128.421 2.688 . . . . 0.0 113.93 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -72.08 -61.01 1.94 Allowed 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.266 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -102.54 -178.18 3.61 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.786 0.803 . . . . 0.0 109.923 -175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.23 152.94 43.8 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.36 -0.837 . . . . 0.0 108.821 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 0.0 OUTLIER -94.86 125.88 39.82 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 170.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -87.4 34.32 0.7 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.973 1.309 . . . . 0.0 110.812 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.0 mt 37.5 42.31 0.34 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.115 1.766 . . . . 0.0 112.531 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.32 20.09 35.27 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 125.613 1.578 . . . . 0.0 114.856 175.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -61.58 -31.97 72.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.94 1.37 . . . . 0.0 111.51 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.72 -31.25 53.43 Favored Glycine 0 CA--C 1.536 1.363 0 O-C-N 122.292 -0.255 . . . . 0.0 112.747 172.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.87 33.81 75.21 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.805 -0.82 . . . . 0.0 113.135 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.457 HD22 ' C ' ' A' ' 131' ' ' ASN . 0.4 OUTLIER -128.59 51.58 1.99 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -162.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 56.59 -74.42 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.544 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.958 -169.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.29 -66.27 0.43 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 120.586 1.539 . . . . 0.0 110.676 -176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -50.9 -50.22 57.86 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.73 1.212 . . . . 0.0 111.597 170.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.46 -9.18 23.49 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -109.31 -30.27 8.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.547 1.939 . . . . 0.0 109.135 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 1.3 t -141.53 -19.9 0.76 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 92.07 20.7 35.29 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.7 t30 61.29 21.72 12.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.063 0.932 . . . . 0.0 112.567 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.54 -19.07 58.31 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.83 0.852 . . . . 0.0 112.631 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.75 -153.03 32.5 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 175.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 59.6 m -62.63 166.65 5.15 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 124.191 0.996 . . . . 0.0 113.254 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.26 97.99 10.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.462 1.505 . . . . 0.0 109.694 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.71 -48.34 75.33 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.541 0.61 . . . . 0.0 110.571 175.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.1 149.11 45.65 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 4.4 p -131.55 155.12 48.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 172.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.26 140.45 6.76 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.52 150.89 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 117.53 0.665 . . . . 0.0 110.457 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.495 ' CD1' HD12 ' A' ' 117' ' ' LEU . 8.0 mm -86.42 135.77 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 119.362 -0.352 . . . . 0.0 110.288 174.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.44 160.66 27.92 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 173.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 12.8 mm -64.44 144.31 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 118.92 1.36 . . . . 0.0 109.577 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.58 52.58 1.1 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.361 1.064 . . . . 0.0 111.108 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 128.679 2.792 . . . . 0.0 104.632 171.419 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.8 m -138.64 53.36 1.78 Allowed 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.05 150.35 20.27 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.031 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 113' ' ' ILE . . . -88.51 163.88 15.69 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 170.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.33 146.02 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 C-N-CA 126.904 2.082 . . . . 0.0 107.063 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -134.09 111.21 10.16 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 166.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.9 m -83.06 97.46 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.811 0.815 . . . . 0.0 109.271 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.51 140.28 58.86 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.675 -0.641 . . . . 0.0 109.737 169.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? -142.6 149.55 39.14 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 168.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.6 -170.38 13.6 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 173.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.11 -43.38 82.23 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.769 0.828 . . . . 0.0 110.237 170.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.21 -161.53 32.84 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 -177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.64 -2.33 12.53 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.704 2.269 . . . . 0.0 112.024 -176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.6 t -48.88 113.86 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 0.0 109.366 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -149.44 153.97 38.13 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 118.414 -0.803 . . . . 0.0 109.732 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.63 126.18 1.69 Allowed Glycine 0 C--O 1.223 -0.538 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.698 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.1 mp -89.01 90.49 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HD13 ' HA3' ' A' ' 33' ' ' GLY . 47.1 mm -78.13 157.35 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -147.08 136.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 126.258 1.823 . . . . 0.0 107.429 -173.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 69.0 m-85 -122.75 100.43 6.9 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.53 1.132 . . . . 0.0 108.707 173.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.84 157.07 28.43 Favored 'General case' 0 CA--C 1.524 -0.041 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 171.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -145.2 -55.05 0.31 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.019 1.328 . . . . 0.0 109.958 174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? 63.55 -62.45 0.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.397 1.479 . . . . 0.0 112.305 -167.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -95.83 116.85 29.52 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.2 m -41.9 -36.45 1.07 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.372 1.469 . . . . 0.0 114.234 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -122.63 39.61 3.89 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.401 0.68 . . . . 0.0 110.785 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.61 172.9 15.91 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.699 1.142 . . . . 0.0 110.796 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.99 134.17 38.77 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.746 2.964 . . . . 0.0 110.783 -170.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 t -82.03 146.14 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.03 104.62 13.54 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 126.329 1.851 . . . . 0.0 106.596 172.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 72.0 t -87.43 131.18 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -159.91 153.78 22.99 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 119.055 0.843 . . . . 0.0 109.892 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' HD13 ' A' ' 18' ' ' ILE . . . -172.09 -176.91 41.26 Favored Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.539 -174.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 p -161.09 100.82 1.24 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.525 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -73.7 167.16 2.37 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.164 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 174.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.0 87.42 1.34 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 176.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.54 6.54 0.14 Allowed Glycine 0 CA--C 1.531 1.09 0 CA-C-N 114.893 -1.049 . . . . 0.0 114.28 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.77 -161.8 0.09 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.448 1.124 . . . . 0.0 110.094 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.8 t -140.71 162.9 34.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.08 145.49 16.84 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 123.997 0.811 . . . . 0.0 111.251 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.04 -153.03 16.87 Favored Glycine 0 C--N 1.334 0.439 0 N-CA-C 106.395 -2.682 . . . . 0.0 106.395 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.07 144.79 51.7 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.966 0.883 . . . . 0.0 112.236 -172.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 121' ' ' GLU . 8.3 m-70 -132.02 133.62 44.62 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.716 1.606 . . . . 0.0 109.646 -171.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.38 115.34 5.33 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-O 118.25 -1.305 . . . . 0.0 110.983 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.13 121.01 42.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 120.33 2.065 . . . . 0.0 109.408 -172.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.38 162.3 39.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.9 t -92.1 95.69 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.324 1.45 . . . . 0.0 108.888 176.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -69.92 144.72 52.33 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.762 1.165 . . . . 0.0 111.969 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.41 -179.91 5.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.508 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 68.34 -62.33 0.37 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.327 2.251 . . . . 0.0 111.882 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 98.78 -58.08 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 128.818 2.847 . . . . 0.0 109.958 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -56.92 100.27 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 126.29 1.836 . . . . 0.0 111.563 -170.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -85.65 59.83 5.87 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.333 -0.855 . . . . 0.0 110.126 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 p -60.53 -40.47 91.61 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 123.427 0.691 . . . . 0.0 111.034 -172.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.19 -18.71 16.83 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.263 1.425 . . . . 0.0 113.583 173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.49 82.57 1.49 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 4.8 t 45.55 63.96 1.6 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.565 1.546 . . . . 0.0 110.946 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.3 t -166.13 84.19 0.31 Allowed 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.771 -0.581 . . . . 0.0 109.819 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.0 m -64.21 98.5 0.23 Allowed 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.014 -1.054 . . . . 0.0 110.146 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.75 -50.63 32.95 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.497 1.119 . . . . 0.0 110.978 174.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.02 145.63 29.69 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.724 1.154 . . . . 0.0 110.621 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 -171.13 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.784 2.322 . . . . 0.0 112.483 -175.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.91 124.47 23.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.141 -1.39 . . . . 0.0 107.507 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -41.38 121.26 1.6 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.312 1.845 . . . . 0.0 113.258 -170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -73.95 138.33 76.22 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.841 0.856 . . . . 0.0 110.955 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 67' ' ' LEU . 56.9 Cg_endo -84.54 -63.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.399 2.733 . . . . 0.0 109.862 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 66' ' ' PRO . 5.2 mp -126.93 31.78 5.22 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.633 1.173 . . . . 0.0 108.961 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t 65.89 85.33 0.14 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.719 0.808 . . . . 0.0 110.397 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -136.58 164.42 28.25 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -80.57 176.56 9.68 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.841 0.829 . . . . 0.0 110.82 177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -66.08 153.81 41.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.898 174.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.27 -155.65 15.5 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 106.378 -2.689 . . . . 0.0 106.378 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.512 ' CA ' HD22 ' A' ' 126' ' ' LEU . . . -109.31 167.12 12.77 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 118.459 1.129 . . . . 0.0 113.103 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -62.53 -16.18 50.62 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.322 2.681 . . . . 0.0 112.986 -168.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.6 9.58 19.4 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.494 1.517 . . . . 0.0 112.579 -177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.3 165.4 11.08 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.486 1.114 . . . . 0.0 110.207 -167.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.56 -33.26 73.78 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.21 0.604 . . . . 0.0 111.671 178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -110.54 141.89 43.08 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 161.83 119.86 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.885 2.074 . . . . 0.0 108.642 -168.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -63.58 -178.81 0.31 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.113 0.965 . . . . 0.0 110.865 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -54.16 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 O-C-N 119.976 -1.703 . . . . 0.0 110.358 -177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.2 44.42 1.69 Allowed Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -93.61 72.18 4.3 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.787 1.235 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.6 mt -86.29 48.79 1.67 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 29.09 -119.14 0.07 OUTLIER Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.478 1.99 . . . . 0.0 113.471 -170.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -130.28 154.52 47.53 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.776 1.231 . . . . 0.0 110.13 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.9 m -109.99 162.36 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.4 m -110.75 119.54 39.46 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.54 145.23 25.85 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.329 0.651 . . . . 0.0 109.953 173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -78.19 176.13 9.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.69 1.196 . . . . 0.0 110.52 177.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -21.51 41.22 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.65 1.58 . . . . 0.0 111.662 173.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.32 -3.63 57.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.692 0.797 . . . . 0.0 110.317 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 72.88 35.17 58.47 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.573 -0.704 . . . . 0.0 112.131 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.48 121.82 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 126.115 1.766 . . . . 0.0 106.944 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.525 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.84 103.33 12.37 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 173.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.75 104.41 12.97 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 124.548 1.155 . . . . 0.0 108.211 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -84.32 141.8 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 32.9 t -158.79 107.94 1.95 Allowed 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.19 1.396 . . . . 0.0 107.459 165.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 11.5 tt -147.29 176.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.28 144.43 29.83 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.615 1.166 . . . . 0.0 108.184 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.18 151.03 34.84 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 p -101.42 -15.57 17.14 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.528 1.131 . . . . 0.0 111.364 171.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.97 -36.29 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 122.548 0.339 . . . . 0.0 111.213 -170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -94.32 157.75 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.023 1.329 . . . . 0.0 109.77 172.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -156.37 -173.94 4.72 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.334 1.054 . . . . 0.0 108.748 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 mp -97.29 15.79 21.87 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.601 0.76 . . . . 0.0 109.006 171.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.8 p -173.66 -162.47 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 -168.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.89 -71.23 2.62 Favored Glycine 0 C--N 1.336 0.55 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 177.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -162.27 -58.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 177.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -75.47 56.53 0.87 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.442 1.497 . . . . 0.0 111.399 176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.2 t -65.59 110.38 2.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.753 1.221 . . . . 0.0 108.199 169.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -20.38 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 118.184 0.447 . . . . 0.0 111.326 170.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 4' ' ' ALA . 42.9 mm -59.09 118.78 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 171.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.64 36.93 9.02 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 124.277 0.986 . . . . 0.0 113.188 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -127.52 162.66 25.91 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.323 -1.104 . . . . 0.0 110.15 164.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.9 m -102.51 118.7 37.43 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.067 1.347 . . . . 0.0 109.62 178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD13 HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.2 139.31 30.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.091 0.956 . . . . 0.0 108.846 176.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.5 t -135.91 141.08 42.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.33 1.052 . . . . 0.0 109.352 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.21 -19.26 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.789 2.036 . . . . 0.0 113.609 -175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 59.82 160.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 128.1 2.56 . . . . 0.0 113.841 -176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.422 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 47.6 tt0 -70.98 -53.45 14.81 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.623 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -174.89 2.64 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.664 0.786 . . . . 0.0 109.015 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.85 164.38 6.44 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.792 0.837 . . . . 0.0 109.846 167.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.9 127.37 50.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 165.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -85.92 26.58 0.98 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.095 1.358 . . . . 0.0 110.37 -173.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.512 HD22 ' CA ' ' A' ' 73' ' ' GLY . 13.9 mt 45.06 42.4 6.49 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.663 1.185 . . . . 0.0 111.555 -173.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 70.25 5.91 55.74 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.176 -0.92 . . . . 0.0 113.804 175.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -24.98 43.45 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -167.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.81 -33.37 83.94 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 124.325 1.015 . . . . 0.0 112.063 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.08 62.14 6.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 117.862 0.831 . . . . 0.0 111.981 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -154.25 52.58 0.67 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.042 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 60.35 -78.16 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.004 0.922 . . . . 0.0 109.651 -174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.426 HE21 ' C ' ' A' ' 133' ' ' GLN 0.251 0.0 OUTLIER -60.83 -27.99 68.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.259 0.624 . . . . 0.0 112.066 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.436 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 68.4 m -69.95 -52.03 27.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.164 -1.585 . . . . 0.0 110.818 166.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 17.0 p -66.45 -14.33 62.05 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -98.94 -45.22 6.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 128.128 2.571 . . . . 0.0 110.045 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.4 p -122.12 -35.38 3.16 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -170.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.97 32.31 5.06 Favored Glycine 0 C--O 1.22 -0.776 0 C-N-CA 124.949 1.261 . . . . 0.0 110.685 -173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 43.0 t30 77.13 -11.38 1.2 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.194 1.497 . . . . 0.0 111.77 170.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.09 77.19 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 125.323 1.449 . . . . 0.0 112.956 -165.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 102.47 -151.15 18.19 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 63.9 m -56.72 165.43 1.19 Allowed 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.009 1.324 . . . . 0.0 113.462 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 61.7 mtt85 -98.58 94.14 6.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.768 1.627 . . . . 0.0 108.853 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 144' ' ' LEU . 0.1 OUTLIER -50.96 -49.07 60.75 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.006 0.366 . . . . 0.0 111.185 176.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.33 159.06 43.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.26 0.624 . . . . 0.0 109.516 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.1 p -154.18 144.35 22.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 126.405 1.882 . . . . 0.0 106.436 -167.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.13 153.89 24.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.43 143.18 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 124.551 1.14 . . . . 0.0 109.007 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 117' ' ' LEU . 3.8 mt -97.28 125.49 50.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.184 0.594 . . . . 0.0 109.757 -175.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.79 164.81 26.33 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.99 137.46 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.494 1.118 . . . . 0.0 109.528 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.18 -173.13 3.0 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.229 1.011 . . . . 0.0 112.18 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.7 -1.143 . . . . 0.0 108.29 164.077 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.438 . . . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 2' ' ' THR . 7.2 t -161.54 76.2 0.51 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.715 0.769 . . . . 0.0 109.261 -174.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.04 74.57 0.02 OUTLIER 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -171.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -117.32 153.73 32.49 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.436 0.695 . . . . 0.0 109.263 174.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.64 150.88 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 125.577 1.551 . . . . 0.0 107.8 -175.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 149' ' ' ILE . . . -135.88 109.87 8.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 165.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 m -83.39 111.79 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.425 HD11 HD22 ' A' ' 117' ' ' LEU . 4.9 mp -74.58 148.09 41.12 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.104 1.362 . . . . 0.0 109.31 172.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.19 138.9 16.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.845 1.658 . . . . 0.0 107.026 176.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.71 -159.28 11.57 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 174.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -64.57 -43.59 93.41 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.068 1.347 . . . . 0.0 108.994 167.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.24 -159.03 31.11 Favored Glycine 0 N--CA 1.439 -1.119 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -174.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.25 -4.6 14.43 Favored 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 121.9 1.734 . . . . 0.0 111.842 -177.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.492 HG13 HD22 ' A' ' 38' ' ' LEU . 6.7 t -43.35 103.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 125.895 1.678 . . . . 0.0 109.609 171.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -141.62 151.89 43.5 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -157.76 128.64 2.15 Favored Glycine 0 C--O 1.223 -0.592 0 CA-C-N 119.011 0.823 . . . . 0.0 112.884 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.8 91.88 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 41.3 mm -76.12 156.18 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.16 139.31 25.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.732 2.013 . . . . 0.0 105.922 -174.084 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.462 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 94.9 m-85 -132.7 128.67 37.47 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.852 0.861 . . . . 0.0 109.064 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.17 145.75 50.64 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.013 1.325 . . . . 0.0 109.126 173.181 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.401 ' CG ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -142.93 -63.66 0.41 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.364 1.066 . . . . 0.0 110.003 -172.565 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? 74.75 -55.6 0.65 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.221 1.408 . . . . 0.0 111.914 177.224 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -58.92 -20.21 49.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 112.633 178.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m 74.84 -34.93 0.28 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.428 1.891 . . . . 0.0 112.256 179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.9 m120 -131.44 18.12 4.84 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.22 1.008 . . . . 0.0 111.931 172.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.86 -160.36 33.94 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.23 136.2 19.65 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.181 1.921 . . . . 0.0 110.875 -178.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.401 HG23 ' CG ' ' A' ' 22' ' ' GLN . 0.3 OUTLIER -89.36 132.56 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 170.784 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -85.84 119.68 26.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 64.1 t -101.31 127.95 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -157.75 151.43 23.91 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.907 176.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.47 -179.17 39.61 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.197 -173.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.8 t -156.37 108.05 2.49 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.213 -2.144 . . . . 0.0 105.213 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -76.69 164.89 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 175.239 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -153.27 98.76 2.3 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 170.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 148.53 -6.53 0.91 Allowed Glycine 0 CA--C 1.528 0.851 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.577 166.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 35' ' ' ILE . 1.7 mm? -71.25 -173.93 0.94 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.213 1.007 . . . . 0.0 109.869 173.294 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 p -117.7 153.01 34.09 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.904 1.682 . . . . 0.0 109.168 173.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -51.3 145.72 7.83 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.27 1.428 . . . . 0.0 111.918 -178.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.82 -132.52 9.93 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 104.413 -3.475 . . . . 0.0 104.413 -179.215 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.428 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -141.13 154.39 45.86 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.435 1.118 . . . . 0.0 111.622 -174.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.59 ' CE1' HD12 ' A' ' 38' ' ' LEU . 86.0 m-70 -141.22 131.15 24.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.049 0.94 . . . . 0.0 109.527 -172.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.08 146.88 38.93 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-O 118.688 -1.062 . . . . 0.0 110.974 178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -142.52 119.96 11.67 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.153 0.981 . . . . 0.0 109.013 -174.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.408 ' NE2' ' OD2' ' A' ' 124' ' ' ASP . 1.8 m80 -145.37 167.83 21.97 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.13 104.3 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 113.637 -1.619 . . . . 0.0 107.567 166.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 118' ' ' VAL . 20.7 m-70 -79.15 142.76 36.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.931 0.892 . . . . 0.0 108.657 175.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.54 -161.04 0.34 Allowed 'General case' 0 CA--C 1.539 0.55 0 O-C-N 123.467 0.479 . . . . 0.0 110.917 178.748 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 62.77 -61.5 0.13 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.741 2.017 . . . . 0.0 113.3 -171.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 65.56 -81.36 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.081 1.752 . . . . 0.0 110.157 -175.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -70.95 72.41 0.57 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.479 1.112 . . . . 0.0 110.261 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -166.91 -47.36 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.573 0.749 . . . . 0.0 110.55 -179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 t -82.12 51.62 1.81 Allowed 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.204 0.526 . . . . 0.0 111.737 -172.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -38.32 -42.85 0.75 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 126.98 2.112 . . . . 0.0 113.331 -175.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.58 63.72 0.59 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 173.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 53.69 41.44 32.07 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.678 0.751 . . . . 0.0 109.817 172.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.8 m -107.85 -70.88 0.78 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.701 1.2 . . . . 0.0 109.891 -167.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.2 m -55.05 -34.33 63.45 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 123.264 0.626 . . . . 0.0 110.975 178.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 55.76 52.38 10.95 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.168 0.587 . . . . 0.0 110.167 170.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -39.18 138.52 0.94 Allowed Glycine 0 C--N 1.34 0.769 0 C-N-CA 126.894 2.188 . . . . 0.0 111.934 -169.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -65.93 160.04 46.11 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 CA-C-N 119.599 1.699 . . . . 0.0 110.783 -170.363 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -47.0 117.06 1.55 Allowed 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 169.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -64.97 113.75 4.08 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.375 -0.53 . . . . 0.0 109.628 -176.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -126.68 68.39 69.1 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.963 1.305 . . . . 0.0 111.616 -175.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.01 -19.77 17.5 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.139 1.893 . . . . 0.0 110.869 176.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.5 mt -72.81 -15.42 61.63 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.606 0.763 . . . . 0.0 111.024 176.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.3 t 62.38 38.58 12.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.279 1.032 . . . . 0.0 111.493 179.213 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -113.31 175.27 5.52 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 123.624 0.77 . . . . 0.0 109.73 176.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -79.92 171.45 15.09 Favored 'General case' 0 N--CA 1.443 -0.794 0 O-C-N 121.044 -1.035 . . . . 0.0 110.665 172.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -69.93 152.09 44.88 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.474 1.11 . . . . 0.0 109.367 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.86 -155.08 9.77 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.024 -1.631 . . . . 0.0 109.024 167.241 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -125.43 174.86 17.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 172.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -66.32 -3.38 8.7 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.142 2.561 . . . . 0.0 113.016 179.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.33 14.63 18.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.482 1.113 . . . . 0.0 112.62 171.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -106.65 164.37 12.13 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.017 0.826 . . . . 0.0 109.218 167.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -66.15 -34.73 78.7 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.503 1.121 . . . . 0.0 110.524 175.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -105.04 149.19 26.0 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.763 1.625 . . . . 0.0 108.177 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -177.66 135.94 0.18 Allowed 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 178.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -75.08 171.37 14.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 170.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.0 p -58.32 -43.23 85.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 O-C-N 121.834 -0.541 . . . . 0.0 110.827 -176.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.33 26.88 22.62 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 118.758 -1.023 . . . . 0.0 113.215 -177.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -88.07 74.31 8.89 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 118.937 1.368 . . . . 0.0 111.182 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.07 48.44 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.192 -178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.47 -124.97 0.08 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.354 1.93 . . . . 0.0 114.183 -171.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.77 156.33 43.71 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.355 1.462 . . . . 0.0 109.42 -175.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.7 m -108.39 165.65 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.0 m -114.78 115.39 26.94 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.801 1.24 . . . . 0.0 108.119 -174.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.27 143.88 27.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.3 0.64 . . . . 0.0 110.406 176.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -81.44 174.57 11.33 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.364 1.866 . . . . 0.0 110.387 175.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.23 -13.86 51.81 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.545 1.538 . . . . 0.0 112.461 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.35 -3.38 53.51 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.637 0.732 . . . . 0.0 110.936 174.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.47 29.22 45.11 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.021 -177.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.28 117.62 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.345 1.458 . . . . 0.0 108.577 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.517 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.4 106.69 17.29 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -81.64 111.64 18.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.02 140.62 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 176.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.1 t -163.24 100.38 0.95 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.8 tt -150.84 175.27 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -142.01 130.05 21.99 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -176.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -121.72 142.94 49.68 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.4 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 37.8 m -104.05 -2.88 25.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.112 1.365 . . . . 0.0 112.831 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 84.0 t -100.93 -61.43 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.088 0 C-N-CA 123.185 0.594 . . . . 0.0 109.404 -176.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' HG11 ' A' ' 29' ' ' VAL . 2.1 pp -69.44 152.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -155.95 -178.32 7.22 Favored 'General case' 0 C--O 1.22 -0.49 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.33 20.49 9.26 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.44 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p -177.01 -178.83 0.85 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -165.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.87 -88.83 1.48 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -176.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -139.34 -63.47 0.52 Allowed 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 -172.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -80.43 46.96 0.89 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.082 -178.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -58.0 107.12 0.43 Allowed 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.282 1.033 . . . . 0.0 109.604 175.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 30.9 pt -65.87 -23.84 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.52 0.728 . . . . 0.0 111.437 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.3 mm -62.98 115.2 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 175.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.58 46.55 6.01 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.496 -0.642 . . . . 0.0 111.496 -174.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -124.31 164.48 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.928 0.891 . . . . 0.0 109.069 161.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -101.05 115.62 30.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.305 1.042 . . . . 0.0 110.005 172.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.425 HD22 HD11 ' A' ' 8' ' ' LEU . 7.3 tt -91.8 134.68 34.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 176.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.402 ' HB ' ' CD2' ' A' ' 48' ' ' HIS . 7.2 t -143.48 147.47 20.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.195 0.452 . . . . 0.0 110.357 -173.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.4 p -119.24 146.66 23.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.642 1.577 . . . . 0.0 110.605 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -108.22 158.3 17.57 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.095 1.358 . . . . 0.0 112.5 -171.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -61.58 -62.56 1.73 Allowed 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.336 177.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -91.83 -175.99 4.31 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.749 0.785 . . . . 0.0 110.272 -176.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.77 149.82 44.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.67 170.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' OD2' ' NE2' ' A' ' 46' ' ' HIS . 76.9 m-20 -75.45 128.11 34.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 166.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -75.06 9.46 1.96 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.841 0.856 . . . . 0.0 113.018 172.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.3 mt 43.69 42.73 4.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.371 1.068 . . . . 0.0 112.027 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 73.91 -7.24 15.91 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.84 0.733 . . . . 0.0 113.886 175.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -29.74 65.02 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.482 1.113 . . . . 0.0 111.61 -170.097 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.69 -28.95 57.5 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.681 -0.511 . . . . 0.0 112.978 178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.63 51.52 30.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 118.419 1.11 . . . . 0.0 112.04 175.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -148.81 155.73 41.35 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 116.845 -1.55 . . . . 0.0 108.451 171.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -48.2 -42.64 30.51 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.597 1.09 . . . . 0.0 110.718 -176.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -77.6 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.67 0.788 . . . . 0.0 110.76 178.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.491 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 11.0 t -44.15 -52.98 6.88 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.42 1.888 . . . . 0.0 111.307 172.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 72.0 p -73.39 1.91 8.72 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.361 0.528 . . . . 0.0 111.766 -173.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -115.29 -33.46 5.3 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 117.192 -1.385 . . . . 0.0 110.116 168.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.5 p -123.65 -31.82 3.42 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.303 1.411 . . . . 0.0 114.102 -169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 100.68 0.1 55.37 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-O 118.669 -1.073 . . . . 0.0 110.673 -165.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.69 10.84 6.3 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.435 1.618 . . . . 0.0 112.322 172.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -61.32 -50.83 71.37 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.867 0.841 . . . . 0.0 109.983 -170.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 129.82 -162.14 22.93 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -174.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.7 t -68.64 176.27 3.05 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.711 1.243 . . . . 0.0 112.281 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.5 112.77 24.48 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 112.976 -1.92 . . . . 0.0 109.204 -170.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.22 -31.88 73.27 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 119.119 -0.467 . . . . 0.0 110.394 176.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.09 151.32 19.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 119.035 0.834 . . . . 0.0 111.329 177.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.9 p -125.38 154.65 41.56 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.574 2.349 . . . . 0.0 107.664 177.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -158.24 165.73 33.91 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 175.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 75.4 t -111.4 134.35 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 C-N-CA 124.493 1.117 . . . . 0.0 108.191 -179.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 19.9 mt -87.18 122.3 38.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.3 -174.93 18.87 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 1.6 mp -72.06 146.2 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.39 61.54 5.62 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.167 0.987 . . . . 0.0 109.208 171.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.247 0.97 0 C-N-CA 126.657 1.983 . . . . 0.0 106.064 168.764 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.34 . . . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 116.672 -1.632 . . . . 0.0 107.734 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.251 0.7 OUTLIER 58.0 64.45 1.52 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 124.376 1.048 . . . . 0.0 113.672 159.165 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -171.86 54.83 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.637 -0.664 . . . . 0.0 110.652 -176.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -111.93 154.96 24.47 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.245 0.618 . . . . 0.0 109.455 178.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -145.68 149.9 16.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.827 1.251 . . . . 0.0 108.304 -173.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -132.91 112.1 11.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.258 0.481 . . . . 0.0 109.839 163.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.9 m -83.83 97.19 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.468 0.651 . . . . 0.0 109.565 175.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.58 143.26 54.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.669 0.788 . . . . 0.0 109.783 169.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 tptt -150.6 155.84 40.21 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.984 1.714 . . . . 0.0 107.07 171.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.09 -166.25 11.04 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 175.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.69 -41.52 95.32 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.494 0.717 . . . . 0.0 110.32 175.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -99.89 -165.28 29.11 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.85 -17.4 25.56 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.724 2.283 . . . . 0.0 112.018 -171.309 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -39.49 96.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 125.686 1.595 . . . . 0.0 111.116 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -141.97 153.58 44.41 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.97 128.07 1.83 Allowed Glycine 0 C--O 1.224 -0.49 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.387 -176.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -85.26 94.63 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.07 142.2 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 170.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -118.56 147.96 43.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.018 1.327 . . . . 0.0 108.216 170.3 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m-85 -130.73 117.21 19.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -122.01 150.55 41.92 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 172.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -143.11 -59.31 0.43 Allowed 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 122.664 0.386 . . . . 0.0 110.694 -176.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? 77.22 -43.84 0.44 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.225 1.41 . . . . 0.0 111.075 175.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -14.32 59.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.398 0.679 . . . . 0.0 111.418 179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t 76.24 -40.91 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.036 1.334 . . . . 0.0 112.308 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -137.28 34.5 2.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.236 1.415 . . . . 0.0 109.801 -179.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.3 -160.95 10.55 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.279 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -65.18 119.85 6.96 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 119.75 1.775 . . . . 0.0 111.377 -174.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.6 t -78.41 143.76 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.625 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 169.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -102.72 119.52 38.98 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.345 1.458 . . . . 0.0 107.207 165.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.38 120.95 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 126.277 1.831 . . . . 0.0 106.6 179.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 p90 -145.12 166.2 26.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.014 173.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -175.84 -174.58 42.52 Favored Glycine 0 CA--C 1.509 -0.34 0 N-CA-C 109.916 -1.273 . . . . 0.0 109.916 176.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.2 t -159.17 109.02 1.94 Allowed 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.65 164.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 174.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -148.3 97.38 2.76 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.26 21.95 0.11 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.104 -0.953 . . . . 0.0 113.089 165.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 89' ' ' ALA . 3.1 tp -89.81 -154.36 0.32 Allowed 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.662 1.185 . . . . 0.0 107.975 -178.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 t -142.04 159.64 41.81 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 166.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 150.18 14.18 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 124.204 0.94 . . . . 0.0 111.487 -178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -145.65 18.71 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 105.747 -2.941 . . . . 0.0 105.747 -178.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -135.69 145.21 46.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.371 1.086 . . . . 0.0 112.192 -173.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.476 ' CG ' HD21 ' A' ' 38' ' ' LEU . 5.6 m-70 -132.5 134.86 45.54 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.37 1.868 . . . . 0.0 109.787 -170.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.48 118.68 5.58 Favored Glycine 0 C--O 1.219 -0.803 0 C-N-CA 124.909 1.242 . . . . 0.0 111.951 -171.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.27 118.16 32.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.323 1.562 . . . . 0.0 109.703 -168.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 63' ' ' HIS . 0.6 OUTLIER -144.24 163.45 33.63 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.76 -176.052 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -97.38 106.34 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 C-N-CA 125.69 1.596 . . . . 0.0 107.126 171.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -77.28 158.43 30.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.656 -0.652 . . . . 0.0 109.838 174.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.24 155.74 39.9 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.736 179.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 46.74 -162.77 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.921 2.488 . . . . 0.0 112.487 -168.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -146.04 -42.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.62 1.568 . . . . 0.0 112.186 -175.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.17 82.9 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.59 1.556 . . . . 0.0 113.543 -170.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.74 36.68 0.96 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 120.789 -1.194 . . . . 0.0 112.49 -169.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.2 p -54.49 -46.48 73.43 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.363 1.465 . . . . 0.0 111.726 -175.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.0 -16.55 5.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.936 1.294 . . . . 0.0 113.777 176.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.03 83.11 1.53 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -176.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 3.0 t 56.22 25.82 9.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.08 . . . . 0.0 112.895 170.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.4 m -114.77 -64.07 1.37 Allowed 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 125.355 1.462 . . . . 0.0 110.023 -169.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.7 m -47.15 -50.76 19.76 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 124.731 1.212 . . . . 0.0 112.41 -178.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.46 123.17 3.98 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 123.603 0.564 . . . . 0.0 110.556 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -73.11 -167.45 11.78 Favored Glycine 0 N--CA 1.445 -0.721 0 O-C-N 125.088 1.493 . . . . 0.0 111.085 -161.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.87 -168.1 0.43 Allowed 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.218 1.279 . . . . 0.0 109.81 170.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 137' ' ' THR . 8.8 m170 -53.51 125.72 19.04 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 123.281 0.632 . . . . 0.0 110.407 178.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -67.7 115.25 7.06 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.762 0.315 . . . . 0.0 110.725 -177.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -142.59 85.91 10.05 Favored Pre-proline 0 C--O 1.227 -0.119 0 C-N-CA 125.153 1.381 . . . . 0.0 110.865 -173.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.71 -40.61 0.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 120.993 1.128 . . . . 0.0 112.883 178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 pp -159.35 16.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.394 0.678 . . . . 0.0 110.743 176.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 62.0 m -94.15 42.36 1.09 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.735 0.778 . . . . 0.0 111.693 -171.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.7 mtt85 70.63 -154.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.028 1.331 . . . . 0.0 108.903 165.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -88.45 178.08 6.64 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.214 0.915 . . . . 0.0 110.639 172.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -61.85 147.82 45.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.739 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.49 -154.93 11.04 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 165.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 126' ' ' LEU . . . -143.42 177.89 21.95 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.49 -30.41 91.57 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 123.06 2.507 . . . . 0.0 112.668 -171.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt -70.13 -21.02 63.14 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 177.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.33 164.46 11.84 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.071 0.939 . . . . 0.0 109.498 -179.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.77 -27.7 40.42 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.82 1.248 . . . . 0.0 110.764 177.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -85.39 144.37 28.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 169.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 165.48 118.22 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 C-N-CA 127.097 2.159 . . . . 0.0 107.131 -169.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -66.99 -177.99 0.71 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 122.922 0.489 . . . . 0.0 110.384 178.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.9 t -55.64 -51.89 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 121.319 -0.863 . . . . 0.0 110.275 -175.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.43 59.41 0.41 Allowed Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -176.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.22 73.62 0.83 Allowed 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.088 0.955 . . . . 0.0 108.651 -171.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.8 mt -85.5 49.96 1.86 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.659 -170.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.46 -112.58 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 126.159 1.838 . . . . 0.0 112.55 -168.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -134.95 164.4 27.7 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.451 1.5 . . . . 0.0 109.172 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.25 161.91 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 m -108.21 125.35 51.54 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.185 1.394 . . . . 0.0 107.25 -176.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -94.98 144.95 25.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.267 0.627 . . . . 0.0 110.548 173.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.86 172.76 8.33 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.249 1.819 . . . . 0.0 110.728 174.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -56.04 -23.19 31.83 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.995 1.718 . . . . 0.0 112.094 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.82 0.55 57.43 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.824 1.249 . . . . 0.0 110.134 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.43 41.31 77.86 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.582 -0.699 . . . . 0.0 111.503 179.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 35' ' ' ILE . 83.9 t -117.94 119.51 61.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 126.725 2.01 . . . . 0.0 106.585 177.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.545 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -108.11 106.55 16.8 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -84.2 101.35 11.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 124.529 1.143 . . . . 0.0 108.193 178.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.56 146.36 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.1 p -168.91 85.18 0.15 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.731 1.212 . . . . 0.0 109.273 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -138.22 177.02 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.747 1.219 . . . . 0.0 107.9 178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.82 144.3 29.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -131.47 137.24 48.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.159 0.984 . . . . 0.0 108.583 -173.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.6 p -93.64 -22.27 18.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.763 1.625 . . . . 0.0 111.341 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.6 t -79.31 -59.95 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 123.047 0.539 . . . . 0.0 110.375 -175.39 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.55 161.87 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-N 118.117 0.417 . . . . 0.0 110.099 -176.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.9 m -153.51 -173.43 4.57 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.3 mp -92.45 10.61 29.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.084 0.554 . . . . 0.0 109.545 165.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.5 p -153.74 -159.05 0.93 Allowed 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.365 -0.834 . . . . 0.0 110.203 -172.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.57 -69.61 2.57 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.319 0.961 . . . . 0.0 111.335 174.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.67 -63.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -175.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.35 44.21 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 128.63 2.772 . . . . 0.0 112.693 171.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t -64.27 110.62 2.29 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 167.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -23.07 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.016 177.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.2 mm -57.41 117.12 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 175.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.7 41.51 7.69 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.562 -175.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.436 ' HB2' HD12 ' A' ' 149' ' ' ILE . 71.3 mmt-85 -128.29 152.37 48.2 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.685 -0.891 . . . . 0.0 111.356 164.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -83.01 133.26 35.1 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.116 0.966 . . . . 0.0 110.03 173.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.1 mp -96.16 148.02 23.14 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.556 166.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.5 t -137.71 142.66 35.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 125.411 1.484 . . . . 0.0 108.409 174.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.55 -17.23 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 126.557 1.943 . . . . 0.0 112.978 -177.726 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 59.65 155.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 128.434 2.694 . . . . 0.0 114.019 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.447 ' HA ' ' HG ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -74.62 -38.61 62.51 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.158 -179.623 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -108.35 -179.47 3.89 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 122.01 0.909 . . . . 0.0 110.407 173.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.92 160.47 12.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.336 163.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -104.21 123.45 47.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 170.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -70.83 18.16 0.06 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.837 1.655 . . . . 0.0 112.646 -174.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 73' ' ' GLY . 20.4 mt 41.05 41.47 1.3 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 112.22 -173.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.17 12.35 65.5 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.256 0.931 . . . . 0.0 114.134 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt -88.52 12.11 15.34 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.329 1.065 . . . . 0.0 111.425 -176.471 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.76 0.14 89.16 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-N 118.602 0.637 . . . . 0.0 112.596 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 57.01 38.65 86.72 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-N 118.206 1.003 . . . . 0.0 112.011 176.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 134' ' ' SER . 1.8 t30 -151.74 132.51 14.08 Favored 'General case' 0 C--O 1.22 -0.45 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.97 -169.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -37.98 -57.37 1.05 Allowed 'General case' 0 C--O 1.232 0.135 0 C-N-CA 124.793 1.237 . . . . 0.0 111.751 179.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.463 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.65 -42.72 79.43 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.193 0.597 . . . . 0.0 111.328 -178.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 10.5 p -62.03 -47.91 82.64 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.631 1.172 . . . . 0.0 110.683 173.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 40.5 p -74.12 -1.87 22.09 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.19 -0.944 . . . . 0.0 111.893 -179.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -105.48 -36.24 7.21 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.687 1.595 . . . . 0.0 109.553 172.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.432 ' HA ' ' CE1' ' A' ' 63' ' ' HIS . 3.9 t -134.5 -16.0 2.11 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 -175.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 88.6 24.99 31.51 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -173.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.4 t30 69.89 10.24 7.41 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.011 0.906 . . . . 0.0 111.331 167.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.68 62.97 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.253 0.621 . . . . 0.0 111.95 -164.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.59 -137.38 17.38 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.9 p -67.55 172.57 4.95 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.362 1.077 . . . . 0.0 112.015 -161.031 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -98.58 91.04 4.95 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 176.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 121' ' ' GLU . 0.3 OUTLIER -46.82 -50.48 18.36 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.245 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.43 167.27 22.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.306 1.442 . . . . 0.0 109.267 174.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 7.6 p -155.33 158.59 38.97 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 126.854 2.062 . . . . 0.0 106.699 -175.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -157.62 173.28 35.0 Favored Glycine 0 CA--C 1.519 0.312 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -176.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.0 t -122.77 133.86 67.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.073 0 C-N-CA 124.977 1.311 . . . . 0.0 108.457 -177.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.725 HD11 ' CD1' ' A' ' 117' ' ' LEU . 31.4 mt -87.44 122.44 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.469 0.708 . . . . 0.0 109.802 178.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -146.45 -174.77 18.87 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 177.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mt -66.81 143.98 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.984 1.313 . . . . 0.0 109.688 178.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -98.16 69.96 2.04 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.203 1.401 . . . . 0.0 110.861 179.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 C--O 1.254 1.324 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 164.994 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.417 . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.0 t -78.01 58.82 2.04 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.711 0.804 . . . . 0.0 109.831 -177.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 1.1 mptp? -154.65 87.0 1.14 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.569 1.548 . . . . 0.0 106.954 176.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -113.57 153.35 28.95 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.303 1.041 . . . . 0.0 108.41 172.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 152' ' ' ALA . 11.5 p -135.47 149.17 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.925 1.69 . . . . 0.0 108.555 -176.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -131.0 113.96 14.61 Favored 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 163.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.64 100.36 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-O 121.68 0.753 . . . . 0.0 109.093 176.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.9 134.57 51.06 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 123.892 0.877 . . . . 0.0 109.536 170.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 pttt -125.2 145.53 49.93 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.243 1.817 . . . . 0.0 107.034 174.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.91 -171.24 12.89 Favored Glycine 0 C--N 1.335 0.502 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.05 -36.7 84.45 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.237 0.541 . . . . 0.0 109.917 177.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -110.93 -161.67 17.62 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 178.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.3 11.92 2.49 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.742 2.962 . . . . 0.0 112.284 -174.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.4 t -61.09 91.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 124.959 1.304 . . . . 0.0 107.641 170.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.77 149.02 25.41 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -136.75 111.63 0.87 Allowed Glycine 0 C--O 1.221 -0.705 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.183 175.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.4 mm -87.3 91.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 6.6 mm -77.15 147.08 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.125 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -131.83 143.38 50.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.072 0.949 . . . . 0.0 108.815 169.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.449 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 91.8 m-85 -122.27 134.46 54.68 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.322 0.649 . . . . 0.0 109.353 169.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' OE2' ' NZ ' ' A' ' 3' ' ' LYS . 4.6 mm-40 -118.26 138.87 52.06 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.112 1.365 . . . . 0.0 107.898 169.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' A' ' 29' ' ' VAL . 3.7 tp60 -174.97 115.74 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 129.077 2.951 . . . . 0.0 105.058 -179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.63 8.8 27.2 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.378 0.671 . . . . 0.0 111.479 -178.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -132.71 154.86 49.77 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.053 1.741 . . . . 0.0 107.77 -171.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.5 p -75.78 -21.56 57.26 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.905 -0.497 . . . . 0.0 111.386 174.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.07 21.54 2.44 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.182 0.593 . . . . 0.0 111.723 -171.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.17 179.51 42.37 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -178.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.36 116.9 4.89 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.077 2.518 . . . . 0.0 109.569 175.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 104' ' ' ILE . 2.9 t -72.01 134.46 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 171.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.61 125.17 45.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 65.5 t -104.8 112.86 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 126.679 1.991 . . . . 0.0 107.214 177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -114.48 158.49 21.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -166.91 178.78 41.05 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 119.797 -1.192 . . . . 0.0 112.537 169.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 p -166.71 93.26 0.47 Allowed 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -170.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -65.18 158.02 4.86 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.119 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -147.62 103.57 3.54 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 105.291 -2.115 . . . . 0.0 105.291 161.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 145.43 -7.06 1.53 Allowed Glycine 0 CA--C 1.529 0.924 0 O-C-N 123.097 0.248 . . . . 0.0 113.082 169.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB2' HG21 ' A' ' 35' ' ' ILE . 6.7 tp -74.73 -155.47 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.231 1.812 . . . . 0.0 109.436 177.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.4 p -147.21 158.93 44.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -51.05 147.68 5.01 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.131 1.373 . . . . 0.0 112.242 -178.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.48 -155.59 16.49 Favored Glycine 0 C--N 1.332 0.354 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -178.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -129.7 144.81 51.46 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.529 1.165 . . . . 0.0 112.708 -174.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CG ' HD21 ' A' ' 38' ' ' LEU . 11.7 m-70 -137.27 135.53 37.25 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.655 1.582 . . . . 0.0 110.105 -170.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.9 120.3 5.93 Favored Glycine 0 C--O 1.218 -0.875 0 CA-C-O 118.001 -1.444 . . . . 0.0 110.495 -174.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -115.63 124.85 51.97 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 120.617 2.208 . . . . 0.0 108.783 -172.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -153.46 156.69 38.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.552 1.069 . . . . 0.0 112.986 -171.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.1 t -87.91 109.72 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.116 0.966 . . . . 0.0 108.606 171.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -79.97 160.52 25.9 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 123.745 0.818 . . . . 0.0 110.07 173.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.87 171.03 7.13 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.22 -0.445 . . . . 0.0 109.883 172.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 65.11 -176.45 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.685 1.994 . . . . 0.0 112.401 -171.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -140.46 -86.8 0.19 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.468 1.907 . . . . 0.0 107.228 178.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -94.99 118.41 31.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.469 1.107 . . . . 0.0 109.82 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 174.06 -42.76 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 127.472 2.309 . . . . 0.0 107.722 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.421 ' HA ' HG22 ' A' ' 58' ' ' THR . 7.7 t -74.03 49.86 0.35 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.193 1.797 . . . . 0.0 112.732 -177.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -39.02 -53.82 1.74 Allowed 'General case' 0 C--O 1.233 0.224 0 C-N-CA 126.81 2.044 . . . . 0.0 110.731 177.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.32 58.8 0.7 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 174.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.87 40.81 5.22 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 163.056 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 58' ' ' THR . 2.4 t -86.9 55.17 3.45 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.35 -0.844 . . . . 0.0 111.62 -173.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.7 t 70.72 -63.88 0.39 Allowed 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.924 -1.11 . . . . 0.0 111.826 -176.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 75.05 -76.37 0.06 Allowed 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 127.489 2.316 . . . . 0.0 108.731 -170.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -171.41 170.27 43.18 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 107.117 -2.393 . . . . 0.0 107.117 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -75.05 -172.45 1.27 Allowed 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 122.901 2.401 . . . . 0.0 110.207 175.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.7 m170 -55.87 131.67 47.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.937 0.895 . . . . 0.0 109.596 176.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.27 125.67 27.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.513 0.597 . . . . 0.0 110.824 -175.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 34.4 p-10 -146.63 67.71 11.57 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 124.358 1.063 . . . . 0.0 113.254 -178.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.34 -14.92 44.39 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 121.915 1.744 . . . . 0.0 112.195 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -77.17 -9.43 58.76 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.647 -0.658 . . . . 0.0 111.296 173.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 t 62.98 49.44 3.49 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.951 0.881 . . . . 0.0 110.605 178.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.76 152.44 26.6 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 169.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -80.41 -179.71 7.28 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.657 0.783 . . . . 0.0 109.907 -177.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -60.74 159.55 10.78 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.219 174.01 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.43 179.11 41.1 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 107.257 -2.337 . . . . 0.0 107.257 173.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -102.17 165.79 17.31 Favored Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.332 1.066 . . . . 0.0 110.976 -179.471 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.67 -24.97 61.91 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.643 2.229 . . . . 0.0 111.577 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -75.76 -10.68 59.63 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.23 163.77 12.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 122.637 1.208 . . . . 0.0 110.545 -168.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.7 -43.35 93.76 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 113.891 -1.504 . . . . 0.0 108.802 177.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -92.54 151.51 20.13 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.093 177.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.1 ptt-85 164.91 136.81 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 127.867 2.467 . . . . 0.0 105.765 -172.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -69.03 178.44 2.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.383 1.073 . . . . 0.0 109.111 168.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -42.12 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 O-C-N 121.018 -1.051 . . . . 0.0 111.105 -175.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -114.07 49.71 0.83 Allowed Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -94.24 86.91 5.07 Favored 'General case' 0 CA--C 1.523 -0.082 0 C-N-CA 125.45 1.5 . . . . 0.0 111.228 173.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.478 HD22 ' N ' ' A' ' 84' ' ' LEU . 1.6 mm? -88.0 45.8 1.32 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 27.37 -108.1 0.01 OUTLIER Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.678 2.085 . . . . 0.0 112.382 -171.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -138.94 158.55 44.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.938 1.295 . . . . 0.0 110.17 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.94 163.73 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.831 1.652 . . . . 0.0 107.705 -179.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 m -112.57 117.78 33.27 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 124.358 1.063 . . . . 0.0 108.354 -177.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.94 143.24 32.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.058 0.543 . . . . 0.0 110.316 172.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.49 168.59 19.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.181 1.793 . . . . 0.0 110.539 173.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -22.94 26.78 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.13 1.772 . . . . 0.0 112.211 170.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.9 -1.38 57.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.141 0.496 . . . . 0.0 110.341 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.18 37.57 55.14 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.82 0.724 . . . . 0.0 111.569 -179.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.7 t -116.97 114.62 46.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 126.386 1.874 . . . . 0.0 107.642 175.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.604 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.46 104.04 15.42 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 168.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -70.79 147.29 49.1 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 164.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.37 147.22 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 174.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.1 p -165.1 86.59 0.41 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.283 1.433 . . . . 0.0 108.19 -177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.17 177.64 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.34 151.83 38.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.738 0.815 . . . . 0.0 108.891 177.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -139.28 144.26 38.27 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 178.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.4 m -103.61 8.58 37.57 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.282 1.033 . . . . 0.0 111.811 174.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 p -93.94 -43.91 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.504 0.593 . . . . 0.0 110.581 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 29' ' ' VAL . 4.4 pt -78.54 165.32 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 123.375 0.67 . . . . 0.0 110.016 175.307 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.3 m -165.66 171.93 12.48 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.224 1.41 . . . . 0.0 108.012 -177.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.9 mp -100.29 25.25 7.78 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.419 1.487 . . . . 0.0 108.215 174.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.1 p -155.21 174.31 15.39 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.22 -153.54 52.9 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -172.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -68.51 -43.89 75.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.702 0.763 . . . . 0.0 109.176 172.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -49.75 -26.88 4.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.196 2.198 . . . . 0.0 115.148 -174.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -21.32 93.54 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.081 2.152 . . . . 0.0 113.981 177.295 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 pp -65.83 -29.39 46.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 -178.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.4 mm -58.33 113.08 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.77 51.22 3.69 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 123.904 0.752 . . . . 0.0 113.2 -174.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.448 ' HB2' HD12 ' A' ' 149' ' ' ILE . 6.7 mmp_? -129.84 160.28 34.0 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.932 1.293 . . . . 0.0 110.023 161.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.8 m -84.23 132.78 34.62 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.999 1.319 . . . . 0.0 112.225 169.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.35 150.45 32.59 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.386 1.474 . . . . 0.0 110.785 172.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -140.24 148.66 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.164 1.785 . . . . 0.0 110.225 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.4 p -102.88 -22.48 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.15 2.18 . . . . 0.0 114.496 177.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 63.06 159.77 0.08 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 128.278 2.631 . . . . 0.0 114.73 -175.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -70.78 -49.12 50.02 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.328 174.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -114.54 178.9 4.11 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.581 0.705 . . . . 0.0 110.042 -172.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.57 158.39 24.39 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.493 173.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.18 141.44 31.04 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 169.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.43 9.81 0.95 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.572 1.549 . . . . 0.0 112.75 -175.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 mm? 57.64 29.61 17.53 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 120.004 1.274 . . . . 0.0 110.452 -172.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 38.58 43.77 1.65 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.169 1.842 . . . . 0.0 113.809 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -61.9 -5.38 2.06 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 172.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 70.9 34.58 65.57 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 178.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -62.19 -16.16 52.79 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.186 0.422 . . . . 0.0 112.759 178.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.633 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER 172.79 165.59 0.13 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 128.336 2.655 . . . . 0.0 109.103 -175.746 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -48.52 -49.33 36.48 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-O 121.788 0.804 . . . . 0.0 109.266 178.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.4 HE21 ' C ' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -47.4 -46.43 26.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.015 1.326 . . . . 0.0 111.718 178.175 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.633 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 47.9 t -63.37 -58.79 5.96 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.632 1.973 . . . . 0.0 110.263 173.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.19 -25.45 67.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -173.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -93.18 -38.35 11.61 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 126.881 2.072 . . . . 0.0 109.932 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 12.1 p -143.67 -18.16 0.61 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 116.983 2.216 . . . . 0.0 116.983 -172.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.37 27.64 9.09 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 177.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.1 t30 55.25 23.77 5.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.113 0.956 . . . . 0.0 110.686 176.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.3 0.42 45.84 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.004 0.521 . . . . 0.0 111.511 -164.82 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 72.36 -163.94 54.58 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 176.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.8 t -62.73 173.31 1.34 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 122.795 1.283 . . . . 0.0 111.134 -175.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 86.22 3.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.569 1.547 . . . . 0.0 108.323 -177.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -38.7 -50.93 1.67 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.743 1.217 . . . . 0.0 111.244 175.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.67 153.27 49.85 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 123.853 0.72 . . . . 0.0 109.42 173.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 6.4 p -138.15 149.5 45.94 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.488 2.315 . . . . 0.0 106.496 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.43 175.37 33.36 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 177.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.93 148.59 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 118.114 0.957 . . . . 0.0 109.17 175.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 115' ' ' ARG . 28.6 mt -94.63 128.89 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.916 0.887 . . . . 0.0 109.908 -175.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.49 178.47 21.63 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.69 144.66 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 124.612 1.165 . . . . 0.0 108.877 174.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . . . -105.43 117.07 33.08 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 124.379 1.071 . . . . 0.0 110.545 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--O 1.248 1.006 0 C-N-CA 125.667 1.587 . . . . 0.0 110.607 178.92 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.381 . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.1 m -82.43 156.76 23.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 160.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -145.71 140.8 27.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 175.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -104.85 163.48 12.49 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.596 1.158 . . . . 0.0 109.469 177.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.72 149.62 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 126.213 1.805 . . . . 0.0 107.197 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 112.25 10.26 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 165.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 m -86.96 92.82 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-O 121.918 0.866 . . . . 0.0 109.356 -178.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.701 HD11 HD23 ' A' ' 117' ' ' LEU . 5.2 mp -58.01 140.5 52.25 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.503 0.721 . . . . 0.0 109.515 171.048 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.85 141.26 19.71 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.402 1.481 . . . . 0.0 108.673 171.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.86 -161.74 11.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 124.019 0.818 . . . . 0.0 111.057 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -65.2 -38.96 92.11 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.845 0.858 . . . . 0.0 110.412 178.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -108.42 -151.84 15.74 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.38 -9.7 21.8 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.776 2.317 . . . . 0.0 112.202 -174.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.553 HG13 HD22 ' A' ' 38' ' ' LEU . 6.1 t -41.31 101.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 109.019 170.064 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -149.74 163.89 36.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -167.83 130.9 2.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.54 178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.8 mp -87.71 92.65 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 31.4 mm -81.5 154.94 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 171.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -143.16 138.63 29.9 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.921 2.088 . . . . 0.0 106.449 -170.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 84.3 m-85 -133.58 112.44 11.48 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.722 1.209 . . . . 0.0 110.07 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 10.2 tm-20 -100.57 126.12 47.0 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.383 0.992 . . . . 0.0 109.027 173.687 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.586 ' HB2' HG23 ' A' ' 29' ' ' VAL . 6.4 tt0 -149.43 143.87 25.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 165.666 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 0.1 OUTLIER -135.36 16.06 3.44 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.326 1.05 . . . . 0.0 109.929 179.815 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -137.68 154.79 49.63 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.84 2.056 . . . . 0.0 106.128 -177.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.8 m -61.41 -51.46 68.67 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.303 0.573 . . . . 0.0 109.72 171.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -122.18 31.15 6.28 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 124.285 1.034 . . . . 0.0 110.652 -167.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.97 160.76 24.25 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 175.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -64.88 118.56 5.53 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.096 2.53 . . . . 0.0 109.714 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -72.98 142.0 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.259 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -101.25 117.83 35.76 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 169.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.9 t -101.66 131.43 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -160.92 156.19 24.56 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.769 173.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.89 -173.12 39.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.346 -177.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 m -154.01 103.84 2.6 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -177.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.736 HG21 HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -71.59 163.38 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 167.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -153.71 104.17 2.68 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 164.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 150.34 -7.86 0.74 Allowed Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.587 -0.563 . . . . 0.0 113.765 168.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.736 HD23 HG21 ' A' ' 35' ' ' ILE . 2.0 mm? -68.59 -178.6 1.18 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.494 1.147 . . . . 0.0 109.487 171.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.2 t -109.67 159.5 17.08 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 167.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -56.11 153.4 9.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.073 1.349 . . . . 0.0 112.788 -175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.53 -125.84 6.88 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 104.018 -3.633 . . . . 0.0 104.018 176.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -143.34 153.86 43.16 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 118.639 1.219 . . . . 0.0 111.611 -176.581 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.511 ' CE1' HD12 ' A' ' 38' ' ' LEU . 77.0 m-70 -140.63 129.81 23.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.726 1.21 . . . . 0.0 108.677 -171.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.62 143.63 31.56 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CZ ' HD21 ' A' ' 117' ' ' LEU . 32.7 t80 -139.85 117.06 11.21 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -176.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.58 171.22 20.32 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 118.953 0.797 . . . . 0.0 109.541 -177.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -102.45 119.66 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -89.38 172.4 9.05 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 0.0 110.331 174.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.42 -144.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.03 0.831 . . . . 0.0 110.591 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 71.84 -55.81 0.65 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.409 1.459 . . . . 0.0 111.187 -167.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 59.89 -95.97 0.06 Allowed 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.611 1.164 . . . . 0.0 109.404 -169.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -103.61 88.81 3.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.543 0.737 . . . . 0.0 109.033 -178.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -40.53 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.855 0.359 . . . . 0.0 111.653 177.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 54' ' ' THR . 7.0 t -77.02 42.1 0.31 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.899 1.679 . . . . 0.0 112.398 -173.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.18 -38.95 27.56 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.768 1.227 . . . . 0.0 112.808 -170.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -132.78 38.48 1.87 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 175.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 57.88 85.57 0.09 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.119 0.967 . . . . 0.0 112.962 179.092 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.8 m -124.64 -79.9 0.62 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.515 0.726 . . . . 0.0 109.217 176.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -52.2 -47.46 65.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.557 1.543 . . . . 0.0 112.993 -172.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 54.45 51.44 14.15 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.27 1.028 . . . . 0.0 113.349 170.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -55.59 162.72 5.18 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 125.81 1.672 . . . . 0.0 111.541 178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.38 -175.16 2.52 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.179 1.919 . . . . 0.0 111.474 -173.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.54 138.67 10.18 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 171.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -60.81 166.05 3.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 169.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -138.88 133.18 16.38 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 125.963 1.705 . . . . 0.0 108.187 174.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -84.37 -67.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.036 2.491 . . . . 0.0 108.461 -179.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.88 40.1 3.71 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.106 1.363 . . . . 0.0 108.258 176.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 46.0 p 53.66 39.6 30.38 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.218 1.007 . . . . 0.0 112.252 176.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 64.0 mtp85 -73.79 161.75 29.87 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 170.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -67.28 172.97 4.25 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 122.392 1.091 . . . . 0.0 110.574 168.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.479 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 54.2 t60 -69.44 164.03 23.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.084 174.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.78 -146.13 7.13 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 164.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.15 -178.69 15.55 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 125.144 1.354 . . . . 0.0 110.645 175.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.6 -18.74 59.69 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.882 2.388 . . . . 0.0 113.012 -171.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -96.16 1.48 52.35 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.032 175.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -91.15 161.8 14.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.174 1.464 . . . . 0.0 110.462 -174.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -72.61 -37.36 68.12 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.508 -1.678 . . . . 0.0 109.99 175.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.49 125.73 54.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -158.69 137.85 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.6 m170 -76.8 171.07 15.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 118.118 0.417 . . . . 0.0 110.482 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -37.55 -64.34 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 124.692 1.197 . . . . 0.0 112.202 -177.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -107.51 40.85 2.37 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.796 -0.521 . . . . 0.0 111.796 -178.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -81.14 76.14 8.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 118.105 0.952 . . . . 0.0 110.563 175.097 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.5 mt -92.64 48.83 1.4 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.09 -102.68 0.01 OUTLIER Glycine 0 CA--C 1.528 0.889 0 C-N-CA 126.885 2.183 . . . . 0.0 113.957 -177.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -140.17 166.29 25.06 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.371 1.468 . . . . 0.0 109.899 -174.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 m -119.33 165.3 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.538 1.535 . . . . 0.0 107.018 175.03 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 m -115.33 118.57 33.62 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.009 1.323 . . . . 0.0 107.99 -173.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.3 142.57 27.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.11 0.564 . . . . 0.0 111.145 178.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -70.13 171.74 9.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.537 1.935 . . . . 0.0 111.252 174.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -13.6 12.51 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.88 2.072 . . . . 0.0 113.032 169.42 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.69 -1.4 35.28 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.807 1.243 . . . . 0.0 110.291 176.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.92 24.78 54.61 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 121.761 -0.587 . . . . 0.0 112.904 175.607 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 35' ' ' ILE . 70.8 t -106.97 119.58 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 125.579 1.552 . . . . 0.0 107.535 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -103.5 111.0 23.25 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -78.59 127.68 32.46 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 169.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.67 141.27 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 175.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.2 t -161.52 101.28 1.19 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 177.358 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.4 tt -153.24 178.8 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.176 0.99 . . . . 0.0 108.403 177.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -145.27 148.5 33.54 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 172.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -134.33 153.41 51.9 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.5 t -109.77 16.3 22.15 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.408 0.683 . . . . 0.0 111.574 173.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.9 p -117.15 -60.1 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.044 0.938 . . . . 0.0 109.764 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.541 HD12 HG11 ' A' ' 29' ' ' VAL . 2.9 pp -75.67 142.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -171.43 159.74 5.75 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 -161.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.36 12.23 16.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.675 1.125 . . . . 0.0 110.423 177.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -167.1 -171.89 1.88 Allowed 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -167.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.7 -73.11 2.46 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.32 -64.51 0.06 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.939 0.896 . . . . 0.0 108.787 -170.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -67.69 8.34 0.38 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 116.721 -1.609 . . . . 0.0 115.063 -176.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.5 t -15.19 103.08 0.02 OUTLIER 'General case' 0 C--N 1.343 0.321 0 C-N-CA 127.888 2.475 . . . . 0.0 113.279 178.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 51.1 pt -70.87 -14.15 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 123.973 0.909 . . . . 0.0 112.122 177.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 49.7 mm -61.18 112.93 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.99 -27.17 9.84 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 -176.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.27 158.48 35.8 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.191 0.996 . . . . 0.0 112.548 -173.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.1 m -101.23 103.16 14.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.065 1.746 . . . . 0.0 109.524 -177.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.701 HD23 HD11 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -86.09 133.74 33.87 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.643 0.777 . . . . 0.0 109.072 177.042 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.56 156.2 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.162 0.437 . . . . 0.0 110.014 -177.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -179.7 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 C-N-CA 123.23 0.612 . . . . 0.0 110.369 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -135.62 162.03 33.84 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 115.988 1.848 . . . . 0.0 115.988 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -68.69 -68.18 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.967 0.907 . . . . 0.0 111.479 -179.385 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 45.3 mmtt -79.13 179.19 7.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 122.045 0.926 . . . . 0.0 109.476 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.04 152.92 43.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.952 0.901 . . . . 0.0 110.066 172.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 10.2 t70 -69.57 132.29 46.01 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.118 0.567 . . . . 0.0 110.538 166.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -75.39 4.04 8.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.654 1.981 . . . . 0.0 112.813 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mm? 48.89 39.64 14.79 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 120.788 -1.195 . . . . 0.0 109.726 -174.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 57.0 21.22 37.18 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.352 -1.249 . . . . 0.0 114.727 175.389 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -123.79 20.29 9.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.373 1.586 . . . . 0.0 113.232 -173.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.25 -11.68 81.98 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.776 0.716 . . . . 0.0 112.612 177.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.0 33.02 55.95 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.892 0.846 . . . . 0.0 112.708 175.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.442 HD21 ' CB ' ' A' ' 133' ' ' GLN . 0.1 OUTLIER -151.82 136.08 16.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.687 178.808 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -29.3 -69.38 0.06 Allowed 'General case' 0 C--N 1.345 0.399 0 C-N-CA 125.877 1.671 . . . . 0.0 111.902 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.442 ' CB ' HD21 ' A' ' 131' ' ' ASN . 0.0 OUTLIER -40.67 -80.52 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 125.757 1.623 . . . . 0.0 109.464 174.702 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -27.76 -44.71 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 O-C-N 118.517 -2.614 . . . . 0.0 117.203 165.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 76.8 p -90.16 6.38 42.87 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.897 0.879 . . . . 0.0 112.576 -176.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -126.28 -52.22 1.51 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 128.374 2.669 . . . . 0.0 109.117 -178.696 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.88 -19.61 15.21 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.868 1.213 . . . . 0.0 112.65 -175.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 87.06 23.25 41.88 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -169.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.1 20.16 3.16 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.161 1.48 . . . . 0.0 111.689 176.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -79.71 6.2 11.41 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 122.108 -0.37 . . . . 0.0 110.732 -163.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 70.51 -164.97 52.47 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.0 t -67.97 173.65 4.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 122.073 0.939 . . . . 0.0 110.885 -177.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 100.81 12.07 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 113.866 -1.516 . . . . 0.0 110.973 -177.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.454 ' HB3' HG11 ' A' ' 14' ' ' VAL . 1.1 mm? -50.46 -38.58 44.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.468 1.507 . . . . 0.0 110.744 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.25 157.55 43.21 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 19.8 p -139.86 157.12 46.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 127.346 2.259 . . . . 0.0 107.967 -178.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.97 154.98 26.12 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 177.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 70.1 t -96.1 140.78 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 21.6 mt -92.02 129.61 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.984 1.313 . . . . 0.0 108.198 -179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.88 179.6 26.51 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.6 140.41 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 124.223 1.009 . . . . 0.0 108.333 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.94 167.24 17.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.102 0.477 . . . . 0.0 111.402 176.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.006 178.108 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.533 . . . . . . . 0 N--CA 1.476 0.868 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 36.4 p -163.1 -179.55 6.76 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 118.99 0.814 . . . . 0.0 110.14 -173.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -76.84 125.29 29.04 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.315 1.846 . . . . 0.0 111.707 168.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -126.91 161.1 29.09 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.668 2.387 . . . . 0.0 108.28 176.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.47 150.19 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.031 1.732 . . . . 0.0 107.303 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -136.02 111.71 9.37 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 118.993 0.815 . . . . 0.0 108.926 167.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.55 102.75 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.576 0.75 . . . . 0.0 110.033 -179.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.13 133.56 40.22 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.827 1.251 . . . . 0.0 109.22 173.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -145.91 159.18 43.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.263 . . . . 0.0 107.773 163.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -133.59 -149.67 6.12 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 120.053 1.297 . . . . 0.0 110.128 173.05 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -62.85 -44.83 95.09 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.936 1.294 . . . . 0.0 109.109 168.331 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.13 -178.48 45.86 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.28 12.32 2.88 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.763 2.309 . . . . 0.0 112.177 -172.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.38 92.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.964 1.705 . . . . 0.0 110.212 -178.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.65 114.08 27.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.036 -170.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 35' ' ' ILE . . . -120.98 94.1 0.54 Allowed Glycine 0 C--O 1.222 -0.619 0 CA-C-N 118.264 0.484 . . . . 0.0 112.648 -174.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 22.0 mt -81.69 90.74 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 176.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 27.6 mm -77.58 155.71 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 172.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -138.17 140.11 39.67 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 126.526 1.931 . . . . 0.0 106.463 176.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 36.9 m-85 -126.29 126.6 44.23 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.31 1.444 . . . . 0.0 107.229 175.243 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -126.27 140.21 52.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 119.643 1.11 . . . . 0.0 108.342 171.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -134.96 -63.88 0.68 Allowed 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.564 0.697 . . . . 0.0 109.846 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt 67.62 -43.2 0.46 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.578 1.551 . . . . 0.0 114.253 -177.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -62.46 157.22 20.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 120.386 1.448 . . . . 0.0 109.319 175.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -77.44 -28.84 52.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.057 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.02 36.61 0.55 Allowed 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.448 1.099 . . . . 0.0 108.716 -175.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.43 172.64 24.27 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 177.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -62.25 135.57 54.98 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.249 1.966 . . . . 0.0 109.657 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 t -75.35 127.06 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 167.372 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -94.87 125.83 39.79 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 167.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 0.2 OUTLIER -117.65 142.12 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.532 1.533 . . . . 0.0 107.055 179.03 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -161.36 164.82 29.77 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.11 -174.45 43.54 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-O 118.506 -1.163 . . . . 0.0 111.317 -177.134 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 73.7 m -157.18 101.96 1.93 Allowed 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -73.01 157.12 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 172.038 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -140.68 96.62 3.05 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 167.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.09 -0.99 0.74 Allowed Glycine 0 CA--C 1.532 1.111 0 CA-C-O 119.769 -0.462 . . . . 0.0 113.803 175.215 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 mp -67.02 -167.76 0.06 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.165 0.983 . . . . 0.0 110.063 170.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.2 t -137.74 156.51 47.91 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 168.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -48.69 138.14 11.24 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 125.786 1.929 . . . . 0.0 111.386 -178.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.3 -141.64 14.34 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 105.493 -3.043 . . . . 0.0 105.493 -175.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.1 pt? -139.4 152.47 47.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 118.223 1.011 . . . . 0.0 111.84 -169.144 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -144.56 129.67 18.58 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.849 -170.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.96 149.84 49.24 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 115.86 6.7 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.846 0.859 . . . . 0.0 111.413 -167.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.411 ' CE1' ' CD2' ' A' ' 120' ' ' HIS . 0.7 OUTLIER -149.36 157.63 43.49 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.69 0.757 . . . . 0.0 112.958 -173.983 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.85 101.35 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 171.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -76.78 155.41 33.13 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 168.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -166.93 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.199 175.25 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 56.57 -163.66 0.16 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.775 1.23 . . . . 0.0 111.702 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -155.08 -108.61 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 -177.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -71.5 97.52 1.68 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 119.955 1.252 . . . . 0.0 110.158 171.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -157.93 -44.95 0.06 Allowed 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 122.855 0.462 . . . . 0.0 111.116 172.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 60' ' ' ALA . 1.5 t -78.36 48.02 0.73 Allowed 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.401 -0.812 . . . . 0.0 111.72 -174.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.17 -39.47 43.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.638 1.175 . . . . 0.0 112.285 -173.42 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.8 40.14 2.47 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 175.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 57.13 30.76 18.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 117.893 0.847 . . . . 0.0 111.655 178.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.8 m -48.88 -57.84 5.79 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.778 2.031 . . . . 0.0 112.191 -175.624 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 166.41 -51.79 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.989 1.716 . . . . 0.0 108.921 -175.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . 59.95 -86.91 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.54 1.136 . . . . 0.0 110.263 -170.282 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -150.01 165.69 29.81 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -178.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -73.47 -170.64 0.69 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.646 2.231 . . . . 0.0 109.987 173.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -58.49 137.92 57.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.964 0.905 . . . . 0.0 110.089 178.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.43 101.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.285 1.034 . . . . 0.0 111.288 -174.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -125.65 76.22 70.02 Favored Pre-proline 0 CA--C 1.521 -0.167 0 C-N-CA 124.868 1.267 . . . . 0.0 110.309 -177.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -75.19 -41.6 0.61 Allowed 'Trans proline' 0 N--CA 1.442 -1.547 0 CA-C-N 118.56 0.521 . . . . 0.0 112.04 -175.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -166.31 30.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 127.053 2.141 . . . . 0.0 106.519 -173.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.2 t -88.57 -120.17 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 175.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.66 -174.04 4.3 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -171.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.409 ' HB3' HG22 ' A' ' 135' ' ' THR . 25.8 mttt -70.63 177.6 3.44 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-O 121.54 0.686 . . . . 0.0 110.256 173.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 33.7 t60 -60.13 146.07 44.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.873 179.641 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.05 -156.6 11.26 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 166.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.85 173.04 22.82 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -59.1 -23.46 69.12 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.242 2.628 . . . . 0.0 112.457 -176.147 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -73.52 -22.65 60.06 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 176.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -104.89 167.78 9.49 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 123.932 0.893 . . . . 0.0 109.18 -174.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -71.51 -42.5 67.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 173.705 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -76.09 144.15 40.88 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 169.95 131.98 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 127.333 2.253 . . . . 0.0 107.91 -172.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -66.69 174.18 3.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.481 0.713 . . . . 0.0 109.523 171.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 t -60.13 -39.87 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 O-C-N 121.268 -0.895 . . . . 0.0 110.522 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -121.02 68.29 0.42 Allowed Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -120.19 77.95 1.3 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.541 1.536 . . . . 0.0 110.651 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 84' ' ' LEU . 2.1 mm? -88.12 40.7 0.96 Allowed 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.389 -0.82 . . . . 0.0 110.218 -168.666 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 31.32 -125.63 0.2 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.752 1.168 . . . . 0.0 112.041 -166.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -118.37 164.6 14.99 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 124.575 1.15 . . . . 0.0 111.118 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.7 m -115.72 168.93 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 125.509 1.524 . . . . 0.0 107.088 174.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.7 m -114.57 121.67 44.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.985 1.314 . . . . 0.0 108.296 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.99 147.75 22.88 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.037 0.535 . . . . 0.0 110.449 173.145 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -79.26 179.26 7.5 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.509 1.524 . . . . 0.0 111.521 172.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -66.17 -15.89 63.52 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.03 1.332 . . . . 0.0 112.307 176.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -13.54 48.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.121 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.07 30.01 26.83 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -176.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -114.14 119.27 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 125.413 1.485 . . . . 0.0 107.711 177.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.21 111.5 23.73 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 166.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -77.89 125.21 29.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 165.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.58 146.15 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.2 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.7 m -164.95 100.04 0.76 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 126.157 1.783 . . . . 0.0 107.714 174.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.2 tt -146.51 172.95 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -140.81 126.32 18.89 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.707 1.603 . . . . 0.0 107.176 -174.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -129.17 150.17 50.67 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.597 0.759 . . . . 0.0 109.639 179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.2 p -96.61 -27.21 14.92 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.22 1.008 . . . . 0.0 111.521 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 p -73.16 -44.6 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.702 -169.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 104' ' ' ILE . 3.6 pt -76.05 148.13 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 173.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -158.92 175.78 13.14 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 173.408 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 106' ' ' LEU . 6.3 mp -93.96 33.18 1.36 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 m -82.47 -103.59 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -167.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 -86.46 0.23 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -49.38 -51.52 34.4 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 117.671 0.736 . . . . 0.0 110.735 170.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -80.33 -18.2 49.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 116.591 -1.671 . . . . 0.0 113.446 -178.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.9 t -33.92 101.95 0.02 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 119.784 1.175 . . . . 0.0 112.621 177.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 38.1 pt -70.23 -20.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.719 172.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.1 122.96 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 175.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.51 33.69 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.313 -174.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -110.58 167.97 9.82 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.764 0.826 . . . . 0.0 109.58 161.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.8 m -105.71 101.52 11.03 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.87 1.268 . . . . 0.0 109.09 177.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -88.93 126.56 35.45 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 120.768 -1.207 . . . . 0.0 108.454 -179.636 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.4 t -136.5 141.77 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 118.393 0.542 . . . . 0.0 109.904 -170.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.63 157.39 5.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 C-N-CA 125.098 1.359 . . . . 0.0 109.341 177.122 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.411 ' CD2' ' CE1' ' A' ' 46' ' ' HIS . 92.8 m-70 -116.29 157.36 25.09 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 124.628 1.171 . . . . 0.0 112.736 -178.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.88 -50.42 73.48 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.118 -179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -108.99 -174.4 2.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.327 0.584 . . . . 0.0 110.979 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.404 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -69.3 147.47 51.11 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 172.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.521 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.2 OUTLIER -74.51 134.97 42.2 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.18 0.514 . . . . 0.0 110.942 163.64 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.21 11.89 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.903 2.081 . . . . 0.0 113.364 174.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt 40.94 42.12 1.42 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.852 1.261 . . . . 0.0 112.389 -176.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 55.69 29.77 55.0 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.611 1.577 . . . . 0.0 113.585 176.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -84.1 -16.15 44.75 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.334 1.067 . . . . 0.0 111.359 -178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.27 -9.03 47.46 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 124.272 0.939 . . . . 0.0 114.021 -177.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 58.77 37.1 89.44 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-N 118.781 1.29 . . . . 0.0 111.894 176.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.51 135.64 25.21 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 116.733 -1.603 . . . . 0.0 107.074 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -39.57 -61.52 0.8 Allowed 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.759 1.224 . . . . 0.0 111.783 -177.65 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.92 -67.5 0.27 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 118.641 -0.695 . . . . 0.0 111.893 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 t -49.88 -50.1 47.06 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 120.716 1.598 . . . . 0.0 112.501 172.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 70' ' ' LYS . 13.8 m -66.87 -7.36 21.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.23 0.612 . . . . 0.0 111.335 -174.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -107.59 -35.65 6.67 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 127.903 2.481 . . . . 0.0 111.51 172.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 6.5 p -125.4 -31.47 3.02 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 -172.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.28 5.84 51.94 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 125.022 1.296 . . . . 0.0 110.595 -169.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 t30 60.35 20.05 9.61 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.047 1.423 . . . . 0.0 112.402 170.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.33 32.1 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -172.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 142.45 -161.09 27.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 108.825 -1.71 . . . . 0.0 108.825 -172.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.3 t -71.3 179.86 2.72 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.677 0.751 . . . . 0.0 111.404 -176.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.48 107.41 18.7 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.571 1.148 . . . . 0.0 111.288 -173.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.36 -34.59 72.58 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.325 0.65 . . . . 0.0 111.357 177.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.11 154.11 25.04 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.505 0.593 . . . . 0.0 110.388 175.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 1.5 p -131.0 140.0 50.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.458 2.703 . . . . 0.0 106.928 -177.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -146.15 168.16 27.74 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 177.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 8.5 p -117.13 135.32 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 13.0 mt -86.64 125.96 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -177.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -144.16 -175.95 17.74 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 35.4 mm -75.68 148.43 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.8 51.81 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.152 -0.343 . . . . 0.0 110.826 178.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.243 0.74 0 CA-C-O 116.777 -1.583 . . . . 0.0 107.019 172.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.427 . . . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.9 p -74.23 -175.07 2.15 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.534 1.534 . . . . 0.0 110.248 -172.885 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -135.89 104.34 5.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.065 0.46 . . . . 0.0 109.832 175.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.35 156.84 44.81 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.826 179.323 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.17 154.04 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 125.156 1.382 . . . . 0.0 107.968 -169.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.04 114.45 11.7 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 119.432 1.014 . . . . 0.0 109.377 166.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 m -81.64 93.51 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.243 1.02 . . . . 0.0 108.737 174.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mp -59.14 141.92 52.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.515 -0.741 . . . . 0.0 109.254 167.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.47 147.08 26.42 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.448 1.499 . . . . 0.0 107.154 171.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.66 -157.67 10.22 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 174.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -56.5 -51.14 69.63 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.012 0.925 . . . . 0.0 109.028 168.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -97.51 -143.62 15.32 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -166.329 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -87.95 3.65 6.08 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.613 2.209 . . . . 0.0 111.288 175.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.6 t -56.2 104.11 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 171.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -144.4 155.47 43.78 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 -179.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -160.45 143.15 8.74 Favored Glycine 0 C--O 1.219 -0.813 0 CA-C-N 119.661 1.118 . . . . 0.0 112.165 176.466 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.7 mp -97.68 91.19 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.76 151.28 5.89 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 171.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -128.59 143.5 50.97 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.991 2.116 . . . . 0.0 107.722 178.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -133.09 132.39 41.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.446 1.098 . . . . 0.0 109.522 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -137.67 157.05 47.3 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.722 0.809 . . . . 0.0 109.838 165.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -110.19 -94.82 0.42 Allowed 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.468 0.707 . . . . 0.0 110.867 -175.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm 148.51 -47.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 128.356 2.662 . . . . 0.0 106.528 -175.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -150.94 141.94 23.01 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -166.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.8 m -39.67 -45.3 1.65 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.535 1.534 . . . . 0.0 112.356 175.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -116.35 37.36 3.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.296 1.438 . . . . 0.0 109.443 179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.83 163.14 16.19 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 172.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.46 138.72 61.33 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.063 1.842 . . . . 0.0 109.712 177.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.11 136.87 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 172.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -99.81 126.33 45.88 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.568 1.547 . . . . 0.0 107.449 167.121 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG13 HG23 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -121.46 135.75 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 105.572 -2.011 . . . . 0.0 105.572 -178.878 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -159.61 166.07 31.46 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -177.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.77 -167.39 39.19 Favored Glycine 0 C--O 1.228 -0.224 0 C-N-CA 119.553 -1.308 . . . . 0.0 112.243 -177.454 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 p -164.73 114.49 1.14 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -176.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -77.67 170.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-O 121.184 0.516 . . . . 0.0 110.336 171.193 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -153.99 90.95 1.4 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 172.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.18 -15.34 0.87 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.489 -0.386 . . . . 0.0 112.958 171.889 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB2' HG21 ' A' ' 35' ' ' ILE . 20.0 tp -66.58 171.36 5.15 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.962 1.305 . . . . 0.0 111.03 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 p -92.1 151.6 20.34 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.171 0.988 . . . . 0.0 109.477 175.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -51.25 154.1 1.8 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.515 1.926 . . . . 0.0 111.61 175.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.93 -171.29 22.5 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 171.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.58 142.56 30.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.19 0.495 . . . . 0.0 111.005 -172.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.46 ' CG ' HD21 ' A' ' 38' ' ' LEU . 69.9 m-70 -136.22 126.43 26.38 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.967 1.307 . . . . 0.0 111.156 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.95 124.01 6.81 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 110.461 -1.055 . . . . 0.0 110.461 -171.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.65 120.49 37.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 118.84 1.32 . . . . 0.0 109.001 -166.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.445 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.5 OUTLIER -146.99 157.55 43.65 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -173.714 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 74.9 t -87.15 109.91 19.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 164.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -76.89 162.77 27.34 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 123.544 0.738 . . . . 0.0 109.509 167.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -147.34 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.925 177.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.4 -55.08 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.372 2.269 . . . . 0.0 114.869 -174.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 68.16 -83.54 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.26 1.424 . . . . 0.0 109.809 -179.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -105.43 76.88 1.24 Allowed 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.58 1.152 . . . . 0.0 109.479 -176.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -163.5 -52.45 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.992 174.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.4 t -77.1 55.18 1.12 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.426 0.691 . . . . 0.0 111.279 -176.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.88 -43.21 49.19 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.533 1.533 . . . . 0.0 112.482 -177.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.04 -101.2 0.74 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 171.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -161.64 31.27 0.13 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.444 -0.445 . . . . 0.0 110.383 168.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.2 m -71.42 -71.46 0.26 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.033 0.933 . . . . 0.0 110.972 -167.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.6 m -59.97 -48.99 79.44 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.805 0.842 . . . . 0.0 109.995 -178.112 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 44.46 57.49 4.38 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.003 1.321 . . . . 0.0 112.015 176.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.06 157.94 5.62 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.206 1.384 . . . . 0.0 110.812 -178.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.51 -174.03 1.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.222 1.948 . . . . 0.0 112.987 -164.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -52.28 125.8 17.05 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.307 172.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.86 116.93 10.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -177.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' CB ' ' HB3' ' A' ' 80' ' ' HIS . 7.2 p-10 -127.57 53.09 9.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.822 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -64.3 -23.96 65.41 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.155 1.904 . . . . 0.0 111.792 -178.016 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.73 -13.5 57.72 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.933 0.493 . . . . 0.0 111.281 174.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.5 m 64.17 61.88 0.88 Allowed 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.826 0.822 . . . . 0.0 111.121 168.141 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -131.01 164.87 24.43 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 170.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 169.76 17.47 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 119.152 0.887 . . . . 0.0 110.772 -173.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -59.34 148.82 30.93 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 119.974 -0.69 . . . . 0.0 110.761 175.111 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -177.5 -150.46 8.49 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 107.1 -2.4 . . . . 0.0 107.1 166.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 179.14 28.29 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 118.637 1.219 . . . . 0.0 110.5 178.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -61.24 -27.55 83.68 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.129 2.552 . . . . 0.0 112.468 -171.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -10.5 59.86 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 177.269 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -118.65 161.86 19.36 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.512 1.525 . . . . 0.0 108.518 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.46 -31.07 47.77 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.968 -178.617 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -91.36 134.15 34.85 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.63 0.772 . . . . 0.0 109.319 -179.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.15 140.08 2.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 127.658 2.383 . . . . 0.0 104.769 176.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 65' ' ' ASN . 40.9 m80 -57.07 -86.3 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.108 1.363 . . . . 0.0 110.215 -178.228 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -137.67 -70.18 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 127.045 2.138 . . . . 0.0 107.085 154.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -83.4 44.45 3.3 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-O 120.028 -0.318 . . . . 0.0 113.488 -166.078 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.55 76.72 3.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.028 1.731 . . . . 0.0 109.235 -173.834 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.43 51.81 2.2 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.557 -0.714 . . . . 0.0 110.175 -171.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.13 -124.49 0.07 OUTLIER Glycine 0 C--N 1.341 0.832 0 C-N-CA 126.851 2.167 . . . . 0.0 112.691 -168.523 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.78 163.01 26.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.453 1.101 . . . . 0.0 110.067 177.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.2 m -113.97 176.5 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 C-N-CA 125.595 1.558 . . . . 0.0 107.373 170.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.4 m -126.65 119.61 27.45 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 125.449 1.5 . . . . 0.0 108.063 -178.701 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.2 137.75 32.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 122.652 0.381 . . . . 0.0 110.683 174.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -66.71 166.43 13.05 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.312 1.445 . . . . 0.0 110.55 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -23.25 22.41 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.324 1.849 . . . . 0.0 112.161 171.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.6 -3.46 58.79 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.093 0.557 . . . . 0.0 110.491 179.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.89 35.51 24.53 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.244 0.449 . . . . 0.0 112.197 177.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.3 t -115.05 111.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 125.835 1.654 . . . . 0.0 107.854 176.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.557 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -100.76 112.5 24.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 168.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -81.93 143.37 31.69 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.745 1.278 . . . . 0.0 108.293 171.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.76 149.3 21.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 p -171.57 94.22 0.16 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.695 1.198 . . . . 0.0 109.435 -179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.4 HG23 HG13 ' A' ' 31' ' ' VAL . 9.7 tt -151.01 179.32 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.955 0.902 . . . . 0.0 109.627 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -136.88 148.79 47.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.15 1.38 . . . . 0.0 109.081 -179.18 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.447 ' HB2' HD11 ' A' ' 104' ' ' ILE . 4.0 m-20 -122.89 153.27 39.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.068 1.347 . . . . 0.0 109.038 174.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.3 t -115.62 -7.02 12.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.86 1.264 . . . . 0.0 111.886 175.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.1 -59.91 2.96 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 123.096 0.558 . . . . 0.0 109.57 -176.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 101' ' ' ASP . 1.3 pp -67.61 163.02 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 O-C-N 122.24 -0.288 . . . . 0.0 110.618 178.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 12.9 m -165.06 161.76 19.9 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -171.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mp -92.74 33.97 1.11 Allowed 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.992 0.917 . . . . 0.0 109.088 175.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.2 p -154.52 167.94 28.41 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.665 0.786 . . . . 0.0 108.898 -173.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.91 -159.56 27.47 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.591 -0.604 . . . . 0.0 111.591 -176.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -64.63 -31.56 72.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.975 1.71 . . . . 0.0 110.352 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -65.04 -33.18 75.43 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 117.811 -1.09 . . . . 0.0 112.826 -178.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 31.1 t -8.4 90.86 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.429 2.292 . . . . 0.0 114.207 176.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.9 pt -55.56 -20.0 6.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 CA-C-N 118.991 0.814 . . . . 0.0 113.006 -176.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.02 119.66 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 174.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.41 -29.16 10.35 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.217 0.913 . . . . 0.0 112.76 -176.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -70.97 141.55 51.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.608 1.204 . . . . 0.0 110.472 -165.138 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.0 m -85.27 107.5 17.33 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.612 1.165 . . . . 0.0 110.57 -175.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.99 138.72 31.31 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.913 0.885 . . . . 0.0 109.387 177.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.07 150.35 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.322 1.449 . . . . 0.0 109.353 -175.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.2 p -113.82 -20.22 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 126.512 1.925 . . . . 0.0 114.13 -170.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.86 161.48 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 128.625 2.77 . . . . 0.0 115.532 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.01 -43.43 71.4 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 113.171 -1.831 . . . . 0.0 111.045 -175.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 31.0 mttm -128.39 -176.33 3.78 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.483 0.713 . . . . 0.0 109.952 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.47 151.57 19.88 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.375 1.47 . . . . 0.0 109.304 171.757 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.445 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 9.1 p-10 -100.79 123.74 45.43 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 172.249 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD2' ' NZ ' ' A' ' 128' ' ' LYS . 0.8 OUTLIER -73.69 26.88 0.07 Allowed 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 126.039 1.735 . . . . 0.0 112.927 -171.725 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 mt 35.47 45.98 0.26 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.62 1.568 . . . . 0.0 112.048 -175.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 72.95 -8.53 7.79 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.008 172.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.414 ' NZ ' ' OD2' ' A' ' 125' ' ' ASP . 19.2 pttm -60.2 -24.59 64.93 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.25 1.525 . . . . 0.0 113.231 -163.289 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.82 -30.98 37.68 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 123.48 0.562 . . . . 0.0 112.571 173.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 65.6 55.04 22.41 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 176.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.4 OUTLIER -154.29 150.73 28.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 124.545 1.138 . . . . 0.0 108.055 -179.683 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -48.53 -40.12 25.78 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.618 1.099 . . . . 0.0 111.644 -172.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.43 -86.69 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.652 0.781 . . . . 0.0 111.176 170.102 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.433 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 3.9 m -39.65 -51.71 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.111 1.764 . . . . 0.0 112.793 175.167 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 14.4 m -62.75 -19.93 64.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.054 1.342 . . . . 0.0 111.415 -174.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -103.47 -35.99 8.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.166 1.786 . . . . 0.0 111.492 175.58 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -44.79 1.89 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.827 1.194 . . . . 0.0 112.641 -168.127 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.26 2.73 24.65 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 124.985 1.279 . . . . 0.0 112.303 -169.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.2 t30 63.65 30.32 14.89 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.657 1.728 . . . . 0.0 110.853 178.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -56.25 4.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.153 -177.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 130.19 -153.02 19.92 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -174.536 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 58.6 m -69.72 178.73 2.45 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.987 0.898 . . . . 0.0 111.935 -171.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -102.21 90.04 3.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.434 1.494 . . . . 0.0 108.538 -177.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.47 -50.86 29.77 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.163 0.585 . . . . 0.0 110.666 176.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.01 159.64 42.63 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.247 0.619 . . . . 0.0 109.682 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 26.8 p -155.87 143.25 19.34 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -174.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.17 142.33 7.99 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -175.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 17.1 m -88.09 138.78 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.07 0.548 . . . . 0.0 109.797 -179.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 18.4 mt -77.58 144.73 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -149.52 177.23 27.83 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.364 1.459 . . . . 0.0 110.085 -175.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.34 143.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 124.901 1.28 . . . . 0.0 109.005 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -86.92 95.44 9.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.725 0.41 . . . . 0.0 111.773 -177.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 . . . . . 0 C--O 1.25 1.092 0 C-N-CA 125.421 1.488 . . . . 0.0 111.187 170.413 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.409 . . . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 50.0 m -71.34 106.95 4.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -124.57 150.8 45.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.612 1.565 . . . . 0.0 107.945 179.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -84.12 170.43 13.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 168.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -131.09 147.51 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 127.24 2.216 . . . . 0.0 107.001 170.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.07 113.9 15.11 Favored 'General case' 0 CA--C 1.524 -0.046 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 160.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.9 m -80.87 107.68 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mp -73.69 139.97 45.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.639 1.175 . . . . 0.0 108.275 170.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 tttm -145.2 147.21 32.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.28 1.032 . . . . 0.0 108.56 171.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.41 -163.6 10.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 176.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.67 -45.98 84.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.215 1.006 . . . . 0.0 110.332 178.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.56 -159.51 32.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -175.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -82.15 2.8 8.29 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.049 2.499 . . . . 0.0 111.503 178.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.408 HG13 HD22 ' A' ' 38' ' ' LEU . 72.5 t -45.9 108.93 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 163.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.81 154.79 51.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 176.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.66 123.38 1.44 Allowed Glycine 0 C--O 1.222 -0.638 0 C-N-CA 119.759 -1.21 . . . . 0.0 114.272 176.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.16 87.86 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -178.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.3 mm -73.55 148.49 8.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -133.29 141.76 48.15 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.648 1.179 . . . . 0.0 108.935 170.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 24.5 m-85 -123.84 100.0 6.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.066 0.946 . . . . 0.0 109.558 178.564 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.8 154.59 24.64 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.379 0.991 . . . . 0.0 110.188 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.514 ' CG ' HD13 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -136.35 -59.02 0.74 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 127.171 2.188 . . . . 0.0 108.752 175.164 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt 72.18 -57.68 0.61 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.312 1.445 . . . . 0.0 110.925 -171.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.52 -24.16 29.47 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.634 1.573 . . . . 0.0 111.864 -176.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 78.38 -28.87 0.16 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.502 1.521 . . . . 0.0 111.909 -175.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -122.46 25.89 8.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.591 1.157 . . . . 0.0 110.421 174.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.9 -176.68 22.95 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 178.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.33 132.18 45.07 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.433 2.089 . . . . 0.0 109.018 177.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.53 134.66 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 176.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -103.86 114.05 28.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.512 1.125 . . . . 0.0 108.344 172.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG22 ' CE1' ' A' ' 20' ' ' PHE . 60.2 t -91.35 109.17 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.806 1.242 . . . . 0.0 108.091 175.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.4 m-90 -112.02 161.04 16.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.702 0.801 . . . . 0.0 108.886 170.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.53 -178.07 41.68 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 164.676 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.4 p -164.12 97.34 0.82 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -70.76 165.48 2.73 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.069 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.436 174.248 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -153.83 91.19 1.44 Allowed 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 155.27 -8.09 0.31 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.032 -0.871 . . . . 0.0 114.017 170.431 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 35' ' ' ILE . 1.3 mm? -68.81 -173.77 0.51 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.35 1.075 . . . . 0.0 110.968 176.216 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.7 t -116.63 158.87 23.05 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 164.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -47.3 152.35 0.62 Allowed 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 126.95 2.1 . . . . 0.0 112.495 -179.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.95 -175.04 23.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 178.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.36 145.18 25.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.377 -0.412 . . . . 0.0 111.627 -164.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.562 ' CE1' HD12 ' A' ' 38' ' ' LEU . 78.5 m-70 -133.82 125.78 29.16 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.366 1.467 . . . . 0.0 109.726 179.124 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.36 115.43 4.84 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-O 118.725 -1.042 . . . . 0.0 111.59 -173.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.89 121.33 42.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 120.074 1.937 . . . . 0.0 109.758 -175.205 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.02 160.12 41.87 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.49 0.587 . . . . 0.0 112.171 176.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.6 t -87.48 104.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -79.92 148.49 31.23 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.135 0.969 . . . . 0.0 111.344 167.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -77.94 72.04 4.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.889 1.676 . . . . 0.0 107.788 178.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 8.1 mt-10 -115.42 -62.14 1.64 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.629 0.371 . . . . 0.0 111.72 -179.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 58.19 -139.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.934 1.294 . . . . 0.0 110.993 171.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -73.83 71.99 1.52 Allowed 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.365 -0.834 . . . . 0.0 109.83 177.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.98 -38.88 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.638 0.775 . . . . 0.0 110.873 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.422 ' HA ' HG22 ' A' ' 58' ' ' THR . 10.2 t -66.99 56.29 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.902 1.681 . . . . 0.0 113.395 174.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.11 -31.96 63.74 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.263 -0.898 . . . . 0.0 111.873 178.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.22 53.0 0.53 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 176.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.21 44.56 30.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.609 0.764 . . . . 0.0 111.481 175.2 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.4 t -73.77 -170.19 0.84 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.687 0.795 . . . . 0.0 110.59 -177.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 t -55.53 -40.64 72.1 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.097 0.959 . . . . 0.0 110.207 178.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 47.43 -111.78 0.4 Allowed 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 123.641 0.776 . . . . 0.0 111.511 179.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.79 145.85 11.62 Favored Glycine 0 CA--C 1.536 1.372 0 CA-C-O 118.797 -1.002 . . . . 0.0 110.851 176.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 2.362 12.3 Cg_endo 10.42 154.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.899 1 C-N-CA 130.747 7.631 . . . . 0.0 122.112 155.453 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -42.0 117.52 0.98 Allowed 'General case' 0 C--N 1.349 0.582 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 143.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.402 ' CD1' ' HD3' ' A' ' 66' ' ' PRO . 0.7 OUTLIER -62.15 122.74 16.32 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -178.308 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -133.71 52.11 7.73 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -177.438 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' CD1' ' A' ' 64' ' ' PHE . 89.8 Cg_endo -65.82 -27.83 51.42 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.614 2.21 . . . . 0.0 110.4 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.6 mt -77.03 -13.87 59.9 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.622 174.177 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.5 t 63.08 74.33 0.43 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.286 1.041 . . . . 0.0 111.074 165.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -148.74 146.08 27.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 102.898 -3.001 . . . . 0.0 102.898 -176.58 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp -70.97 169.14 15.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 121.409 1.913 . . . . 0.0 110.331 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.503 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 18.5 t60 -63.87 146.3 54.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.312 -176.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.43 -169.91 41.74 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 107.388 -2.285 . . . . 0.0 107.388 168.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 166.24 23.34 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.66 1.124 . . . . 0.0 113.678 -166.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -61.83 -30.22 83.99 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.595 2.864 . . . . 0.0 111.788 -173.513 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -99.86 6.18 45.34 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.423 1.089 . . . . 0.0 112.833 177.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -91.2 167.22 12.49 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.224 0.92 . . . . 0.0 109.819 176.18 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -73.29 -26.57 61.13 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.431 1.092 . . . . 0.0 111.376 173.631 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -106.15 144.17 33.23 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.137 1.775 . . . . 0.0 109.49 172.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.5 ptt-85 173.64 131.29 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.146 2.578 . . . . 0.0 104.386 -179.045 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 44.6 m80 -61.48 -80.66 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 120.141 1.337 . . . . 0.0 111.619 -174.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.15 -60.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.111 1.364 . . . . 0.0 108.984 158.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.34 45.3 2.42 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 -169.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.08 77.47 3.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 109.389 -170.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.0 mt -86.42 51.86 2.34 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.56 -0.713 . . . . 0.0 109.755 -173.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 33.38 -114.48 0.1 Allowed Glycine 0 CA--C 1.523 0.581 0 C-N-CA 127.53 2.49 . . . . 0.0 112.801 -177.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 24.6 p30 -144.36 156.82 44.41 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.803 0.841 . . . . 0.0 109.369 -179.475 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.7 m -114.38 167.62 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 125.261 1.425 . . . . 0.0 107.414 175.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.2 m -114.8 125.11 53.31 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 124.636 1.174 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 143.17 28.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 118.188 0.449 . . . . 0.0 110.948 170.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.23 170.95 9.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.673 1.589 . . . . 0.0 109.941 172.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.65 -15.98 23.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.061 2.144 . . . . 0.0 112.746 171.197 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.21 -5.54 46.72 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.925 1.69 . . . . 0.0 110.149 177.607 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.04 34.22 30.81 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.686 -0.634 . . . . 0.0 112.357 178.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.4 t -119.82 113.61 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 125.985 1.714 . . . . 0.0 108.004 -179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.62 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -101.67 105.91 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -84.29 126.98 33.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 172.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.58 149.76 9.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.9 p -168.95 76.92 0.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.339 1.456 . . . . 0.0 108.618 -176.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.8 177.49 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.704 1.202 . . . . 0.0 107.828 179.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -147.23 153.55 39.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.128 0.971 . . . . 0.0 109.054 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.22 158.99 43.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.569 1.148 . . . . 0.0 108.803 -178.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -131.3 32.77 4.19 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.927 1.291 . . . . 0.0 109.961 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -115.06 -61.83 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.135 1.374 . . . . 0.0 108.636 177.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -72.41 167.49 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-O 121.024 0.44 . . . . 0.0 110.749 174.796 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.3 m -163.09 173.19 13.84 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 176.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.514 HD13 ' CG ' ' A' ' 22' ' ' GLN . 6.3 mp -94.05 17.91 11.6 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.23 1.412 . . . . 0.0 108.527 172.274 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.0 m -108.07 140.08 41.77 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.385 1.474 . . . . 0.0 108.737 -178.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -19.75 -60.75 0.01 OUTLIER Glycine 0 C--N 1.344 0.978 0 C-N-CA 127.762 2.601 . . . . 0.0 112.971 -173.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -20.41 -69.22 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 129.284 3.033 . . . . 0.0 114.342 173.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -121.43 4.63 10.19 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.917 -1.516 . . . . 0.0 111.015 177.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -20.42 100.14 0.02 OUTLIER 'General case' 0 C--N 1.347 0.491 0 C-N-CA 125.837 1.655 . . . . 0.0 112.812 -169.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.1 pt -67.63 -20.68 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 118.914 -0.565 . . . . 0.0 111.379 177.318 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 37.8 mm -59.85 117.84 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.03 -23.24 27.95 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-O 118.552 -1.138 . . . . 0.0 112.98 -175.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -75.03 166.41 23.72 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.414 1.607 . . . . 0.0 111.748 -172.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 90.0 m -110.05 128.97 55.73 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.022 0.529 . . . . 0.0 110.581 179.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 12.0 tp -105.62 138.92 41.02 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 108.661 177.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 32.2 t -128.65 145.38 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 126.629 1.972 . . . . 0.0 108.192 -176.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 p -107.04 -22.3 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.436 1.894 . . . . 0.0 114.12 -173.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 60.93 150.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.688 2.395 . . . . 0.0 114.835 -178.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.04 -51.7 62.91 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.036 -175.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt -109.86 -176.93 3.13 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 122.063 0.935 . . . . 0.0 111.338 175.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.94 146.56 46.34 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.919 172.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.503 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 29.3 t0 -80.91 120.37 24.64 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 163.097 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -78.27 32.25 0.18 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.841 1.656 . . . . 0.0 110.399 178.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.9 mt 30.25 50.21 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 127.592 2.357 . . . . 0.0 111.536 -166.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 63.78 0.27 3.79 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.398 1.475 . . . . 0.0 116.38 177.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.73 -5.11 44.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.291 1.545 . . . . 0.0 114.612 -166.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.91 -45.54 25.6 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 118.964 0.802 . . . . 0.0 111.843 175.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 100.14 54.42 1.03 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 170.17 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.3 OUTLIER -168.34 158.68 10.02 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 124.157 0.983 . . . . 0.0 110.047 -178.126 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -54.05 -18.68 3.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.924 0.89 . . . . 0.0 112.823 175.614 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -80.33 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 167.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.562 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 54.3 p -44.28 -53.29 6.81 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 126.655 1.982 . . . . 0.0 112.858 177.753 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 74.6 p -69.84 -5.92 28.96 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.445 0.566 . . . . 0.0 111.641 -174.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -101.58 -42.39 6.24 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.562 165.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.8 p -115.29 -36.13 4.44 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 120.551 1.523 . . . . 0.0 114.486 -166.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 103.41 6.61 44.27 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 118.279 -1.289 . . . . 0.0 112.09 -163.551 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.2 t30 68.65 13.32 8.9 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.325 1.562 . . . . 0.0 111.301 173.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.83 -67.55 0.46 Allowed 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.123 0.569 . . . . 0.0 110.54 -175.544 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 138.69 -165.52 25.55 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 -169.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.8 m -60.42 164.81 4.08 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.107 1.363 . . . . 0.0 112.857 -175.786 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 104.78 8.88 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.815 0.846 . . . . 0.0 108.856 171.243 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -49.02 66.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.178 0.445 . . . . 0.0 109.827 169.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -144.47 161.08 39.96 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.318 1.047 . . . . 0.0 108.469 -179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 24.4 p -142.4 151.56 41.95 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.1 151.82 23.64 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -178.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.01 138.1 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 124.467 1.107 . . . . 0.0 109.589 -174.66 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -82.4 129.62 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.202 1.001 . . . . 0.0 109.689 -177.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -143.98 166.38 27.08 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 175.203 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.7 mp -67.52 146.41 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.257 1.423 . . . . 0.0 109.607 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -117.68 69.05 0.77 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.128 0.971 . . . . 0.0 111.302 177.766 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.254 1.327 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 161.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 106' ' ' LEU 2.406 . . . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 115.804 -2.046 . . . . 0.0 106.88 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t 176.57 -144.27 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 127.008 2.123 . . . . 0.0 109.169 -174.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.74 126.35 47.28 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 110.392 172.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.23 160.46 16.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.206 1.802 . . . . 0.0 108.365 170.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.81 150.93 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 126.709 2.004 . . . . 0.0 107.976 -178.597 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 149' ' ' ILE . . . -135.88 115.0 12.34 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 167.239 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.6 m -84.83 92.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 121.702 0.763 . . . . 0.0 109.317 176.626 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.5 mp -55.08 136.81 47.76 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 164.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -150.47 135.03 17.31 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.42 -165.63 12.88 Favored Glycine 0 C--N 1.337 0.634 0 CA-C-N 119.406 1.003 . . . . 0.0 112.591 176.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.02 -44.57 83.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.26 0.624 . . . . 0.0 109.894 176.858 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.88 -152.8 29.04 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -177.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.31 4.11 7.12 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.371 2.714 . . . . 0.0 111.557 177.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG13 HD22 ' A' ' 38' ' ' LEU . 10.7 t -55.25 102.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 125.136 1.374 . . . . 0.0 108.357 175.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -119.37 161.24 20.82 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.964 1.306 . . . . 0.0 107.482 177.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -161.51 118.52 0.83 Allowed Glycine 0 C--O 1.223 -0.59 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.145 164.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 mt -90.54 87.19 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -176.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.6 156.95 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -139.88 135.63 33.1 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 127.055 2.142 . . . . 0.0 105.53 -176.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -131.05 113.31 13.79 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 117.345 -1.312 . . . . 0.0 107.718 176.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -105.41 137.59 42.98 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 120.026 1.284 . . . . 0.0 110.333 175.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.62 ' HB2' HG23 ' A' ' 29' ' ' VAL . 1.5 tm0? -168.1 106.97 0.51 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 175.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.01 28.12 8.46 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.841 0.856 . . . . 0.0 110.703 -175.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -116.07 -16.83 11.01 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.546 1.139 . . . . 0.0 111.542 -178.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 t 73.22 -53.11 0.7 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.184 1.394 . . . . 0.0 110.318 -169.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.88 27.92 9.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.223 1.009 . . . . 0.0 111.703 -178.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.16 169.2 19.57 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.17 130.29 19.78 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.383 2.055 . . . . 0.0 108.679 174.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 22' ' ' GLN . 0.6 OUTLIER -71.43 139.12 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.625 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 100' ' ' GLU . 3.0 mmtt -102.88 119.98 39.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 164.286 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.3 p -111.88 136.0 49.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.852 1.661 . . . . 0.0 106.964 -177.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 5.8 p90 -165.53 152.48 10.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -175.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -168.05 -171.03 33.54 Favored Glycine 0 CA--C 1.503 -0.661 0 C-N-CA 119.859 -1.163 . . . . 0.0 111.155 -172.007 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 p -160.04 97.9 1.29 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -172.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.792 HG21 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -67.02 161.55 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.568 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.39 103.85 3.73 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 162.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.37 23.35 0.09 OUTLIER Glycine 0 CA--C 1.525 0.717 0 CA-C-N 115.17 -0.923 . . . . 0.0 113.369 161.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.792 HD23 HG21 ' A' ' 35' ' ' ILE . 0.4 OUTLIER -102.47 -174.89 2.67 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.616 1.208 . . . . 0.0 110.998 -178.48 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.1 p -110.53 147.84 33.35 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 126.371 1.868 . . . . 0.0 107.503 170.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -51.73 150.39 4.01 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.806 1.642 . . . . 0.0 111.978 -178.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.62 -122.59 5.41 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 104.141 -3.584 . . . . 0.0 104.141 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' A' ' 123' ' ' ALA . 1.5 pt? -155.6 151.34 27.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 118.987 1.393 . . . . 0.0 109.472 -167.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.597 ' CE1' HD12 ' A' ' 38' ' ' LEU . 75.9 m-70 -141.07 136.73 32.29 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.601 1.16 . . . . 0.0 109.442 -170.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.62 142.4 45.42 Favored Glycine 0 C--N 1.339 0.708 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 176.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -145.6 112.69 6.09 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.162 0.985 . . . . 0.0 108.398 -168.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.436 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -154.63 155.08 34.03 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 119.271 0.941 . . . . 0.0 112.465 -169.697 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.43 116.25 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 168.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.408 ' HB3' ' OE1' ' A' ' 50' ' ' GLU . 13.4 m170 -85.4 -174.29 5.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.199 1.0 . . . . 0.0 109.693 174.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -80.72 -112.64 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.994 0.917 . . . . 0.0 108.649 169.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.408 ' OE1' ' HB3' ' A' ' 48' ' ' HIS 0.273 4.6 pm0 45.91 -108.44 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.819 1.648 . . . . 0.0 112.89 -175.372 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 70.67 2.6 4.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.866 1.267 . . . . 0.0 112.256 -178.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -81.64 -168.8 2.03 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 125.165 1.386 . . . . 0.0 110.078 175.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -25.98 68.05 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.805 0.842 . . . . 0.0 111.493 172.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -74.92 59.22 0.89 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.405 1.002 . . . . 0.0 110.276 175.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.81 -22.97 62.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.579 0.752 . . . . 0.0 111.247 175.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.85 145.69 45.51 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 178.551 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 21.5 m -75.92 49.67 0.55 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.448 1.499 . . . . 0.0 111.153 -173.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 56.4 m -114.38 -100.43 0.43 Allowed 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 124.477 1.111 . . . . 0.0 109.356 -172.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 t -71.64 -79.87 0.07 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.231 -2.136 . . . . 0.0 105.231 167.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 50.47 -117.92 1.13 Allowed 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -173.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.27 166.17 34.08 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.834 1.197 . . . . 0.0 112.132 177.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.3 -172.28 1.48 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.232 2.622 . . . . 0.0 110.039 174.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -49.69 141.43 9.86 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 172.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.32 171.85 2.86 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.161 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.419 ' N ' ' CD ' ' A' ' 66' ' ' PRO . 13.2 t-20 -154.2 32.35 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.529 1.531 . . . . 0.0 112.361 -176.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 65' ' ' ASN . 91.5 Cg_endo -66.82 -25.15 45.96 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 121.367 1.378 . . . . 0.0 111.327 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD12 HG23 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -84.37 -25.5 29.09 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.807 0.276 . . . . 0.0 110.659 179.629 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.1 t 75.21 44.83 0.16 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.637 0.775 . . . . 0.0 111.225 173.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -124.14 159.39 30.15 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 167.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' HG22 ' A' ' 135' ' ' THR . 47.3 mmtt -73.87 176.21 6.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 118.953 0.797 . . . . 0.0 111.528 -177.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . 32.2 t60 -62.94 148.36 47.7 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.28 -173.46 46.24 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 173.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.27 165.46 20.58 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.829 0.728 . . . . 0.0 113.236 -168.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -63.34 -21.72 71.69 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.445 2.763 . . . . 0.0 111.762 -176.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -111.86 19.14 18.24 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.798 1.239 . . . . 0.0 111.978 177.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -112.44 160.61 17.58 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.2 -38.7 88.62 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.415 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.44 145.12 27.6 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.855 0.862 . . . . 0.0 108.947 176.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 163.15 132.29 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 128.461 2.704 . . . . 0.0 105.154 -174.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 71' ' ' HIS . 38.3 m80 -67.77 -81.21 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.413 1.006 . . . . 0.0 110.052 -177.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -147.42 -60.95 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.013 1.325 . . . . 0.0 108.668 160.799 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.12 43.29 3.22 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 121.595 -0.691 . . . . 0.0 112.325 -172.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.04 75.21 2.03 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.153 1.381 . . . . 0.0 108.203 -169.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 mt -86.27 51.32 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -173.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 22.07 -109.13 0.01 OUTLIER Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.31 2.386 . . . . 0.0 113.411 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -143.39 170.04 16.53 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.527 1.531 . . . . 0.0 108.919 -172.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.17 -157.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -168.21 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.2 m -146.73 102.56 3.56 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 119.993 1.27 . . . . 0.0 109.035 176.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.19 138.31 39.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.889 0.376 . . . . 0.0 110.57 176.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -75.48 173.23 11.24 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 126.714 2.006 . . . . 0.0 109.77 175.213 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -18.68 29.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 127.42 2.288 . . . . 0.0 111.988 174.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.98 2.29 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.02 0.928 . . . . 0.0 110.772 179.572 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 73.73 31.99 59.76 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 112.175 -0.37 . . . . 0.0 112.175 177.752 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.74 117.03 54.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 C-N-CA 126.74 2.016 . . . . 0.0 107.452 176.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.65 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -104.47 110.02 22.13 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 170.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -76.83 123.24 25.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 167.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 t -99.23 147.23 7.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 174.876 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.6 t -164.9 97.91 0.75 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.558 1.143 . . . . 0.0 108.35 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.3 tt -149.88 -177.18 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.443 1.097 . . . . 0.0 108.215 177.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.433 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.1 pt-20 -143.68 158.43 43.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.512 1.525 . . . . 0.0 108.279 178.486 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -146.04 164.15 33.0 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 123.833 0.708 . . . . 0.0 109.259 166.249 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.2 m -116.33 2.82 13.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.842 1.257 . . . . 0.0 111.85 171.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 p -94.96 -18.1 6.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 CA-C-N 118.604 0.638 . . . . 0.0 111.734 -176.415 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.7 pp -129.31 153.17 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 125.856 1.662 . . . . 0.0 108.027 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -162.01 164.69 28.14 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 175.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -82.36 14.69 2.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 120.122 1.328 . . . . 0.0 110.91 177.343 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -166.29 -174.23 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -174.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 85.16 -81.44 1.75 Allowed Glycine 0 C--N 1.339 0.713 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 -170.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -154.28 -55.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 125.667 1.587 . . . . 0.0 108.405 -177.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 38.38 0.2 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.884 1.674 . . . . 0.0 112.718 -177.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t -41.75 110.28 0.16 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 127.697 2.399 . . . . 0.0 110.068 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 36.0 pt -73.55 -10.6 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 123.912 0.885 . . . . 0.0 112.704 176.029 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.7 mm -58.1 116.91 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 173.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.53 28.39 36.0 Favored Glycine 0 N--CA 1.436 -1.36 0 CA-C-O 117.883 -1.51 . . . . 0.0 112.962 -175.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 149' ' ' ILE . 21.3 mmt-85 -94.55 146.51 24.06 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.534 1.667 . . . . 0.0 111.741 169.176 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.4 m -93.28 103.78 16.0 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.026 0.83 . . . . 0.0 110.928 178.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER -83.63 132.7 34.87 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 172.237 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 117' ' ' LEU . 8.4 t -132.2 144.01 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.611 1.165 . . . . 0.0 109.559 177.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.6 p -115.87 148.23 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.106 1.363 . . . . 0.0 109.962 179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -112.59 161.89 16.29 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 125.03 1.332 . . . . 0.0 112.306 -171.092 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -60.17 -49.03 79.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.335 0.654 . . . . 0.0 112.254 -177.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -115.9 176.92 4.87 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' A' ' 42' ' ' LEU . . . -65.3 151.93 45.02 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.516 0.675 . . . . 0.0 110.023 169.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.436 ' CG ' ' HE2' ' A' ' 46' ' ' HIS . 3.7 p-10 -86.67 128.99 35.04 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.273 -1.33 . . . . 0.0 109.361 175.595 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -77.46 27.52 0.16 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.868 2.067 . . . . 0.0 111.634 -172.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.9 mt 39.82 43.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.025 1.33 . . . . 0.0 111.269 -176.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 69.14 2.85 34.27 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.076 1.322 . . . . 0.0 115.231 173.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -88.21 17.68 4.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.359 1.079 . . . . 0.0 113.175 -166.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.25 -9.49 84.22 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 168.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.76 45.82 95.45 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 118.189 0.994 . . . . 0.0 110.901 175.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.438 HD22 ' H ' ' A' ' 134' ' ' SER . 0.0 OUTLIER -161.56 131.29 4.75 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.233 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -36.25 -57.02 0.75 Allowed 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 124.124 0.97 . . . . 0.0 113.457 -179.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.83 -59.86 3.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.19 -0.909 . . . . 0.0 110.961 -177.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.438 ' H ' HD22 ' A' ' 131' ' ' ASN . 52.0 p -50.07 -53.66 25.64 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 120.898 1.681 . . . . 0.0 112.001 169.77 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 70' ' ' LYS . 8.5 m -72.22 -0.0 10.95 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.497 1.119 . . . . 0.0 111.35 -173.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -110.45 -32.83 6.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.65 2.78 . . . . 0.0 111.292 169.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.7 p -123.4 -35.96 2.87 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.761 1.618 . . . . 0.0 114.344 -175.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 106.84 12.05 25.11 Favored Glycine 0 N--CA 1.439 -1.148 0 C-N-CA 127.923 2.678 . . . . 0.0 110.095 -172.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.13 20.7 12.3 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.966 1.883 . . . . 0.0 110.115 178.243 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.26 -16.71 61.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.626 1.17 . . . . 0.0 111.15 -170.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 88.93 -167.96 35.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -177.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.5 t -60.65 162.59 6.38 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.65 0.738 . . . . 0.0 111.659 -170.039 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -81.42 108.0 14.66 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.508 1.523 . . . . 0.0 107.944 177.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.04 -36.44 72.35 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.026 -179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.23 35.08 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.002 0.521 . . . . 0.0 110.367 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.0 150.94 47.42 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 126.974 2.109 . . . . 0.0 106.952 -175.171 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.76 18.38 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 72.1 t -100.0 137.08 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 123.774 0.83 . . . . 0.0 109.182 -179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 115' ' ' ARG . 19.9 mt -76.68 135.93 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.084 0.954 . . . . 0.0 109.62 176.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.3 24.94 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 174.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.65 139.59 21.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 118.454 1.127 . . . . 0.0 109.034 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.62 151.65 22.8 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 123.218 0.607 . . . . 0.0 109.992 176.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.954 -1.498 . . . . 0.0 109.146 176.738 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.5 t -165.12 74.99 0.24 Allowed 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 120.573 1.533 . . . . 0.0 110.893 -157.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.96 76.0 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.968 0.907 . . . . 0.0 108.657 -176.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.649 ' HB3' ' HB2' ' A' ' 20' ' ' PHE . . . -119.84 149.71 41.63 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.377 1.071 . . . . 0.0 108.949 173.224 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -135.03 147.53 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.568 1.947 . . . . 0.0 108.016 -176.126 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' A' ' 18' ' ' ILE . . . -135.27 98.86 4.08 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 168.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.4 m -72.57 133.1 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.311 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -77.51 -128.58 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.858 1.663 . . . . 0.0 107.764 169.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm 97.5 109.68 0.02 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 127.392 2.277 . . . . 0.0 108.963 -174.387 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.56 -157.02 28.67 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.523 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -67.03 -41.28 86.85 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 176.337 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.5 -159.17 32.83 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.17 -12.32 21.18 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.522 2.148 . . . . 0.0 111.504 -178.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.415 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.0 t -48.79 114.42 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 123.878 0.871 . . . . 0.0 109.529 173.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.02 169.63 17.47 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 177.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -156.58 168.95 33.86 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 168.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.81 96.2 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.745 1.618 . . . . 0.0 108.137 177.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.55 ' HB ' ' HB3' ' A' ' 6' ' ' ALA . 24.5 mm -84.13 157.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 173.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -148.0 141.1 24.98 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 126.576 1.95 . . . . 0.0 106.041 -172.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.649 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 58.0 m-85 -132.16 127.8 36.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 126.506 1.922 . . . . 0.0 108.506 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -125.15 124.57 42.07 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 108.951 171.468 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.668 ' HB2' HG23 ' A' ' 29' ' ' VAL . 1.6 tt0 -140.77 71.72 1.37 Allowed 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.409 1.084 . . . . 0.0 109.165 177.448 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -65.0 -18.99 65.77 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.554 -1.341 . . . . 0.0 113.057 -175.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.85 148.07 30.12 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 169.58 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.6 m -67.33 -50.36 60.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.742 -0.598 . . . . 0.0 109.905 172.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -129.03 34.01 4.5 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.587 0.755 . . . . 0.0 111.071 -171.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.48 177.36 18.93 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 176.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.85 119.13 6.14 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.395 2.73 . . . . 0.0 111.396 -170.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.668 HG23 ' HB2' ' A' ' 22' ' ' GLN . 4.4 p -66.42 153.62 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -113.78 110.71 20.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 166.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -96.42 153.21 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.528 1.131 . . . . 0.0 108.011 168.177 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -167.11 159.79 13.34 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.31 -173.11 37.36 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.139 -178.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.5 p -156.31 114.9 3.39 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -177.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' HG13 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -84.77 169.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 171.573 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 tptt -158.09 89.77 1.02 Allowed 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 178.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 146.74 6.07 0.35 Allowed Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.287 1.423 . . . . 0.0 114.762 172.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 mp -72.04 -163.61 0.11 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.439 1.12 . . . . 0.0 109.902 173.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.0 t -138.73 154.15 48.53 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 170.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.86 132.07 14.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 127.511 2.324 . . . . 0.0 110.898 -177.342 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.37 -141.36 13.65 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 105.588 -3.005 . . . . 0.0 105.588 -176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.2 pt? -136.93 149.73 47.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.935 0.868 . . . . 0.0 110.033 -168.647 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -138.0 134.42 34.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 117.819 -1.086 . . . . 0.0 108.885 -172.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.51 147.59 50.94 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -177.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -151.97 116.91 5.17 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 117.503 0.651 . . . . 0.0 111.24 -169.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -148.43 161.03 42.43 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -170.181 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.2 t -87.48 110.28 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 124.59 1.181 . . . . 0.0 108.689 165.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.97 149.39 32.29 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -48.53 -75.58 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.711 1.205 . . . . 0.0 112.589 -172.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.19 162.83 13.36 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.132 0.573 . . . . 0.0 110.2 178.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -99.35 -27.72 13.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.593 1.157 . . . . 0.0 114.058 176.268 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -73.5 75.25 1.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 122.032 0.92 . . . . 0.0 110.937 -167.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -108.75 51.88 0.73 Allowed 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.004 0.921 . . . . 0.0 110.779 -167.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.1 p -54.02 -27.07 29.74 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.031 0.932 . . . . 0.0 112.858 -177.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.09 -22.85 52.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.878 0.871 . . . . 0.0 113.289 175.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.53 -112.05 0.5 Allowed Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.65 -26.5 5.7 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.559 0.744 . . . . 0.0 112.751 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -152.46 121.69 6.71 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.9 t -168.47 -44.15 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.365 1.866 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -48.98 -74.74 0.03 OUTLIER 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.775 1.63 . . . . 0.0 112.554 -175.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.16 139.69 11.11 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -175.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.61 -163.31 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.942 2.428 . . . . 0.0 111.029 -179.097 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -50.42 122.92 7.69 Favored 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.415 0.686 . . . . 0.0 109.949 172.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -69.17 112.96 6.1 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -129.08 52.49 9.37 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -63.04 -17.24 59.2 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.364 2.709 . . . . 0.0 113.331 -178.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.0 mp -74.17 -7.23 51.9 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.531 -0.731 . . . . 0.0 111.638 174.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.0 t 64.17 77.17 0.33 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.246 1.019 . . . . 0.0 110.173 179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.28 162.74 40.81 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 177.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -82.24 171.27 14.46 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.151 0.977 . . . . 0.0 109.187 170.54 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.536 ' HE2' ' HB2' ' A' ' 124' ' ' ASP . 72.6 t60 -70.3 145.25 51.39 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.485 1.514 . . . . 0.0 110.214 -173.19 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -174.41 -175.5 42.03 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 172.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.6 162.52 18.69 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -59.42 -26.9 83.52 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.465 2.11 . . . . 0.0 111.781 177.333 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -72.13 -24.06 61.41 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.407 1.083 . . . . 0.0 111.547 175.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -95.53 166.94 11.6 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.112 0.965 . . . . 0.0 109.953 -170.823 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -66.84 -45.09 79.29 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.553 174.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -81.35 148.06 29.54 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 165.97 123.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.836 2.054 . . . . 0.0 106.252 -175.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -67.39 -178.02 0.8 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.196 0.598 . . . . 0.0 110.692 172.494 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.66 -50.15 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 121.079 -1.013 . . . . 0.0 110.336 -176.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -106.79 49.79 0.85 Allowed Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 -178.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.53 71.75 1.22 Allowed 'General case' 0 C--O 1.231 0.107 0 C-N-CA 125.473 1.509 . . . . 0.0 108.995 -177.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 mt -86.15 50.47 1.99 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -172.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 19.98 -117.55 0.01 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.649 2.071 . . . . 0.0 113.803 -164.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.19 154.23 40.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.536 1.534 . . . . 0.0 110.198 -177.118 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.0 m -91.63 -160.06 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.808 0.843 . . . . 0.0 109.05 177.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 18.9 m -148.54 111.04 4.71 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.62 143.65 29.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.632 0.373 . . . . 0.0 110.833 177.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -75.84 178.01 6.5 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.333 1.453 . . . . 0.0 110.188 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -60.96 -18.41 57.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.452 1.501 . . . . 0.0 111.564 174.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.47 -1.31 57.59 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.169 0.988 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 70.79 36.42 66.3 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -177.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 35' ' ' ILE . 60.2 t -116.12 112.55 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 125.495 1.518 . . . . 0.0 107.138 179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.36 107.94 20.39 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 170.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -84.7 111.22 19.38 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -84.38 147.1 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.08 100.69 0.45 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 172.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.37 159.77 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.053 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -124.72 137.59 54.33 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.62 151.21 43.26 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.328 1.051 . . . . 0.0 108.996 -178.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.5 m -106.81 -4.74 18.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.784 1.234 . . . . 0.0 111.786 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 69.1 t -104.13 -68.73 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -175.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -71.02 152.9 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.3 m -178.98 -168.48 0.13 Allowed 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -165.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 mt -93.44 5.58 51.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.964 2.506 . . . . 0.0 109.687 167.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.7 m -61.3 171.8 1.29 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.069 0.948 . . . . 0.0 111.273 174.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -51.19 -89.71 0.01 OUTLIER Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.203 0.906 . . . . 0.0 113.684 -172.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -82.84 56.78 3.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.505 1.145 . . . . 0.0 109.653 179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -154.69 -44.15 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.981 1.312 . . . . 0.0 109.451 -169.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.5 t -25.46 101.73 0.02 OUTLIER 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.802 2.041 . . . . 0.0 111.339 178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.26 -22.41 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 39.8 mm -57.66 125.94 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 177.022 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.1 3.06 70.42 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 121.061 -0.59 . . . . 0.0 114.16 -179.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.2 174.69 7.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 118.87 1.335 . . . . 0.0 109.485 166.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.12 129.59 52.48 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.874 1.27 . . . . 0.0 110.69 174.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 HD11 ' A' ' 149' ' ' ILE . 0.1 OUTLIER -110.05 117.35 33.53 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 177.656 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.4 142.22 37.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 -174.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 p -108.28 142.4 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.858 0.863 . . . . 0.0 110.063 177.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.402 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 88.6 m-70 -108.79 151.19 26.55 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 124.844 1.258 . . . . 0.0 111.056 -173.324 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -61.58 -55.74 27.49 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.096 0.407 . . . . 0.0 110.744 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.0 mmpt? -82.75 169.28 16.34 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.138 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.3 149.06 46.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 163.702 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' HB2' ' HE2' ' A' ' 71' ' ' HIS . 0.1 OUTLIER -69.23 138.93 54.4 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.487 1.137 . . . . 0.0 109.773 162.416 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -76.29 2.49 13.19 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.727 2.811 . . . . 0.0 112.92 177.315 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.3 mt 47.88 38.2 8.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.545 1.138 . . . . 0.0 111.633 -179.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 53.73 35.8 53.34 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 125.424 1.488 . . . . 0.0 113.456 179.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -11.63 36.0 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.01 0.905 . . . . 0.0 113.183 177.077 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.07 -5.47 76.07 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-N 119.267 0.939 . . . . 0.0 114.274 -175.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 60.44 43.79 98.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.734 1.267 . . . . 0.0 112.245 175.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.494 HD22 ' H ' ' A' ' 134' ' ' SER . 0.1 OUTLIER -155.98 132.05 9.96 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -175.014 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -26.98 -72.77 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 126.827 2.051 . . . . 0.0 113.846 173.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.29 -51.57 10.78 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.875 1.27 . . . . 0.0 112.994 179.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.494 ' H ' HD22 ' A' ' 131' ' ' ASN . 0.3 OUTLIER -54.09 -54.43 39.53 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 118.828 -2.42 . . . . 0.0 112.188 166.335 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 64.6 p -80.07 2.62 23.2 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.027 -1.046 . . . . 0.0 112.703 -171.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -120.66 -46.49 2.36 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.722 2.009 . . . . 0.0 108.253 178.516 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -28.71 9.5 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.339 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.57 14.68 43.12 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 124.793 1.187 . . . . 0.0 110.549 -171.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 51.71 28.83 5.14 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.778 1.289 . . . . 0.0 110.262 -177.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -76.05 -5.23 45.46 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.18 -168.581 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 82.11 -168.1 48.32 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 171.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 41.6 m -56.9 148.13 21.81 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.256 1.027 . . . . 0.0 110.685 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.48 109.96 18.85 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.083 -177.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.45 -31.58 69.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 119.028 -0.51 . . . . 0.0 111.119 -176.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.4 148.01 28.26 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.491 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 15.7 p -142.87 157.4 44.64 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -175.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.57 156.32 15.97 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.647 -178.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.97 162.39 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 125.333 1.453 . . . . 0.0 110.013 -175.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 117' ' ' LEU . 0.5 OUTLIER -107.11 132.05 55.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 122.638 0.375 . . . . 0.0 110.4 -175.178 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.38 167.14 25.6 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.768 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 2.5 mp -67.7 136.6 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.15 62.65 5.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.544 1.137 . . . . 0.0 109.568 178.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 117.304 -1.331 . . . . 0.0 107.773 177.015 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 2.434 . . . . . . . 0 N--CA 1.467 0.379 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.7 t -75.51 -167.7 0.71 Allowed 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.976 0.798 . . . . 0.0 110.441 179.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -130.96 115.02 15.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 170.505 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.39 156.92 21.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 171.609 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.91 151.32 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 125.359 1.464 . . . . 0.0 107.939 -174.831 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -133.18 114.92 14.4 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 119.345 0.975 . . . . 0.0 108.479 165.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.08 101.65 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 172.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 mp -65.75 137.16 57.08 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.358 1.063 . . . . 0.0 108.668 165.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -150.62 150.48 31.21 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 167.21 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -125.31 -163.5 11.63 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-O 122.174 0.874 . . . . 0.0 112.031 179.006 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -58.4 -48.4 80.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.356 -0.922 . . . . 0.0 109.371 171.571 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.31 -160.06 36.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -177.201 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.33 -1.19 10.95 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.391 . . . . 0.0 111.507 -179.233 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.417 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 11.2 t -50.65 112.39 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.135 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -143.21 157.07 44.82 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -179.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -158.27 137.88 5.48 Favored Glycine 0 C--O 1.221 -0.717 0 C-N-CA 119.923 -1.132 . . . . 0.0 112.265 173.734 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.99 109.94 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 171.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.36 153.08 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 169.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -128.26 143.88 51.07 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.66 2.384 . . . . 0.0 107.07 177.67 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.23 138.11 47.8 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -129.22 134.68 48.1 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.571 1.548 . . . . 0.0 106.891 171.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -142.9 139.07 30.62 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 176.17 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -129.53 29.18 5.1 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.668 1.587 . . . . 0.0 109.753 -174.18 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -163.95 173.55 12.5 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.185 1.394 . . . . 0.0 107.856 -176.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 m -88.14 -30.25 19.95 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.655 1.182 . . . . 0.0 110.725 169.252 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -144.45 43.53 1.4 Allowed 'General case' 0 C--N 1.335 -0.049 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -177.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.37 -178.48 19.83 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -177.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.48 109.7 2.11 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.404 2.07 . . . . 0.0 110.328 -178.301 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.26 146.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 168.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? -109.12 124.37 50.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 163.868 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -120.3 138.43 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 176.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -163.0 165.52 24.79 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 173.34 -170.52 43.67 Favored Glycine 0 C--O 1.225 -0.439 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.633 -177.093 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.8 p -156.86 114.14 3.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -178.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -79.0 171.35 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 172.095 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 3.5 tttp -153.97 95.88 1.91 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 14' ' ' VAL . . . 148.33 5.28 0.28 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.86 1.695 . . . . 0.0 114.347 171.635 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 35' ' ' ILE . 6.1 mp -73.43 -169.15 0.62 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.001 1.4 . . . . 0.0 109.714 172.371 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.9 t -133.38 155.06 50.16 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -49.22 137.7 13.55 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.831 2.052 . . . . 0.0 111.218 -176.396 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 121.2 -139.02 12.94 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 105.684 -2.966 . . . . 0.0 105.684 -178.187 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 42' ' ' LEU . 1.8 pt? -138.41 149.73 45.8 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.492 1.146 . . . . 0.0 112.492 -173.305 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -136.59 136.55 39.33 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.619 1.568 . . . . 0.0 109.258 -172.245 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.96 146.32 49.09 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.763 -1.02 . . . . 0.0 111.247 179.285 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 120.32 15.32 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.046 0.938 . . . . 0.0 109.48 -179.143 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -145.68 157.31 43.97 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 118.756 0.707 . . . . 0.0 112.473 -178.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 115' ' ' ARG . 64.8 t -82.98 102.76 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 165.523 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -72.35 155.52 40.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.005 0.522 . . . . 0.0 109.604 169.701 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -85.48 111.74 20.26 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 177.111 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 160.75 178.79 0.01 OUTLIER 'General case' 0 C--O 1.238 0.453 0 C-N-CA 128.663 2.785 . . . . 0.0 108.651 -178.424 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -143.1 -37.39 0.36 Allowed 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.483 2.313 . . . . 0.0 111.464 173.524 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.51 158.02 16.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.759 1.163 . . . . 0.0 110.476 178.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.91 46.85 0.42 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.624 0.726 . . . . 0.0 110.139 -170.556 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.2 p -54.86 -46.76 74.72 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.821 0.848 . . . . 0.0 111.635 -177.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.48 -11.59 7.35 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.571 1.549 . . . . 0.0 113.762 176.043 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.17 -83.59 0.34 Allowed Glycine 0 C--N 1.334 0.445 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.391 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -135.82 26.8 3.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.291 1.046 . . . . 0.0 112.365 -176.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.1 m -101.89 -49.49 3.94 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 124.694 1.197 . . . . 0.0 111.206 -174.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 m -53.18 -51.74 61.09 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.495 0.589 . . . . 0.0 109.423 178.518 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -25.74 101.8 0.02 OUTLIER 'General case' 0 C--N 1.346 0.432 0 C-N-CA 126.544 1.938 . . . . 0.0 112.228 171.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.56 -179.24 23.02 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -178.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.45 -169.17 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.031 1.821 . . . . 0.0 111.785 -177.769 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -53.98 128.22 29.49 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.579 -0.7 . . . . 0.0 109.948 175.107 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.55 115.54 5.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.175 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.521 HD21 ' CD2' ' A' ' 80' ' ' HIS . 1.3 m120 -124.72 91.74 48.94 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.685 1.994 . . . . 0.0 109.671 179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.4 -43.52 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.373 2.049 . . . . 0.0 109.812 171.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.08 -6.46 59.18 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.537 1.135 . . . . 0.0 112.059 -176.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.6 m 53.12 64.14 1.97 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.065 0.946 . . . . 0.0 112.374 179.627 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -118.48 168.8 10.33 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 125.262 1.425 . . . . 0.0 108.257 175.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.9 mtpt -82.24 161.04 22.83 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 110.278 -179.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' HE2' ' CG ' ' A' ' 124' ' ' ASP . 74.5 t60 -72.55 144.52 47.9 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 123.91 0.884 . . . . 0.0 110.218 -174.234 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 126' ' ' LEU . . . 175.18 -171.37 44.52 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 107.48 -2.248 . . . . 0.0 107.48 167.396 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.71 170.47 24.15 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 125.293 1.425 . . . . 0.0 111.986 -165.125 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -59.68 -22.75 68.74 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.086 1.858 . . . . 0.0 111.571 171.828 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -81.9 -27.28 33.49 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 123.34 0.656 . . . . 0.0 111.681 175.196 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -87.5 162.07 17.44 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 122.086 0.946 . . . . 0.0 109.311 -172.012 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -62.14 -42.59 99.4 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.061 172.1 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -87.19 139.95 30.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.849 0.86 . . . . 0.0 109.436 178.871 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.7 ptt180 -177.76 135.97 0.18 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -179.101 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' CD2' HD21 ' A' ' 65' ' ' ASN . 13.7 m170 -83.39 -177.44 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.555 0.742 . . . . 0.0 109.671 171.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.8 p -62.37 -44.32 99.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 O-C-N 121.779 -0.576 . . . . 0.0 110.347 -177.775 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.83 29.42 11.33 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-O 118.433 -1.204 . . . . 0.0 114.142 -172.152 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -90.23 74.61 7.05 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.949 1.375 . . . . 0.0 111.145 -175.548 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.6 mt -82.18 52.97 2.12 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.203 1.001 . . . . 0.0 108.674 179.06 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.564 ' HA2' HD11 ' A' ' 126' ' ' LEU . . . 6.94 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.86 0 C-N-CA 126.156 1.836 . . . . 0.0 116.466 -158.322 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -142.86 166.15 25.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.548 1.139 . . . . 0.0 109.923 -172.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 m -124.59 163.01 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 124.886 1.274 . . . . 0.0 107.574 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.4 m -111.88 110.05 20.18 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.167 1.387 . . . . 0.0 108.662 -174.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.0 145.73 30.1 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.926 0.393 . . . . 0.0 110.71 174.048 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -81.41 177.08 9.19 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.527 1.931 . . . . 0.0 109.74 176.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 0.55 5.85 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.967 2.107 . . . . 0.0 112.464 174.587 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' OD2' ' NZ ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -107.17 3.86 26.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.414 1.085 . . . . 0.0 110.389 170.723 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 69.33 28.77 72.26 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 179.927 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 70.4 t -108.93 121.41 61.98 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 C-N-CA 125.916 1.686 . . . . 0.0 107.524 175.815 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' H ' HG22 ' A' ' 35' ' ' ILE . . . -109.44 104.88 14.04 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.375 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.08 104.23 9.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 175.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.2 t -80.5 144.1 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 178.503 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.3 t -164.64 102.45 0.81 Allowed 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 168.184 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.7 tt -150.66 -178.85 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 124.166 0.986 . . . . 0.0 108.394 178.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -143.27 145.5 32.79 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.28 1.432 . . . . 0.0 108.353 -179.412 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -128.34 169.28 14.43 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.269 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 70.6 m -136.53 22.66 3.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.705 1.202 . . . . 0.0 111.676 177.112 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.53 -68.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 123.943 0.897 . . . . 0.0 108.617 174.623 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.9 160.33 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 123.071 0.548 . . . . 0.0 110.941 176.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -172.64 174.78 3.62 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.596 1.158 . . . . 0.0 109.176 -172.05 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.13 7.39 38.15 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.309 2.644 . . . . 0.0 110.226 173.236 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.88 151.59 34.17 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.937 -0.477 . . . . 0.0 110.223 176.789 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -48.36 -32.42 10.03 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 122.951 0.31 . . . . 0.0 112.389 -179.003 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -77.56 -74.13 0.27 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.195 0.998 . . . . 0.0 111.281 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -68.8 -25.76 64.85 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.028 -175.471 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -1.84 99.2 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.179 2.191 . . . . 0.0 114.039 -169.619 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.8 pt -64.67 -22.42 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 120.589 -0.444 . . . . 0.0 111.818 173.735 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.48 117.26 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 169.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.54 34.55 28.21 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 124.008 0.818 . . . . 0.0 112.96 -171.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' HB3' HG13 ' A' ' 47' ' ' VAL . 11.5 mmp_? -108.03 154.17 22.05 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.056 0.928 . . . . 0.0 111.421 162.497 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.9 m -95.51 101.25 12.94 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 109.324 177.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.8 tp -88.27 123.37 32.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.372 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.7 t -129.04 138.71 53.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -174.627 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.5 p -97.83 153.0 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.449 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 80.6 m-70 -112.87 152.63 29.03 Favored 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 124.032 0.933 . . . . 0.0 111.085 176.667 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.38 -52.61 31.17 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 123.898 0.749 . . . . 0.0 110.186 -179.503 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -85.59 167.58 15.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 122.1 0.952 . . . . 0.0 109.537 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.11 138.17 58.32 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.111 -0.949 . . . . 0.0 109.266 173.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' CG ' ' HE2' ' A' ' 71' ' ' HIS . 61.7 t0 -71.9 117.0 12.96 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 165.457 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -74.32 -0.67 17.83 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 125.688 1.595 . . . . 0.0 113.857 176.702 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD11 ' HA2' ' A' ' 85' ' ' GLY . 2.4 mm? 46.3 47.42 13.61 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.893 1.277 . . . . 0.0 112.652 -176.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 71.31 5.01 58.44 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.464 175.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -12.44 61.33 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.189 1.495 . . . . 0.0 111.364 -176.193 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.83 -51.9 47.21 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 167.128 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.56 60.96 3.29 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 134' ' ' SER . 0.5 OUTLIER -160.1 47.78 0.26 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -171.023 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 58.36 -72.88 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 124.488 1.115 . . . . 0.0 111.567 -174.252 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.79 -57.34 6.51 Favored 'General case' 0 C--O 1.216 -0.676 0 C-N-CA 124.108 0.963 . . . . 0.0 110.875 -178.283 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 131' ' ' ASN . 88.8 p -52.34 -57.17 10.62 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.638 1.175 . . . . 0.0 110.812 167.18 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.3 m -65.4 -4.17 5.27 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.793 1.637 . . . . 0.0 112.939 -172.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -119.74 -30.66 4.72 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 128.378 2.671 . . . . 0.0 109.472 176.462 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.3 p -133.85 -43.07 0.82 Allowed 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -172.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 116.39 23.83 3.99 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 125.582 1.563 . . . . 0.0 112.389 176.285 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 56.51 21.46 5.67 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.855 1.328 . . . . 0.0 111.087 -175.246 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' HB1' ' CB ' ' A' ' 120' ' ' HIS . . . -72.44 -17.95 61.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.915 1.286 . . . . 0.0 110.395 -173.56 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 73.88 -157.63 51.59 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 172.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 69.5 m -62.85 159.79 15.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.112 0.958 . . . . 0.0 111.298 -177.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.76 109.48 21.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.254 -172.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mt -57.01 -40.23 76.24 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.481 0.582 . . . . 0.0 110.219 176.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.13 160.52 39.99 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.102 0.561 . . . . 0.0 110.464 -176.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.86 138.16 30.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 -165.013 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.87 153.77 25.49 Favored Glycine 0 C--N 1.334 0.455 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.06 136.35 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.8 mt -84.8 128.28 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 123.67 0.788 . . . . 0.0 109.232 -179.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -140.96 -176.62 15.51 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.239 1.4 . . . . 0.0 109.917 177.816 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.05 140.25 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 125.337 1.455 . . . . 0.0 109.236 178.01 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -87.51 57.47 4.43 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.147 0.579 . . . . 0.0 111.168 178.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 . . . . . 0 C--O 1.249 1.051 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 166.923 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_